geneSet,link,size,overlap,expect,enrichmentRatio,pValue,FDR,overlapId,userId
GO:0030198,extracellular matrix organization (GO:0030198),299,62,20.67952986,2.998133924,3.00E-15,1.80E-11,2934;8728;6696;79625;1511;2335;3918;3909;3908;667;3914;23768;2247;255743;2201;10319;10516;1308;1281;3679;1842;2824;3038;4314;4318;4320;101;25818;5650;11096;4148;1462;1278;3384;10631;5212;633;1634;1277;1290;1289;283208;4921;7373;1303;84171;140766;1300;1288;1805;1301;4237;8038;64093;54507;1311;58494;79148;170692;7450;9510;90993,COL10A1;MMP11;COL11A1;ADAMTS5;COMP;FN1;VIT;DST;ADAMTS14;LOXL4;HAS3;ADAMTS1;FGF2;ITGA7;POSTN;P4HA3;GSN;JAM2;MATN3;BGN;MFAP2;ADAM8;ADAM19;COL17A1;DPT;LAMB3;VCAN;COL5A2;COL5A1;FBN2;GPM6B;FLRT2;FBLN5;MMP3;MMP9;SMOC1;ADAMTS18;SPP1;LAMA3;ADAMTSL4;DCN;CREB3L1;VWF;COL12A1;ICAM2;ECM2;MMP28;KLK5;DDR2;NPNT;CTSG;COL4A6;ADAM12;KLK7;LAMA2;COL14A1;NDNF;LAMC3;LAMC2;COL1A1;COL3A1;COL1A2
GO:0043062,extracellular structure organization (GO:0043062),215,48,14.86989605,3.227998355,2.42E-13,5.82E-10,8728;6696;79625;2335;3918;3909;3908;3914;2247;255743;2201;10319;10516;1308;1281;3679;1842;4314;4318;4320;11096;4148;1462;1278;3384;10631;5212;633;1634;1277;1290;1289;4921;7373;140766;1300;1288;1301;4237;8038;64093;54507;1311;58494;79148;170692;7450;9510,COL10A1;MMP11;COL11A1;ADAMTS5;COMP;FN1;VIT;ADAMTS14;ADAMTS1;FGF2;ITGA7;POSTN;JAM2;MATN3;BGN;MFAP2;ADAM19;COL17A1;LAMB3;VCAN;COL5A2;COL5A1;FBN2;FBLN5;MMP3;MMP9;SMOC1;ADAMTS18;SPP1;LAMA3;ADAMTSL4;DCN;VWF;ICAM2;ECM2;MMP28;DDR2;NPNT;COL4A6;ADAM12;LAMA2;COL14A1;NDNF;LAMC3;LAMC2;COL1A1;COL3A1;COL1A2
GO:0045229,external encapsulating structure organization (GO:0045229),216,48,14.93905836,3.213053918,2.91E-13,5.82E-10,8728;6696;79625;2335;3918;3909;3908;3914;2247;255743;2201;10319;10516;1308;1281;3679;1842;4314;4318;4320;11096;4148;1462;1278;3384;10631;5212;633;1634;1277;1290;1289;4921;7373;140766;1300;1288;1301;4237;8038;64093;54507;1311;58494;79148;170692;7450;9510,COL10A1;MMP11;COL11A1;ADAMTS5;COMP;FN1;VIT;ADAMTS14;ADAMTS1;FGF2;ITGA7;POSTN;JAM2;MATN3;BGN;MFAP2;ADAM19;COL17A1;LAMB3;VCAN;COL5A2;COL5A1;FBN2;FBLN5;MMP3;MMP9;SMOC1;ADAMTS18;SPP1;LAMA3;ADAMTSL4;DCN;VWF;ICAM2;ECM2;MMP28;DDR2;NPNT;COL4A6;ADAM12;LAMA2;COL14A1;NDNF;LAMC3;LAMC2;COL1A1;COL3A1;COL1A2
GO:1902850,microtubule cytoskeleton organization involved in mitosis (GO:1902850),128,31,8.852775324,3.501726731,5.05E-10,7.59E-07,991;701;4085;6790;9212;5347;891;24137;81930;11004;1062;3832;9700;83540;10403;1063;11130;699;332;9787;64105;79019;6491;51203;55143;10460;284403;220134;57405;54821;7272,KIF4A;NUF2;CENPF;BUB1;SPC25;CDCA8;DLGAP5;ERCC6L;NUSAP1;ZWINT;NDC80;PLK1;AURKA;KIF2C;CCNB1;BIRC5;BUB1B;KIF11;SKA1;CDC20;CENPE;TTK;AURKB;CENPM;KIF18A;TACC3;STIL;WDR62;ESPL1;MAD2L1;CENPK
GO:0045765,regulation of angiogenesis (GO:0045765),200,38,13.83246144,2.7471611,9.67E-09,1.16E-05,2152;5468;10563;3952;2246;3569;51129;3627;57556;358;947;3202;7122;5740;1944;4881;2247;168667;23213;10411;6422;3373;57381;7010;79924;2296;9314;10253;5140;1634;306;26051;64102;8038;9510;641700;140862;126393,SPRY2;HOXA5;LEP;FGF1;TNMD;HSPB6;SFRP1;ADAMTS1;FGF2;NPR1;CLDN5;RAPGEF3;CXCL10;ISM1;BMPER;AQP1;PPARG;RHOJ;SULF1;F3;KLF4;HYAL1;SEMA6A;CD34;ANGPTL4;ECSCR;PPP1R16B;ADM2;DCN;IL6;PTGIS;ANXA3;PDE3B;ADAM12;TEK;FOXC1;EFNA3;CXCL13
GO:0007052,mitotic spindle organization (GO:0007052),157,32,10.85848223,2.947004868,2.51E-08,2.51E-05,22974;991;701;4085;6790;9212;5347;891;24137;9493;81930;11004;1062;3832;83540;10403;1063;11130;699;332;9787;64105;79019;6491;55143;284403;220134;57405;54821;7272;3833;9055,KIF4A;TPX2;NUF2;CENPF;BUB1;SPC25;CDCA8;DLGAP5;ERCC6L;ZWINT;NDC80;PLK1;AURKA;KIF2C;CCNB1;BIRC5;BUB1B;KIF11;KIFC1;SKA1;CDC20;CENPE;KIF23;PRC1;TTK;AURKB;CENPM;KIF18A;STIL;WDR62;MAD2L1;CENPK
GO:0008284,positive regulation of cell population proliferation (GO:0008284),471,65,32.5754467,1.995367879,6.06E-08,5.21E-05,2255;2252;4916;4915;1956;3479;150;2246;3084;7048;9928;3569;7292;51085;5737;5744;2350;358;4057;650;7122;8644;1378;2335;6664;6285;8660;3918;51176;1906;1907;2247;7049;654;4212;10763;1646;6422;130497;3373;6376;8317;1869;2305;57111;55022;4680;332;8013;3590;146433;3977;85480;2146;4921;5764;348093;89958;219790;7272;9055;4072;3226;80310;11082,TSLP;NTRK2;IL11RA;CX3CL1;FN1;KIF14;FGF1;FOXM1;BIRC5;S100B;LIFR;ESM1;OSR1;SFRP1;PRC1;TTK;FGF2;CLDN5;TGFBR3;EZH2;MLXIPL;TGFBR2;MEIS2;AKR1C2;AQP1;PTN;BMP2;TNFSF4;E2F1;EGFR;NES;PTGFR;RTKN2;LEF1;PID1;HYAL1;PDGFD;NTRK3;IRS2;FGF10;CDC7;AKR1C3;IL34;BMP6;CEACAM6;SAPCD2;NRG1;IGF1;IL6;EDN1;DDR2;FGF7;EDN2;FOLR2;HOXC10;ADRA2A;RBPMS2;NR4A3;CR1;PTHLH;EPCAM;LAMC2;RAB25;SOX11;LTF
GO:1901655,cellular response to ketone (GO:1901655),39,14,2.697329982,5.190317868,1.54E-07,1.16E-04,111;7292;54331;5737;5734;2770;358;6696;8644;1646;6422;5105;687;2908,SFRP1;PCK1;KLF9;AKR1C2;AQP1;TNFSF4;PTGFR;NR3C1;PTGER4;GNAI1;AKR1C3;ADCY5;SPP1;GNG2
GO:0016525,negative regulation of angiogenesis (GO:0016525),85,21,5.878796114,3.572159945,2.17E-07,1.45E-04,5468;3627;57556;3202;7122;1944;4881;10365;23213;7010;2296;9314;10253;5140;1634;1870;64102;9510;90993;641700;140862,SPRY2;HOXA5;TNMD;ADAMTS1;NPR1;CLDN5;CXCL10;ISM1;PPARG;SULF1;E2F2;KLF4;SEMA6A;ECSCR;DCN;CREB3L1;PDE3B;TEK;FOXC1;EFNA3;KLF2
GO:0000070,mitotic sister chromatid segregation (GO:0000070),101,23,6.985393029,3.292584956,2.87E-07,1.72E-04,9928;983;5347;891;9493;81930;11004;1062;9700;10403;11130;9787;64105;113130;64151;23397;10051;51203;55143;55165;3833;10615;9055,CDK1;CDCA8;CEP55;DLGAP5;NUSAP1;ZWINT;NCAPG;NDC80;PLK1;KIF2C;KIF14;CCNB1;SPAG5;KIFC1;CENPE;CDCA5;KIF23;PRC1;NCAPH;KIF18A;SMC4;ESPL1;CENPK
GO:0009968,negative regulation of signal transduction (GO:0009968),265,42,18.32801141,2.291574304,3.54E-07,1.93E-04,9368;55366;6622;7498;1956;2719;57556;4057;650;57502;26153;2625;7301;347;2247;23213;56603;5727;4435;9370;6422;10252;6376;23542;55022;5753;10253;1634;2146;64102;6725;23189;90993;440503;5064;114804;79812;25928;5997;147495;8643;11197,SPRY2;CX3CL1;TNMD;WIF1;SFRP1;GPC3;APCDD1;FGF2;ADIPOQ;EZH2;SNCA;KANK1;BMP2;SULF1;EGFR;SOSTDC1;RGS2;APOD;PID1;PTCH2;SEMA6A;SPRY1;PTCH1;MMRN2;LGR4;CITED1;KIF26A;DCN;CREB3L1;MAPK8IP2;CYP26B1;SLC9A3R1;NLGN4X;RNF157;SRMS;PTK6;PALM;TYRO3;XDH;GATA3;PLIN5;LTF
GO:0097306,cellular response to alcohol (GO:0097306),48,15,3.319790747,4.518357073,4.48E-07,2.23E-04,111;7292;54331;5737;5734;2770;1066;8644;2822;5727;1646;6422;641;687;5888,SFRP1;RAD51;KLF9;CES1;AKR1C2;TNFSF4;PTGFR;GPLD1;PTGER4;BLM;GNAI1;PTCH1;AKR1C3;ADCY5;GNG2
GO:0030335,positive regulation of cell migration (GO:0030335),268,42,18.53549834,2.265922353,4.83E-07,2.23E-04,3815;2255;11170;2152;4916;1956;3479;150;2246;857;7481;54437;80031;57556;10371;223117;56920;650;4638;2335;5979;59352;6387;3918;51176;1906;3373;57111;4680;55612;4318;5168;10253;8784;1277;4921;51512;2159;153769;131578;80310;286077,SEMA5B;SPRY2;FN1;LRRC15;FGF1;FAM107A;CAV1;GTSE1;MYLK;KIT;ENPP2;SEMA3G;BMP2;EGFR;F10;F3;LEF1;SEMA3D;HYAL1;LGR6;PDGFD;SEMA6D;SEMA6A;CXCL12;NTRK3;FGF10;MMP9;CEACAM6;IGF1;FAM83H;EDN1;DDR2;WNT11;SEMA3A;TNFRSF18;RET;ADRA2A;FERMT1;SH3RF2;LAMC2;RAB25;COL1A1
GO:0006936,muscle contraction (GO:0006936),129,26,8.921937632,2.914165182,6.34E-07,2.72E-04,25802;7111;4604;1674;4621;7138;7140;1756;6329;10580;9172;30819;4638;5021;6261;4629;845;3270;1410;5348;1160;59;10398;8082;8736;72,FXYD1;LMOD1;DMD;MYH11;KCNIP2;CRYAB;OXTR;MYOM1;MYLK;TMOD1;ACTG2;SCN4A;SORBS1;CKMT2;TNNT3;TNNT1;MYH3;SSPN;DES;CASQ2;MYL9;MYBPC1;MYOM2;ACTA2;HRC;RYR1
GO:0071379,cellular response to prostaglandin stimulus (GO:0071379),10,7,0.691623072,10.12111984,7.40E-07,2.97E-04,7292;54331;5737;5734;8644;1646;6422,SFRP1;AKR1C2;TNFSF4;PTGFR;PTGER4;AKR1C3;GNG2
GO:0001501,skeletal system development (GO:0001501),156,29,10.78931993,2.687843182,8.64E-07,3.25E-04,3479;5745;5744;5734;1009;7481;650;7704;6664;654;658;23213;55553;5950;3373;6660;4148;1462;1278;2662;1277;1300;249;91461;1311;5549;4883;60529;5307,COL10A1;COMP;PITX1;ZBTB16;RBP4;GDF10;MATN3;BMP2;SULF1;ALX4;HYAL1;PTGER4;CDH11;VCAN;PTH1R;ALPL;BMP6;IGF1;SOX6;PKDCC;PRELP;WNT11;BMPR1B;SOX5;PTHLH;COL1A1;SOX11;NPR3;COL1A2
GO:0030334,regulation of cell migration (GO:0030334),405,55,28.01073442,1.96353295,1.07E-06,3.78E-04,301;3815;2255;2252;11170;4804;2152;4916;1956;3479;150;2246;9928;857;7481;154810;54437;80031;57556;10371;223117;56920;4248;650;4638;84612;7122;5979;59352;54538;6387;91584;3918;51176;1906;2247;23213;9370;6422;6376;4680;4318;5168;10253;1277;3868;51512;2159;23189;153769;131578;9079;80310;286077;285313,SEMA5B;SPRY2;CX3CL1;KIF14;LRRC15;FGF1;IGSF10;FAM107A;CAV1;ANXA1;GTSE1;SFRP1;MYLK;FGF2;CLDN5;ADIPOQ;KIT;ENPP2;LDB2;SEMA3G;AMOTL1;KANK1;BMP2;SULF1;EGFR;NGFR;F10;F3;LEF1;SEMA3D;LGR6;PDGFD;SEMA6D;MGAT3;SEMA6A;PLXNA4;CXCL12;NTRK3;FGF10;MMP9;CEACAM6;ROBO4;IGF1;FAM83H;EDN1;WNT11;FGF7;SEMA3A;PARD6B;RET;ADRA2A;SH3RF2;LAMC2;COL1A1;KRT16
GO:0007411,axon guidance (GO:0007411),202,34,13.97078606,2.43364975,1.13E-06,3.79E-04,54437;80031;57556;10371;223117;56920;9378;6586;64221;9638;57549;5979;7436;6711;2675;4781;59352;54538;6387;1949;5649;10381;1944;494470;8660;91584;4684;3918;219699;90249;2051;3909;3908;2047,SEMA5B;ROBO3;RELN;EPHB1;TUBB3;NRXN1;UNC5B;SEMA3G;NFIB;SPTBN1;NCAM1;SEMA3D;LGR6;EPHB6;SEMA6D;SEMA6A;PLXNA4;GFRA2;CXCL12;IRS2;FEZ1;SLIT3;LAMA3;ROBO4;SEMA3A;VLDLR;LAMA2;EFNA3;EFNB3;IGSF9;RNF165;RET;LAMC2;UNC5A
GO:0000819,sister chromatid segregation (GO:0000819),34,12,2.351518446,5.103085635,1.48E-06,4.68E-04,5347;81930;7153;9700;10403;11130;64105;10051;51203;55143;3833;10615,CDCA8;TOP2A;NUSAP1;ZWINT;NDC80;PLK1;SPAG5;KIFC1;KIF18A;SMC4;ESPL1;CENPK
GO:0030199,collagen fibril organization (GO:0030199),89,20,6.155445343,3.249155648,2.11E-06,6.07E-04,3918;3909;667;3914;1308;1281;1278;1277;1290;1289;283208;4921;7373;1303;84171;140766;1300;1288;1805;1301,COL10A1;COL11A1;DST;ADAMTS14;LOXL4;P4HA3;COL17A1;DPT;LAMB3;COL5A2;COL5A1;LAMA3;COL12A1;DDR2;COL4A6;COL14A1;LAMC2;COL1A1;COL3A1;COL1A2
GO:0045597,positive regulation of cell differentiation (GO:0045597),255,39,17.63638834,2.211337109,2.28E-06,6.07E-04,7538;5468;1894;3479;7048;3569;4023;1000;948;4057;947;185;650;3202;5919;8626;7704;6664;51176;654;658;55273;55553;255743;2201;6422;7477;6660;2296;1277;2146;4921;5320;5764;91461;55885;51704;23531;91653,HOXA5;ZBTB16;BOC;SFRP1;LPL;ECT2;EZH2;TMEM100;CD36;TGFBR2;PTN;BMP2;PPARG;LEF1;GPRC5B;FBN2;ZFP36;CD34;TP63;BMP6;IGF1;IL6;SOX6;PKDCC;DDR2;NPNT;FOXC1;BMPR1B;SOX5;MMD;LMO3;CDH2;AGTR1;PLA2G2A;RARRES2;COL1A1;WNT7B;SOX11;LTF
GO:0045596,negative regulation of cell differentiation (GO:0045596),190,32,13.14083837,2.435156654,2.30E-06,6.07E-04,5468;7498;1956;3569;857;5744;2625;7704;2308;3249;5727;4212;4435;9370;2202;6422;10252;130497;1869;63923;1840;10253;57761;2662;23461;3169;1290;1289;54756;51232;25928;862,SPRY2;ZBTB16;CAV1;OSR1;SFRP1;GDF10;ADIPOQ;ABCA5;MEIS2;PPARG;E2F1;EGFR;SOSTDC1;FOXO1;CRIM1;RUNX1T1;COL5A2;SPRY1;COL5A1;EFEMP1;TRIB3;DTX1;PTCH1;IL17RD;CITED1;IL6;HPN;PTHLH;XDH;GATA3;TNN;FOXA1
GO:0045667,regulation of osteoblast differentiation (GO:0045667),82,19,5.671309192,3.350196464,2.32E-06,6.07E-04,5468;3479;3569;4057;650;8626;6664;654;658;5727;255743;4435;2201;7477;63923;2662;4921;64093;51232,GDF10;BMP2;PPARG;CRIM1;FBN2;TP63;PTCH1;SMOC1;BMP6;CITED1;IGF1;IL6;DDR2;NPNT;BMPR1B;TNN;WNT7B;SOX11;LTF
GO:2000147,positive regulation of cell motility (GO:2000147),220,35,15.21570759,2.30025451,3.02E-06,7.05E-04,3815;11170;2152;6366;4916;1956;3479;150;2246;857;7481;54437;80031;57556;10371;223117;56920;650;4638;5979;59352;6387;3918;51176;1906;4680;4318;10253;1277;51512;2159;153769;131578;80310;286077,SEMA5B;SPRY2;LRRC15;FGF1;FAM107A;CAV1;GTSE1;MYLK;KIT;SEMA3G;BMP2;EGFR;F10;F3;LEF1;SEMA3D;LGR6;PDGFD;SEMA6D;CCL21;SEMA6A;CXCL12;NTRK3;MMP9;CEACAM6;IGF1;FAM83H;EDN1;WNT11;SEMA3A;RET;ADRA2A;SH3RF2;LAMC2;COL1A1
GO:0032870,cellular response to hormone stimulus (GO:0032870),76,18,5.256335349,3.424439045,3.05E-06,7.05E-04,2690;3952;150;857;10267;6586;8644;1645;1583;1646;6422;477;7068;8835;8013;687;2908;7035,LEP;ATP1A2;CAV1;SFRP1;KLF9;AKR1C1;AKR1C2;NR3C1;GHR;CYP11A1;TFPI;SOCS2;AKR1C3;THRB;SLIT3;RAMP1;ADRA2A;NR4A3
GO:2000181,negative regulation of blood vessel morphogenesis (GO:2000181),76,18,5.256335349,3.424439045,3.05E-06,7.05E-04,5468;3627;57556;3202;7122;1944;4881;23213;7010;2296;9314;10253;5140;1634;64102;9510;641700;140862,SPRY2;HOXA5;TNMD;ADAMTS1;NPR1;CLDN5;CXCL10;ISM1;PPARG;SULF1;KLF4;SEMA6A;ECSCR;DCN;PDE3B;TEK;FOXC1;EFNA3
GO:0048522,positive regulation of cellular process (GO:0048522),617,73,42.67314356,1.710677816,4.01E-06,8.93E-04,7538;32;2255;2252;9472;4916;4915;1956;3479;150;2246;3084;7048;9928;3569;7292;6288;51085;857;5737;5744;2350;948;80736;7122;8644;11076;1378;2335;6664;6285;6387;8660;3918;3249;51176;3043;1906;1907;2247;654;658;1959;4212;1646;6422;3373;6376;8317;2305;57111;4680;101;990;332;5753;3590;146433;3977;85480;8784;2146;5764;6886;89958;219790;7272;10615;9055;4072;3226;80310;11082,TSLP;NTRK2;IL11RA;CX3CL1;FN1;KIF14;FGF1;FOXM1;SPAG5;BIRC5;S100B;LIFR;ESM1;CAV1;CDC6;SFRP1;PRC1;SAA1;ACACB;TTK;FGF2;CLDN5;EZH2;HBB;MLXIPL;CD36;TGFBR2;MEIS2;AKR1C2;PTN;TNFSF4;EGFR;ADAM8;PTGFR;RTKN2;EGR2;LEF1;HYAL1;TAL1;PDGFD;AKAP6;CXCL12;NTRK3;IRS2;ZFP36;FGF10;CDC7;TPPP;AKR1C3;IL34;BMP6;CEACAM6;SAPCD2;NRG1;IGF1;IL6;EDN1;FGF7;BMPR1B;TNFRSF18;PTK6;EDN2;FOLR2;SLC44A4;HOXC10;HPN;ADRA2A;CR1;PTHLH;EPCAM;LAMC2;RAB25;SOX11
GO:0031581,hemidesmosome assembly (GO:0031581),12,7,0.829947687,8.434266536,4.32E-06,9.03E-04,3918;3909;667;3914;1308;3852;3861,DST;COL17A1;LAMB3;KRT14;KRT5;LAMA3;LAMC2
GO:0042127,regulation of cell population proliferation (GO:0042127),755,85,52.21754195,1.627805462,4.75E-06,9.03E-04,1128;9368;3815;2255;2252;554;4916;4915;1956;3479;150;2246;3084;7048;9928;3624;3569;7292;51085;3627;5737;4283;5744;2350;185;650;2625;7122;8644;1378;2335;6664;6285;8660;3918;51176;1906;1907;2822;2247;654;4212;1646;6422;1050;6376;8317;1033;2305;57111;4680;990;3489;332;5784;10110;8013;3725;3590;6776;146433;3977;79801;9314;85480;54997;943;6713;8854;50943;2146;5764;29128;83595;89958;9510;219790;7272;9055;92304;4072;4883;3226;80310;11082,INHBA;TSLP;NTRK2;IL11RA;CX3CL1;UHRF1;FN1;KIF14;CDKN3;FGF1;FOXM1;BIRC5;S100B;LIFR;IGFBP6;ESM1;TESC;CDC6;SFRP1;SHCBP1;PRC1;ALDH1A2;TTK;AVPR2;ADAMTS1;FGF2;CLDN5;KIT;EZH2;MLXIPL;SQLE;TGFBR2;CXCL10;MEIS2;AKR1C2;SGK2;PTN;BMP2;TNFSF4;PTPN14;EGFR;PTGFR;JUN;GPLD1;RTKN2;LEF1;KLF4;PDGFD;STAT5A;FOXP3;NTRK3;IRS2;FGF10;CDC7;AKR1C3;SCGB3A1;SOX7;IL34;BMP6;CEACAM6;SAPCD2;NRG1;IGF1;IL6;EDN1;CXCL9;SLC9A3R1;FGF7;TNFRSF8;EDN2;FOLR2;HOXC10;AGTR1;ADRA2A;NR4A3;CEBPA;CR1;PTHLH;EPCAM;LAMC2;RAB25;GATA3;SOX11;NPR3;CHRM1
GO:0007094,mitotic spindle assembly checkpoint signaling (GO:0007094),21,9,1.452408452,6.196603985,4.81E-06,9.03E-04,991;701;4085;5347;1063;11130;699;9319;7272,CENPF;BUB1;ZWINT;PLK1;BUB1B;CDC20;TTK;TRIP13;MAD2L1
GO:0071174,mitotic spindle checkpoint signaling (GO:0071174),21,9,1.452408452,6.196603985,4.81E-06,9.03E-04,991;701;4085;5347;1063;11130;699;9319;7272,CENPF;BUB1;ZWINT;PLK1;BUB1B;CDC20;TTK;TRIP13;MAD2L1
GO:0071173,spindle assembly checkpoint signaling (GO:0071173),21,9,1.452408452,6.196603985,4.81E-06,9.03E-04,991;701;4085;5347;1063;11130;699;9319;7272,CENPF;BUB1;ZWINT;PLK1;BUB1B;CDC20;TTK;TRIP13;MAD2L1
GO:0045841,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),22,9,1.521570759,5.914940168,7.64E-06,0.001363043,991;701;4085;5347;1063;11130;699;9319;7272,CENPF;BUB1;ZWINT;PLK1;BUB1B;CDC20;TTK;TRIP13;MAD2L1
GO:1903670,regulation of sprouting angiogenesis (GO:1903670),33,11,2.282356138,4.819580878,7.71E-06,0.001363043,2246;57556;10365;2247;168667;57381;9314;1870;26051;90993;6271,FGF1;FGF2;BMPER;RHOJ;E2F2;KLF4;SEMA6A;PPP1R16B;CREB3L1;KLF2;S100A1
GO:0045778,positive regulation of ossification (GO:0045778),40,12,2.766492289,4.33762279,1.02E-05,0.001758474,650;7704;6664;654;658;2201;130497;2824;9636;9365;5764;91461,ZBTB16;OSR1;KL;PTN;BMP2;FBN2;GPM6B;BMP6;ISG15;PKDCC;BMPR1B;SOX11
GO:0061035,regulation of cartilage development (GO:0061035),18,8,1.24492153,6.426107837,1.19E-05,0.001990772,5744;7481;650;7704;658;55553;6660;129642,ZBTB16;BMP2;MBOAT2;SOX6;WNT11;BMPR1B;SOX5;PTHLH
GO:0097435,supramolecular fiber organization (GO:0097435),346,46,23.9301583,1.922260581,1.41E-05,0.002238059,2934;25802;7111;390;27289;1674;6622;9928;825;5239;6288;948;4057;4240;9627;81930;11004;11076;3918;3909;667;3914;4629;10516;1308;1281;1278;4239;1277;1290;1289;283208;4921;7373;1303;84171;140766;1300;1288;1805;1301;55137;79745;7148;51673;79649,COL10A1;COL11A1;LMOD1;MYH11;TNXB;KIF2C;KIF14;DST;ADAMTS14;LOXL4;SAA1;PGM5;TMOD1;KIF18A;SNCA;CD36;P4HA3;GSN;CLIP4;COL17A1;CAPN3;DPT;LAMB3;RND3;COL5A2;COL5A1;DES;MFAP4;TPPP;FBLN5;MAP7D3;FIGN;LAMA3;MFGE8;COL12A1;DDR2;SNCAIP;COL4A6;COL14A1;TPPP3;LAMC2;RND1;COL1A1;LTF;COL3A1;COL1A2
GO:0010001,glial cell differentiation (GO:0010001),29,10,2.005706909,4.985773322,1.43E-05,0.002238059,2255;1000;6663;11076;6664;4781;5649;1959;5803;79006,RELN;PTPRZ1;SOX10;NFIB;EGR2;FGF10;TPPP;METRN;CDH2;SOX11
GO:0051896,regulation of protein kinase B signaling (GO:0051896),207,32,14.31659759,2.235167943,1.45E-05,0.002238059,9368;3815;2255;2252;2152;7498;6366;4916;4915;64805;1956;3952;2246;284;3084;2625;8644;5979;8660;55024;2247;4233;1646;6376;7010;101;9365;152831;10253;57761;2159;9542,SPRY2;NTRK2;CX3CL1;LEP;NRG2;FGF1;KL;FGF2;KIT;AKR1C2;KLB;P2RY12;EGFR;ADAM8;F10;F3;ANGPT1;MET;CCL21;NTRK3;IRS2;FGF10;TRIB3;AKR1C3;NRG1;SLC9A3R1;FGF7;TEK;RET;XDH;GATA3;BANK1
GO:0051897,positive regulation of protein kinase B signaling (GO:0051897),161,27,11.13513146,2.424758081,1.51E-05,0.002265609,3815;2255;2252;2152;6366;64805;1956;3952;2246;284;3084;2625;8644;5979;8660;2247;4233;1646;6376;7010;101;9365;152831;10253;57761;2159;9542,SPRY2;CX3CL1;LEP;NRG2;FGF1;KL;FGF2;KIT;AKR1C2;KLB;P2RY12;EGFR;ADAM8;F10;F3;ANGPT1;MET;CCL21;IRS2;FGF10;TRIB3;AKR1C3;NRG1;FGF7;TEK;RET;GATA3
GO:0050678,regulation of epithelial cell proliferation (GO:0050678),93,19,6.432094572,2.953936667,1.64E-05,0.002400518,7538;2255;2252;1956;3952;3479;2246;284;3249;2247;3164;7049;654;6422;130497;3373;8013;29128;1028,LEP;UHRF1;FGF1;OSR1;SFRP1;FGF2;TGFBR3;CDKN1C;EGFR;ANGPT1;HYAL1;ZFP36;FGF10;NR4A1;BMP6;IGF1;FGF7;HPN;NR4A3
GO:0030501,positive regulation of bone mineralization (GO:0030501),36,11,2.48984306,4.417949138,1.97E-05,0.002760302,4057;650;654;658;2201;130497;2824;9636;9365;5764;91461,OSR1;KL;PTN;BMP2;FBN2;GPM6B;BMP6;ISG15;PKDCC;BMPR1B;LTF
GO:0001706,endoderm formation (GO:0001706),36,11,2.48984306,4.417949138,1.97E-05,0.002760302,3624;2335;3909;3914;64321;3679;4318;1843;1303;1301;83595,COL11A1;INHBA;FN1;ITGA7;LAMB3;SOX17;DUSP1;SOX7;MMP9;LAMA3;COL12A1
GO:0045669,positive regulation of osteoblast differentiation (GO:0045669),43,12,2.973979211,4.034997944,2.32E-05,0.003165121,3479;3569;4057;650;8626;6664;654;658;255743;2201;7477;4921,BMP2;FBN2;TP63;BMP6;IGF1;IL6;DDR2;NPNT;BMPR1B;WNT7B;SOX11;LTF
GO:0060429,epithelium development (GO:0060429),122,22,8.437801481,2.607314245,2.90E-05,0.003840445,9368;2255;5468;6663;983;947;1066;650;6664;1645;4223;64321;5727;1646;230;7477;130497;6491;8854;3868;6876;4222,CDK1;OSR1;ALDH1A2;STIL;CES1;AKR1C1;MEOX2;AKR1C2;BMP2;PPARG;SOX10;MEOX1;ALDOC;SOX17;FGF10;CD34;PTCH1;TAGLN;SLC9A3R1;WNT7B;SOX11;KRT16
GO:1901992,positive regulation of mitotic cell cycle phase transition (GO:1901992),58,14,4.011413819,3.490041325,3.00E-05,0.003840445,301;2255;1956;11065;983;891;9700;3373;993;8317;51514;9787;113130;9510,UBE2C;CDK1;DTL;DLGAP5;CCNB1;CDCA5;ANXA1;ADAMTS1;ESPL1;EGFR;HYAL1;FGF10;CDC7;CDC25A
GO:0001654,eye development (GO:0001654),58,14,4.011413819,3.490041325,3.00E-05,0.003840445,64220;658;4212;2201;2202;5950;91851;2296;1290;1289;64093;170692;4081;27151,RBP4;MAB21L1;CHRDL1;MEIS2;COL5A2;COL5A1;EFEMP1;FBN2;CPAMD8;SMOC1;ADAMTS18;FOXC1;BMPR1B;STRA6
GO:0048568,embryonic organ development (GO:0048568),66,15,4.564712277,3.286077871,3.39E-05,0.004245524,3815;7048;64220;23493;5919;2625;64321;10763;220;7477;5950;6491;91461;7173;6886,RBP4;STIL;KIT;TGFBR2;NES;TAL1;SOX17;TPO;ALDH1A3;PKDCC;HEY2;RARRES2;STRA6;GATA3;WNT7B
GO:0034695,response to prostaglandin E (GO:0034695),11,6,0.760785379,7.886586891,3.68E-05,0.004479963,6366;7292;54331;5734;7049;6422,SFRP1;TGFBR3;TNFSF4;PTGER4;CCL21;GNG2
GO:0086010,membrane depolarization during action potential (GO:0086010),26,9,1.798219988,5.004949373,3.73E-05,0.004479963,6329;6326;6335;6332;6328;55800;6327;6330;477,SCN4B;SCN3A;ATP1A2;SCN2B;SCN3B;SCN4A;SCN2A;SCN9A;SCN7A
GO:0071345,cellular response to cytokine stimulus (GO:0071345),480,57,33.19790747,1.716975688,4.15E-05,0.004890723,7538;301;1901;3815;9472;2152;6366;2690;3569;6288;3627;5138;6382;948;4311;1511;2625;2920;2308;5740;5743;2335;6387;51176;1907;2247;255743;6422;1050;3953;3373;4128;58480;6376;55022;4314;4318;4501;1843;332;5803;8835;5784;2353;2296;1278;1271;4582;115362;3590;4692;1958;6776;146433;3977;4882;64388,CXCL2;MME;IL11RA;CX3CL1;FN1;BIRC5;LIFR;LEPR;PDE2A;ANXA1;SFRP1;SAA1;EGR1;FGF2;KIT;MT1X;MAOA;CD36;CXCL10;PTPRZ1;PTPN14;CNTFR;F3;FOXO1;LEF1;GHR;PID1;HYAL1;FOS;STAT5A;AKAP6;PTGS2;CCL21;CXCL12;NDN;DUSP1;NPR2;ZFP36;SOCS2;S1PR1;MMP3;IL34;MUC1;MMP9;RHOU;GREM2;IL6;PTGIS;NPNT;CTSG;SDC1;FOXC1;EDN2;GBP5;CEBPA;GATA3;COL1A2
GO:0010604,positive regulation of macromolecule metabolic process (GO:0010604),383,48,26.48916367,1.81206174,4.36E-05,0.005044975,2934;2255;2252;554;6622;2152;4916;4915;3479;2246;284;3624;3569;5138;7481;948;8728;947;650;3202;23493;7122;287;2335;6664;3249;51176;10365;2247;654;4435;10891;130497;1869;5317;55022;79924;1958;9314;10253;54997;90865;27303;5304;10551;59;8736;72,INHBA;SPRY2;NTRK2;HOXA5;FN1;FGF1;TESC;PDE2A;OSR1;MYOM1;EGR1;AVPR2;FGF2;ACTG2;CLDN5;SNCA;CD36;GSN;IL33;RBMS3;BMP2;E2F1;F3;ADAM19;LEF1;KLF4;ANGPT1;PID1;NTRK3;FGF10;CD34;PPARGC1A;ANK2;PKP1;BMP6;ACTA2;CITED1;ADM2;IGF1;IL6;HEY2;WNT11;FGF7;KLF2;HPN;SOX11;AGR2;PIP
GO:0043066,negative regulation of apoptotic process (GO:0043066),482,57,33.33623208,1.709851307,4.67E-05,0.005291772,301;6622;4804;4915;1956;3479;284;9928;825;3569;51129;857;7481;358;4057;983;4085;5347;79625;1511;7301;2537;2308;219699;3249;51176;1960;4435;10891;6422;5166;130497;6376;7010;23542;4680;4318;101;213;332;5803;8835;81788;847;9314;1410;10253;85480;6491;1311;5329;3875;1149;92291;114804;8793;153769,SPRY2;TSLP;NTRK2;CDK1;COMP;CX3CL1;PLK1;KIF14;BIRC5;PDK4;CRYAB;CAV1;OSR1;ANXA1;SFRP1;CIDEA;NUAK2;STIL;TNFRSF10D;SNCA;UNC5B;AQP1;PTPRZ1;EGFR;MAD2L1;ADAM8;NGFR;FOXO1;LEF1;CAPN3;KLF4;ANGPT1;EGR3;ALB;SOCS2;CAT;PPARGC1A;ANGPTL4;MMP9;IFI6;PLAUR;CEACAM6;CITED1;IGF1;IL6;MAPK8IP2;WNT11;CTSG;TEK;RNF157;HPN;NDNF;TYRO3;SH3RF2;KRT18;LTF;CAPN13
GO:0062013,positive regulation of small molecule metabolic process (GO:0062013),16,7,1.106596916,6.325699902,4.87E-05,0.005423777,5468;133;1066;5366;8660;2822;9370,ADIPOQ;CES1;PPARG;GPLD1;IRS2;PMAIP1;ADM
GO:0090068,positive regulation of cell cycle process (GO:0090068),101,19,6.985393029,2.719961485,5.48E-05,0.005938079,1894;3479;9928;11113;4085;6790;9212;891;29127;9493;10403;1906;8317;10733;990;8555;51203;168448;10615,NUSAP1;NDC80;AURKA;KIF14;CCNB1;SPAG5;CDC6;KIF23;CIT;AURKB;CDC14B;ECT2;RACGAP1;MAD2L1;PLK4;CDC14C;CDC7;IGF1;EDN1
GO:0009967,positive regulation of signal transduction (GO:0009967),251,35,17.35973911,2.016159331,5.53E-05,0.005938079,2152;4916;3479;2246;10580;3569;5653;79971;650;9378;2625;8626;5740;59352;5649;10365;147372;654;23213;9370;6422;6517;858;55679;7010;51473;25818;85480;84441;23189;7450;55885;284654;11082;84870,TSLP;FGF1;RELN;ESM1;SLC2A4;SFRP1;CAV2;LIMS2;ADIPOQ;RSPO3;NRXN1;SORBS1;MAML2;KANK1;BMP2;SULF1;F3;LGR6;CCBE1;NTRK3;TP63;BMP6;WLS;IGF1;IL6;VWF;PTGIS;KLK5;TEK;KLF2;LMO3;KLK6;RSPO1;GATA3;DCDC2
GO:0051241,negative regulation of multicellular organismal process (GO:0051241),213,31,14.73157144,2.104324045,6.45E-05,0.00679822,7138;55366;1956;130399;133;5734;7481;216;650;3204;23493;4857;2625;4781;3249;5727;9370;6422;10252;4038;11096;10253;50943;3169;675;1149;54756;25928;5997;4883;3226,ADAMTS5;SPRY2;SFRP1;HOXA7;CIDEA;ADIPOQ;ACVR1C;BMP2;ALDH1A1;EGFR;TNNT1;NFIB;SOSTDC1;LRP4;RGS2;PTGER4;FOXP3;SPRY1;PTCH1;LGR4;NOVA1;IL17RD;BRCA2;HEY2;WNT11;ADM;HOXC10;HPN;GATA3;NPR3;FOXA1
GO:0071363,cellular response to growth factor stimulus (GO:0071363),156,25,10.78931993,2.317106191,6.70E-05,0.006923644,7538;301;4916;4915;1956;7048;130399;5138;57556;79625;650;1960;3164;654;658;55273;55553;6422;3373;6660;2296;2908;9314;7123;10253,SPRY2;NTRK2;PDE2A;CLEC3B;ANXA1;SFRP1;TMEM100;TGFBR2;ACVR1C;BMP2;EGFR;NR3C1;KLF4;HYAL1;EGR3;SEMA6A;NTRK3;ZFP36;NR4A1;BMP6;SOX6;FOXC1;BMPR1B;SOX5;NDNF
GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),34,10,2.351518446,4.252571363,6.80E-05,0.006923644,4804;5468;2625;2247;3725;2353;2908;1958;9314;84913,ATOH8;EGR1;FGF2;PPARG;NGFR;NR3C1;JUN;KLF4;FOS;GATA3
GO:0000022,mitotic spindle elongation (GO:0000022),8,5,0.553298458,9.036714145,7.36E-05,0.007249871,9212;24137;29127;9493;9055,KIF4A;KIF23;PRC1;AURKB;RACGAP1
GO:0051256,mitotic spindle midzone assembly (GO:0051256),8,5,0.553298458,9.036714145,7.36E-05,0.007249871,9212;24137;29127;9493;9055,KIF4A;KIF23;PRC1;AURKB;RACGAP1
GO:0050727,regulation of inflammatory response (GO:0050727),205,30,14.17827298,2.115913556,7.59E-05,0.007278664,301;6622;5468;3569;7292;6288;11343;4023;5734;5138;185;2625;7301;1776;5740;5743;9370;1050;6376;7010;145581;4314;4318;9314;85480;90865;5320;5169;64838;51704,TSLP;CX3CL1;PDE2A;ANXA1;SAA1;LPL;ADIPOQ;SNCA;IL33;DNASE1L3;TNFSF4;PPARG;KLF4;LRFN5;PTGER4;GPRC5B;PTGS2;MMP3;MMP9;MGLL;FNDC4;IL6;PTGIS;TEK;AGTR1;TYRO3;ENPP3;CEBPA;PLA2G2A;GATA3
GO:0000281,mitotic cytokinesis (GO:0000281),48,12,3.319790747,3.614685658,7.63E-05,0.007278664,1894;11113;5347;24137;29127;9493;9700;6711;54443;51203;10112;55165,KIF4A;KIF20A;CEP55;NUSAP1;ANLN;PLK1;KIF23;CIT;ECT2;ESPL1;RACGAP1;SPTBN1
GO:0071398,cellular response to fatty acid (GO:0071398),17,7,1.175759223,5.953599908,7.79E-05,0.007298734,84649;4023;8644;1645;1646;5166;55022,PDK4;LPL;AKR1C1;AKR1C2;PID1;AKR1C3;DGAT2
GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),403,49,27.87240981,1.758010891,7.89E-05,0.007298734,3815;2255;2252;154;4804;4916;2690;4915;1956;3479;2246;284;3084;10580;5919;7301;2308;5979;2675;1949;1944;8660;2051;2047;3249;23768;2822;2247;23213;4233;5166;858;7010;4318;5753;8835;8013;2296;9365;54845;152831;79801;1277;4921;1288;6725;399694;9068;80310,NTRK2;FGF1;PDK4;SHCBP1;ADRB2;KL;CAV2;EPHB1;FGF2;ANGPTL1;KIT;SORBS1;KLB;SULF1;EGFR;NGFR;GPLD1;FOXO1;GHR;ANGPT1;MET;EPHB6;PDGFD;GFRA2;NTRK3;IRS2;SOCS2;FGF10;FLRT2;MMP9;NRG1;IGF1;DDR2;FGF7;COL4A6;TEK;FOXC1;EFNA3;SRMS;PTK6;EFNB3;HPN;RET;ESRP1;NR4A3;TYRO3;RARRES2;SHC4;COL1A1
GO:0030324,lung development (GO:0030324),35,10,2.420680753,4.131069324,8.93E-05,0.008132437,2255;2252;2246;7481;64220;6664;2247;7477;5950;1050,FGF1;RBP4;FGF2;FGF10;WNT11;FGF7;CEBPA;STRA6;WNT7B;SOX11
GO:0010564,regulation of cell cycle process (GO:0010564),105,19,7.262042258,2.616343905,9.48E-05,0.008507768,1894;6790;9212;5347;29127;3832;6422;858;699;10733;9088;4751;116028;83987;90293;10112;10615;9055;4288,NEK2;PKMYT1;KIF20A;BUB1;MKI67;PLK1;AURKA;KLHL13;SPAG5;KIF11;SFRP1;PRC1;AURKB;CAV2;RMI2;ECT2;RACGAP1;PLK4;CCDC8
GO:0010875,positive regulation of cholesterol efflux (GO:0010875),23,8,1.590733066,5.029127872,9.78E-05,0.00853338,5468;857;10351;26154;1066;5727;9370;80820,CAV1;ABCA8;ADIPOQ;CES1;PPARG;EEPD1;PTCH1;ABCA12
GO:0045598,regulation of fat cell differentiation (GO:0045598),80,16,5.532984578,2.891748527,9.80E-05,0.00853338,7538;5468;3952;3569;4023;650;5919;2625;7704;2308;9370;6422;1869;57761;862;55885,LEP;ZBTB16;SFRP1;LPL;ADIPOQ;BMP2;PPARG;E2F1;FOXO1;RUNX1T1;ZFP36;TRIB3;IL6;LMO3;RARRES2;GATA3
GO:0050679,positive regulation of epithelial cell proliferation (GO:0050679),123,21,8.506963788,2.468565815,9.97E-05,0.008558448,2255;2252;2152;1956;3479;2246;650;6664;3249;1960;2247;3164;654;6422;130497;3373;7010;8013;6776;5764;26051,FGF1;OSR1;SFRP1;FGF2;PTN;BMP2;EGFR;F3;HYAL1;EGR3;STAT5A;FGF10;NR4A1;PPP1R16B;BMP6;IGF1;FGF7;TEK;HPN;NR4A3;SOX11
GO:1904995,negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995),5,4,0.345811536,11.56699411,1.08E-04,0.00910173,6366;6387;56477;9314,KLF4;CCL21;CCL28;CXCL12
GO:0071385,cellular response to glucocorticoid stimulus (GO:0071385),18,7,1.24492153,5.622844357,1.20E-04,0.00998583,7538;301;11170;358;5105;687;2908,FAM107A;ANXA1;PCK1;KLF9;AQP1;NR3C1;ZFP36
GO:0051383,kinetochore organization (GO:0051383),13,6,0.899109994,6.67326583,1.21E-04,0.00998583,1062;81620;83540;10403;1063;9787,NUF2;CENPF;DLGAP5;NDC80;CENPE;CDT1
GO:0140014,mitotic nuclear division (GO:0140014),74,15,5.118010734,2.930826209,1.37E-04,0.011119623,22974;11065;27338;5347;81930;3832;9700;10403;11130;64105;10051;51203;55143;3833;10615,TPX2;UBE2C;CDCA8;NUSAP1;ZWINT;NDC80;PLK1;SPAG5;KIF11;KIFC1;KIF18A;SMC4;ESPL1;UBE2S;CENPK
GO:0007080,mitotic metaphase plate congression (GO:0007080),51,12,3.527277668,3.40205709,1.43E-04,0.011491206,9928;891;81930;11004;1062;81620;83540;10403;113130;55143;55165;3833,NUF2;CDCA8;CEP55;NDC80;KIF2C;KIF14;CCNB1;KIFC1;CENPE;CDCA5;KIF18A;CDT1
GO:0051781,positive regulation of cell division (GO:0051781),44,11,3.043141518,3.614685658,1.51E-04,0.011955169,1894;2246;9928;11113;9212;29127;9493;990;8555;168448;6886,KIF14;FGF1;CDC6;KIF23;CIT;AURKB;CDC14B;ECT2;RACGAP1;TAL1;CDC14C
GO:0008544,epidermis development (GO:0008544),83,16,5.740471499,2.787227495,1.54E-04,0.012060038,2252;5744;3918;3909;3914;2012;1308;3852;3861;25818;5650;2125;5017;3866;1382;79987,SVEP1;COL17A1;LAMB3;KRT14;KRT5;LAMA3;EMP1;KLK5;FGF7;KRT15;EVPL;KLK7;CRABP2;PTHLH;LAMC2;OVOL1
GO:0061640,cytoskeleton-dependent cytokinesis (GO:0061640),59,13,4.080576126,3.185824648,1.57E-04,0.012065266,1894;11113;9212;5347;24137;29127;9493;9700;6711;54443;51203;10112;55165,KIF4A;KIF20A;CEP55;NUSAP1;ANLN;PLK1;KIF23;CIT;AURKB;ECT2;ESPL1;RACGAP1;SPTBN1
GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),165,25,11.41178069,2.190718581,1.68E-04,0.012811966,1901;554;55366;111;196883;154;64805;150;2774;3627;5737;135;4283;133;5745;5744;10267;5734;1268;8685;2770;9590;5138;117;5746,GNAL;PDE2A;ADCYAP1R1;ADRB2;AVPR2;CXCL10;P2RY12;PTGFR;ADCY4;PTGER4;AKAP12;S1PR1;GNAI1;PTH1R;ADCY5;LGR4;RAMP1;MARCO;CXCL9;CNR1;ADORA2A;ADM;ADRA2A;PTH2R;PTHLH
GO:0051279,regulation of release of sequestered calcium ion into cytosol (GO:0051279),52,12,3.596439976,3.336632915,1.75E-04,0.013028857,1756;9472;6622;825;3627;4283;287;57158;845;6376;3270;2946,DMD;CX3CL1;JPH2;SNCA;CXCL10;CAPN3;GSTM2;AKAP6;CASQ2;ANK2;CXCL9;HRC
GO:0006693,prostaglandin metabolic process (GO:0006693),31,9,2.144031524,4.197699474,1.76E-04,0.013028857,5321;5730;5740;8644;5743;1645;1906;1907;1646,AKR1C1;AKR1C2;PLA2G4A;PTGS2;AKR1C3;PTGDS;PTGIS;EDN1;EDN2
GO:0001516,prostaglandin biosynthetic process (GO:0001516),19,7,1.314083837,5.32690518,1.79E-04,0.013086616,5321;5730;5740;8644;5743;1906;1907,PLA2G4A;PTGS2;AKR1C3;PTGDS;PTGIS;EDN1;EDN2
GO:0001508,action potential (GO:0001508),45,11,3.112303825,3.53435931,1.88E-04,0.013431849,1756;3745;6329;6326;3753;23704;9472;6335;6332;6328;55800,DMD;KCNE1;SCN3A;SCN3B;SCN4A;SCN2A;KCNB1;AKAP6;SCN9A;SCN7A;KCNE4
GO:1902893,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),45,11,3.112303825,3.53435931,1.88E-04,0.013431849,4804;5468;2625;4781;2247;3725;2353;2908;1958;9314;84913,ATOH8;EGR1;FGF2;PPARG;NFIB;NGFR;NR3C1;JUN;KLF4;FOS;GATA3
GO:0008016,regulation of heart contraction (GO:0008016),93,17,6.432094572,2.642995965,1.92E-04,0.013559063,1674;30819;287;4881;6263;6261;477;845;10060;482;3270;4882;5348;10659;6271;27129;10699,FXYD1;ATP1A2;RYR3;KCNIP2;NPR1;HSPB7;NPR2;DES;CASQ2;ATP1B2;CORIN;ANK2;CELF2;HRC;RYR1;ABCC9;S100A1
GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),14,6,0.968272301,6.196603985,2.00E-04,0.013966981,2625;2247;23213;10252;10253;90993,SPRY2;FGF2;SULF1;SPRY1;CREB3L1;GATA3
GO:0030111,regulation of Wnt signaling pathway (GO:0030111),111,19,7.677016102,2.47491991,2.03E-04,0.014026719,2719;2348;79971;650;59352;83439;23213;4435;6422;51473;50943;83595;23189;25928;23500;147495;11197;284654;84870,WIF1;SFRP1;GPC3;APCDD1;RSPO3;KANK1;BMP2;SULF1;SOSTDC1;LGR6;FOXP3;SOX7;WLS;DAAM2;FOLR1;CITED1;TCF7L1;RSPO1;DCDC2
GO:1904029,regulation of cyclin-dependent protein kinase activity (GO:1904029),53,12,3.665602283,3.273677577,2.12E-04,0.014477189,891;993;1033;890;9134;898;9088;9133;990;641;9077;1028,PKMYT1;CDKN3;CCNB2;CCNB1;CCNE2;CCNA2;CDC6;CDKN1C;BLM;CDC25A;CCNE1;DIRAS3
GO:0007409,axonogenesis (GO:0007409),238,32,16.46062912,1.944032623,2.25E-04,0.015174186,54437;80031;57556;10371;223117;56920;9378;6586;84612;64221;6285;9638;57549;5979;7436;6711;2675;59352;54538;6387;1949;5649;10381;1944;8660;4684;219699;90249;2051;3909;3908;2047,SEMA5B;ROBO3;S100B;RELN;EPHB1;TUBB3;NRXN1;UNC5B;SEMA3G;SPTBN1;NCAM1;SEMA3D;LGR6;EPHB6;SEMA6D;SEMA6A;GFRA2;CXCL12;IRS2;FEZ1;SLIT3;LAMA3;ROBO4;SEMA3A;VLDLR;LAMA2;EFNA3;PARD6B;EFNB3;IGSF9;RET;UNC5A
GO:0007096,regulation of exit from mitosis (GO:0007096),39,10,2.697329982,3.707369906,2.40E-04,0.015855024,11065;991;27338;701;4085;4751;8555;54443;113130;168448,NEK2;UBE2C;ANLN;BUB1B;CDC20;CDCA5;CDC14B;MAD2L1;UBE2S;CDC14C
GO:2001259,positive regulation of cation channel activity (GO:2001259),39,10,2.697329982,3.707369906,2.40E-04,0.015855024,9472;154;30819;287;5649;57158;2946;23237;6769;342667,RELN;KCNIP2;ADRB2;JPH2;STAC2;ARC;GSTM2;AKAP6;ANK2;STAC
GO:0071375,cellular response to peptide hormone stimulus (GO:0071375),104,18,7.192879951,2.502474686,2.57E-04,0.01619731,111;196883;5468;5577;10580;857;2308;8660;2822;3164;9370;1583;5105;6517;11031;8013;5140;57761,SLC2A4;CAV1;ADIPOQ;PCK1;SORBS1;PPARG;ADCY4;GPLD1;FOXO1;CYP11A1;IRS2;TRIB3;ADCY5;NR4A1;RAB31;PDE3B;PRKAR2B;NR4A3
GO:0045823,positive regulation of heart contraction (GO:0045823),20,7,1.383246144,5.060559921,2.58E-04,0.01619731,55800;133;1906;1907;477;3270;5997,ATP1A2;SCN3B;RGS2;EDN1;EDN2;HRC;ADM
GO:0032330,regulation of chondrocyte differentiation (GO:0032330),26,8,1.798219988,4.448843887,2.59E-04,0.01619731,5744;7704;658;55553;2202;6660;91461;129642,ZBTB16;EFEMP1;MBOAT2;SOX6;PKDCC;BMPR1B;SOX5;PTHLH
GO:0007076,mitotic chromosome condensation (GO:0007076),26,8,1.798219988,4.448843887,2.59E-04,0.01619731,983;5347;891;113130;64151;23397;10051;51203,CDK1;NUSAP1;NCAPG;PLK1;CCNB1;CDCA5;NCAPH;SMC4
GO:0030071,regulation of mitotic metaphase/anaphase transition (GO:0030071),26,8,1.798219988,4.448843887,2.59E-04,0.01619731,11065;5347;891;1062;9700;990;1843;9787,UBE2C;DLGAP5;PLK1;CCNB1;CENPE;CDC6;ESPL1;DUSP1
GO:0043069,negative regulation of programmed cell death (GO:0043069),379,45,26.21251444,1.716737252,2.62E-04,0.016223713,301;6622;4804;1956;3479;284;9928;825;3569;51129;7481;358;4057;983;4085;5347;2537;84883;2308;3249;51176;1960;347902;4233;6422;130497;6376;7010;4318;213;332;8835;81788;847;1410;10253;85480;6491;1311;5329;3875;92291;114804;8793;153769,SPRY2;TSLP;CDK1;COMP;CX3CL1;PLK1;KIF14;BIRC5;CRYAB;OSR1;ANXA1;SFRP1;NUAK2;STIL;TNFRSF10D;SNCA;AQP1;EGFR;MAD2L1;NGFR;FOXO1;LEF1;CAPN3;ANGPT1;MET;EGR3;ALB;SOCS2;CAT;ANGPTL4;MMP9;IFI6;PLAUR;IGF1;IL6;WNT11;TEK;AIFM2;RNF157;HPN;AMIGO2;SH3RF2;KRT18;LTF;CAPN13
GO:0031325,positive regulation of cellular metabolic process (GO:0031325),105,18,7.262042258,2.478641594,2.90E-04,0.017615851,32;6622;5468;7498;284;7048;3624;983;891;185;2625;8644;3249;1645;9370;55022;9314;29128,INHBA;CDK1;UHRF1;CCNB1;ACACB;ADIPOQ;AKR1C1;SNCA;TGFBR2;PPARG;KLF4;ANGPT1;PID1;AKR1C3;HPN;AGTR1;XDH;GATA3
GO:0051988,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),10,5,0.691623072,7.229371316,2.94E-04,0.017615851,1894;891;29127;4751;10615,NEK2;CCNB1;SPAG5;ECT2;RACGAP1
GO:0032376,positive regulation of cholesterol transport (GO:0032376),33,9,2.282356138,3.943293445,2.96E-04,0.017615851,5468;857;10351;26154;1066;5727;9370;23461;80820,CAV1;ABCA8;ADIPOQ;ABCA5;CES1;PPARG;EEPD1;PTCH1;ABCA12
GO:0010874,regulation of cholesterol efflux (GO:0010874),33,9,2.282356138,3.943293445,2.96E-04,0.017615851,5468;857;10351;26154;1066;5727;9370;23461;80820,CAV1;ABCA8;ADIPOQ;ABCA5;CES1;PPARG;EEPD1;PTCH1;ABCA12
GO:0050728,negative regulation of inflammatory response (GO:0050728),211,29,14.59324682,1.987220551,2.99E-04,0.017615851,554;111;196883;154;5468;5577;3479;3569;6288;54331;135;133;5745;5744;10267;5734;117;5746;2209;2625;7301;5740;9370;7010;145581;79924;9314;5169;64838,ADCYAP1R1;SAA1;ADRB2;AVPR2;ADIPOQ;PPARG;ADCY4;KLF4;LRFN5;PTGER4;FCGR1A;PTH1R;ADCY5;FNDC4;RAMP1;ADM2;IGF1;IL6;PTGIS;ADORA2A;TEK;PRKAR2B;GNG2;ADM;TYRO3;ENPP3;PTH2R;PTHLH;GATA3
GO:0002692,negative regulation of cellular extravasation (GO:0002692),6,4,0.414973843,9.639161755,3.05E-04,0.017615851,6366;5734;6387;56477,PTGER4;CCL21;CCL28;CXCL12
GO:0072012,glomerulus vasculature development (GO:0072012),6,4,0.414973843,9.639161755,3.05E-04,0.017615851,284;947;130497;7010,OSR1;ANGPT1;CD34;TEK
GO:0046457,prostanoid biosynthetic process (GO:0046457),15,6,1.037434608,5.783497053,3.14E-04,0.017784296,5321;5730;5740;5743;1906;1907,PLA2G4A;PTGS2;PTGDS;PTGIS;EDN1;EDN2
GO:0033623,regulation of integrin activation (GO:0033623),15,6,1.037434608,5.783497053,3.14E-04,0.017784296,10563;9928;5734;54922;6403;55612,KIF14;PTGER4;RASIP1;SELP;FERMT1;CXCL13
GO:0050680,negative regulation of epithelial cell proliferation (GO:0050680),72,14,4.97968612,2.811422179,3.57E-04,0.020066316,7498;857;2625;4781;3249;7049;23213;6422;858;687;675;64102;84913;1028,ATOH8;TNMD;CAV1;SFRP1;CAV2;TGFBR3;KLF9;CDKN1C;SULF1;NFIB;BRCA2;HPN;XDH;GATA3
GO:0048483,autonomic nervous system development (GO:0048483),21,7,1.452408452,4.819580878,3.65E-04,0.020187523,6663;10371;26153;2625;2335;6664;1910,FN1;SOX10;EDNRB;KIF26A;SEMA3A;GATA3;SOX11
GO:0006027,glycosaminoglycan catabolic process (GO:0006027),56,12,3.873089204,3.098301993,3.66E-04,0.020187523,2719;6382;60495;2247;3373;10894;1462;633;1634;4969;5549;3161,HPSE2;LYVE1;HMMR;GPC3;FGF2;BGN;HYAL1;OGN;VCAN;DCN;PRELP;SDC1
GO:0070169,positive regulation of biomineral tissue development (GO:0070169),41,10,2.835654596,3.526522593,3.73E-04,0.020383675,650;654;658;2201;130497;2824;9636;9365;5764;91461,OSR1;KL;PTN;BMP2;FBN2;GPM6B;BMP6;ISG15;PKDCC;BMPR1B
GO:0007044,cell-substrate junction assembly (GO:0007044),34,9,2.351518446,3.827314226,3.78E-04,0.020495374,10580;2335;3918;3909;667;3914;1308;3852;3861,FN1;DST;SORBS1;COL17A1;LAMB3;KRT14;KRT5;LAMA3;LAMC2
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),81,15,5.602146885,2.677544932,3.88E-04,0.02068732,1956;5347;891;1050;993;1033;890;9134;898;9088;9133;990;641;9077;1028,PKMYT1;PLK1;CDKN3;CCNB2;CCNB1;CCNE2;CCNA2;CDC6;CDKN1C;EGFR;BLM;CDC25A;CCNE1;DIRAS3;CEBPA
GO:0010628,positive regulation of gene expression (GO:0010628),476,53,32.92125824,1.609902016,3.89E-04,0.02068732,2934;2255;2252;554;2152;4916;4915;1956;3479;150;2246;284;3624;3569;7292;6288;5734;5138;7481;948;8728;947;650;3202;23493;7122;287;2335;6664;3249;51176;2247;654;4435;10891;130497;1869;5317;55022;79924;1958;9314;10253;54997;90865;27303;5304;10551;59;8736;72;23034;55323,INHBA;SPRY2;NTRK2;HOXA5;FN1;FGF1;TESC;PDE2A;OSR1;MYOM1;SAA1;EGR1;AVPR2;FGF2;ACTG2;CLDN5;CD36;GSN;IL33;RBMS3;BMP2;TNFSF4;E2F1;EGFR;F3;ADAM19;LEF1;KLF4;ANGPT1;PID1;PTGER4;LARP6;NTRK3;FGF10;CD34;PPARGC1A;SAMD4A;ANK2;PKP1;BMP6;ACTA2;CITED1;ADM2;IGF1;IL6;HEY2;WNT11;FGF7;HPN;ADRA2A;SOX11;AGR2;PIP
GO:0030500,regulation of bone mineralization (GO:0030500),57,12,3.942251512,3.043945817,4.35E-04,0.022934376,1901;650;654;658;2201;130497;2824;9636;9365;4921;5764;91461,OSR1;KL;PTN;BMP2;FBN2;S1PR1;GPM6B;BMP6;ISG15;PKDCC;DDR2;BMPR1B
GO:0034394,protein localization to cell surface (GO:0034394),28,8,1.936544602,4.131069324,4.55E-04,0.023764488,2255;2252;284;338328;7481;287;10516;79608,GPIHBP1;ANGPT1;RIC3;FGF10;FBLN5;ANK2;WNT11;FGF7
GO:0043408,regulation of MAPK cascade (GO:0043408),166,24,11.480943,2.090420622,4.59E-04,0.023773549,3815;2255;154;4916;4915;1956;3952;3479;150;3569;857;650;2335;5979;2047;2247;7049;858;6376;7010;1843;57161;81610;56981,NTRK2;CX3CL1;LEP;FN1;FAM83D;CAV1;ADRB2;CAV2;EPHB1;FGF2;TGFBR3;KIT;PRDM11;BMP2;PELI2;EGFR;DUSP1;NTRK3;FGF10;IGF1;IL6;TEK;RET;ADRA2A
GO:0001990,regulation of systemic arterial blood pressure by hormone (GO:0001990),16,6,1.106596916,5.422028487,4.73E-04,0.023869633,554;185;1906;1907;5021;10699,OXTR;AVPR2;CORIN;EDN1;EDN2;AGTR1
GO:0030857,negative regulation of epithelial cell differentiation (GO:0030857),16,6,1.106596916,5.422028487,4.73E-04,0.023869633,7498;857;10252;130497;4318;10253,SPRY2;CAV1;OSR1;SPRY1;MMP9;XDH
GO:0010965,regulation of mitotic sister chromatid separation (GO:0010965),16,6,1.106596916,5.422028487,4.73E-04,0.023869633,11065;9232;5347;1062;990;10460,UBE2C;PLK1;PTTG1;CENPE;CDC6;TACC3
GO:0030261,chromosome condensation (GO:0030261),35,9,2.420680753,3.717962391,4.79E-04,0.023972391,983;5347;891;7153;113130;64151;23397;10051;51203,CDK1;TOP2A;NUSAP1;NCAPG;PLK1;CCNB1;CDCA5;NCAPH;SMC4
GO:0001823,mesonephros development (GO:0001823),11,5,0.760785379,6.572155742,5.09E-04,0.024938802,2255;2246;2625;7704;130497,FGF1;ZBTB16;OSR1;FGF10;GATA3
GO:0032332,positive regulation of chondrocyte differentiation (GO:0032332),11,5,0.760785379,6.572155742,5.09E-04,0.024938802,7704;658;55553;6660;91461,ZBTB16;SOX6;PKDCC;BMPR1B;SOX5
GO:0007517,muscle organ development (GO:0007517),58,12,4.011413819,2.991463993,5.14E-04,0.024938802,4621;1756;3479;825;3627;3908;1960;55553;3679;6876;2273;22808,DMD;FHL1;ITGA7;CXCL10;MRAS;CAPN3;MYH3;EGR3;IGF1;TAGLN;SOX6;LAMA2
GO:0045444,fat cell differentiation (GO:0045444),58,12,4.011413819,2.991463993,5.14E-04,0.024938802,5468;2308;3164;1959;9370;63976;10891;1050;55022;8013;9314;79689,ADIPOQ;PPARG;FOXO1;EGR2;KLF4;PID1;PPARGC1A;NR4A1;PRDM16;STEAP4;NR4A3;CEBPA
GO:0001523,retinoid metabolic process (GO:0001523),92,16,6.362932264,2.514563936,5.24E-04,0.025018427,4023;338328;64220;2719;216;6382;5919;8644;1645;56603;220;5950;8854;125;126;124,GPIHBP1;RBP4;ADH1C;ALDH1A2;LPL;ADH1A;GPC3;ADH1B;AKR1C1;ALDH1A1;AKR1C3;ALDH1A3;CYP26B1;SDC1;RARRES2;STRA6
GO:0001936,regulation of endothelial cell proliferation (GO:0001936),92,16,6.362932264,2.514563936,5.24E-04,0.025018427,2152;7498;3952;284;857;650;1960;2247;3164;23213;858;7010;6776;26051;64102;84913,ATOH8;LEP;TNMD;CAV1;CAV2;FGF2;BMP2;SULF1;F3;ANGPT1;EGR3;STAT5A;NR4A1;PPP1R16B;TEK;XDH
GO:0009966,regulation of signal transduction (GO:0009966),198,27,13.69413683,1.971646723,5.39E-04,0.025532472,11343;948;26153;2625;8644;4684;83439;23213;5727;9370;3993;6376;51473;23542;1840;3489;5753;8835;23235;3977;50943;6725;5997;9628;84870;2788;5999,CX3CL1;LIFR;IGFBP6;ADIPOQ;RSPO3;CD36;RGS6;SULF1;NCAM1;RGS2;SIK2;FOXP3;SOCS2;DTX1;PTCH1;AKR1C3;MGLL;LLGL2;RGS4;GNG7;KIF26A;TCF7L1;MAPK8IP2;SRMS;PTK6;GATA3;DCDC2
GO:0030239,myofibril assembly (GO:0030239),43,10,2.973979211,3.362498287,5.62E-04,0.026201327,80206;25802;7111;4621;7138;7140;3880;825;9172;5239,LMOD1;PGM5;TMOD1;TNNT3;TNNT1;CAPN3;MYH3;MYOM2;FHOD3;KRT19
GO:0048562,embryonic organ morphogenesis (GO:0048562),43,10,2.973979211,3.362498287,5.62E-04,0.026201327,3201;3200;6664;64321;220;2201;2202;5950;348093;4237,HOXA4;RBP4;HOXA3;MFAP2;SOX17;EFEMP1;FBN2;ALDH1A3;RBPMS2;SOX11
GO:0032465,regulation of cytokinesis (GO:0032465),84,15,5.809633807,2.581918327,5.81E-04,0.026865892,1894;9928;11113;6790;9212;5347;29127;9493;10733;990;90293;8555;168448;10112;9055,KIF20A;PLK1;AURKA;KLHL13;KIF14;CDC6;KIF23;PRC1;CIT;AURKB;CDC14B;ECT2;RACGAP1;PLK4;CDC14C
GO:0046686,response to cadmium ion (GO:0046686),29,8,2.005706909,3.988618657,5.90E-04,0.027080707,1956;23498;8644;4318;4499;4501;3725;2353,MT1M;MT1X;EGFR;JUN;FOS;AKR1C3;MMP9;HAAO
GO:1904705,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),36,9,2.48984306,3.614685658,5.99E-04,0.027296008,5468;3479;2247;9370;4318;8013;3725;9510;1264,CNN1;ADAMTS1;FGF2;ADIPOQ;PPARG;JUN;MMP9;IGF1;NR4A3
GO:0042327,positive regulation of phosphorylation (GO:0042327),252,32,17.42890142,1.83603081,6.25E-04,0.028227846,3815;2255;2252;4916;4915;1956;3952;3479;2246;284;51085;8685;650;5919;7301;5979;2051;2047;8671;2247;4233;9370;5207;3953;7010;4318;146433;57161;4921;5329;5209;284654,NTRK2;LEP;FGF1;LEPR;EPHB1;FGF2;ADIPOQ;KIT;MLXIPL;BMP2;PELI2;EGFR;PFKFB1;ANGPT1;MET;EPHB6;NTRK3;FGF10;IL34;MMP9;PLAUR;SLC4A4;IGF1;MARCO;DDR2;FGF7;TEK;PFKFB3;RSPO1;RET;TYRO3;RARRES2
GO:0031032,actomyosin structure organization (GO:0031032),76,14,5.256335349,2.66345259,6.35E-04,0.028256383,80206;25802;7111;4621;7138;7140;3880;825;10580;11113;257019;9172;2037;5239,LMOD1;PGM5;CIT;TMOD1;SORBS1;TNNT3;TNNT1;CAPN3;MYH3;EPB41L2;FRMD3;MYOM2;FHOD3;KRT19
GO:0010717,regulation of epithelial to mesenchymal transition (GO:0010717),76,14,5.256335349,2.66345259,6.35E-04,0.028256383,7048;3569;650;2625;3249;51176;6422;10252;2296;10253;1277;2146;3169;54756,SPRY2;SFRP1;EZH2;TGFBR2;BMP2;LEF1;SPRY1;IL17RD;IL6;FOXC1;HPN;GATA3;COL1A1;FOXA1
GO:0071248,cellular response to metal ion (GO:0071248),131,20,9.060262246,2.207441623,6.60E-04,0.028318096,6622;1894;1956;825;358;7018;8644;2822;654;6263;6261;90019;83849;57586;4318;4499;4501;3725;2353;27132,RYR3;MT1M;TF;ECT2;MT1X;SNCA;AQP1;EGFR;JUN;GPLD1;CAPN3;FOS;AKR1C3;MMP9;BMP6;SYT8;SYT15;RYR1;SYT13;CPNE7
GO:0042593,glucose homeostasis (GO:0042593),85,15,5.878796114,2.551542818,6.61E-04,0.028318096,3745;4804;5468;150;3569;51085;2308;9370;10891;5950;5105;1050;6517;3953;5166,PDK4;SLC2A4;RBP4;LEPR;ADIPOQ;PCK1;MLXIPL;PPARG;NGFR;KCNB1;FOXO1;PPARGC1A;IL6;ADRA2A;CEBPA
GO:0043549,regulation of kinase activity (GO:0043549),94,16,6.501256879,2.461062576,6.70E-04,0.028318096,9368;3815;1894;4916;4915;1956;7301;5979;8660;2051;2047;4233;7010;4921;1028;9079,NTRK2;EPHB1;ECT2;KIT;LDB2;CDKN1C;EGFR;MET;EPHB6;NTRK3;IRS2;DDR2;SLC9A3R1;TEK;RET;TYRO3
GO:0071380,cellular response to prostaglandin E stimulus (GO:0071380),7,4,0.484136151,8.262138647,6.72E-04,0.028318096,7292;54331;5734;6422,SFRP1;TNFSF4;PTGER4;GNG2
GO:1905208,negative regulation of cardiocyte differentiation (GO:1905208),7,4,0.484136151,8.262138647,6.72E-04,0.028318096,1956;650;23493;55553,BMP2;EGFR;SOX6;HEY2
GO:0071313,cellular response to caffeine (GO:0071313),7,4,0.484136151,8.262138647,6.72E-04,0.028318096,6263;6261;845;2946,RYR3;GSTM2;CASQ2;RYR1
GO:0031000,response to caffeine (GO:0031000),7,4,0.484136151,8.262138647,6.72E-04,0.028318096,6263;6261;845;2946,RYR3;GSTM2;CASQ2;RYR1
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),23,7,1.590733066,4.400486888,6.80E-04,0.028318096,1756;9472;287;477;845;3270;2946,DMD;ATP1A2;GSTM2;AKAP6;CASQ2;ANK2;HRC
GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),17,6,1.175759223,5.103085635,6.88E-04,0.028318096,1756;287;477;845;3270;2946,DMD;ATP1A2;GSTM2;CASQ2;ANK2;HRC
GO:0000076,DNA replication checkpoint signaling (GO:0000076),17,6,1.175759223,5.103085635,6.88E-04,0.028318096,63967;81620;1763;990;4998;8318,CLSPN;CDC6;CDC45;ORC1;CDT1;DNA2
GO:0051983,regulation of chromosome segregation (GO:0051983),17,6,1.175759223,5.103085635,6.88E-04,0.028318096,9212;11004;699;116028;990;4288,BUB1;MKI67;KIF2C;CDC6;AURKB;RMI2
GO:0051240,positive regulation of multicellular organismal process (GO:0051240),341,40,23.58434676,1.696040192,7.16E-04,0.029261908,554;154;2690;3952;150;7048;3624;3569;7292;6288;2167;857;5734;5746;2180;948;650;7704;6664;51176;4881;2247;658;5021;55553;9370;63976;10891;3953;6660;2034;2296;1277;2146;90865;5764;4237;50486;338442;64641,INHBA;LEP;FABP4;ZBTB16;LEPR;OXTR;CAV1;SAA1;ADRB2;AVPR2;FGF2;NPR1;ADIPOQ;G0S2;EZH2;CD36;TGFBR2;IL33;PTN;BMP2;TNFSF4;MFAP2;HCAR2;LEF1;GHR;PTGER4;PPARGC1A;PRDM16;EPAS1;IL6;SOX6;EBF2;ACSL1;FOXC1;BMPR1B;SOX5;ADRA2A;PTH2R;COL1A1;SOX11
GO:0032467,positive regulation of cytokinesis (GO:0032467),37,9,2.559005367,3.516991451,7.44E-04,0.030018925,1894;9928;11113;9212;29127;9493;990;8555;168448,KIF14;CDC6;KIF23;CIT;AURKB;CDC14B;ECT2;RACGAP1;CDC14C
GO:0001755,neural crest cell migration (GO:0001755),37,9,2.559005367,3.516991451,7.44E-04,0.030018925,6663;54437;80031;57556;10371;223117;56920;2348;2335,SEMA5B;FN1;SEMA3G;SOX10;SEMA3D;SEMA6D;SEMA6A;FOLR1;SEMA3A
GO:0150104,transport across blood-brain barrier (GO:0150104),86,15,5.947958421,2.521873715,7.51E-04,0.030088811,9368;9429;8140;948;9194;6581;8671;6517;3953;6523;5243;477;222962;10060;482,ATP1A2;SLC2A4;LEPR;CD36;ABCB1;SLC22A3;ATP1B2;SLC4A4;SLC16A7;SLC9A3R1;SLC7A5;ABCG2;SLC29A4;ABCC9;SLC5A1
GO:0086001,cardiac muscle cell action potential (GO:0086001),30,8,2.074869217,3.855664702,7.57E-04,0.030116591,1756;3753;55800;6327;30819;287;6330;477,DMD;SCN4B;KCNE1;ATP1A2;KCNIP2;SCN2B;SCN3B;ANK2
GO:0033500,carbohydrate homeostasis (GO:0033500),69,13,4.772199198,2.724110931,7.86E-04,0.031081521,3745;4804;5468;150;3569;51085;9370;5950;5105;1050;6517;3953;5166,PDK4;SLC2A4;RBP4;LEPR;ADIPOQ;PCK1;MLXIPL;PPARG;NGFR;KCNB1;IL6;ADRA2A;CEBPA
GO:0033993,response to lipid (GO:0033993),114,18,7.884503023,2.282959363,8.05E-04,0.031181557,301;6622;5468;1373;948;6696;6590;2308;4435;57402;6403;5950;5105;8835;2878;3169;249;3294,RBP4;ANXA1;PCK1;SNCA;CD36;PPARG;GPX3;FOXO1;SOCS2;ALPL;CPS1;SPP1;CITED1;S100A14;HSD17B2;SELP;SLPI;FOXA1
GO:0046321,positive regulation of fatty acid oxidation (GO:0046321),12,5,0.829947687,6.024476097,8.23E-04,0.031181557,8660;10891;8013;225;440503,ABCD2;IRS2;PPARGC1A;NR4A3;PLIN5
GO:0006069,ethanol oxidation (GO:0006069),12,5,0.829947687,6.024476097,8.23E-04,0.031181557,216;125;126;124;217,ADH1C;ADH1A;ADH1B;ALDH1A1;ALDH2
GO:1904668,positive regulation of ubiquitin protein ligase activity (GO:1904668),12,5,0.829947687,6.024476097,8.23E-04,0.031181557,11065;991;27338;5347;8555,UBE2C;PLK1;CDC20;CDC14B;UBE2S
GO:0051315,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),12,5,0.829947687,6.024476097,8.23E-04,0.031181557,11004;1062;81620;83540;10403,NUF2;NDC80;KIF2C;CENPE;CDT1
GO:0050921,positive regulation of chemotaxis (GO:0050921),45,10,3.112303825,3.213053918,8.25E-04,0.031181557,2152;6366;4916;64805;3569;5919;1907;2247;4233;5764,FGF2;PTN;P2RY12;F3;MET;CCL21;NTRK3;IL6;EDN2;RARRES2
GO:0014032,neural crest cell development (GO:0014032),45,10,3.112303825,3.213053918,8.25E-04,0.031181557,3084;1000;6663;54437;80031;57556;10371;223117;56920;6664,SEMA5B;SEMA3G;SOX10;SEMA3D;SEMA6D;SEMA6A;NRG1;SEMA3A;CDH2;SOX11
GO:0085029,extracellular matrix assembly (GO:0085029),24,7,1.659895373,4.217133268,9.03E-04,0.033589537,3914;4629;10516;2824;3038;4239;7148,MYH11;TNXB;HAS3;LAMB3;MFAP4;GPM6B;FBLN5
GO:0010811,positive regulation of cell-substrate adhesion (GO:0010811),70,13,4.841361506,2.68519506,9.05E-04,0.033589537,6366;948;79625;2335;255743;6422;56477;6376;55679;1842;5212;10551;10562,CX3CL1;FN1;VIT;SFRP1;LIMS2;CD36;CCL21;CCL28;OLFM4;ECM2;NPNT;NDNF;AGR2
GO:0001822,kidney development (GO:0001822),70,13,4.841361506,2.68519506,9.05E-04,0.033589537,2255;64220;4311;185;2625;7704;64321;23213;1063;4435;130497;4038;2296,MME;CENPF;ZBTB16;OSR1;SULF1;LRP4;SOX17;FGF10;CITED1;FOXC1;AGTR1;STRA6;GATA3
GO:0001934,positive regulation of protein phosphorylation (GO:0001934),368,42,25.45172906,1.650182583,9.29E-04,0.033961429,2255;2252;6622;6366;4916;2690;4915;1956;3952;3479;2246;284;3624;3569;857;8685;5347;650;5919;1062;5649;55024;2247;353500;654;9370;10411;3953;6376;7010;4318;5168;146433;10253;57161;2662;4921;5329;7272;80310;284654;23531,INHBA;SPRY2;NTRK2;CX3CL1;LEP;PLK1;FGF1;BMP8A;RELN;LEPR;CENPE;CAV1;GDF10;TTK;FGF2;ADIPOQ;RAPGEF3;SNCA;ENPP2;BMP2;PELI2;EGFR;GHR;ANGPT1;PDGFD;CCL21;NTRK3;FGF10;IL34;MMP9;PLAUR;BMP6;IGF1;IL6;MARCO;DDR2;FGF7;TEK;MMD;RSPO1;RARRES2;BANK1
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),106,17,7.331204566,2.318854951,9.30E-04,0.033961429,9368;3815;4916;4915;1956;3952;3479;2335;8660;219699;2247;6403;7010;1634;26051;8395;80310,NTRK2;LEP;FN1;FGF2;KIT;UNC5B;EGFR;PDGFD;NTRK3;IRS2;PPP1R16B;IGF1;DCN;SLC9A3R1;TEK;SELP;PIP5K1B
GO:0090288,negative regulation of cellular response to growth factor stimulus (GO:0090288),79,14,5.463822271,2.562308821,9.47E-04,0.033961429,5468;650;2247;168667;658;23213;10252;10253;348093;64102;90993;79812;51232;25928,SPRY2;TNMD;FGF2;BMPER;BMP2;PPARG;SULF1;SOSTDC1;CRIM1;SPRY1;MMRN2;CREB3L1;BMPR1B;RBPMS2
GO:0043588,skin development (GO:0043588),79,14,5.463822271,2.562308821,9.47E-04,0.033961429,301;26154;8626;8644;4233;6261;1281;2125;1278;1277;1290;1289;3868;10628,ANXA1;TXNIP;MET;COL5A2;COL5A1;TP63;AKR1C3;EVPL;RYR1;ABCA12;COL1A1;COL3A1;COL1A2;KRT16
GO:0120162,positive regulation of cold-induced thermogenesis (GO:0120162),97,16,6.708743801,2.384947238,9.53E-04,0.033961429,154;3952;2167;857;5746;2180;948;5021;9370;63976;10891;3953;2034;4237;50486;64641,LEP;FABP4;LEPR;OXTR;CAV1;ADRB2;ADIPOQ;G0S2;CD36;MFAP2;PPARGC1A;PRDM16;EPAS1;EBF2;ACSL1;PTH2R
GO:0043405,regulation of MAP kinase activity (GO:0043405),97,16,6.708743801,2.384947238,9.53E-04,0.033961429,3815;1956;150;2246;1906;2247;9370;10252;101;1843;146433;10253;57761;2146;5997;80310,SPRY2;FGF1;FGF2;ADIPOQ;KIT;EZH2;EGFR;ADAM8;RGS2;PDGFD;SPRY1;DUSP1;TRIB3;IL34;EDN1;ADRA2A
GO:0050995,negative regulation of lipid catabolic process (GO:0050995),18,6,1.24492153,4.819580878,9.72E-04,0.033961429,150;2822;5140;1149;440503;338442,CIDEA;HCAR2;GPLD1;PDE3B;ADRA2A;PLIN5
GO:0061036,positive regulation of cartilage development (GO:0061036),18,6,1.24492153,4.819580878,9.72E-04,0.033961429,650;7704;658;55553;6660;91461,ZBTB16;BMP2;SOX6;PKDCC;BMPR1B;SOX5
GO:0071312,cellular response to alkaloid (GO:0071312),18,6,1.24492153,4.819580878,9.72E-04,0.033961429,6263;6261;845;641;5888;2946,RYR3;RAD51;GSTM2;BLM;CASQ2;RYR1
GO:0045687,positive regulation of glial cell differentiation (GO:0045687),18,6,1.24492153,4.819580878,9.72E-04,0.033961429,650;1959;5803;274;146433;5764,PTN;BMP2;PTPRZ1;EGR2;IL34;BIN1
GO:1902533,positive regulation of intracellular signal transduction (GO:1902533),542,57,37.48597051,1.520568875,9.80E-04,0.033991825,9368;3815;2255;2252;154;2152;6366;1894;4916;4915;64805;1956;3952;3479;150;2246;284;3084;3569;857;7481;4057;79971;650;2625;5366;8644;2335;6664;6285;5979;5649;8660;219699;2247;4233;9370;1646;6403;858;6376;7010;101;9365;152831;10253;57761;8638;57161;1634;4306;2159;9542;7450;219790;80310;51704,SPRY2;NTRK2;CX3CL1;LEP;FN1;NRG2;FGF1;S100B;RELN;CAV1;NR3C2;ADRB2;KL;CAV2;FGF2;ADIPOQ;ECT2;KIT;UNC5B;AKR1C2;BMP2;KLB;P2RY12;PELI2;EGFR;ADAM8;F10;F3;RTKN2;ANGPT1;MET;PDGFD;GPRC5B;CCL21;NTRK3;IRS2;FGF10;TRIB3;AKR1C3;WLS;NRG1;IGF1;DCN;IL6;VWF;WNT11;SLC9A3R1;FGF7;TEK;SELP;PMAIP1;OASL;RET;ADRA2A;GATA3;SOX11;LTF
GO:0048661,positive regulation of smooth muscle cell proliferation (GO:0048661),46,10,3.181466132,3.14320492,9.90E-04,0.033991825,3479;3569;1906;2247;6376;4318;8013;3725;348093;9510,CX3CL1;ADAMTS1;FGF2;JUN;MMP9;IGF1;IL6;EDN1;RBPMS2;NR4A3
GO:0051101,regulation of DNA binding (GO:0051101),46,10,3.181466132,3.14320492,9.90E-04,0.033991825,5468;3479;81620;51176;1869;4318;3725;2296;55355;5329,HJURP;PPARG;E2F1;JUN;LEF1;CDT1;MMP9;PLAUR;IGF1;FOXC1
GO:0006941,striated muscle contraction (GO:0006941),54,11,3.73476459,2.945299425,9.99E-04,0.034119616,4621;7138;7140;1756;55800;6327;6330;477;845;6769;342667,DMD;SCN4B;ATP1A2;SCN2B;SCN3B;TNNT3;STAC2;TNNT1;MYH3;CASQ2;STAC
GO:1903508,positive regulation of nucleic acid-templated transcription (GO:1903508),509,54,35.20361438,1.533933403,0.001080924,0.036708674,2252;5468;1956;3479;3624;825;3569;51085;7481;6663;6696;650;23493;2625;8626;7704;2308;6664;5979;4781;51176;10365;2247;64321;1959;9915;4435;63976;10891;6422;8322;1869;2305;3038;641;3725;2353;2296;1958;9314;54997;1277;50943;675;6886;59;84913;79190;1028;56981;29028;3229;253738;9586,INHBA;ATOH8;FOXM1;ZBTB16;TESC;SFRP1;HAS3;EGR1;FGF2;CREB5;MLXIPL;PRDM11;CDKN1C;BMP2;PPARG;SOX10;E2F1;EGFR;NFIB;EBF3;JUN;FOXO1;EGR2;ATAD2;LEF1;CAPN3;KLF4;TAL1;FOS;SOX17;FOXP3;IRX6;BLM;TP63;PPARGC1A;SPP1;FZD4;ACTA2;CITED1;PRDM16;BRCA2;IGF1;IL6;HEY2;WNT11;FGF7;FOXC1;HOXC13;KLF2;RET;ARNT2;GATA3;COL1A1;SOX11
GO:0006260,DNA replication (GO:0006260),108,17,7.46952918,2.275913192,0.001151852,0.038897645,63967;983;1763;8317;374393;83990;116028;990;9401;10535;641;4173;55388;23594;4998;8318;9156,CDK1;EXO1;CLSPN;FAM111B;CDC6;RMI2;CDC45;MCM10;RNASEH2A;RECQL4;ORC6;BRIP1;ORC1;MCM4;BLM;DNA2;CDC7
GO:1903779,regulation of cardiac conduction (GO:1903779),55,11,3.803926897,2.891748527,0.001172104,0.03925765,287;4881;6263;6261;477;845;10060;482;4882;5348;10699,FXYD1;ATP1A2;RYR3;NPR1;NPR2;CASQ2;ATP1B2;CORIN;ANK2;RYR1;ABCC9
GO:0015909,long-chain fatty acid transport (GO:0015909),32,8,2.213193831,3.614685658,0.001201698,0.03925765,32;5468;2167;2180;948;7069;225;28965,FABP4;ACACB;CD36;PPARG;SLC27A6;ABCD2;THRSP;ACSL1
GO:0051899,membrane depolarization (GO:0051899),32,8,2.213193831,3.614685658,0.001201698,0.03925765,6329;6326;6335;6332;6328;55800;857;27092,SCN3A;CAV1;SCN3B;SCN4A;SCN2A;SCN9A;SCN7A;CACNG4
GO:0002062,chondrocyte differentiation (GO:0002062),32,8,2.213193831,3.614685658,0.001201698,0.03925765,650;4781;2822;658;23213;55553;130497;6660,OSR1;BMP2;SULF1;NFIB;GPLD1;SOX6;BMPR1B;SOX5
GO:0035987,endodermal cell differentiation (GO:0035987),32,8,2.213193831,3.614685658,0.001201698,0.03925765,3624;2335;3909;3914;3679;4318;1303;1301,COL11A1;INHBA;FN1;ITGA7;LAMB3;MMP9;LAMA3;COL12A1
GO:0000083,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),32,8,2.213193831,3.614685658,0.001201698,0.03925765,81620;6241;1869;898;990;7298;4998;8318,RRM2;CDC6;CDC45;E2F1;ORC1;TYMS;CDT1;CCNE1
GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),118,18,8.161152252,2.20557091,0.001214001,0.039445179,1901;55366;111;196883;154;150;54331;2774;3627;5737;135;4283;133;5745;5744;10267;5734;1268,GNAL;ADRB2;CXCL10;PTGFR;ADCY4;PTGER4;S1PR1;PTH1R;ADCY5;LGR4;RAMP1;CXCL9;CNR1;ADORA2A;GNG2;ADM;ADRA2A;PTHLH
GO:0010640,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),13,5,0.899109994,5.561054859,0.001261678,0.039782581,9368;6622;2152;347;9370,ADIPOQ;SNCA;F3;APOD;SLC9A3R1
GO:0010676,positive regulation of cellular carbohydrate metabolic process (GO:0010676),13,5,0.899109994,5.561054859,0.001261678,0.039782581,6622;5745;5366;8660;2822,SNCA;GPLD1;IRS2;PTH1R;PMAIP1
GO:0014829,vascular associated smooth muscle contraction (GO:0014829),8,4,0.553298458,7.229371316,0.001270713,0.039782581,1910;1906;1907;59,EDNRB;ACTA2;EDN1;EDN2
GO:0071493,cellular response to UV-B (GO:0071493),8,4,0.553298458,7.229371316,0.001270713,0.039782581,4311;3373;1396;4239,MME;HYAL1;MFAP4;CRIP1
GO:1904776,regulation of protein localization to cell cortex (GO:1904776),8,4,0.553298458,7.229371316,0.001270713,0.039782581,2037;2770;5347;89958,PLK1;GNAI1;EPB41L2;SAPCD2
GO:0048251,elastic fiber assembly (GO:0048251),8,4,0.553298458,7.229371316,0.001270713,0.039782581,4629;10516;4239;7148,MYH11;TNXB;MFAP4;FBLN5
GO:1902099,regulation of metaphase/anaphase transition of cell cycle (GO:1902099),8,4,0.553298458,7.229371316,0.001270713,0.039782581,11065;5347;1062;990,UBE2C;PLK1;CENPE;CDC6
GO:0032103,positive regulation of response to external stimulus (GO:0032103),138,20,9.544398397,2.095469947,0.00128163,0.039916475,6622;6366;64805;7292;4023;5734;5138;185;5919;654;1050;6376;101;115362;8638;85480;90865;5320;5764;51704,TSLP;CX3CL1;PDE2A;LPL;SNCA;IL33;PTN;TNFSF4;P2RY12;ADAM8;PTGER4;GPRC5B;CCL21;BMP6;OASL;GBP5;AGTR1;CEBPA;PLA2G2A;RARRES2
GO:0071407,cellular response to organic cyclic compound (GO:0071407),148,21,10.23602147,2.051578347,0.001291855,0.040027528,3753;9472;111;64805;1956;54331;2770;5138;2348;358;6696;6263;10411;6422;477;641;8013;5888;2908;1958;7035,KCNE1;ATP1A2;RYR3;PDE2A;SFRP1;RAD51;EGR1;RAPGEF3;AQP1;P2RY12;EGFR;NR3C1;TFPI;AKAP6;BLM;GNAI1;ADCY5;SPP1;FOLR1;GNG2;NR4A3
GO:0006067,ethanol metabolic process (GO:0006067),19,6,1.314083837,4.565918726,0.001337898,0.040412576,27233;216;125;126;124;217,ADH1C;ADH1A;ADH1B;ALDH1A1;SULT1C4;ALDH2
GO:0048592,eye morphogenesis (GO:0048592),19,6,1.314083837,4.565918726,0.001337898,0.040412576,220;2201;2202;1290;1289;4237,MFAP2;COL5A2;COL5A1;EFEMP1;FBN2;ALDH1A3
GO:0150077,regulation of neuroinflammatory response (GO:0150077),19,6,1.314083837,4.565918726,0.001337898,0.040412576,3479;3569;5743;4314;4318;90865,IL33;PTGS2;MMP3;MMP9;IGF1;IL6
GO:0001657,ureteric bud development (GO:0001657),19,6,1.314083837,4.565918726,0.001337898,0.040412576,7481;2719;650;255743;130497;2296,OSR1;GPC3;BMP2;WNT11;NPNT;FOXC1
GO:0060675,ureteric bud morphogenesis (GO:0060675),19,6,1.314083837,4.565918726,0.001337898,0.040412576,7481;650;2625;2247;255743;4435,FGF2;BMP2;CITED1;WNT11;NPNT;GATA3
GO:0045428,regulation of nitric oxide biosynthetic process (GO:0045428),40,9,2.766492289,3.253217092,0.001356425,0.04057811,857;948;947;5740;5743;3043;1906;10365;9314,CAV1;HBB;CD36;KLF4;PTGS2;CD34;PTGIS;EDN1;KLF2
GO:0031328,positive regulation of cellular biosynthetic process (GO:0031328),179,24,12.38005299,1.938602364,0.001356879,0.04057811,6622;6366;1956;3479;10580;3569;51085;5745;948;5743;81620;8660;1763;3043;1906;10365;2822;2247;10891;1958;9314;440503;23034;55323,EGR1;FGF2;HBB;SNCA;SORBS1;MLXIPL;CD36;EGFR;GPLD1;KLF4;PTGS2;CCL21;CDT1;LARP6;IRS2;DNA2;PPARGC1A;PTH1R;SAMD4A;IGF1;IL6;EDN1;KLF2;PLIN5
GO:0007423,sensory organ development (GO:0007423),56,11,3.873089204,2.84011016,0.001369135,0.040741937,64220;2625;658;4212;5950;91851;2296;64093;170692;4081;27151,RBP4;MAB21L1;CHRDL1;MEIS2;CPAMD8;SMOC1;ADAMTS18;FOXC1;BMPR1B;STRA6;GATA3
GO:0042552,myelination (GO:0042552),48,10,3.319790747,3.012238048,0.001400252,0.041316114,6326;6663;5653;5354;11076;225;163175;84668;23114;114569,FAM126A;PLP1;LGI4;SOX10;SCN2A;ABCD2;TPPP;MAL2;NFASC;KLK6
GO:0007167,enzyme linked receptor protein signaling pathway (GO:0007167),139,20,9.613560704,2.080394623,0.001402177,0.041316114,3815;4916;4915;1956;7301;5979;2675;2051;2047;4881;4233;7010;5753;3977;4882;4921;5764;6725;399694;9068,NTRK2;LIFR;EPHB1;NPR1;ANGPTL1;KIT;PTN;EGFR;MET;EPHB6;GFRA2;NTRK3;NPR2;DDR2;TEK;SRMS;PTK6;RET;TYRO3;SHC4
GO:0007399,nervous system development (GO:0007399),445,48,30.77722671,1.559594711,0.001418761,0.041600841,1128;2934;6326;1894;3084;3624;130399;135;1000;6663;57556;5653;320;9378;7301;7704;2335;1910;6285;9638;7436;2675;1949;5649;2047;2247;1959;55553;10763;5050;9915;4233;79633;2824;8128;1462;5803;1271;7368;6491;8854;5764;284403;57716;23114;51232;10644;9079,INHBA;FN1;S100B;RELN;ZBTB16;ALDH1A2;EPHB1;FGF2;PAFAH1B3;STIL;ECT2;WDR62;NRXN1;GSN;LDB2;PTN;ACVR1C;PTPRZ1;SOX10;NES;PRX;SCN2A;EDNRB;CNTFR;CRIM1;EGR2;APBA1;MET;VCAN;SEMA6A;GFRA2;GPM6B;FEZ1;FAT4;IGF2BP2;NRG1;SOX6;ADORA2A;VLDLR;NFASC;EFNB3;KLK6;CDH2;ARNT2;UGT8;TYRO3;ST8SIA2;CHRM1
GO:1901701,cellular response to oxygen-containing compound (GO:1901701),320,37,22.13193831,1.671792117,0.001444449,0.042148463,7538;3753;9472;10563;64805;1956;3569;7292;4023;54331;3627;4283;5138;7481;2348;358;1511;2920;2308;8644;5979;2822;6263;10411;6422;8322;7477;5166;55022;4314;4318;5753;8013;3725;2353;1958;54997,CXCL2;KCNE1;RYR3;TESC;PDK4;PDE2A;SFRP1;LPL;EGR1;RAPGEF3;CXCL10;AQP1;TNFSF4;P2RY12;EGFR;JUN;GPLD1;FOXO1;PID1;FOS;AKAP6;ZFP36;AKR1C3;MMP3;MMP9;FZD4;FOLR1;IL6;CXCL9;WNT11;CTSG;PTK6;GNG2;RET;NR4A3;CXCL13;WNT7B
GO:0001570,vasculogenesis (GO:0001570),33,8,2.282356138,3.505149729,0.001491433,0.043309204,7048;857;133;23493;7049;54922;64321;7477,CAV1;TGFBR3;TGFBR2;SOX17;RASIP1;HEY2;ADM;WNT7B
GO:0031641,regulation of myelination (GO:0031641),26,7,1.798219988,3.892738401,0.001520451,0.043939561,9928;11076;1959;5803;5764;58494;163175,KIF14;LGI4;JAM2;PTN;PTPRZ1;EGR2;TPPP
GO:0044344,cellular response to fibroblast growth factor stimulus (GO:0044344),92,15,6.362932264,2.35740369,0.001532572,0.044077951,7538;2255;2252;2246;79625;23768;1960;2247;3164;6422;3373;9365;54845;152831;79801,FGF1;SFRP1;SHCBP1;KL;FGF2;KLB;HYAL1;EGR3;ZFP36;FGF10;FLRT2;NR4A1;FGF7;NDNF;ESRP1
GO:0007088,regulation of mitotic nuclear division (GO:0007088),57,11,3.942251512,2.790283666,0.001592526,0.045584156,3479;6790;891;1906;858;9088;4751;1843;83987;51203;4288,NEK2;PKMYT1;NUSAP1;MKI67;AURKA;CCNB1;CAV2;DUSP1;CCDC8;IGF1;EDN1
GO:0150063,visual system development (GO:0150063),41,9,2.835654596,3.173870334,0.001633009,0.046521396,658;4212;5950;91851;2296;64093;170692;4081;27151,RBP4;MAB21L1;CHRDL1;MEIS2;CPAMD8;SMOC1;ADAMTS18;FOXC1;BMPR1B
GO:0010634,positive regulation of epithelial cell migration (GO:0010634),93,15,6.432094572,2.332055263,0.001713152,0.048574333,2255;2252;2246;284;2625;1906;2822;2247;3373;7010;57111;4318;5168;306;84913,ATOH8;FGF1;FGF2;ENPP2;GPLD1;ANGPT1;HYAL1;FGF10;MMP9;ANXA3;EDN1;FGF7;TEK;RAB25;GATA3
GO:0010232,vascular transport (GO:0010232),84,14,5.809633807,2.409790439,0.001751329,0.049423657,9368;9429;8140;9194;6581;8671;6517;3953;6523;5243;477;222962;10060;482,ATP1A2;SLC2A4;LEPR;ABCB1;SLC22A3;ATP1B2;SLC4A4;SLC16A7;SLC9A3R1;SLC7A5;ABCG2;SLC29A4;ABCC9;SLC5A1
GO:0042908,xenobiotic transport (GO:0042908),20,6,1.383246144,4.33762279,0.001800566,0.050107412,10351;9429;8140;6581;5243;222962,ABCA8;ABCB1;SLC22A3;SLC7A5;ABCG2;SLC29A4
GO:0010954,positive regulation of protein processing (GO:0010954),20,6,1.383246144,4.33762279,0.001800566,0.050107412,2934;3249;147372;101;7123;2161,CLEC3B;GSN;ADAM8;CCBE1;F12;HPN
GO:0048843,negative regulation of axon extension involved in axon guidance (GO:0048843),20,6,1.383246144,4.33762279,0.001800566,0.050107412,54437;80031;57556;10371;223117;56920,SEMA5B;SEMA3G;SEMA3D;SEMA6D;SEMA6A;SEMA3A
GO:0051281,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),34,8,2.351518446,3.40205709,0.001833883,0.050566387,9472;6622;825;3627;4283;57158;6376;2946,CX3CL1;JPH2;SNCA;CXCL10;CAPN3;GSTM2;AKAP6;CXCL9
GO:0048706,embryonic skeletal system development (GO:0048706),34,8,2.351518446,3.40205709,0.001833883,0.050566387,7481;3201;3200;6664;23213;5950;130497;1277,HOXA4;RBP4;OSR1;HOXA3;SULF1;WNT11;COL1A1;SOX11
GO:0043009,chordate embryonic development (GO:0043009),58,11,4.011413819,2.742175327,0.001844839,0.050590633,7481;650;2625;23213;5727;9915;7477;5950;1277;6491;8854,RBP4;ALDH1A2;STIL;BMP2;SULF1;PTCH1;WNT11;ARNT2;GATA3;COL1A1;WNT7B
GO:0055002,striated muscle cell development (GO:0055002),14,5,0.968272301,5.163836655,0.001851595,0.050590633,25802;7111;825;5239;6382,LMOD1;PGM5;TMOD1;CAPN3;SDC1
GO:0006812,cation transport (GO:0006812),173,23,11.96507915,1.922260581,0.001891764,0.051454274,6329;6326;6335;6332;6328;55800;11254;358;6581;3779;30819;3777;6330;8671;140803;6523;477;222962;10060;57156;7881;9132;3742,SCN4B;SCN3A;ATP1A2;KCNIP2;KCNMB1;SCN3B;SCN4A;AQP1;SCN2A;SLC22A3;KCNAB1;TRPM6;KCNA6;SLC4A4;SCN9A;SLC6A14;KCNQ4;SLC29A4;KCNK3;SCN7A;ABCC9;TMEM63C;SLC5A1
GO:0009893,positive regulation of metabolic process (GO:0009893),113,17,7.815340716,2.175209069,0.001911656,0.051761098,32;154;3952;2167;857;5746;2180;948;5021;9370;63976;10891;3953;2034;4237;50486;64641,LEP;FABP4;LEPR;OXTR;CAV1;ADRB2;ACACB;ADIPOQ;G0S2;CD36;MFAP2;PPARGC1A;PRDM16;EPAS1;EBF2;ACSL1;PTH2R
GO:1904427,positive regulation of calcium ion transmembrane transport (GO:1904427),27,7,1.867382295,3.748562905,0.001931682,0.051836351,9472;6622;825;3627;4283;287;6376,CX3CL1;SNCA;CXCL10;CAPN3;AKAP6;ANK2;CXCL9
GO:0071276,cellular response to cadmium ion (GO:0071276),27,7,1.867382295,3.748562905,0.001931682,0.051836351,1956;8644;4318;4499;4501;3725;2353,MT1M;MT1X;EGFR;JUN;FOS;AKR1C3;MMP9
GO:0051302,regulation of cell division (GO:0051302),76,13,5.256335349,2.473205977,0.001983856,0.052999805,2246;6790;9212;5347;8626;10733;641;23594;90293;10112;6886;10628;9055,KIF20A;PLK1;AURKA;KLHL13;FGF1;PRC1;AURKB;TXNIP;ORC6;TAL1;PLK4;BLM;TP63
GO:0032147,activation of protein kinase activity (GO:0032147),114,17,7.884503023,2.156128287,0.002105565,0.056002433,111;196883;154;1894;4916;2690;5577;3952;3479;150;22974;2246;63967;284;3084;7048;9928,TPX2;LEP;CLSPN;KIF14;FGF1;ADRB2;ECT2;TGFBR2;ADCY4;GHR;ANGPT1;NTRK3;ADCY5;NRG1;IGF1;PRKAR2B;ADRA2A
GO:0071396,cellular response to lipid (GO:0071396),217,27,15.00822067,1.79901406,0.002156781,0.056514178,7538;111;10563;1956;3569;7292;4023;3627;4283;2770;7481;358;6696;1511;2920;5979;2822;6422;8322;7477;5166;477;55022;5753;2908;7035;54997,CXCL2;ATP1A2;TESC;PDK4;SFRP1;LPL;CXCL10;AQP1;TNFSF4;EGFR;NR3C1;GPLD1;PID1;TFPI;ZFP36;GNAI1;ADCY5;SPP1;FZD4;IL6;CXCL9;WNT11;CTSG;PTK6;RET;CXCL13;WNT7B
GO:0003094,glomerular filtration (GO:0003094),9,4,0.622460765,6.426107837,0.002162412,0.056514178,4162;947;23213;57156,SULF1;CD34;MCAM;TMEM63C
GO:2000258,negative regulation of protein activation cascade (GO:2000258),9,4,0.622460765,6.426107837,0.002162412,0.056514178,2152;7035;2159;2161,F10;F3;TFPI;F12
GO:0045601,regulation of endothelial cell differentiation (GO:0045601),9,4,0.622460765,6.426107837,0.002162412,0.056514178,7498;55273;84913;81575,ATOH8;TMEM100;APOLD1;XDH
GO:0018108,peptidyl-tyrosine phosphorylation (GO:0018108),68,12,4.703036891,2.551542818,0.002221139,0.057518385,3815;2690;1956;3952;660;5649;2202;7010;5753;4921;91461;6725,LEP;RELN;KIT;BMX;EGFR;GHR;EFEMP1;PKDCC;DDR2;TEK;SRMS;PTK6
GO:0071526,semaphorin-plexin signaling pathway (GO:0071526),35,8,2.420680753,3.304855459,0.002235457,0.057518385,54437;80031;57556;10371;223117;56920;91584;4233,SEMA5B;SEMA3G;SEMA3D;MET;SEMA6D;SEMA6A;PLXNA4;SEMA3A
GO:0019935,cyclic-nucleotide-mediated signaling (GO:0019935),35,8,2.420680753,3.304855459,0.002235457,0.057518385,9472;5138;358;948;27115;1672;10411;5152,PDE2A;RAPGEF3;CD36;AQP1;AKAP6;DEFB1;PDE7B;PDE9A
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),77,13,5.325497656,2.441086418,0.002239112,0.057518385,3815;4916;4915;3952;3479;2335;8660;219699;2247;6403;7010;1634;80310,NTRK2;LEP;FN1;FGF2;KIT;UNC5B;PDGFD;NTRK3;IRS2;IGF1;DCN;TEK;SELP
GO:0043410,positive regulation of MAPK cascade (GO:0043410),273,32,18.88130987,1.694797671,0.002359637,0.059983336,3815;2255;154;6366;4916;4915;1956;3952;3479;150;2246;284;3569;8685;948;650;5979;1906;2247;168667;255743;858;6376;7010;101;146433;10253;4281;57161;2146;5320;80310,SPRY2;NTRK2;CX3CL1;LEP;FGF1;ADRB2;CAV2;FGF2;KIT;EZH2;CD36;BMPER;BMP2;PELI2;EGFR;ADAM8;ANGPT1;PDGFD;CCL21;NTRK3;MID1;FGF10;IL34;IGF1;IL6;MARCO;EDN1;NPNT;TEK;RET;ADRA2A;PLA2G2A
GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),21,6,1.452408452,4.131069324,0.002374985,0.059983336,3479;2247;4318;8013;3725;9510,ADAMTS1;FGF2;JUN;MMP9;IGF1;NR4A3
GO:1904666,regulation of ubiquitin protein ligase activity (GO:1904666),21,6,1.452408452,4.131069324,0.002374985,0.059983336,11065;991;27338;4085;5347;8555,UBE2C;PLK1;CDC20;CDC14B;MAD2L1;UBE2S
GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),21,6,1.452408452,4.131069324,0.002374985,0.059983336,1756;287;477;845;3270;2946,DMD;ATP1A2;GSTM2;CASQ2;ANK2;HRC
GO:0006937,regulation of muscle contraction (GO:0006937),28,7,1.936544602,3.614685658,0.002424026,0.060459827,7138;7140;857;477;4660;10398;1264,PPP1R12B;ATP1A2;CNN1;CAV1;TNNT3;TNNT1;MYL9
GO:0045214,sarcomere organization (GO:0045214),28,7,1.936544602,3.614685658,0.002424026,0.060459827,80206;4621;7138;7140;3880;825;9172,TNNT3;TNNT1;CAPN3;MYH3;MYOM2;FHOD3;KRT19
GO:0010647,positive regulation of cell communication (GO:0010647),28,7,1.936544602,3.614685658,0.002424026,0.060459827,79971;2625;6664;1906;9370;9783;4828,ADIPOQ;RIMS3;WLS;EDN1;NMB;GATA3;SOX11
GO:0006954,inflammatory response (GO:0006954),230,28,15.90733066,1.760194755,0.002489365,0.061832954,301;3815;10563;6366;3569;7292;11343;3627;5737;135;4283;133;5734;2350;8639;185;650;2920;4973;3373;6376;101;2353;8111;1036;3868;6869;5806,CXCL2;CX3CL1;ANXA1;CDO1;KIT;CXCL10;TACR1;BMP2;TNFSF4;AOC3;PTX3;ADAM8;PTGFR;OLR1;HYAL1;FOS;PTGER4;GPR68;CCL21;MGLL;IL6;CXCL9;ADORA2A;FOLR2;ADM;AGTR1;CXCL13;KRT16
GO:0045766,positive regulation of angiogenesis (GO:0045766),116,17,8.022827638,2.118953662,0.002543008,0.062905425,2152;2246;51129;358;947;5740;2247;168667;10411;3373;7010;79924;9314;306;8038;6271;126393,FGF1;HSPB6;FGF2;RAPGEF3;BMPER;AQP1;F3;KLF4;HYAL1;CD34;ANGPTL4;ADM2;PTGIS;ANXA3;ADAM12;TEK;S100A1
GO:0010889,regulation of sequestering of triglyceride (GO:0010889),15,5,1.037434608,4.819580878,0.002620586,0.06361539,5468;57104;4023;1149;440503,LPL;CIDEA;PPARG;PNPLA2;PLIN5
GO:1903672,positive regulation of sprouting angiogenesis (GO:1903672),15,5,1.037434608,4.819580878,0.002620586,0.06361539,2246;2247;168667;9314;6271,FGF1;FGF2;BMPER;KLF4;S100A1
GO:0048546,digestive tract morphogenesis (GO:0048546),15,5,1.037434608,4.819580878,0.002620586,0.06361539,64220;6664;64321;10551;348093,SOX17;RBPMS2;STRA6;SOX11;AGR2
GO:0051216,cartilage development (GO:0051216),52,10,3.596439976,2.780527429,0.002635207,0.06361539,650;7704;4781;2822;2247;23213;55553;130497;3373;6660,ZBTB16;OSR1;FGF2;BMP2;SULF1;NFIB;GPLD1;HYAL1;SOX6;SOX5
GO:0002040,sprouting angiogenesis (GO:0002040),52,10,3.596439976,2.780527429,0.002635207,0.06361539,284;2822;1960;2247;3164;168667;147372;7010;11082;84870,ESM1;FGF2;RSPO3;BMPER;GPLD1;ANGPT1;EGR3;CCBE1;NR4A1;TEK
GO:0001667,ameboidal-type cell migration (GO:0001667),52,10,3.596439976,2.780527429,0.002635207,0.06361539,6663;154810;54437;2719;80031;57556;2196;10371;223117;56920,SEMA5B;GPC3;SEMA3G;FAT2;AMOTL1;SOX10;SEMA3D;SEMA6D;SEMA6A;SEMA3A
GO:0030278,regulation of ossification (GO:0030278),36,8,2.48984306,3.213053918,0.002702899,0.064988495,1901;650;7704;6664;6422;4038;4921;5764,ZBTB16;SFRP1;PTN;BMP2;LRP4;S1PR1;DDR2;SOX11
GO:0044818,mitotic G2/M transition checkpoint (GO:0044818),44,9,3.043141518,2.957470084,0.002742335,0.06549744,63967;983;5347;990;641;4998;51514;8555;168448,CDK1;DTL;CLSPN;PLK1;CDC6;CDC14B;ORC1;CDC14C;BLM
GO:0050729,positive regulation of inflammatory response (GO:0050729),88,14,6.086283036,2.30025451,0.002745858,0.06549744,6622;3569;7292;4023;5734;5138;185;1050;6376;101;85480;90865;5320;51704,TSLP;CX3CL1;PDE2A;LPL;SNCA;IL33;TNFSF4;ADAM8;PTGER4;GPRC5B;IL6;AGTR1;CEBPA;PLA2G2A
GO:0009651,response to salt stress (GO:0009651),5,3,0.345811536,8.67524558,0.002967328,0.068602331,825;8564;358,AQP1;CAPN3;KMO
GO:2000969,positive regulation of AMPA receptor activity (GO:2000969),5,3,0.345811536,8.67524558,0.002967328,0.068602331,154;5649;23237,RELN;ADRB2;ARC
GO:0014820,tonic smooth muscle contraction (GO:0014820),5,3,0.345811536,8.67524558,0.002967328,0.068602331,4638;1906;1907,MYLK;EDN1;EDN2
GO:0034694,response to prostaglandin (GO:0034694),5,3,0.345811536,8.67524558,0.002967328,0.068602331,6366;8644;7049,TGFBR3;CCL21;AKR1C3
GO:0071295,cellular response to vitamin (GO:0071295),5,3,0.345811536,8.67524558,0.002967328,0.068602331,2348;6422;10631,SFRP1;POSTN;FOLR1
GO:0045578,negative regulation of B cell differentiation (GO:0045578),5,3,0.345811536,8.67524558,0.002967328,0.068602331,3624;1378;6422,INHBA;SFRP1;CR1
GO:0072177,mesonephric duct development (GO:0072177),5,3,0.345811536,8.67524558,0.002967328,0.068602331,7481;2719;130497,OSR1;GPC3;WNT11
GO:0038026,reelin-mediated signaling pathway (GO:0038026),5,3,0.345811536,8.67524558,0.002967328,0.068602331,7436;5649;6776,RELN;STAT5A;VLDLR
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),108,16,7.46952918,2.142035946,0.00300321,0.069000819,5468;7048;857;650;168667;658;63976;10252;10253;348093;1149;54756;3547;54829;51232;25928,SPRY2;CAV1;CIDEA;TGFBR2;BMPER;BMP2;PPARG;SOSTDC1;CRIM1;SPRY1;IL17RD;PRDM16;IGSF1;BMPR1B;ASPN;RBPMS2
GO:0010719,negative regulation of epithelial to mesenchymal transition (GO:0010719),29,7,2.005706909,3.490041325,0.003007522,0.069000819,2625;3249;6422;10252;10253;3169;54756,SPRY2;SFRP1;SPRY1;IL17RD;HPN;GATA3;FOXA1
GO:2001257,regulation of cation channel activity (GO:2001257),89,14,6.155445343,2.274408953,0.003056165,0.069850219,1756;3753;2892;2893;287;5649;57158;7881;23542;3270;4318;27092;6769;729993,DMD;KCNE1;RELN;GRIA4;JPH2;KCNAB1;ANK2;MMP9;STAC;MAPK8IP2;HRC;GRIA3;CACNG4;SHISA9
GO:1901021,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),22,6,1.521570759,3.943293445,0.003077,0.070060025,9472;287;57158;2946;6769;342667,JPH2;STAC2;GSTM2;AKAP6;ANK2;STAC
GO:0051495,positive regulation of cytoskeleton organization (GO:0051495),80,13,5.532984578,2.349545678,0.003171134,0.071660484,1073;25802;6366;4916;1906;10763;6376;10733;7010;274;10615;11346;171024,LMOD1;CX3CL1;SPAG5;SYNPO2;NES;CFL2;PLK4;CCL21;NTRK3;BIN1;EDN1;TEK;SYNPO
GO:0045785,positive regulation of cell adhesion (GO:0045785),80,13,5.532984578,2.349545678,0.003171134,0.071660484,6366;64805;6288;79625;5979;6387;255743;3373;1842;101;8784;5212;10551,VIT;SAA1;P2RY12;ADAM8;HYAL1;CCL21;CXCL12;ECM2;NPNT;TNFRSF18;NDNF;RET;AGR2
GO:0001937,negative regulation of endothelial cell proliferation (GO:0001937),37,8,2.559005367,3.126214623,0.003243255,0.073015759,4804;5468;7498;857;23213;858;64102;84913,ATOH8;TNMD;CAV1;CAV2;PPARG;SULF1;NGFR;XDH
GO:0071900,regulation of protein serine/threonine kinase activity (GO:0071900),109,16,7.538691487,2.12238424,0.00329988,0.074013353,154;6622;4057;891;993;1033;890;9134;898;9088;9133;990;641;57761;2146;9077,PKMYT1;CDKN3;CCNB2;CCNB1;CCNE2;CCNA2;CDC6;ADRB2;EZH2;SNCA;BLM;TRIB3;CDC25A;CCNE1;DIRAS3;LTF
GO:0097205,renal filtration (GO:0097205),10,4,0.691623072,5.783497053,0.003407761,0.075033148,4162;947;23213;57156,SULF1;CD34;MCAM;TMEM63C
GO:1900747,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),10,4,0.691623072,5.783497053,0.003407761,0.075033148,7498;57556;10253;1634,SPRY2;SEMA6A;DCN;XDH
GO:1903236,regulation of leukocyte tethering or rolling (GO:1903236),10,4,0.691623072,5.783497053,0.003407761,0.075033148,6366;6387;6403;56477,CCL21;CCL28;CXCL12;SELP
GO:0071415,cellular response to purine-containing compound (GO:0071415),10,4,0.691623072,5.783497053,0.003407761,0.075033148,6263;6261;845;2946,RYR3;GSTM2;CASQ2;RYR1
GO:0043951,negative regulation of cAMP-mediated signaling (GO:0043951),10,4,0.691623072,5.783497053,0.003407761,0.075033148,5138;5140;114804;50940,PDE2A;PDE11A;PDE3B;RNF157
GO:0071384,cellular response to corticosteroid stimulus (GO:0071384),16,5,1.106596916,4.518357073,0.003596967,0.078623149,7538;301;11170;8644;2908,FAM107A;ANXA1;NR3C1;ZFP36;AKR1C3
GO:0086009,membrane repolarization (GO:0086009),16,5,1.106596916,4.518357073,0.003596967,0.078623149,3753;23704;30819;477;482,KCNE1;ATP1A2;KCNIP2;ATP1B2;KCNE4
GO:0030323,respiratory tube development (GO:0030323),30,7,2.074869217,3.373706614,0.003692601,0.080421109,2252;2246;64220;2247;7477;5950;1050,FGF1;RBP4;FGF2;FGF7;CEBPA;STRA6;WNT7B
GO:0003281,ventricular septum development (GO:0003281),38,8,2.628167674,3.043945817,0.00386385,0.083245879,7048;5138;64220;23493;2625;6586;6664;7049,PDE2A;TGFBR3;TGFBR2;SLIT3;HEY2;STRA6;GATA3;SOX11
GO:0023056,positive regulation of signaling (GO:0023056),38,8,2.628167674,3.043945817,0.00386385,0.083245879,6622;79971;2625;6664;1906;9370;9783;4828,ADIPOQ;SNCA;RIMS3;WLS;EDN1;NMB;GATA3;SOX11
GO:0006270,DNA replication initiation (GO:0006270),38,8,2.628167674,3.043945817,0.00386385,0.083245879,81620;8317;990;4173;55388;23594;4998;8318,CDC6;CDC45;MCM10;ORC6;ORC1;MCM4;CDT1;CDC7
GO:0045744,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),23,6,1.590733066,3.771845904,0.003922934,0.084216978,6622;4233;112609;114804;5997;9737,GPRASP1;SNCA;RGS2;MET;MRAP2;RNF157
GO:0032868,response to insulin (GO:0032868),82,13,5.671309192,2.292239686,0.003951923,0.084537394,5468;3952;10580;2308;8660;2822;4435;9370;5105;6517;11031;5140;57761,LEP;SLC2A4;ADIPOQ;PCK1;SORBS1;PPARG;GPLD1;FOXO1;IRS2;TRIB3;RAB31;CITED1;PDE3B
GO:0016101,diterpenoid metabolic process (GO:0016101),64,11,4.426387662,2.48509639,0.004126716,0.087963429,4023;338328;64220;2719;216;6382;5919;8644;1645;5950;125,GPIHBP1;RBP4;LPL;GPC3;ADH1B;AKR1C1;ALDH1A1;AKR1C3;SDC1;RARRES2;STRA6
GO:0043266,regulation of potassium ion transport (GO:0043266),31,7,2.144031524,3.264877369,0.00449001,0.095033283,3753;150;30819;287;845;7881;2273,KCNE1;KCNIP2;FHL1;KCNAB1;CASQ2;ANK2;ADRA2A
GO:0010743,regulation of macrophage derived foam cell differentiation (GO:0010743),31,7,2.144031524,3.264877369,0.00449001,0.095033283,5468;4023;948;185;9370;23461;5320,LPL;ADIPOQ;ABCA5;CD36;PPARG;AGTR1;PLA2G2A
GO:0044772,mitotic cell cycle phase transition (GO:0044772),207,25,14.31659759,1.746224956,0.004567922,0.0957622,5577;3624;11065;27338;983;6790;5347;891;9833;10763;5243;993;8317;1033;1869;890;9134;898;10733;9088;2305;9133;4751;4660;10460,NEK2;INHBA;PKMYT1;UBE2C;PPP1R12B;CDK1;PLK1;AURKA;MELK;CDKN3;CCNB2;FOXM1;CCNB1;CCNE2;CCNA2;TACC3;ABCB1;E2F1;NES;UBE2S;PLK4;CDC7;CDC25A;CCNE1;PRKAR2B
GO:0086091,regulation of heart rate by cardiac conduction (GO:0086091),39,8,2.697329982,2.965895925,0.004572243,0.0957622,3753;23704;55800;857;6327;287;6330;274,SCN4B;KCNE1;CAV1;SCN2B;SCN3B;ANK2;BIN1;KCNE4
GO:0042476,odontogenesis (GO:0042476),39,8,2.697329982,2.965895925,0.004572243,0.0957622,3624;358;650;362;130497;2296;1278;7286,INHBA;OSR1;TUFT1;AQP1;BMP2;AQP5;FOXC1;COL1A2
GO:0048514,blood vessel morphogenesis (GO:0048514),56,10,3.873089204,2.581918327,0.004618717,0.096399673,7048;857;133;1000;64220;23493;7049;54922;147372;64321,CAV1;TGFBR3;TGFBR2;SOX17;RASIP1;CCBE1;HEY2;ADM;CDH2;STRA6
GO:0019221,cytokine-mediated signaling pathway (GO:0019221),618,60,42.74230586,1.403761421,0.004674302,0.097222237,301;1901;3815;2152;10563;6366;2690;3952;3569;7292;6288;3627;4283;6382;948;1511;10437;2209;2625;2920;2537;2308;5743;2335;6387;8660;4684;1907;2247;1050;3953;4128;58480;6376;4314;4318;332;5803;8835;9636;2353;2296;1278;1271;4582;3590;4692;1958;6776;146433;3977;64388;4281;8638;57161;4001;85480;943;8784;90865,CXCL2;TSLP;IL11RA;CX3CL1;LEP;FN1;BIRC5;LIFR;LEPR;LMNB1;ANXA1;SAA1;EGR1;FGF2;KIT;MAOA;CD36;CXCL10;IL33;TNFSF4;PTPRZ1;PELI2;CNTFR;F3;FOXO1;NCAM1;GHR;FOS;STAT5A;PTGS2;CCL21;CXCL12;NDN;IRS2;MID1;SOCS2;S1PR1;FCGR1A;IFI30;MMP3;IL34;MUC1;MMP9;IFI6;RHOU;GREM2;ISG15;IL6;CXCL9;CTSG;SDC1;FOXC1;TNFRSF8;TNFRSF18;OASL;EDN2;CEBPA;CXCL13;GATA3;COL1A2
GO:0033674,positive regulation of kinase activity (GO:0033674),113,16,7.815340716,2.047255594,0.004738235,0.097991811,3815;6366;4916;4915;1956;1062;7301;5979;5649;2051;2047;4233;7010;1917;4921;23531,NTRK2;RELN;CENPE;EPHB1;KIT;EGFR;MET;EPHB6;CCL21;NTRK3;DDR2;TEK;MMD;EEF1A2;RET;TYRO3
GO:0033688,regulation of osteoblast proliferation (GO:0033688),17,5,1.175759223,4.252571363,0.004809114,0.097991811,4057;650;6422;63923;4883,SFRP1;BMP2;TNN;NPR3;LTF
GO:0042063,gliogenesis (GO:0042063),17,5,1.175759223,4.252571363,0.004809114,0.097991811,301;1000;4781;5649;79006,RELN;ANXA1;NFIB;METRN;CDH2
GO:0010460,positive regulation of heart rate (GO:0010460),17,5,1.175759223,4.252571363,0.004809114,0.097991811,55800;133;1906;1907;3270,SCN3B;EDN1;EDN2;HRC;ADM
GO:0055023,positive regulation of cardiac muscle tissue growth (GO:0055023),17,5,1.175759223,4.252571363,0.004809114,0.097991811,9472;3479;1906;2247;7049,FGF2;TGFBR3;AKAP6;IGF1;EDN1
GO:0086012,membrane depolarization during cardiac muscle cell action potential (GO:0086012),17,5,1.175759223,4.252571363,0.004809114,0.097991811,55800;6327;287;6330;477,SCN4B;ATP1A2;SCN2B;SCN3B;ANK2
GO:0048841,regulation of axon extension involved in axon guidance (GO:0048841),24,6,1.659895373,3.614685658,0.004929415,0.099155757,54437;80031;57556;10371;223117;56920,SEMA5B;SEMA3G;SEMA3D;SEMA6D;SEMA6A;SEMA3A
GO:0045833,negative regulation of lipid metabolic process (GO:0045833),24,6,1.659895373,3.614685658,0.004929415,0.099155757,150;347;5140;1149;338442;83643,CIDEA;HCAR2;APOD;CCDC3;PDE3B;ADRA2A
GO:0019371,cyclooxygenase pathway (GO:0019371),11,4,0.760785379,5.257724594,0.005064185,0.099155757,5730;5740;8644;5743,PTGS2;AKR1C3;PTGDS;PTGIS
GO:0010642,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),11,4,0.760785379,5.257724594,0.005064185,0.099155757,9368;6622;347;9370,ADIPOQ;SNCA;APOD;SLC9A3R1
GO:0033625,positive regulation of integrin activation (GO:0033625),11,4,0.760785379,5.257724594,0.005064185,0.099155757,10563;64805;54922;55612,P2RY12;RASIP1;FERMT1;CXCL13
GO:1903817,negative regulation of voltage-gated potassium channel activity (GO:1903817),11,4,0.760785379,5.257724594,0.005064185,0.099155757,3753;23704;857;7881,KCNE1;CAV1;KCNAB1;KCNE4
GO:0042310,vasoconstriction (GO:0042310),11,4,0.760785379,5.257724594,0.005064185,0.099155757,1910;1906;1907;59,EDNRB;ACTA2;EDN1;EDN2
GO:1902932,positive regulation of alcohol biosynthetic process (GO:1902932),11,4,0.760785379,5.257724594,0.005064185,0.099155757,6622;2246;5745;654,FGF1;SNCA;PTH1R;BMP6
GO:0090128,regulation of synapse maturation (GO:0090128),11,4,0.760785379,5.257724594,0.005064185,0.099155757,22899;991;9378;5649,CDC20;RELN;NRXN1;ARHGEF15
GO:0061053,somite development (GO:0061053),11,4,0.760785379,5.257724594,0.005064185,0.099155757,6664;4223;5727;4222,MEOX2;MEOX1;PTCH1;SOX11
GO:1903671,negative regulation of sprouting angiogenesis (GO:1903671),11,4,0.760785379,5.257724594,0.005064185,0.099155757,57556;10365;1870;90993,E2F2;SEMA6A;CREB3L1;KLF2
GO:0048048,embryonic eye morphogenesis (GO:0048048),11,4,0.760785379,5.257724594,0.005064185,0.099155757,220;2201;2202;4237,MFAP2;EFEMP1;FBN2;ALDH1A3
GO:0072001,renal system development (GO:0072001),57,10,3.942251512,2.536621514,0.005262587,0.102705879,64220;4311;185;2625;64321;23213;1063;5950;4038;2296,MME;CENPF;RBP4;SULF1;LRP4;SOX17;FOXC1;AGTR1;STRA6;GATA3
GO:0050777,negative regulation of immune response (GO:0050777),177,22,12.24172838,1.797131853,0.005359405,0.104243414,554;111;196883;154;5577;3569;54331;135;133;5745;5744;10267;5734;117;5746;2209;7301;1378;1281;79924;50943;5169,ADCYAP1R1;ADRB2;AVPR2;ADCY4;PTGER4;FOXP3;FCGR1A;PTH1R;ADCY5;RAMP1;ADM2;IL6;ADORA2A;PRKAR2B;GNG2;ADM;TYRO3;ENPP3;CR1;PTH2R;PTHLH;COL3A1
GO:0000082,G1/S transition of mitotic cell cycle (GO:0000082),85,13,5.878796114,2.211337109,0.005407526,0.104243414,3624;81620;6241;993;8317;1033;1869;9134;898;990;7298;4998;8318,INHBA;RRM2;CDKN3;CCNE2;CDC6;CDC45;E2F1;ORC1;TYMS;CDT1;CDC7;CDC25A;CCNE1
GO:0090049,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),32,7,2.213193831,3.162849951,0.005410738,0.104243414,301;5743;4223;2247;57381;9314;79812,ANXA1;FGF2;MEOX2;RHOJ;KLF4;PTGS2;MMRN2
GO:0001889,liver development (GO:0001889),32,7,2.213193831,3.162849951,0.005410738,0.104243414,301;3569;6790;7049;4233;5105;1050,AURKA;ANXA1;PCK1;TGFBR3;MET;IL6;CEBPA
GO:0071702,organic substance transport (GO:0071702),135,18,9.336911475,1.927832351,0.005431133,0.104302052,10267;10351;26154;9429;6581;1063;55974;222962;23461;8029;6947;10628;225;10349;23460;10350;53353;148641,ABCA10;CENPF;SLC50A1;ABCA9;ABCA8;ABCA5;ABCA6;TXNIP;ABCD2;SLC22A3;CUBN;RAMP1;ABCG2;SLC29A4;SLC35F3;LRP1B;ABCA12;TCN1
GO:0007171,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),6,3,0.414973843,7.229371316,0.005629873,0.104771405,154;284;3084,ADRB2;ANGPT1;NRG1
GO:0019530,taurine metabolic process (GO:0019530),6,3,0.414973843,7.229371316,0.005629873,0.104771405,2690;6776;1036,CDO1;GHR;STAT5A
GO:0110110,positive regulation of animal organ morphogenesis (GO:0110110),6,3,0.414973843,7.229371316,0.005629873,0.104771405,947;650;2625,BMP2;CD34;GATA3
GO:0071503,response to heparin (GO:0071503),6,3,0.414973843,7.229371316,0.005629873,0.104771405,338328;6422;1958,GPIHBP1;SFRP1;EGR1
GO:2001223,negative regulation of neuron migration (GO:2001223),6,3,0.414973843,7.229371316,0.005629873,0.104771405,6376;63923;1281,CX3CL1;TNN;COL3A1
GO:0098596,imitative learning (GO:0098596),6,3,0.414973843,7.229371316,0.005629873,0.104771405,64220;9378;26047,NRXN1;CNTNAP2;STRA6
GO:0042297,vocal learning (GO:0042297),6,3,0.414973843,7.229371316,0.005629873,0.104771405,64220;9378;26047,NRXN1;CNTNAP2;STRA6
GO:0072178,nephric duct morphogenesis (GO:0072178),6,3,0.414973843,7.229371316,0.005629873,0.104771405,2719;2625;130497,OSR1;GPC3;GATA3
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),6,3,0.414973843,7.229371316,0.005629873,0.104771405,5366;6422;467,SFRP1;ATF3;PMAIP1
GO:0010756,positive regulation of plasminogen activation (GO:0010756),6,3,0.414973843,7.229371316,0.005629873,0.104771405,3249;7123;2161,CLEC3B;F12;HPN
GO:0048660,regulation of smooth muscle cell proliferation (GO:0048660),49,9,3.388953054,2.655687422,0.005831156,0.108182351,5468;3479;3569;347;1906;6376;8013;348093;4969,CX3CL1;PPARG;APOD;OGN;IGF1;IL6;EDN1;RBPMS2;NR4A3
GO:0015980,energy derivation by oxidation of organic compounds (GO:0015980),25,6,1.729057681,3.470098232,0.006113205,0.112031942,3952;10891;3953;55022;8013;112609,LEP;LEPR;PID1;PPARGC1A;MRAP2;NR4A3
GO:2000311,regulation of AMPA receptor activity (GO:2000311),25,6,1.729057681,3.470098232,0.006113205,0.112031942,154;5649;23542;23237;27092;729993,RELN;ADRB2;ARC;MAPK8IP2;CACNG4;SHISA9
GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),25,6,1.729057681,3.470098232,0.006113205,0.112031942,1756;9472;57158;845;3270;2946,DMD;JPH2;GSTM2;AKAP6;CASQ2;HRC
GO:0043949,regulation of cAMP-mediated signaling (GO:0043949),25,6,1.729057681,3.470098232,0.006113205,0.112031942,5577;2770;5138;5140;114804;50940,PDE2A;PDE11A;GNAI1;PDE3B;RNF157;PRKAR2B
GO:0010631,epithelial cell migration (GO:0010631),41,8,2.835654596,2.821218075,0.006283637,0.113792792,3815;2196;2191;55612;54443;3868;6286;23189,ANLN;S100P;KIT;FAT2;KANK1;FAP;FERMT1;KRT16
GO:0045923,positive regulation of fatty acid metabolic process (GO:0045923),18,5,1.24492153,4.016317398,0.006285012,0.113792792,5468;51085;9370;10891;8013,ADIPOQ;MLXIPL;PPARG;PPARGC1A;NR4A3
GO:0050918,positive chemotaxis (GO:0050918),18,5,1.24492153,4.016317398,0.006285012,0.113792792,2255;2252;284;4233;6376,CX3CL1;ANGPT1;MET;FGF10;FGF7
GO:0010613,positive regulation of cardiac muscle hypertrophy (GO:0010613),18,5,1.24492153,4.016317398,0.006285012,0.113792792,9472;3479;1906;8013;5152,AKAP6;PDE9A;IGF1;EDN1;NR4A3
GO:1903580,positive regulation of ATP metabolic process (GO:1903580),33,7,2.282356138,3.067006013,0.006465935,0.115416173,3479;51085;8671;10891;5207;55022;5209,MLXIPL;PFKFB1;PID1;PPARGC1A;SLC4A4;IGF1;PFKFB3
GO:0050919,negative chemotaxis (GO:0050919),33,7,2.282356138,3.067006013,0.006465935,0.115416173,80031;57556;10371;223117;56920;6586;59352,SEMA3G;SEMA3D;LGR6;SEMA6D;SEMA6A;SLIT3;SEMA3A
GO:0055001,muscle cell development (GO:0055001),33,7,2.282356138,3.067006013,0.006465935,0.115416173,1756;3479;6382;23493;287;4629;274,DMD;MYH11;ANK2;BIN1;IGF1;HEY2;SDC1
GO:0007095,mitotic G2 DNA damage checkpoint signaling (GO:0007095),33,7,2.282356138,3.067006013,0.006465935,0.115416173,63967;983;5347;641;51514;8555;168448,CDK1;DTL;CLSPN;PLK1;CDC14B;CDC14C;BLM
GO:0070372,regulation of ERK1 and ERK2 cascade (GO:0070372),235,27,16.2531422,1.661217239,0.006470679,0.115416173,9368;2255;6366;4916;4915;1956;284;8685;57556;948;650;2335;2047;2247;168667;7049;255743;9370;10252;6376;7010;1848;10253;5320;81610;55885;80310,SPRY2;NTRK2;CX3CL1;FN1;FAM83D;EPHB1;FGF2;ADIPOQ;TGFBR3;CD36;BMPER;BMP2;EGFR;ANGPT1;DUSP6;PDGFD;CCL21;SEMA6A;SPRY1;NTRK3;FGF10;MARCO;SLC9A3R1;NPNT;TEK;LMO3;PLA2G2A
GO:0035725,sodium ion transmembrane transport (GO:0035725),87,13,6.017120728,2.160501773,0.006596007,0.117303542,6329;6326;6335;6332;6328;55800;11254;6327;6330;8671;6523;477;482,SCN4B;SCN3A;ATP1A2;SCN2B;SCN3B;SCN4A;SCN2A;ATP1B2;SLC4A4;SCN9A;SLC6A14;SCN7A;SLC5A1
GO:0031349,positive regulation of defense response (GO:0031349),97,14,6.708743801,2.086828834,0.006714747,0.119062961,6622;7292;4023;5734;5138;185;1050;6376;101;115362;85480;90865;5320;51704,TSLP;CX3CL1;PDE2A;LPL;SNCA;IL33;TNFSF4;ADAM8;PTGER4;GPRC5B;GBP5;AGTR1;CEBPA;PLA2G2A
GO:0051258,protein polymerization (GO:0051258),59,10,4.080576126,2.450634345,0.006759483,0.119503686,2934;11170;81624;10810;11065;27338;11076;845;51673;79649,UBE2C;FAM107A;GSN;DIAPH3;WASF3;UBE2S;CASQ2;TPPP;MAP7D3;TPPP3
GO:0043117,positive regulation of vascular permeability (GO:0043117),12,4,0.829947687,4.819580878,0.007184748,0.124459707,284;5138;654;27134,PDE2A;ANGPT1;BMP6;TJP3
GO:1902548,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),12,4,0.829947687,4.819580878,0.007184748,0.124459707,7498;57556;10253;1634,SPRY2;SEMA6A;DCN;XDH
GO:0007077,mitotic nuclear membrane disassembly (GO:0007077),12,4,0.829947687,4.819580878,0.007184748,0.124459707,983;5347;891;9133,CDK1;PLK1;CCNB2;CCNB1
GO:0046068,cGMP metabolic process (GO:0046068),12,4,0.829947687,4.819580878,0.007184748,0.124459707,5138;4881;4882;5152,PDE2A;NPR1;NPR2;PDE9A
GO:0015669,gas transport (GO:0015669),12,4,0.829947687,4.819580878,0.007184748,0.124459707,358;3043;362;4151,HBB;AQP1;AQP5;MB
GO:0051782,negative regulation of cell division (GO:0051782),12,4,0.829947687,4.819580878,0.007184748,0.124459707,9212;641;23594;10628,AURKB;TXNIP;ORC6;BLM
GO:0000727,double-strand break repair via break-induced replication (GO:0000727),12,4,0.829947687,4.819580878,0.007184748,0.124459707,8317;4173;8318;51659,CDC45;MCM4;CDC7;GINS2
GO:0010594,regulation of endothelial cell migration (GO:0010594),88,13,6.086283036,2.135950616,0.007263366,0.125460036,2246;284;2625;1906;2822;2247;168667;57381;7010;1634;306;5764;84913,ATOH8;FGF1;FGF2;BMPER;PTN;RHOJ;GPLD1;ANGPT1;DCN;ANXA3;EDN1;TEK;GATA3
GO:1900087,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),26,6,1.798219988,3.336632915,0.007491032,0.126841103,301;2255;1956;3373;990;9510,CDC6;ANXA1;ADAMTS1;EGFR;HYAL1;FGF10
GO:0042573,retinoic acid metabolic process (GO:0042573),26,6,1.798219988,3.336632915,0.007491032,0.126841103,56603;220;8854;125;126;124,ADH1C;ALDH1A2;ADH1A;ADH1B;ALDH1A3;CYP26B1
GO:0001656,metanephros development (GO:0001656),26,6,1.798219988,3.336632915,0.007491032,0.126841103,2255;64321;5727;4435;7477;130497,OSR1;SOX17;FGF10;PTCH1;CITED1;WNT7B
GO:0001885,endothelial cell development (GO:0001885),26,6,1.798219988,3.336632915,0.007491032,0.126841103,5138;54538;4233;10411;26051;64102,TNMD;PDE2A;RAPGEF3;MET;PPP1R16B;ROBO4
GO:1901016,regulation of potassium ion transmembrane transporter activity (GO:1901016),26,6,1.798219988,3.336632915,0.007491032,0.126841103,3753;287;845;7881;482;2273,KCNE1;FHL1;KCNAB1;CASQ2;ATP1B2;ANK2
GO:1901342,regulation of vasculature development (GO:1901342),26,6,1.798219988,3.336632915,0.007491032,0.126841103,10563;3952;3569;2247;168667;6422,LEP;SFRP1;FGF2;BMPER;IL6;CXCL13
GO:0045589,regulation of regulatory T cell differentiation (GO:0045589),26,6,1.798219988,3.336632915,0.007491032,0.126841103,7292;259307;1378;2175;8784;50943,TNFSF4;FOXP3;IL4I1;FANCA;TNFRSF18;CR1
GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),60,10,4.149738433,2.409790439,0.007621944,0.128371478,1128;111;196883;64805;150;2774;8685;2770;9590;5138,GNAL;PDE2A;P2RY12;ADCY4;AKAP12;GNAI1;ADCY5;MARCO;ADRA2A;CHRM1
GO:0045600,positive regulation of fat cell differentiation (GO:0045600),51,9,3.527277668,2.551542818,0.007632395,0.128371478,7538;5468;4023;650;5919;7704;5743;6422;55885,ZBTB16;SFRP1;LPL;BMP2;PPARG;PTGS2;ZFP36;LMO3;RARRES2
GO:0060048,cardiac muscle contraction (GO:0060048),34,7,2.351518446,2.976799954,0.007666838,0.128371478,2934;1756;55800;6327;6330;477;845,DMD;SCN4B;ATP1A2;SCN2B;SCN3B;GSN;CASQ2
GO:0010524,positive regulation of calcium ion transport into cytosol (GO:0010524),34,7,2.351518446,2.976799954,0.007666838,0.128371478,9472;6622;825;857;3627;4283;6376,CX3CL1;CAV1;SNCA;CXCL10;CAPN3;AKAP6;CXCL9
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),99,14,6.847068415,2.044670675,0.008031961,0.131520655,7048;857;2348;6664;7049;4435;63976;10252;10253;8425;1149;54756;54829;1028,SPRY2;CAV1;CIDEA;LTBP4;TGFBR3;TGFBR2;CDKN1C;SPRY1;IL17RD;FOLR1;CITED1;PRDM16;ASPN;SOX11
GO:0086003,cardiac muscle cell contraction (GO:0086003),19,5,1.314083837,3.804932272,0.008051838,0.131520655,2934;3753;55800;6327;6330,SCN4B;KCNE1;SCN2B;SCN3B;GSN
GO:0061384,heart trabecula morphogenesis (GO:0061384),19,5,1.314083837,3.804932272,0.008051838,0.131520655,1901;3084;7049;5950;7010,RBP4;TGFBR3;S1PR1;NRG1;TEK
GO:1900746,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),19,5,1.314083837,3.804932272,0.008051838,0.131520655,7498;57556;147372;10253;1634,SPRY2;SEMA6A;CCBE1;DCN;XDH
GO:0006112,energy reserve metabolic process (GO:0006112),19,5,1.314083837,3.804932272,0.008051838,0.131520655,3952;3953;55022;5837;112609,LEP;LEPR;PYGM;PID1;MRAP2
GO:0001658,branching involved in ureteric bud morphogenesis (GO:0001658),19,5,1.314083837,3.804932272,0.008051838,0.131520655,2246;650;2247;255743;4435,FGF1;FGF2;BMP2;CITED1;NPNT
GO:0014031,mesenchymal cell development (GO:0014031),19,5,1.314083837,3.804932272,0.008051838,0.131520655,3084;1000;23493;6664;2296,NRG1;HEY2;FOXC1;CDH2;SOX11
GO:0030856,regulation of epithelial cell differentiation (GO:0030856),19,5,1.314083837,3.804932272,0.008051838,0.131520655,857;2625;130497;23764;81575,CAV1;OSR1;MAFF;APOLD1;GATA3
GO:0070542,response to fatty acid (GO:0070542),19,5,1.314083837,3.804932272,0.008051838,0.131520655,4023;948;2308;5166;55022,PDK4;LPL;CD36;FOXO1;PID1
GO:0010810,regulation of cell-substrate adhesion (GO:0010810),43,8,2.973979211,2.689998629,0.008441223,0.137507298,79625;255743;8322;6376;1842;5212;10551;10391,CX3CL1;VIT;CORO2B;FZD4;ECM2;NPNT;NDNF;AGR2
GO:0071705,nitrogen compound transport (GO:0071705),141,18,9.751885318,1.845796932,0.008495164,0.138011983,10267;11254;9429;8140;23657;6545;358;80736;6581;3043;1906;1063;222962;8029;6947;10628;53353;148641,CENPF;HBB;AQP1;TXNIP;SLC22A3;CUBN;SLC6A14;RAMP1;EDN1;SLC7A5;ABCG2;SLC29A4;SLC44A4;SLC35F3;SLC7A11;LRP1B;SLC7A4;TCN1
GO:0001932,regulation of protein phosphorylation (GO:0001932),263,29,18.1896868,1.594310024,0.008595888,0.139271929,9368;2255;2252;7498;1894;4916;4915;1956;3952;2246;284;8685;650;5919;2335;2247;168667;9370;3953;7010;55022;3270;4318;467;146433;57161;5329;401265;284654,NTRK2;LEP;FN1;FGF1;LEPR;FGF2;ADIPOQ;ECT2;BMPER;BMP2;KLHL31;PELI2;EGFR;ANGPT1;PID1;NTRK3;FGF10;ATF3;IL34;MMP9;PLAUR;MARCO;SLC9A3R1;FGF7;TEK;HRC;RSPO1;RARRES2;XDH
GO:0043434,response to peptide hormone (GO:0043434),52,9,3.596439976,2.502474686,0.008678318,0.139853533,301;3952;857;2770;7049;4435;1583;5105;6776,LEP;CAV1;ANXA1;PCK1;TGFBR3;CYP11A1;STAT5A;GNAI1;CITED1
GO:0030514,negative regulation of BMP signaling pathway (GO:0030514),52,9,3.596439976,2.502474686,0.008678318,0.139853533,5468;650;168667;658;91851;64388;348093;51232;25928,CHRDL1;BMPER;BMP2;PPARG;SOSTDC1;CRIM1;GREM2;BMPR1B;RBPMS2
GO:2000145,regulation of cell motility (GO:2000145),131,17,9.060262246,1.87632538,0.008838769,0.140831704,2255;2252;6366;1956;2246;3084;9928;154810;4248;2625;84612;54538;91584;2247;5168;9542;9079,KIF14;NRG2;FGF1;FGF2;ENPP2;LDB2;AMOTL1;EGFR;MGAT3;CCL21;PLXNA4;FGF10;ROBO4;NRG1;FGF7;PARD6B;GATA3
GO:0042981,regulation of apoptotic process (GO:0042981),738,68,51.04178273,1.332241869,0.008984588,0.140831704,301;6622;4804;1894;1956;3479;284;9928;130399;825;3569;51129;3627;7481;358;4057;983;4085;5347;650;3202;7153;2537;84883;63924;8626;9833;2308;5366;3249;51176;2822;1960;4435;6422;130497;6376;1869;7010;4318;213;1848;332;8835;81788;274;3725;847;1410;10253;85480;943;6491;3169;54507;1311;5329;50649;3875;1149;92291;114804;8793;153769;25803;10562;80034;23321,SPRY2;TSLP;HOXA5;CDK1;COMP;CX3CL1;TOP2A;PLK1;CIDEC;MELK;KIF14;BIRC5;CRYAB;OSR1;ANXA1;SFRP1;CIDEA;NUAK2;STIL;ECT2;TNFRSF10D;SNCA;CXCL10;AQP1;ACVR1C;BMP2;E2F1;EGFR;MAD2L1;NGFR;JUN;GPLD1;FOXO1;LEF1;CAPN3;ANGPT1;DUSP6;EGR3;ARHGEF4;ALB;SOCS2;OLFM4;TP63;CAT;ANGPTL4;MMP9;IFI6;CSRNP3;PLAUR;ADAMTSL4;BIN1;CITED1;IGF1;TRIM2;IL6;WNT11;TEK;AIFM2;TNFRSF8;PMAIP1;RNF157;HPN;SH3RF2;KRT18;FOXA1;LTF;CAPN13;SPDEF
GO:1902808,positive regulation of cell cycle G1/S phase transition (GO:1902808),35,7,2.420680753,2.891748527,0.009024683,0.140831704,301;2255;1956;3373;2146;81610;9510,FAM83D;ANXA1;ADAMTS1;EZH2;EGFR;HYAL1;FGF10
GO:0060541,respiratory system development (GO:0060541),35,7,2.420680753,2.891748527,0.009024683,0.140831704,2252;2246;64220;2247;7477;5950;1050,FGF1;RBP4;FGF2;FGF7;CEBPA;STRA6;WNT7B
GO:1903522,regulation of blood circulation (GO:1903522),35,7,2.420680753,2.891748527,0.009024683,0.140831704,1674;185;30819;5348;10659;6271;27129,FXYD1;KCNIP2;HSPB7;DES;CELF2;AGTR1;S100A1
GO:0097746,blood vessel diameter maintenance (GO:0097746),35,7,2.420680753,2.891748527,0.009024683,0.140831704,1373;185;1910;4881;1906;1907;10365,NPR1;EDNRB;CPS1;EDN1;KLF2;EDN2;AGTR1
GO:0051384,response to glucocorticoid (GO:0051384),27,6,1.867382295,3.213053918,0.009079417,0.140831704,7538;301;11170;3569;6586;2908,FAM107A;ANXA1;NR3C1;ZFP36;SLIT3;IL6
GO:0031109,microtubule polymerization or depolymerization (GO:0031109),27,6,1.867382295,3.213053918,0.009079417,0.140831704,9928;81930;11004;11076;51673;79649,KIF2C;KIF14;KIF18A;TPPP;MAP7D3;TPPP3
GO:0030193,regulation of blood coagulation (GO:0030193),27,6,1.867382295,3.213053918,0.009079417,0.140831704,857;947;2191;1906;7035;2161,CAV1;TFPI;FAP;CD34;F12;EDN1
GO:0045429,positive regulation of nitric oxide biosynthetic process (GO:0045429),27,6,1.867382295,3.213053918,0.009079417,0.140831704,948;5743;3043;1906;10365;9314,HBB;CD36;KLF4;PTGS2;EDN1;KLF2
GO:0045860,positive regulation of protein kinase activity (GO:0045860),153,19,10.581833,1.795530131,0.009315066,0.140831704,154;6622;6366;1894;150;22974;63967;7048;9928;4057;1062;2209;5649;1958;146433;2146;4921;51704;23531,TPX2;CLSPN;KIF14;RELN;CENPE;ADRB2;EGR1;ECT2;EZH2;SNCA;TGFBR2;GPRC5B;CCL21;FCGR1A;IL34;DDR2;MMD;ADRA2A;LTF
GO:2001280,positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),7,3,0.484136151,6.196603985,0.00934817,0.140831704,301;5743;225,ANXA1;ABCD2;PTGS2
GO:0031340,positive regulation of vesicle fusion (GO:0031340),7,3,0.484136151,6.196603985,0.00934817,0.140831704,301;6622;8447,ANXA1;SNCA;DOC2B
GO:0007599,hemostasis (GO:0007599),7,3,0.484136151,6.196603985,0.00934817,0.140831704,554;64805;7450,AVPR2;P2RY12;VWF
GO:0014842,regulation of skeletal muscle satellite cell proliferation (GO:0014842),7,3,0.484136151,6.196603985,0.00934817,0.140831704,284;2047;2247,EPHB1;FGF2;ANGPT1
GO:2000544,regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),7,3,0.484136151,6.196603985,0.00934817,0.140831704,10563;2246;2247,FGF1;FGF2;CXCL13
GO:0046850,regulation of bone remodeling (GO:0046850),7,3,0.484136151,6.196603985,0.00934817,0.140831704,3952;6422;3953,LEP;LEPR;SFRP1
GO:0061042,vascular wound healing (GO:0061042),7,3,0.484136151,6.196603985,0.00934817,0.140831704,4162;79625;947,CD34;MCAM;NDNF
GO:0060347,heart trabecula formation (GO:0060347),7,3,0.484136151,6.196603985,0.00934817,0.140831704,7049;5950;7010,RBP4;TGFBR3;TEK
GO:0036155,acylglycerol acyl-chain remodeling (GO:0036155),7,3,0.484136151,6.196603985,0.00934817,0.140831704,84649;11343;57104,DGAT2;MGLL;PNPLA2
GO:0043589,skin morphogenesis (GO:0043589),7,3,0.484136151,6.196603985,0.00934817,0.140831704,26154;1278;1277,ABCA12;COL1A1;COL1A2
GO:0032352,positive regulation of hormone metabolic process (GO:0032352),7,3,0.484136151,6.196603985,0.00934817,0.140831704,2625;3249;1958,EGR1;HPN;GATA3
GO:2000271,positive regulation of fibroblast apoptotic process (GO:2000271),7,3,0.484136151,6.196603985,0.00934817,0.140831704,8626;6422;56981,SFRP1;PRDM11;TP63
GO:0006957,"complement activation, alternative pathway (GO:0006957)",7,3,0.484136151,6.196603985,0.00934817,0.140831704,1378;1675;629,CFD;CFB;CR1
GO:1902746,regulation of lens fiber cell differentiation (GO:1902746),7,3,0.484136151,6.196603985,0.00934817,0.140831704,2247;10252;10253,SPRY2;FGF2;SPRY1
GO:0038063,collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),7,3,0.484136151,6.196603985,0.00934817,0.140831704,1277;4921;1288,DDR2;COL4A6;COL1A1
GO:0090307,mitotic spindle assembly (GO:0090307),44,8,3.043141518,2.628862297,0.009707643,0.144635608,22974;9212;24137;29127;9493;3832;3833;9055,KIF4A;TPX2;KIF11;KIFC1;KIF23;PRC1;AURKB;RACGAP1
GO:0048754,branching morphogenesis of an epithelial tube (GO:0048754),44,8,3.043141518,2.628862297,0.009707643,0.144635608,2255;7048;650;2247;54922;255743;4435;4233,FGF2;TGFBR2;BMP2;MET;RASIP1;FGF10;CITED1;NPNT
GO:0006898,receptor-mediated endocytosis (GO:0006898),143,18,9.890209933,1.81998159,0.00978075,0.144635608,154;6622;6288;857;133;10267;8685;2348;948;2209;7436;3043;858;11031;213;8029;4360;53353,CAV1;SAA1;ADRB2;CAV2;HBB;SNCA;CD36;ALB;FCGR1A;CUBN;RAB31;RAMP1;FOLR1;MARCO;MRC1;VLDLR;ADM;LRP1B
GO:0055119,relaxation of cardiac muscle (GO:0055119),13,4,0.899109994,4.448843887,0.009817223,0.144635608,2934;477;2946;5997,ATP1A2;GSN;RGS2;GSTM2
GO:0035162,embryonic hemopoiesis (GO:0035162),13,4,0.899109994,4.448843887,0.009817223,0.144635608,3815;7048;7173;6886,KIT;TGFBR2;TAL1;TPO
GO:0019934,cGMP-mediated signaling (GO:0019934),13,4,0.899109994,4.448843887,0.009817223,0.144635608,5138;358;948;5152,PDE2A;CD36;AQP1;PDE9A
GO:0010224,response to UV-B (GO:0010224),13,4,0.899109994,4.448843887,0.009817223,0.144635608,4311;3373;1396;4239,MME;HYAL1;MFAP4;CRIP1
GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),13,4,0.899109994,4.448843887,0.009817223,0.144635608,4085;891;10403;1843,NDC80;CCNB1;MAD2L1;DUSP1
GO:0030207,chondroitin sulfate catabolic process (GO:0030207),13,4,0.899109994,4.448843887,0.009817223,0.144635608,3373;1462;633;1634,BGN;HYAL1;VCAN;DCN
GO:0071310,cellular response to organic substance (GO:0071310),122,16,8.437801481,1.896228542,0.009868173,0.145030775,9472;2690;150;7048;130399;10267;4311;6586;51176;658;6422;55022;8835;5784;9314;7123,MME;CLEC3B;SFRP1;TGFBR2;ACVR1C;PTPN14;LEF1;GHR;KLF4;PID1;AKAP6;SOCS2;SLIT3;RAMP1;BMPR1B;ADRA2A
GO:1901990,regulation of mitotic cell cycle phase transition (GO:1901990),187,22,12.93335145,1.701028545,0.010085514,0.145663798,5577;22974;9928;11065;991;27338;701;983;4085;6790;5347;891;1062;1063;1869;10733;4751;990;8555;54443;168448;3161,NEK2;TPX2;CENPF;UBE2C;CDK1;HMMR;ANLN;PLK1;AURKA;KIF14;CCNB1;BUB1B;CDC20;CENPE;CDC6;CDC14B;E2F1;MAD2L1;UBE2S;PLK4;CDC14C;PRKAR2B
GO:0015908,fatty acid transport (GO:0015908),20,5,1.383246144,3.614685658,0.010135596,0.145663798,5468;2167;2180;948;28965,FABP4;CD36;PPARG;SLC27A6;ACSL1
GO:0051783,regulation of nuclear division (GO:0051783),20,5,1.383246144,3.614685658,0.010135596,0.145663798,858;9088;4751;83987;4288,NEK2;PKMYT1;MKI67;CAV2;CCDC8
GO:0003009,skeletal muscle contraction (GO:0003009),20,5,1.383246144,3.614685658,0.010135596,0.145663798,4621;7138;7140;6769;342667,TNNT3;STAC2;TNNT1;MYH3;STAC
GO:0010738,regulation of protein kinase A signaling (GO:0010738),20,5,1.383246144,3.614685658,0.010135596,0.145663798,9472;154;5577;9590;9370,ADRB2;ADIPOQ;AKAP6;AKAP12;PRKAR2B
GO:0048566,embryonic digestive tract development (GO:0048566),20,5,1.383246144,3.614685658,0.010135596,0.145663798,64220;5919;6664;91461;348093,PKDCC;RBPMS2;RARRES2;STRA6;SOX11
GO:0046887,positive regulation of hormone secretion (GO:0046887),20,5,1.383246144,3.614685658,0.010135596,0.145663798,6696;6664;1906;338442;4828,HCAR2;SPP1;EDN1;NMB;SOX11
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),20,5,1.383246144,3.614685658,0.010135596,0.145663798,2247;23213;10252;10253;90993,SPRY2;FGF2;SULF1;SPRY1;CREB3L1
GO:0010971,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),20,5,1.383246144,3.614685658,0.010135596,0.145663798,983;891;993;8317;51514,CDK1;DTL;CCNB1;CDC7;CDC25A
GO:0050714,positive regulation of protein secretion (GO:0050714),72,11,4.97968612,2.208974569,0.010153574,0.145663798,3479;79971;8660;654;4826;8447;5950;101;8736;338442;25924,RBP4;MYOM1;NNAT;ADAM8;HCAR2;IRS2;BMP6;WLS;IGF1;DOC2B;MYRIP
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),133,17,9.198586861,1.848109961,0.010227115,0.146021825,3815;2255;2252;2690;3479;284;3569;2209;5649;55024;654;5168;5753;146433;85480;8784;51704,TSLP;RELN;KIT;ENPP2;GHR;ANGPT1;GPRC5B;FGF10;FCGR1A;IL34;BMP6;IGF1;IL6;FGF7;TNFRSF18;PTK6;BANK1
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),133,17,9.198586861,1.848109961,0.010227115,0.146021825,7048;3624;130399;650;7122;7049;353500;56963;654;658;55273;4435;1281;3725;2353;1278;2662,INHBA;BMP8A;GDF10;CLDN5;TGFBR3;TMEM100;TGFBR2;ACVR1C;BMP2;JUN;RGMA;FOS;BMP6;CITED1;BMPR1B;COL3A1;COL1A2
GO:1904018,positive regulation of vasculature development (GO:1904018),102,14,7.054555337,1.984533303,0.010382621,0.147796336,2152;2246;51129;358;947;5740;2247;10411;3373;7010;79924;306;8038;126393,FGF1;HSPB6;FGF2;RAPGEF3;AQP1;F3;HYAL1;CD34;ANGPTL4;ADM2;PTGIS;ANXA3;ADAM12;TEK
GO:0008277,regulation of G protein-coupled receptor signaling pathway (GO:0008277),82,12,5.671309192,2.115913556,0.010425162,0.147796336,11343;5653;1906;25818;1259;112609;114804;5997;9628;2788;9397;5999,RGS6;RGS2;NMT2;MGLL;MRAP2;RGS4;GNG7;CNGA1;EDN1;KLK5;RNF157;KLK6
GO:0045216,cell-cell junction organization (GO:0045216),82,12,5.671309192,2.115913556,0.010425162,0.147796336,253559;57863;1000;1009;57502;84612;7122;1828;83660;5317;55679;27134,LIMS2;CLDN5;CADM3;DSG1;CDH11;TLN2;PKP1;NLGN4X;PARD6B;CDH2;CADM2;TJP3
GO:0045599,negative regulation of fat cell differentiation (GO:0045599),36,7,2.48984306,2.811422179,0.01055063,0.148524214,3569;2625;2308;9370;1869;57761;862,ADIPOQ;E2F1;FOXO1;RUNX1T1;TRIB3;IL6;GATA3
GO:0001895,retina homeostasis (GO:0001895),36,7,2.48984306,2.811422179,0.01055063,0.148524214,4057;7018;482;213;5304;5284;124220,TF;ALB;PIGR;ATP1B2;ZG16B;LTF;PIP
GO:0034508,centromere complex assembly (GO:0034508),36,7,2.48984306,2.811422179,0.01055063,0.148524214,1062;1063;9787;64105;79019;55355;3070,CENPF;HJURP;DLGAP5;CENPE;CENPM;CENPK;HELLS
GO:2000026,regulation of multicellular organismal development (GO:2000026),28,6,1.936544602,3.098301993,0.010894524,0.151941957,983;29127;2625;64321;1848;5764,CDK1;RACGAP1;PTN;DUSP6;SOX17;GATA3
GO:0051261,protein depolymerization (GO:0051261),28,6,1.936544602,3.098301993,0.010894524,0.151941957,2934;9645;1073;9928;81930;11004,KIF2C;KIF14;KIF18A;GSN;MICAL2;CFL2
GO:2001222,regulation of neuron migration (GO:2001222),28,6,1.936544602,3.098301993,0.010894524,0.151941957,57556;10371;6376;63923;1281;285313,CX3CL1;IGSF10;SEMA6A;SEMA3A;TNN;COL3A1
GO:1904407,positive regulation of nitric oxide metabolic process (GO:1904407),28,6,1.936544602,3.098301993,0.010894524,0.151941957,948;5743;3043;1906;10365;9314,HBB;CD36;KLF4;PTGS2;EDN1;KLF2
GO:0051130,positive regulation of cellular component organization (GO:0051130),113,15,7.815340716,1.919302119,0.010997463,0.153022574,6622;3084;2719;991;9378;92359;11076;81620;5649;10411;3373;4038;3038;4314;6886,CDC20;RELN;GPC3;HAS3;RAPGEF3;SNCA;NRXN1;LRP4;HYAL1;TAL1;CDT1;TPPP;MMP3;NRG1;CRB3
GO:1901379,regulation of potassium ion transmembrane transport (GO:1901379),54,9,3.73476459,2.409790439,0.011091791,0.153978649,3753;9472;857;54331;3779;30819;7881;274;2273,KCNE1;KCNIP2;CAV1;FHL1;KCNMB1;AKAP6;KCNAB1;BIN1;GNG2
GO:0048699,generation of neurons (GO:0048699),200,23,13.83246144,1.662755403,0.011238592,0.15565709,4915;11113;7481;10371;79625;55502;23493;57502;29127;6664;5649;4233;8322;7477;6376;51473;26468;460;347733;84913;79192;79190;50805,NTRK2;ATOH8;CX3CL1;RELN;CIT;RACGAP1;IRX1;MET;HES6;TUBB2B;ASTN1;LHX6;IRX6;FZD4;HEY2;WNT11;NLGN4X;SEMA3A;NDNF;IRX4;DCDC2;WNT7B;SOX11
GO:0007346,regulation of mitotic cell cycle (GO:0007346),178,21,12.31089069,1.705806715,0.011410512,0.157674908,9368;11065;991;27338;701;983;4085;5347;891;4212;858;9088;4751;83987;9787;2296;3169;6886;1028;1164;4288,NEK2;PKMYT1;UBE2C;CDK1;DLGAP5;CKS2;MKI67;PLK1;CCNB1;BUB1B;CDC20;CAV2;MEIS2;CDKN1C;MAD2L1;UBE2S;TAL1;CCDC8;SLC9A3R1;FOXC1;FOXA1
GO:0031348,negative regulation of defense response (GO:0031348),83,12,5.740471499,2.090420622,0.011444035,0.157775445,5468;6288;5734;2625;7301;5740;9370;7010;145581;9314;5169;64838,SAA1;ADIPOQ;PPARG;KLF4;LRFN5;PTGER4;FNDC4;PTGIS;TEK;TYRO3;ENPP3;GATA3
GO:0071560,cellular response to transforming growth factor beta stimulus (GO:0071560),114,15,7.884503023,1.902466136,0.011880706,0.163420883,7048;5138;7122;7049;55553;4435;6422;6660;1281;3725;2353;2908;1278;7123;2662,PDE2A;CLEC3B;SFRP1;GDF10;CLDN5;TGFBR3;TGFBR2;NR3C1;JUN;FOS;CITED1;SOX6;SOX5;COL3A1;COL1A2
GO:0007009,plasma membrane organization (GO:0007009),64,10,4.426387662,2.259178536,0.011945099,0.16393149,9368;1378;287;6711;116238;274;30846;1289;225;57088,TLCD1;PLSCR4;SPTBN1;ABCD2;COL5A1;ANK2;BIN1;EHD2;SLC9A3R1;CR1
GO:0072359,circulatory system development (GO:0072359),125,16,8.645288403,1.850719057,0.01232374,0.167016846,8572;9645;4916;7048;64220;650;23493;2335;64321;5950;130497;7010;1281;1396;2296;27295,FN1;RBP4;OSR1;TGFBR2;BMP2;MICAL2;SOX17;NTRK3;PDLIM4;PDLIM3;HEY2;TEK;FOXC1;CRIP1;STRA6;COL3A1
GO:0031401,positive regulation of protein modification process (GO:0031401),213,24,14.73157144,1.629154099,0.012368011,0.167016846,2255;2252;4916;4915;1956;3952;2246;284;10267;8685;650;5919;2247;9370;10411;3953;7010;4318;146433;57161;26051;5329;284654;157313,NTRK2;LEP;FGF1;LEPR;FGF2;ADIPOQ;RAPGEF3;CDCA2;BMP2;PELI2;EGFR;ANGPT1;NTRK3;FGF10;IL34;MMP9;PPP1R16B;PLAUR;RAMP1;MARCO;FGF7;TEK;RSPO1;RARRES2
GO:0030097,hemopoiesis (GO:0030097),94,13,6.501256879,1.999613343,0.012462158,0.167016846,3815;7048;3624;947;7704;9833;7049;6422;1050;7010;7173;6886;219790,INHBA;MELK;ZBTB16;SFRP1;TGFBR3;KIT;TGFBR2;RTKN2;TAL1;TPO;CD34;TEK;CEBPA
GO:0045821,positive regulation of glycolytic process (GO:0045821),21,5,1.452408452,3.44255777,0.012560787,0.167016846,3479;51085;8671;5207;5209,MLXIPL;PFKFB1;SLC4A4;IGF1;PFKFB3
GO:1900544,positive regulation of purine nucleotide metabolic process (GO:1900544),21,5,1.452408452,3.44255777,0.012560787,0.167016846,3479;51085;8671;5207;5209,MLXIPL;PFKFB1;SLC4A4;IGF1;PFKFB3
GO:0050994,regulation of lipid catabolic process (GO:0050994),21,5,1.452408452,3.44255777,0.012560787,0.167016846,150;5919;5140;1149;338442,CIDEA;HCAR2;PDE3B;ADRA2A;RARRES2
GO:0002862,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),136,17,9.406073782,1.807342829,0.012628491,0.167016846,554;111;196883;154;5577;3569;54331;135;133;5745;5744;10267;5734;117;5746;2209;79924,ADCYAP1R1;ADRB2;AVPR2;ADCY4;PTGER4;FCGR1A;PTH1R;ADCY5;RAMP1;ADM2;IL6;ADORA2A;PRKAR2B;GNG2;ADM;PTH2R;PTHLH
GO:0002861,regulation of inflammatory response to antigenic stimulus (GO:0002861),136,17,9.406073782,1.807342829,0.012628491,0.167016846,554;111;196883;154;5577;3569;54331;135;133;5745;5744;10267;5734;117;5746;2209;79924,ADCYAP1R1;ADRB2;AVPR2;ADCY4;PTGER4;FCGR1A;PTH1R;ADCY5;RAMP1;ADM2;IL6;ADORA2A;PRKAR2B;GNG2;ADM;PTH2R;PTHLH
GO:0051347,positive regulation of transferase activity (GO:0051347),147,18,10.16685916,1.770458282,0.012816232,0.167016846,3815;4916;4915;1956;9212;5347;7301;5979;2051;2047;4233;9370;4751;7010;9314;57761;4921;5570,NEK2;NTRK2;PLK1;AURKB;EPHB1;ADIPOQ;KIT;EGFR;KLF4;MET;EPHB6;NTRK3;TRIB3;DDR2;TEK;RET;TYRO3;PKIB
GO:0040001,establishment of mitotic spindle localization (GO:0040001),29,6,2.005706909,2.991463993,0.012952003,0.167016846,4085;5347;9700;10403;51203;89958,NUSAP1;NDC80;PLK1;ESPL1;MAD2L1;SAPCD2
GO:0060173,limb development (GO:0060173),29,6,2.005706909,2.991463993,0.012952003,0.167016846,2255;658;5727;4038;64093;1311,COMP;LRP4;FGF10;PTCH1;SMOC1;BMPR1B
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),29,6,2.005706909,2.991463993,0.012952003,0.167016846,3624;857;5366;5979;6422;50486,INHBA;CAV1;SFRP1;G0S2;PMAIP1;RET
GO:1990868,response to chemokine (GO:1990868),14,4,0.968272301,4.131069324,0.013003474,0.167016846,6366;6387;1843;2296,CCL21;CXCL12;DUSP1;FOXC1
GO:0010560,positive regulation of glycoprotein biosynthetic process (GO:0010560),14,4,0.968272301,4.131069324,0.013003474,0.167016846,6366;3479;10267;90865,IL33;CCL21;RAMP1;IGF1
GO:0070293,renal absorption (GO:0070293),14,4,0.968272301,4.131069324,0.013003474,0.167016846,9368;2934;8644;3043,HBB;GSN;AKR1C3;SLC9A3R1
GO:0008643,carbohydrate transport (GO:0008643),14,4,0.968272301,4.131069324,0.013003474,0.167016846,358;364;6523;55974,SLC50A1;AQP7;AQP1;SLC5A1
GO:0050892,intestinal absorption (GO:0050892),14,4,0.968272301,4.131069324,0.013003474,0.167016846,3952;150;948;6523,LEP;CD36;ADRA2A;SLC5A1
GO:2000403,positive regulation of lymphocyte migration (GO:2000403),14,4,0.968272301,4.131069324,0.013003474,0.167016846,6366;3627;6387;58494,CXCL10;JAM2;CCL21;CXCL12
GO:0090075,relaxation of muscle (GO:0090075),14,4,0.968272301,4.131069324,0.013003474,0.167016846,2934;477;2946;5997,ATP1A2;GSN;RGS2;GSTM2
GO:0060191,regulation of lipase activity (GO:0060191),14,4,0.968272301,4.131069324,0.013003474,0.167016846,6622;4023;338328;440503,GPIHBP1;LPL;SNCA;PLIN5
GO:2001212,regulation of vasculogenesis (GO:2001212),14,4,0.968272301,4.131069324,0.013003474,0.167016846,7498;947;23493;55273,TMEM100;CD34;HEY2;XDH
GO:0010907,positive regulation of glucose metabolic process (GO:0010907),14,4,0.968272301,4.131069324,0.013003474,0.167016846,5366;8660;2822;10891,GPLD1;IRS2;PPARGC1A;PMAIP1
GO:2000479,regulation of cAMP-dependent protein kinase activity (GO:2000479),14,4,0.968272301,4.131069324,0.013003474,0.167016846,154;5577;9370;5570,ADRB2;ADIPOQ;PRKAR2B;PKIB
GO:0071404,cellular response to low-density lipoprotein particle stimulus (GO:0071404),14,4,0.968272301,4.131069324,0.013003474,0.167016846,5468;4023;948;1066,LPL;CES1;CD36;PPARG
GO:1905517,macrophage migration (GO:1905517),14,4,0.968272301,4.131069324,0.013003474,0.167016846,64805;6288;1910;1907,SAA1;P2RY12;EDNRB;EDN2
GO:0070141,response to UV-A (GO:0070141),14,4,0.968272301,4.131069324,0.013003474,0.167016846,1956;4311;4314;4318,MME;EGFR;MMP3;MMP9
GO:0062009,secondary palate development (GO:0062009),14,4,0.968272301,4.131069324,0.013003474,0.167016846,7048;7481;51176;7049,TGFBR3;TGFBR2;LEF1;WNT11
GO:0051081,nuclear membrane disassembly (GO:0051081),14,4,0.968272301,4.131069324,0.013003474,0.167016846,983;5347;891;9133,CDK1;PLK1;CCNB2;CCNB1
GO:0035581,sequestering of extracellular ligand from receptor (GO:0035581),14,4,0.968272301,4.131069324,0.013003474,0.167016846,650;2201;91851;64388,CHRDL1;BMP2;FBN2;GREM2
GO:0048385,regulation of retinoic acid receptor signaling pathway (GO:0048385),14,4,0.968272301,4.131069324,0.013003474,0.167016846,8644;10365;56603;2146,EZH2;AKR1C3;CYP26B1;KLF2
GO:0045944,positive regulation of transcription by RNA polymerase II (GO:0045944),906,80,62.66105034,1.276710166,0.01345077,0.172393557,9645;4804;5468;1956;3479;2246;3624;3569;51085;3627;259307;650;3204;3202;23493;2625;8626;64651;5325;2308;6664;4781;51176;4223;1906;10365;2247;3164;64321;56963;654;658;1959;4212;9915;4435;4233;10891;1050;130497;6376;1869;2305;55022;7068;2034;2078;9787;8013;467;3725;2353;2296;2908;4582;1958;9314;1634;50943;3169;90865;29128;84441;1870;2299;6886;5187;84913;28999;4072;29028;3226;5178;9079;80034;9457;4605;23764;3206;3131,INHBA;PER1;HLF;HOXA5;ATOH8;CX3CL1;DLGAP5;UHRF1;FGF1;FOXM1;KLF15;OSR1;HOXA7;PLAGL1;MYBL2;EGR1;FGF2;MLXIPL;MEOX2;LDB2;CXCL10;MAML2;IL33;MEIS2;BMP2;PPARG;E2F1;EGFR;NFIB;NGFR;NR3C1;E2F2;MICAL2;JUN;FOXO1;RGMA;EGR2;ATAD2;LEF1;KLF4;CSRNP1;PID1;MAFF;MET;TAL1;FOS;SOX17;FOXP3;IL4I1;ATF3;TP63;PPARGC1A;FHL5;NR4A1;ERG;MUC1;CSRNP3;THRB;BMP6;CITED1;IGF1;DCN;EPAS1;IL6;HEY2;EDN1;FOXC1;BMPR1B;KLF2;HOXA10;HOXC10;NR4A3;ARNT2;CEBPA;PEG3;EPCAM;GATA3;SOX11;FOXA1;FOXI1
GO:0051093,negative regulation of developmental process (GO:0051093),75,11,5.187173042,2.120615586,0.013643766,0.174495053,22899;7481;650;23493;4781;10411;6422;2305;2296;23189;53335,FOXM1;SFRP1;RAPGEF3;KANK1;BMP2;NFIB;ARHGEF15;HEY2;WNT11;FOXC1;BCL11A
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),170,20,11.75759223,1.701028545,0.013716697,0.175055337,7048;57863;1000;1009;2196;5010;7122;9073;64221;57549;54538;347902;64072;6403;1828;8641;145581;30835;79633;4680,ROBO3;CLDN11;CLDN5;TGFBR2;FAT2;CADM3;LRFN5;DSG1;CDH11;CD209;CDH23;CEACAM6;FAT4;ROBO4;CLDN8;SELP;CDH2;IGSF9;AMIGO2;PCDHGB4
GO:0009892,negative regulation of metabolic process (GO:0009892),56,9,3.873089204,2.323726495,0.013975576,0.175925787,55366;216;4857;9370;11096;1149;4883;3226;83643,ADAMTS5;CIDEA;ADIPOQ;ALDH1A1;CCDC3;LGR4;NOVA1;HOXC10;NPR3
GO:0043268,positive regulation of potassium ion transport (GO:0043268),38,7,2.628167674,2.66345259,0.014150615,0.175925787,3753;9472;150;54331;3779;287;2273,KCNE1;FHL1;KCNMB1;AKAP6;ANK2;GNG2;ADRA2A
GO:0033275,actin-myosin filament sliding (GO:0033275),38,7,2.628167674,2.66345259,0.014150615,0.175925787,7111;4604;1674;4621;7138;7140;1756,DMD;TMOD1;TNNT3;TNNT1;MYH3;DES;MYBPC1
GO:0030049,muscle filament sliding (GO:0030049),38,7,2.628167674,2.66345259,0.014150615,0.175925787,7111;4604;1674;4621;7138;7140;1756,DMD;TMOD1;TNNT3;TNNT1;MYH3;DES;MYBPC1
GO:0031570,DNA integrity checkpoint signaling (GO:0031570),38,7,2.628167674,2.66345259,0.014150615,0.175925787,63967;81620;1763;1869;83990;990;8318,CLSPN;CDC6;CDC45;E2F1;BRIP1;CDT1;DNA2
GO:0033034,positive regulation of myeloid cell apoptotic process (GO:0033034),8,3,0.553298458,5.422028487,0.014194644,0.175925787,301;9370;338442,ANXA1;ADIPOQ;HCAR2
GO:0006651,diacylglycerol biosynthetic process (GO:0006651),8,3,0.553298458,5.422028487,0.014194644,0.175925787,84649;57104;57678,GPAM;DGAT2;PNPLA2
GO:0060316,positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),8,3,0.553298458,5.422028487,0.014194644,0.175925787,9472;57158;2946,JPH2;GSTM2;AKAP6
GO:0090494,dopamine uptake (GO:0090494),8,3,0.553298458,5.422028487,0.014194644,0.175925787,6622;6581;222962,SNCA;SLC22A3;SLC29A4
GO:0072073,kidney epithelium development (GO:0072073),8,3,0.553298458,5.422028487,0.014194644,0.175925787,2246;7477;130497,FGF1;OSR1;WNT7B
GO:0033622,integrin activation (GO:0033622),8,3,0.553298458,5.422028487,0.014194644,0.175925787,2335;6387;6376,CX3CL1;FN1;CXCL12
GO:0050873,brown fat cell differentiation (GO:0050873),8,3,0.553298458,5.422028487,0.014194644,0.175925787,9370;63976;10891,ADIPOQ;PPARGC1A;PRDM16
GO:0048714,positive regulation of oligodendrocyte differentiation (GO:0048714),8,3,0.553298458,5.422028487,0.014194644,0.175925787,5803;146433;5764,PTN;PTPRZ1;IL34
GO:0038098,sequestering of BMP from receptor via BMP binding (GO:0038098),8,3,0.553298458,5.422028487,0.014194644,0.175925787,650;91851;64388,CHRDL1;BMP2;GREM2
GO:0071902,positive regulation of protein serine/threonine kinase activity (GO:0071902),106,14,7.331204566,1.909645253,0.014317343,0.177081376,3815;154;6622;1956;150;2246;4057;1906;2247;9370;101;146433;2146;80310,FGF1;ADRB2;FGF2;ADIPOQ;KIT;EZH2;SNCA;EGFR;ADAM8;PDGFD;IL34;EDN1;ADRA2A;LTF
GO:0120163,negative regulation of cold-induced thermogenesis (GO:0120163),47,8,3.250628439,2.461062576,0.014354787,0.17717993,55366;216;4857;9370;11096;1149;4883;3226,ADAMTS5;CIDEA;ADIPOQ;ALDH1A1;LGR4;NOVA1;HOXC10;NPR3
GO:0022617,extracellular matrix disassembly (GO:0022617),66,10,4.564712277,2.190718581,0.014699653,0.181064778,2934;1511;3249;4314;4318;4320;101;25818;5650;11096,MMP11;ADAMTS5;GSN;ADAM8;MMP3;MMP9;KLK5;CTSG;KLK7;HPN
GO:0035633,maintenance of blood-brain barrier (GO:0035633),30,6,2.074869217,2.891748527,0.015266853,0.186780706,1756;3569;7122;3908;27134;58494,DMD;CLDN5;JAM2;IL6;LAMA2;TJP3
GO:0090218,positive regulation of lipid kinase activity (GO:0090218),30,6,2.074869217,2.891748527,0.015266853,0.186780706,3815;6366;64805;2247;7010;1917,FGF2;KIT;P2RY12;CCL21;TEK;EEF1A2
GO:0030204,chondroitin sulfate metabolic process (GO:0030204),30,6,2.074869217,2.891748527,0.015266853,0.186780706,79625;3373;1462;633;1634;9469,BGN;CHST3;HYAL1;VCAN;DCN;NDNF
GO:0071470,cellular response to osmotic stress (GO:0071470),22,5,1.521570759,3.286077871,0.015350136,0.186780706,6326;825;358;4638;362,MYLK;AQP1;SCN2A;CAPN3;AQP5
GO:0019228,neuronal action potential (GO:0019228),22,5,1.521570759,3.286077871,0.015350136,0.186780706,6329;6326;6335;6332;6328,SCN3A;SCN4A;SCN2A;SCN9A;SCN7A
GO:0051043,regulation of membrane protein ectodomain proteolysis (GO:0051043),22,5,1.521570759,3.286077871,0.015350136,0.186780706,150;2822;101;152503;7079,TIMP4;ADAM8;GPLD1;SH3D19;ADRA2A
GO:0051592,response to calcium ion (GO:0051592),107,14,7.400366873,1.891798101,0.015460328,0.187741476,1894;825;857;3779;30819;8644;2822;6263;6261;90019;83849;57586;845;27132,RYR3;KCNIP2;CAV1;KCNMB1;ECT2;GPLD1;CAPN3;CASQ2;AKR1C3;SYT8;SYT15;RYR1;SYT13;CPNE7
GO:2000377,regulation of reactive oxygen species metabolic process (GO:2000377),57,9,3.942251512,2.282959363,0.015609262,0.18916789,6622;7498;7048;185;8644;1645;2305;55022;440503,FOXM1;AKR1C1;SNCA;TGFBR2;PID1;AKR1C3;AGTR1;XDH;PLIN5
GO:0000724,double-strand break repair via homologous recombination (GO:0000724),97,13,6.708743801,1.937769631,0.015956115,0.192982308,10721;8317;9401;641;4173;8318;5888;8438;7516;10635;675;51659;4796,RAD51;CDC45;POLQ;RAD54L;RAD51AP1;RECQL4;MCM4;BLM;CDC7;GINS2;TONSL;XRCC2;BRCA2
GO:0006259,DNA metabolic process (GO:0006259),276,29,19.08879679,1.519215711,0.01600691,0.193207902,983;7153;1776;81620;10721;1763;8317;2175;116028;990;9401;7298;10535;641;4173;55388;23594;4998;8318;9156;5888;8438;7516;10635;29089;3070;3149;3838;29128,UBE2T;CDK1;EXO1;TOP2A;UHRF1;CDC6;RAD51;RMI2;CDC45;MCM10;POLQ;KPNA2;HMGB3;RNASEH2A;RAD54L;DNASE1L3;RAD51AP1;RECQL4;ORC6;ORC1;MCM4;TYMS;HELLS;CDT1;BLM;DNA2;CDC7;FANCA;XRCC2
GO:0032872,regulation of stress-activated MAPK cascade (GO:0032872),48,8,3.319790747,2.409790439,0.016213026,0.194918181,1956;2308;2047;7049;2305;23542;4281;5187,PER1;FOXM1;EPHB1;TGFBR3;EGFR;FOXO1;MID1;MAPK8IP2
GO:0048565,digestive tract development (GO:0048565),39,7,2.697329982,2.595158934,0.016245884,0.194918181,3815;64220;5919;1910;79827;91461;10551,KIT;EDNRB;CLMP;PKDCC;RARRES2;STRA6;AGR2
GO:0006310,DNA recombination (GO:0006310),39,7,2.697329982,2.595158934,0.016245884,0.194918181,9401;641;9156;5888;8438;7516;3149,EXO1;RAD51;HMGB3;RAD54L;RECQL4;BLM;XRCC2
GO:0000086,G2/M transition of mitotic cell cycle (GO:0000086),129,16,8.921937632,1.79333242,0.016314629,0.195353053,5577;983;6790;5347;891;9833;10763;5243;993;890;10733;9088;2305;9133;4751;4660,NEK2;PKMYT1;PPP1R12B;CDK1;PLK1;AURKA;MELK;CCNB2;FOXM1;CCNB1;CCNA2;ABCB1;NES;PLK4;CDC25A;PRKAR2B
GO:0071901,negative regulation of protein serine/threonine kinase activity (GO:0071901),77,11,5.325497656,2.065534662,0.016429906,0.196342273,5577;5347;54922;9370;1050;10252;1843;10253;5570;5997;1028,SPRY2;PLK1;ADIPOQ;CDKN1C;RGS2;RASIP1;SPRY1;DUSP1;PRKAR2B;CEBPA;PKIB
GO:0007417,central nervous system development (GO:0007417),265,28,18.32801141,1.527716203,0.01655309,0.197421869,2934;7048;135;1000;6663;5653;7704;11076;6664;6285;4781;5649;347;4826;1959;54510;55553;5727;4212;10763;5050;26047;9915;347902;1462;5803;5212;7368,VIT;S100B;RELN;ZBTB16;PAFAH1B3;GSN;TGFBR2;MEIS2;PTPRZ1;SOX10;NNAT;NFIB;NES;CNTNAP2;EGR2;APOD;VCAN;TPPP;PTCH1;SOX6;PCDH18;ADORA2A;KLK6;CDH2;AMIGO2;ARNT2;UGT8;SOX11
GO:0051046,regulation of secretion (GO:0051046),15,4,1.037434608,3.855664702,0.01677907,0.198151258,2255;3084;1066;2822,CES1;GPLD1;FGF10;NRG1
GO:0001890,placenta development (GO:0001890),15,4,1.037434608,3.855664702,0.01677907,0.198151258,5468;3952;8728;4435,LEP;PPARG;ADAM19;CITED1
GO:0051044,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),15,4,1.037434608,3.855664702,0.01677907,0.198151258,150;2822;101;152503,ADAM8;GPLD1;SH3D19;ADRA2A
GO:2000050,regulation of non-canonical Wnt signaling pathway (GO:2000050),15,4,1.037434608,3.855664702,0.01677907,0.198151258,2719;6422;23500;84870,SFRP1;GPC3;RSPO3;DAAM2
GO:0045445,myoblast differentiation (GO:0045445),15,4,1.037434608,3.855664702,0.01677907,0.198151258,3479;3084;6382;2034,NRG1;IGF1;EPAS1;SDC1
GO:0000302,response to reactive oxygen species (GO:0000302),58,9,4.011413819,2.243597995,0.01737889,0.204832374,1956;8644;347;3043;3373;4318;3725;2353;847,HBB;EGFR;JUN;APOD;HYAL1;FOS;CAT;AKR1C3;MMP9
GO:0044839,cell cycle G2/M phase transition (GO:0044839),130,16,8.991099939,1.779537555,0.017453034,0.205303689,5577;983;6790;5347;891;9833;10763;5243;993;890;10733;9088;2305;9133;4751;4660,NEK2;PKMYT1;PPP1R12B;CDK1;PLK1;AURKA;MELK;CCNB2;FOXM1;CCNB1;CCNA2;ABCB1;NES;PLK4;CDC25A;PRKAR2B
GO:0086002,cardiac muscle cell action potential involved in contraction (GO:0086002),31,6,2.144031524,2.798466316,0.017853295,0.207574775,3753;23704;55800;6327;287;6330,SCN4B;KCNE1;SCN2B;SCN3B;ANK2;KCNE4
GO:0051180,vitamin transport (GO:0051180),31,6,2.144031524,2.798466316,0.017853295,0.207574775,2350;9429;2348;8029;6947;148641,CUBN;FOLR1;ABCG2;FOLR2;SLC35F3;TCN1
GO:0017158,regulation of calcium ion-dependent exocytosis (GO:0017158),31,6,2.144031524,2.798466316,0.017853295,0.207574775,3745;150;8447;90019;83849;57586,KCNB1;SYT8;SYT15;DOC2B;ADRA2A;SYT13
GO:0045668,negative regulation of osteoblast differentiation (GO:0045668),31,6,2.144031524,2.798466316,0.017853295,0.207574775,5468;5727;4435;63923;2662;51232,GDF10;PPARG;CRIM1;PTCH1;CITED1;TNN
GO:0051443,positive regulation of ubiquitin-protein transferase activity (GO:0051443),31,6,2.144031524,2.798466316,0.017853295,0.207574775,11065;991;27338;5347;8555;57761,UBE2C;PLK1;CDC20;CDC14B;UBE2S;TRIB3
GO:0030517,negative regulation of axon extension (GO:0030517),31,6,2.144031524,2.798466316,0.017853295,0.207574775,54437;80031;57556;10371;223117;56920,SEMA5B;SEMA3G;SEMA3D;SEMA6D;SEMA6A;SEMA3A
GO:0032673,regulation of interleukin-4 production (GO:0032673),23,5,1.590733066,3.14320492,0.018524359,0.213218964,7292;8140;2625;51176;50943,TNFSF4;LEF1;FOXP3;SLC7A5;GATA3
GO:0030212,hyaluronan metabolic process (GO:0030212),23,5,1.590733066,3.14320492,0.018524359,0.213218964,2247;3373;10894;3038;3161,LYVE1;HMMR;HAS3;FGF2;HYAL1
GO:1902751,positive regulation of cell cycle G2/M phase transition (GO:1902751),23,5,1.590733066,3.14320492,0.018524359,0.213218964,983;891;993;8317;51514,CDK1;DTL;CCNB1;CDC7;CDC25A
GO:2000649,regulation of sodium ion transmembrane transporter activity (GO:2000649),40,7,2.766492289,2.530279961,0.018551575,0.213218964,9368;1756;55800;6327;6330;130497;5348,FXYD1;DMD;SCN4B;OSR1;SCN2B;SCN3B;SLC9A3R1
GO:0072676,lymphocyte migration (GO:0072676),40,7,2.766492289,2.530279961,0.018551575,0.213218964,1901;6366;6288;2625;5979;6376;101,CX3CL1;SAA1;ADAM8;CCL21;S1PR1;RET;GATA3
GO:0030195,negative regulation of blood coagulation (GO:0030195),40,7,2.766492289,2.530279961,0.018551575,0.213218964,2152;947;1906;7035;2159;5329;2161,F10;F3;TFPI;CD34;F12;PLAUR;EDN1
GO:0060326,cell chemotaxis (GO:0060326),69,10,4.772199198,2.095469947,0.019683042,0.220885235,3815;6366;185;6387;2047;51176;1960;3164;56477;6376,CX3CL1;EPHB1;KIT;LEF1;EGR3;CCL21;CCL28;CXCL12;NR4A1;AGTR1
GO:0043406,positive regulation of MAP kinase activity (GO:0043406),69,10,4.772199198,2.095469947,0.019683042,0.220885235,3815;1956;150;2246;1906;2247;101;146433;2146;80310,FGF1;FGF2;KIT;EZH2;EGFR;ADAM8;PDGFD;IL34;EDN1;ADRA2A
GO:0071277,cellular response to calcium ion (GO:0071277),69,10,4.772199198,2.095469947,0.019683042,0.220885235,1894;825;8644;2822;6263;6261;90019;83849;57586;27132,RYR3;ECT2;GPLD1;CAPN3;AKR1C3;SYT8;SYT15;RYR1;SYT13;CPNE7
GO:0007160,cell-matrix adhesion (GO:0007160),100,13,6.916230722,1.879636542,0.020149364,0.220885235,6366;10580;947;2335;255743;10516;63923;55612;1308;10894;1281;3679;1842,LYVE1;FN1;ITGA7;SORBS1;COL17A1;CCL21;CD34;FBLN5;ECM2;NPNT;FERMT1;TNN;COL3A1
GO:0045019,negative regulation of nitric oxide biosynthetic process (GO:0045019),9,3,0.622460765,4.819580878,0.02021076,0.220885235,857;947;5740,CAV1;CD34;PTGIS
GO:1904406,negative regulation of nitric oxide metabolic process (GO:1904406),9,3,0.622460765,4.819580878,0.02021076,0.220885235,857;947;5740,CAV1;CD34;PTGIS
GO:0060251,regulation of glial cell proliferation (GO:0060251),9,3,0.622460765,4.819580878,0.02021076,0.220885235,1128;3569;6664,IL6;SOX11;CHRM1
GO:0050910,detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),9,3,0.622460765,4.819580878,0.02021076,0.220885235,3815;3249;1301,COL11A1;KIT;HPN
GO:0035767,endothelial cell chemotaxis (GO:0035767),9,3,0.622460765,4.819580878,0.02021076,0.220885235,10563;1960;3164,EGR3;NR4A1;CXCL13
GO:0044320,cellular response to leptin stimulus (GO:0044320),9,3,0.622460765,4.819580878,0.02021076,0.220885235,3952;3953;8013,LEP;LEPR;NR4A3
GO:0044321,response to leptin (GO:0044321),9,3,0.622460765,4.819580878,0.02021076,0.220885235,3952;3953;8013,LEP;LEPR;NR4A3
GO:0071732,cellular response to nitric oxide (GO:0071732),9,3,0.622460765,4.819580878,0.02021076,0.220885235,358;2308;4314,AQP1;FOXO1;MMP3
GO:1902170,cellular response to reactive nitrogen species (GO:1902170),9,3,0.622460765,4.819580878,0.02021076,0.220885235,358;2308;4314,AQP1;FOXO1;MMP3
GO:2000269,regulation of fibroblast apoptotic process (GO:2000269),9,3,0.622460765,4.819580878,0.02021076,0.220885235,8626;6422;56981,SFRP1;PRDM11;TP63
GO:0060192,negative regulation of lipase activity (GO:0060192),9,3,0.622460765,4.819580878,0.02021076,0.220885235,51129;440503;5997,RGS2;ANGPTL4;PLIN5
GO:0010890,positive regulation of sequestering of triglyceride (GO:0010890),9,3,0.622460765,4.819580878,0.02021076,0.220885235,4023;1149;440503,LPL;CIDEA;PLIN5
GO:0032000,positive regulation of fatty acid beta-oxidation (GO:0032000),9,3,0.622460765,4.819580878,0.02021076,0.220885235,8660;225;440503,ABCD2;IRS2;PLIN5
GO:0090129,positive regulation of synapse maturation (GO:0090129),9,3,0.622460765,4.819580878,0.02021076,0.220885235,991;9378;5649,CDC20;RELN;NRXN1
GO:0072182,regulation of nephron tubule epithelial cell differentiation (GO:0072182),9,3,0.622460765,4.819580878,0.02021076,0.220885235,2625;8842;130497,OSR1;GATA3;PROM1
GO:0090596,sensory organ morphogenesis (GO:0090596),9,3,0.622460765,4.819580878,0.02021076,0.220885235,64220;1290;1289,COL5A2;COL5A1;STRA6
GO:0097104,postsynaptic membrane assembly (GO:0097104),9,3,0.622460765,4.819580878,0.02021076,0.220885235,9378;57502;4038,NRXN1;LRP4;NLGN4X
GO:0042448,progesterone metabolic process (GO:0042448),9,3,0.622460765,4.819580878,0.02021076,0.220885235,8644;1645;1646,AKR1C1;AKR1C2;AKR1C3
GO:0019755,one-carbon compound transport (GO:0019755),9,3,0.622460765,4.819580878,0.02021076,0.220885235,6563;358;362,AQP1;SLC14A1;AQP5
GO:0033280,response to vitamin D (GO:0033280),9,3,0.622460765,4.819580878,0.02021076,0.220885235,6696;6422;249,SFRP1;ALPL;SPP1
GO:0051382,kinetochore assembly (GO:0051382),9,3,0.622460765,4.819580878,0.02021076,0.220885235,1062;1063;9787,CENPF;DLGAP5;CENPE
GO:0035358,regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),9,3,0.622460765,4.819580878,0.02021076,0.220885235,5740;440503;55885,PTGIS;LMO3;PLIN5
GO:0038065,collagen-activated signaling pathway (GO:0038065),9,3,0.622460765,4.819580878,0.02021076,0.220885235,1277;4921;1288,DDR2;COL4A6;COL1A1
GO:0043270,positive regulation of ion transport (GO:0043270),50,8,3.458115361,2.313398821,0.020439397,0.222978614,1128;55800;150;4638;287;6330;2273;5652,SCN4B;FHL1;MYLK;SCN3B;ANK2;ADRA2A;PRSS8;CHRM1
GO:0050922,negative regulation of chemotaxis (GO:0050922),32,6,2.213193831,2.711014244,0.020724655,0.224861363,54437;80031;57556;10371;223117;56920,SEMA5B;SEMA3G;SEMA3D;SEMA6D;SEMA6A;SEMA3A
GO:0070839,metal ion export (GO:0070839),32,6,2.213193831,2.711014244,0.020724655,0.224861363,3753;23704;30819;8671;477;482,KCNE1;ATP1A2;KCNIP2;ATP1B2;SLC4A4;KCNE4
GO:0043388,positive regulation of DNA binding (GO:0043388),32,6,2.213193831,2.711014244,0.020724655,0.224861363,5468;3479;2625;4318;2296;5329,PPARG;MMP9;PLAUR;IGF1;FOXC1;GATA3
GO:0006814,sodium ion transport (GO:0006814),90,12,6.22460765,1.927832351,0.020862803,0.224861363,6329;6326;6335;6332;6328;55800;11254;6327;6330;8671;6523;477,SCN4B;SCN3A;ATP1A2;SCN2B;SCN3B;SCN4A;SCN2A;SLC4A4;SCN9A;SLC6A14;SCN7A;SLC5A1
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),90,12,6.22460765,1.927832351,0.020862803,0.224861363,3624;650;6664;494470;353500;654;658;23213;4435;2662;7272;1028,INHBA;BMP8A;GDF10;TTK;CDKN1C;BMP2;SULF1;BMP6;CITED1;BMPR1B;RNF165;SOX11
GO:0051960,regulation of nervous system development (GO:0051960),41,7,2.835654596,2.468565815,0.021077327,0.224861363,9928;55502;23493;6376;5803;5764;163175,CX3CL1;KIF14;LGI4;PTN;PTPRZ1;HES6;HEY2
GO:0009074,aromatic amino acid family catabolic process (GO:0009074),16,4,1.106596916,3.614685658,0.021173105,0.224861363,6898;8564;23498;259307,TAT;IL4I1;HAAO;KMO
GO:0021915,neural tube development (GO:0021915),16,4,1.106596916,3.614685658,0.021173105,0.224861363,6664;5727;6491;8854,ALDH1A2;STIL;PTCH1;SOX11
GO:0007158,neuron cell-cell adhesion (GO:0007158),16,4,1.106596916,3.614685658,0.021173105,0.224861363,9378;57502;5979;460,NRXN1;ASTN1;NLGN4X;RET
GO:0046883,regulation of hormone secretion (GO:0046883),16,4,1.106596916,3.614685658,0.021173105,0.224861363,301;6664;1906;4828,ANXA1;EDN1;NMB;SOX11
GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),16,4,1.106596916,3.614685658,0.021173105,0.224861363,4804;185;2247;26051,FGF2;NGFR;PPP1R16B;AGTR1
GO:0032656,regulation of interleukin-13 production (GO:0032656),16,4,1.106596916,3.614685658,0.021173105,0.224861363,7292;2625;51176;85480,TSLP;TNFSF4;LEF1;GATA3
GO:0070593,dendrite self-avoidance (GO:0070593),16,4,1.106596916,3.614685658,0.021173105,0.224861363,64221;57549;54538;63923,ROBO3;ROBO4;IGSF9;TNN
GO:0046683,response to organophosphorus (GO:0046683),16,4,1.106596916,3.614685658,0.021173105,0.224861363,1645;4435;10060;7298,AKR1C1;TYMS;CITED1;ABCC9
GO:0006268,DNA unwinding involved in DNA replication (GO:0006268),16,4,1.106596916,3.614685658,0.021173105,0.224861363,9401;641;4173;5888,RAD51;RECQL4;MCM4;BLM
GO:1990869,cellular response to chemokine (GO:1990869),60,9,4.149738433,2.168811395,0.02134952,0.226238589,10563;6366;3627;4283;2920;6387;6376;1843;2296,CXCL2;CX3CL1;CXCL10;CCL21;CXCL12;DUSP1;CXCL9;FOXC1;CXCL13
GO:0045786,negative regulation of cell cycle (GO:0045786),80,11,5.532984578,1.988077112,0.02137806,0.226238589,9368;3624;4085;5347;650;2625;3164;1050;1843;2296;1028,INHBA;PLK1;CDKN1C;BMP2;MAD2L1;DUSP1;NR4A1;SLC9A3R1;FOXC1;CEBPA;GATA3
GO:0051726,regulation of cell cycle (GO:0051726),295,30,20.40288063,1.470380607,0.021789366,0.230186084,2255;3952;3624;51085;5347;891;650;2625;5325;2191;3164;1063;6422;993;1033;2305;9133;1843;332;51514;5753;8555;274;9787;3725;168448;56981;4605;55771;1164,INHBA;CENPF;DTL;LEP;DLGAP5;CKS2;PLK1;CDKN3;CCNB2;FOXM1;CCNB1;BIRC5;SFRP1;PLAGL1;MYBL2;CDC14B;MLXIPL;PRDM11;BMP2;PRR11;JUN;CDC14C;FAP;DUSP1;FGF10;NR4A1;CDC25A;BIN1;PTK6;GATA3
GO:0045913,positive regulation of carbohydrate metabolic process (GO:0045913),24,5,1.659895373,3.012238048,0.022101976,0.232670715,3479;51085;8671;5207;5209,MLXIPL;PFKFB1;SLC4A4;IGF1;PFKFB3
GO:0010611,regulation of cardiac muscle hypertrophy (GO:0010611),24,5,1.659895373,3.012238048,0.022101976,0.232670715,3479;1906;8013;5152;5997,RGS2;PDE9A;IGF1;EDN1;NR4A3
GO:0044089,positive regulation of cellular component biogenesis (GO:0044089),91,12,6.293769957,1.90664738,0.022575109,0.236409372,3084;6382;92359;11076;81620;3373;6376;3038;4314;6886;11346;171024,CX3CL1;HAS3;SYNPO2;HYAL1;TAL1;CDT1;TPPP;MMP3;NRG1;SDC1;SYNPO;CRB3
GO:0043409,negative regulation of MAPK cascade (GO:0043409),91,12,6.293769957,1.90664738,0.022575109,0.236409372,9368;857;57556;2308;9370;10252;2305;1848;1843;10253;5997;55885,SPRY2;FOXM1;CAV1;ADIPOQ;FOXO1;RGS2;DUSP6;SEMA6A;SPRY1;DUSP1;SLC9A3R1;LMO3
GO:0050730,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),91,12,6.293769957,1.90664738,0.022575109,0.236409372,2255;2252;2690;1956;3479;284;3569;5649;55024;654;6422;5168,RELN;SFRP1;ENPP2;EGFR;GHR;ANGPT1;FGF10;BMP6;IGF1;IL6;FGF7;BANK1
GO:0045055,regulated exocytosis (GO:0045055),179,20,12.38005299,1.61550197,0.022860579,0.238982508,6622;3479;26154;948;7018;5919;2335;9783;90019;6403;83849;57586;11031;213;7123;1675;5627;25837;7450;22915,FN1;TF;CLEC3B;PROS1;CFD;SNCA;CD36;MMRN1;RIMS3;RAB26;ALB;RAB31;SYT8;IGF1;VWF;SYT15;SELP;SYT13;RARRES2;ABCA12
GO:0010941,regulation of cell death (GO:0010941),102,13,7.054555337,1.842780924,0.023371185,0.243896168,6622;7481;948;6623;8644;6664;2047;3043;2247;1410;10551;155465;10562,CRYAB;EPHB1;FGF2;HBB;SNCA;CD36;OLFM4;SNCG;AKR1C3;WNT11;SOX11;AGR2;AGR3
GO:0006006,glucose metabolic process (GO:0006006),61,9,4.218900741,2.13325711,0.023561908,0.244459421,8660;347;9370;10891;230;5207;5950;5105;6652,RBP4;ADIPOQ;PCK1;PFKFB1;ALDOC;APOD;IRS2;PPARGC1A;SORD
GO:0032526,response to retinoic acid (GO:0032526),61,9,4.218900741,2.13325711,0.023561908,0.244459421,7481;358;5979;8322;7477;5950;5753;54997;3294,TESC;RBP4;AQP1;FZD4;HSD17B2;WNT11;PTK6;RET;WNT7B
GO:2000045,regulation of G1/S transition of mitotic cell cycle (GO:2000045),71,10,4.910523813,2.036442624,0.023628502,0.244459421,301;2255;11170;1956;9928;3373;1869;9314;9510;2273,KIF14;FAM107A;ANXA1;FHL1;ADAMTS1;E2F1;EGFR;KLF4;HYAL1;FGF10
GO:0048732,gland development (GO:0048732),71,10,4.910523813,2.036442624,0.023628502,0.244459421,9368;301;2255;3084;857;7481;64220;7049;4233;1050,CAV1;ANXA1;TGFBR3;MET;FGF10;NRG1;WNT11;SLC9A3R1;CEBPA;STRA6
GO:0043524,negative regulation of neuron apoptotic process (GO:0043524),71,10,4.910523813,2.036442624,0.023628502,0.244459421,4915;9928;79625;7301;219699;4435;10891;6376;101;5803,NTRK2;CX3CL1;KIF14;UNC5B;PTPRZ1;ADAM8;PPARGC1A;CITED1;NDNF;TYRO3
GO:0071300,cellular response to retinoic acid (GO:0071300),42,7,2.904816903,2.409790439,0.023832271,0.245721756,7481;358;5979;8322;7477;5753;54997,TESC;AQP1;FZD4;WNT11;PTK6;RET;WNT7B
GO:0010718,positive regulation of epithelial to mesenchymal transition (GO:0010718),42,7,2.904816903,2.409790439,0.023832271,0.245721756,7048;3569;650;51176;2296;1277;2146,EZH2;TGFBR2;BMP2;LEF1;IL6;FOXC1;COL1A1
GO:0034308,primary alcohol metabolic process (GO:0034308),33,6,2.282356138,2.628862297,0.023893259,0.245928735,3479;1583;5950;125;126;124,RBP4;ADH1C;ADH1A;ADH1B;CYP11A1;IGF1
GO:0051289,protein homotetramerization (GO:0051289),52,8,3.596439976,2.224421943,0.025393691,0.260480337,32;6263;6261;220;362;115362;8854;7083,RYR3;TK1;ALDH1A2;ACACB;ALDH1A3;AQP5;RYR1;GBP5
GO:1904377,positive regulation of protein localization to cell periphery (GO:1904377),52,8,3.596439976,2.224421943,0.025393691,0.260480337,1956;10580;2037;2770;6711;10551;6769;342667,SORBS1;STAC2;EGFR;SPTBN1;GNAI1;EPB41L2;STAC;AGR2
GO:0045893,"positive regulation of transcription, DNA-templated (GO:0045893)",1170,98,80.91989945,1.211074169,0.025457705,0.260692101,2252;5468;1956;3479;2246;3624;825;3569;51085;3627;7481;259307;6663;6696;650;3204;3202;23493;2625;8626;64651;5325;7704;2308;6664;5979;4781;51176;4223;1906;10365;2247;3164;64321;56963;654;658;1959;4212;9915;4435;4233;63976;10891;6422;8322;1050;130497;6376;1869;2305;55022;3038;641;7068;2034;2078;8013;467;3725;2353;2296;2908;1958;9314;54997;1634;1277;50943;3169;90865;29128;675;84441;1870;2299;6886;5187;59;84913;79190;28999;1028;56981;4072;29028;3226;5178;9079;80034;3229;253738;9586;9457;4605;23764;3206;3131,INHBA;PER1;HLF;HOXA5;ATOH8;CX3CL1;UHRF1;FGF1;FOXM1;KLF15;ZBTB16;TESC;OSR1;SFRP1;HOXA7;PLAGL1;MYBL2;HAS3;EGR1;FGF2;CREB5;MLXIPL;MEOX2;LDB2;CXCL10;MAML2;IL33;MEIS2;PRDM11;CDKN1C;BMP2;PPARG;SOX10;E2F1;EGFR;NFIB;NR3C1;E2F2;EBF3;JUN;FOXO1;RGMA;EGR2;ATAD2;LEF1;CAPN3;KLF4;CSRNP1;PID1;MAFF;MET;TAL1;FOS;SOX17;FOXP3;IRX6;BLM;IL4I1;ATF3;TP63;PPARGC1A;FHL5;NR4A1;ERG;CSRNP3;THRB;BMP6;SPP1;FZD4;ACTA2;CITED1;PRDM16;BRCA2;IGF1;DCN;EPAS1;IL6;HEY2;EDN1;WNT11;FGF7;FOXC1;BMPR1B;HOXC13;KLF2;HOXA10;HOXC10;RET;NR4A3;ARNT2;CEBPA;PEG3;EPCAM;GATA3;COL1A1;SOX11;FOXA1;FOXI1
GO:1903532,positive regulation of secretion by cell (GO:1903532),72,10,4.97968612,2.008158699,0.025801877,0.262125393,3745;6622;3479;650;6664;1906;654;101;8736;4828,MYOM1;SNCA;BMP2;ADAM8;KCNB1;BMP6;IGF1;EDN1;NMB;SOX11
GO:0032414,positive regulation of ion transmembrane transporter activity (GO:0032414),25,5,1.729057681,2.891748527,0.026099169,0.262125393,1756;287;5243;482;6769,DMD;ABCB1;ATP1B2;ANK2;STAC
GO:0019933,cAMP-mediated signaling (GO:0019933),25,5,1.729057681,2.891748527,0.026099169,0.262125393,9472;5138;27115;1672;10411,PDE2A;RAPGEF3;AKAP6;DEFB1;PDE7B
GO:0045834,positive regulation of lipid metabolic process (GO:0045834),25,5,1.729057681,2.891748527,0.026099169,0.262125393,5468;10580;51085;9370;1917,ADIPOQ;SORBS1;MLXIPL;PPARG;EEF1A2
GO:2000738,positive regulation of stem cell differentiation (GO:2000738),17,4,1.175759223,3.40205709,0.026208179,0.262125393,55553;6660;2296;5764,PTN;SOX6;FOXC1;SOX5
GO:2000648,positive regulation of stem cell proliferation (GO:2000648),17,4,1.175759223,3.40205709,0.026208179,0.262125393,6664;4435;898;4072,CCNE1;CITED1;EPCAM;SOX11
GO:0010669,epithelial structure maintenance (GO:0010669),17,4,1.175759223,3.40205709,0.026208179,0.262125393,5950;4588;143689;7031,RBP4;PIWIL4;MUC6;TFF1
GO:0060415,muscle tissue morphogenesis (GO:0060415),17,4,1.175759223,3.40205709,0.026208179,0.262125393,650;23493;4638;7049,MYLK;TGFBR3;BMP2;HEY2
GO:0014742,positive regulation of muscle hypertrophy (GO:0014742),17,4,1.175759223,3.40205709,0.026208179,0.262125393,3479;1906;8013;5152,PDE9A;IGF1;EDN1;NR4A3
GO:0046676,negative regulation of insulin secretion (GO:0046676),17,4,1.175759223,3.40205709,0.026208179,0.262125393,3745;150;353500;6422,BMP8A;SFRP1;KCNB1;ADRA2A
GO:0050810,regulation of steroid biosynthetic process (GO:0050810),17,4,1.175759223,3.40205709,0.026208179,0.262125393,1066;650;8644;1958,EGR1;CES1;BMP2;AKR1C3
GO:0098761,cellular response to interleukin-7 (GO:0098761),17,4,1.175759223,3.40205709,0.026208179,0.262125393,8660;8835;6776;85480,TSLP;STAT5A;IRS2;SOCS2
GO:0038111,interleukin-7-mediated signaling pathway (GO:0038111),17,4,1.175759223,3.40205709,0.026208179,0.262125393,8660;8835;6776;85480,TSLP;STAT5A;IRS2;SOCS2
GO:0072164,mesonephric tubule development (GO:0072164),17,4,1.175759223,3.40205709,0.026208179,0.262125393,7481;255743;130497;2296,OSR1;WNT11;NPNT;FOXC1
GO:1903507,negative regulation of nucleic acid-templated transcription (GO:1903507),460,43,31.81466132,1.351578116,0.026754721,0.26279714,5468;3084;825;7292;51085;7481;650;3204;23493;2625;8626;7704;2308;51176;1063;4435;9370;63976;6422;1050;1869;2305;332;3725;2908;9314;1410;57761;50943;2146;83595;5187;90993;84913;1028;862;56981;51222;93986;56849;91133;3400;55635,PER1;CENPF;ATOH8;DEPDC1;FOXM1;BIRC5;ZBTB16;TCEAL7;CRYAB;SFRP1;HOXA7;ID4;ADIPOQ;EZH2;MLXIPL;PRDM11;CDKN1C;BMP2;TNFSF4;PPARG;E2F1;NR3C1;JUN;FOXO1;LEF1;CAPN3;KLF4;ZNF219;RUNX1T1;FOXP3;L3MBTL4;TRIB3;TP63;SOX7;FOXP2;NRG1;CITED1;PRDM16;CREB3L1;HEY2;WNT11;CEBPA;GATA3
GO:0001954,positive regulation of cell-matrix adhesion (GO:0001954),43,7,2.973979211,2.353748801,0.026824975,0.26279714,6366;948;6422;56477;6376;7010;4680,CX3CL1;SFRP1;CD36;CCL21;CCL28;CEACAM6;TEK
GO:0045582,positive regulation of T cell differentiation (GO:0045582),43,7,2.973979211,2.353748801,0.026824975,0.26279714,7292;259307;2625;1378;51176;5105;101,PCK1;TNFSF4;ADAM8;LEF1;IL4I1;CR1;GATA3
GO:0001817,regulation of cytokine production (GO:0001817),148,17,10.23602147,1.660801519,0.026917398,0.26279714,301;55366;3952;150;3569;7292;6288;5734;4057;153579;2625;9636;50943;90865;5187;1149;10644,PER1;BTNL9;LEP;ANXA1;SAA1;CIDEA;IL33;TNFSF4;PTGER4;FOXP3;LGR4;ISG15;IGF2BP2;IL6;ADRA2A;GATA3;LTF
GO:0007420,brain development (GO:0007420),148,17,10.23602147,1.660801519,0.026917398,0.26279714,7048;1000;4781;5649;347;4826;1959;54510;55553;5727;1063;4212;10763;5050;26047;9915;347902,CENPF;RELN;PAFAH1B3;TGFBR2;MEIS2;NNAT;NFIB;NES;CNTNAP2;EGR2;APOD;PTCH1;SOX6;PCDH18;CDH2;AMIGO2;ARNT2
GO:0051480,regulation of cytosolic calcium ion concentration (GO:0051480),148,17,10.23602147,1.660801519,0.026917398,0.26279714,111;10563;6288;857;5737;5734;948;185;1906;1907;6261;64072;477;858;3270;794;6869,ATP1A2;CAV1;SAA1;CAV2;CD36;TACR1;PTGFR;PTGER4;ADCY5;CDH23;CALB2;EDN1;EDN2;HRC;RYR1;AGTR1;CXCL13
GO:0048523,negative regulation of cellular process (GO:0048523),561,51,38.80005435,1.314431148,0.026956838,0.26279714,9368;27289;554;284;3624;3569;5744;7481;947;650;2625;6586;1378;6664;91584;9582;4881;2822;2247;3164;7049;64321;9370;6422;1050;3373;1033;2305;990;641;23594;3489;1843;5784;9314;1410;5140;54997;943;8854;50943;10551;83595;10628;143689;58494;9510;2273;155465;92304;56981,INHBA;CDKN3;FOXM1;IGFBP6;TESC;CRYAB;CDC6;SFRP1;FHL1;ALDH1A2;AVPR2;ADAMTS1;FGF2;NPR1;ADIPOQ;TGFBR3;JAM2;PRDM11;BMP2;TXNIP;PTPN14;ORC6;GPLD1;KLF4;ANGPT1;HYAL1;SOX17;FOXP3;PIWIL4;PLXNA4;DUSP1;BLM;CD34;SCGB3A1;SOX7;NR4A1;APOBEC3B;SLIT3;IL6;PDE3B;WNT11;SLC9A3R1;TNFRSF8;CEBPA;CR1;PTHLH;RND1;GATA3;SOX11;AGR2;AGR3
GO:0050796,regulation of insulin secretion (GO:0050796),104,13,7.192879951,1.807342829,0.026959865,0.26279714,3745;111;150;3569;26154;8660;353500;4826;8447;10411;6422;5950;25924,BMP8A;RBP4;SFRP1;RAPGEF3;NNAT;KCNB1;IRS2;ADCY5;IL6;DOC2B;MYRIP;ADRA2A;ABCA12
GO:1902749,regulation of cell cycle G2/M phase transition (GO:1902749),83,11,5.740471499,1.916218903,0.027341657,0.26279714,5577;22974;9928;983;6790;5347;1063;10733;4751;51512;3161,NEK2;TPX2;CENPF;CDK1;HMMR;PLK1;AURKA;KIF14;GTSE1;PLK4;PRKAR2B
GO:0031145,anaphase-promoting complex-dependent catabolic process (GO:0031145),83,11,5.740471499,1.916218903,0.027341657,0.26279714,11065;991;27338;701;983;4085;6790;9212;9232;5347;891,UBE2C;CDK1;PLK1;AURKA;CCNB1;BUB1B;PTTG1;CDC20;AURKB;MAD2L1;UBE2S
GO:0035924,cellular response to vascular endothelial growth factor stimulus (GO:0035924),34,6,2.351518446,2.551542818,0.02737035,0.26279714,301;57556;1960;3164;2296;10253,SPRY2;ANXA1;EGR3;SEMA6A;NR4A1;FOXC1
GO:0033628,regulation of cell adhesion mediated by integrin (GO:0033628),34,6,2.351518446,2.551542818,0.02737035,0.26279714,6366;64805;5979;4582;5140;54997,TESC;P2RY12;CCL21;MUC1;PDE3B;RET
GO:0046218,indolalkylamine catabolic process (GO:0046218),10,3,0.691623072,4.33762279,0.027412046,0.26279714,8564;23498;259307,IL4I1;HAAO;KMO
GO:0060428,lung epithelium development (GO:0060428),10,3,0.691623072,4.33762279,0.027412046,0.26279714,2255;64220;7477,FGF10;STRA6;WNT7B
GO:0051549,positive regulation of keratinocyte migration (GO:0051549),10,3,0.691623072,4.33762279,0.027412046,0.26279714,2255;2252;4318,FGF10;MMP9;FGF7
GO:0050867,positive regulation of cell activation (GO:0050867),10,3,0.691623072,4.33762279,0.027412046,0.26279714,825;5321;6403,CAPN3;PLA2G4A;SELP
GO:0048745,smooth muscle tissue development (GO:0048745),10,3,0.691623072,4.33762279,0.027412046,0.26279714,64220;4638;5727,MYLK;PTCH1;STRA6
GO:1902260,negative regulation of delayed rectifier potassium channel activity (GO:1902260),10,3,0.691623072,4.33762279,0.027412046,0.26279714,3753;23704;7881,KCNE1;KCNAB1;KCNE4
GO:0035809,regulation of urine volume (GO:0035809),10,3,0.691623072,4.33762279,0.027412046,0.26279714,133;4881;4883,NPR1;ADM;NPR3
GO:1900120,regulation of receptor binding (GO:1900120),10,3,0.691623072,4.33762279,0.027412046,0.26279714,9370;4318;64388,ADIPOQ;MMP9;GREM2
GO:0010559,regulation of glycoprotein biosynthetic process (GO:0010559),10,3,0.691623072,4.33762279,0.027412046,0.26279714,6366;3479;64168,NECAB1;CCL21;IGF1
GO:0033314,mitotic DNA replication checkpoint signaling (GO:0033314),10,3,0.691623072,4.33762279,0.027412046,0.26279714,63967;990;4998,CLSPN;CDC6;ORC1
GO:0070670,response to interleukin-4 (GO:0070670),10,3,0.691623072,4.33762279,0.027412046,0.26279714,2625;51176;4435,LEF1;CITED1;GATA3
GO:0070229,negative regulation of lymphocyte apoptotic process (GO:0070229),10,3,0.691623072,4.33762279,0.027412046,0.26279714,9212;8660;5304,AURKB;IRS2;PIP
GO:0030852,regulation of granulocyte differentiation (GO:0030852),10,3,0.691623072,4.33762279,0.027412046,0.26279714,51176;9370;54997,TESC;ADIPOQ;LEF1
GO:1902969,mitotic DNA replication (GO:1902969),10,3,0.691623072,4.33762279,0.027412046,0.26279714,4173;8318;9837,GINS1;CDC45;MCM4
GO:0007162,negative regulation of cell adhesion (GO:0007162),73,10,5.048848427,1.980649676,0.028114797,0.268677335,27289;284;57556;91584;8322;6376;1843;4582;5140;10391,CX3CL1;CORO2B;ANGPT1;SEMA6A;PLXNA4;DUSP1;MUC1;FZD4;PDE3B;RND1
GO:0071621,granulocyte chemotaxis (GO:0071621),73,10,5.048848427,1.980649676,0.028114797,0.268677335,301;10563;6366;6288;3627;4283;2920;1906;1907;6376,CXCL2;CX3CL1;ANXA1;SAA1;CXCL10;CCL21;EDN1;CXCL9;EDN2;CXCL13
GO:0034614,cellular response to reactive oxygen species (GO:0034614),63,9,4.357225355,2.065534662,0.028467876,0.27161969,301;1894;1956;3569;358;8644;4318;3725;2353,ANXA1;ECT2;AQP1;EGFR;JUN;FOS;AKR1C3;MMP9;IL6
GO:0032102,negative regulation of response to external stimulus (GO:0032102),116,14,8.022827638,1.745020663,0.029131658,0.277512515,5468;6288;5734;4057;2625;7301;5740;2247;9370;7010;145581;9314;5169;64838,SAA1;FGF2;ADIPOQ;PPARG;KLF4;LRFN5;PTGER4;FNDC4;PTGIS;TEK;TYRO3;ENPP3;GATA3;LTF
GO:1901381,positive regulation of potassium ion transmembrane transport (GO:1901381),44,7,3.043141518,2.30025451,0.03006339,0.285935181,3753;9472;54331;3779;30819;287;482,KCNE1;KCNIP2;KCNMB1;AKAP6;ATP1B2;ANK2;GNG2
GO:0032392,DNA geometric change (GO:0032392),26,5,1.798219988,2.780527429,0.030529678,0.288998256,301;1763;9401;641;3149,ANXA1;HMGB3;RECQL4;BLM;DNA2
GO:0030032,lamellipodium assembly (GO:0030032),26,5,1.798219988,2.780527429,0.030529678,0.288998256,1901;3815;64805;22885;50649,KIT;P2RY12;ARHGEF4;S1PR1;ABLIM3
GO:0043010,camera-type eye development (GO:0043010),26,5,1.798219988,2.780527429,0.030529678,0.288998256,64220;10763;220;2201;2202,NES;EFEMP1;FBN2;ALDH1A3;STRA6
GO:0002690,positive regulation of leukocyte chemotaxis (GO:0002690),54,8,3.73476459,2.142035946,0.031129184,0.292716961,3569;3627;5919;6387;1907;57402;146433;5764,CXCL10;PTN;CXCL12;IL34;IL6;S100A14;EDN2;RARRES2
GO:0048813,dendrite morphogenesis (GO:0048813),35,6,2.420680753,2.478641594,0.031166005,0.292716961,2047;4038;51473;23542;23237;5764,EPHB1;PTN;LRP4;ARC;MAPK8IP2;DCDC2
GO:0043627,response to estrogen (GO:0043627),35,6,2.420680753,2.478641594,0.031166005,0.292716961,3880;857;2625;4435;6422;10568,CAV1;SFRP1;CITED1;SLC34A2;GATA3;KRT19
GO:0046890,regulation of lipid biosynthetic process (GO:0046890),35,6,2.420680753,2.478641594,0.031166005,0.292716961,10580;51085;9370;5105;5166;7069,PDK4;ADIPOQ;PCK1;SORBS1;MLXIPL;THRSP
GO:0046464,acylglycerol catabolic process (GO:0046464),35,6,2.420680753,2.478641594,0.031166005,0.292716961,11343;57104;2167;1373;4023;3991,FABP4;LPL;LIPE;CPS1;MGLL;PNPLA2
GO:0040014,regulation of multicellular organism growth (GO:0040014),18,4,1.24492153,3.213053918,0.031900512,0.293475557,2690;3479;5727;6776,GHR;STAT5A;PTCH1;IGF1
GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),18,4,1.24492153,3.213053918,0.031900512,0.293475557,301;5743;2247;57381,ANXA1;FGF2;RHOJ;PTGS2
GO:0002042,cell migration involved in sprouting angiogenesis (GO:0002042),18,4,1.24492153,3.213053918,0.031900512,0.293475557,2822;1960;2247;3164,FGF2;GPLD1;EGR3;NR4A1
GO:0033630,positive regulation of cell adhesion mediated by integrin (GO:0033630),18,4,1.24492153,3.213053918,0.031900512,0.293475557,10563;6366;64805;5979,P2RY12;CCL21;RET;CXCL13
GO:1904063,negative regulation of cation transmembrane transport (GO:1904063),18,4,1.24492153,3.213053918,0.031900512,0.293475557,857;477;4318;274,ATP1A2;CAV1;MMP9;BIN1
GO:0006833,water transport (GO:0006833),18,4,1.24492153,3.213053918,0.031900512,0.293475557,358;364;6523;362,AQP7;AQP1;AQP5;SLC5A1
GO:0090278,negative regulation of peptide hormone secretion (GO:0090278),18,4,1.24492153,3.213053918,0.031900512,0.293475557,3745;150;353500;6422,BMP8A;SFRP1;KCNB1;ADRA2A
GO:1902259,regulation of delayed rectifier potassium channel activity (GO:1902259),18,4,1.24492153,3.213053918,0.031900512,0.293475557,3753;23704;9472;7881,KCNE1;AKAP6;KCNAB1;KCNE4
GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),18,4,1.24492153,3.213053918,0.031900512,0.293475557,3753;23704;287;6330,SCN4B;KCNE1;ANK2;KCNE4
GO:0086005,ventricular cardiac muscle cell action potential (GO:0086005),18,4,1.24492153,3.213053918,0.031900512,0.293475557,3753;23704;55800;287,KCNE1;SCN3B;ANK2;KCNE4
GO:0019217,regulation of fatty acid metabolic process (GO:0019217),18,4,1.24492153,3.213053918,0.031900512,0.293475557,5468;857;9370;5166,PDK4;CAV1;ADIPOQ;PPARG
GO:0010744,positive regulation of macrophage derived foam cell differentiation (GO:0010744),18,4,1.24492153,3.213053918,0.031900512,0.293475557,4023;948;185;5320,LPL;CD36;AGTR1;PLA2G2A
GO:0030214,hyaluronan catabolic process (GO:0030214),18,4,1.24492153,3.213053918,0.031900512,0.293475557,2247;3373;10894;3161,LYVE1;HMMR;FGF2;HYAL1
GO:0010595,positive regulation of endothelial cell migration (GO:0010595),85,11,5.878796114,1.8711314,0.031930297,0.293475557,2246;284;2625;1906;2822;2247;4233;7010;6776;306;84913,ATOH8;FGF1;FGF2;GPLD1;ANGPT1;MET;STAT5A;ANXA3;EDN1;TEK;GATA3
GO:1990778,protein localization to cell periphery (GO:1990778),140,16,9.682723011,1.652427729,0.032454087,0.297834375,9368;3745;55800;857;10267;26154;92359;287;6711;5727;9370;54997;30846;112609;84668;92162,FAM126A;TESC;CAV1;ADIPOQ;SCN3B;TMEM88;KCNB1;SPTBN1;PTCH1;ANK2;MRAP2;RAMP1;EHD2;SLC9A3R1;CRB3;ABCA12
GO:0007507,heart development (GO:0007507),163,18,11.27345608,1.596670966,0.032914358,0.301597878,8572;9645;4916;7048;64220;2719;650;2335;23768;7049;64321;5950;130497;7010;1281;1396;2296;27295,FN1;RBP4;OSR1;GPC3;TGFBR3;TGFBR2;BMP2;MICAL2;SOX17;NTRK3;FLRT2;PDLIM4;PDLIM3;TEK;FOXC1;CRIP1;STRA6;COL3A1
GO:0030510,regulation of BMP signaling pathway (GO:0030510),75,10,5.187173042,1.927832351,0.033175652,0.303529444,5468;650;6664;494470;168667;658;23213;348093;51232;25928,BMPER;BMP2;PPARG;SULF1;SOSTDC1;CRIM1;BMPR1B;RNF165;RBPMS2;SOX11
GO:0018212,peptidyl-tyrosine modification (GO:0018212),55,8,3.803926897,2.103089837,0.034304909,0.313171292,3815;1956;5649;2202;7010;4921;91461;6725,RELN;KIT;EGFR;EFEMP1;PKDCC;DDR2;TEK;SRMS
GO:0031331,positive regulation of cellular catabolic process (GO:0031331),141,16,9.751885318,1.640708384,0.034356395,0.313171292,6622;3479;150;57104;51085;2308;8660;8671;2822;5207;101;1634;152503;225;5209;440503,SNCA;MLXIPL;ADAM8;GPLD1;PFKFB1;FOXO1;SH3D19;ABCD2;IRS2;SLC4A4;IGF1;DCN;PFKFB3;PNPLA2;ADRA2A;PLIN5
GO:0006468,protein phosphorylation (GO:0006468),494,45,34.16617977,1.31709194,0.034972986,0.313171292,3815;4915;1956;63967;7048;130399;11113;3991;7481;983;6790;9212;5347;1511;650;660;7301;9833;5979;5649;2047;7049;658;2202;5105;5166;8317;890;898;10733;4751;7010;332;5602;5753;79924;2078;23235;81788;10110;4921;91461;6725;7272;388228,NEK2;NTRK2;CDK1;CLSPN;PLK1;AURKA;MELK;BIRC5;RELN;PDK4;CCNA2;TTK;CIT;AURKB;NUAK2;EPHB1;PCK1;TGFBR3;LIPE;KIT;BMX;TGFBR2;SGK2;ACVR1C;BMP2;EGFR;SIK2;PLK4;EFEMP1;CDC7;SBK1;ERG;CCNE1;ADM2;PKDCC;DDR2;WNT11;CTSG;TEK;BMPR1B;MAPK10;SRMS;PTK6;RET;TYRO3
GO:0006024,glycosaminoglycan biosynthetic process (GO:0006024),97,12,6.708743801,1.788710429,0.0350874,0.313171292,284;2719;6382;10331;3373;3038;1462;633;1634;9469;4969;5549,GPC3;HAS3;BGN;CHST3;ANGPT1;HYAL1;OGN;VCAN;DCN;PRELP;SDC1;B3GNT3
GO:0045840,positive regulation of mitotic nuclear division (GO:0045840),36,6,2.48984306,2.409790439,0.03528908,0.313171292,3479;6790;9700;1906;9787;51203,DLGAP5;NUSAP1;AURKA;ESPL1;IGF1;EDN1
GO:0032873,negative regulation of stress-activated MAPK cascade (GO:0032873),36,6,2.48984306,2.409790439,0.03528908,0.313171292,2308;2305;1843;5187;153769;401265,PER1;FOXM1;KLHL31;FOXO1;DUSP1;SH3RF2
GO:0030072,peptide hormone secretion (GO:0030072),27,5,1.867382295,2.677544932,0.035404737,0.313171292,301;3569;1906;8425;54097,ANXA1;LTBP4;IL6;EDN1;FAM3B
GO:0017156,calcium-ion regulated exocytosis (GO:0017156),27,5,1.867382295,2.677544932,0.035404737,0.313171292,9783;8447;90019;83849;57586,RIMS3;SYT8;SYT15;DOC2B;SYT13
GO:0042886,amide transport (GO:0042886),27,5,1.867382295,2.677544932,0.035404737,0.313171292,6563;26154;2350;9429;2348,FOLR1;SLC14A1;ABCG2;FOLR2;ABCA12
GO:0030177,positive regulation of Wnt signaling pathway (GO:0030177),153,17,10.581833,1.606526959,0.03555933,0.313171292,2255;55366;1956;857;2719;79971;650;59352;23213;6422;1277;23189;57664;23500;51704;284654;84870,CAV1;SFRP1;GPC3;RSPO3;KANK1;BMP2;SULF1;EGFR;LGR6;GPRC5B;FGF10;LGR4;PLEKHA4;WLS;DAAM2;RSPO1;COL1A1
GO:0006569,tryptophan catabolic process (GO:0006569),11,3,0.760785379,3.943293445,0.035792493,0.313171292,8564;23498;259307,IL4I1;HAAO;KMO
GO:0006568,tryptophan metabolic process (GO:0006568),11,3,0.760785379,3.943293445,0.035792493,0.313171292,8564;23498;259307,IL4I1;HAAO;KMO
GO:0045623,negative regulation of T-helper cell differentiation (GO:0045623),11,3,0.760785379,3.943293445,0.035792493,0.313171292,301;7292;50943,ANXA1;TNFSF4;FOXP3
GO:0030042,actin filament depolymerization (GO:0030042),11,3,0.760785379,3.943293445,0.035792493,0.313171292,2934;9645;1073,GSN;MICAL2;CFL2
GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),11,3,0.760785379,3.943293445,0.035792493,0.313171292,2934;4318;5329,GSN;MMP9;PLAUR
GO:0014904,myotube cell development (GO:0014904),11,3,0.760785379,3.943293445,0.035792493,0.313171292,3479;6261;858,CAV2;IGF1;RYR1
GO:1901380,negative regulation of potassium ion transmembrane transport (GO:1901380),11,3,0.760785379,3.943293445,0.035792493,0.313171292,857;845;274,CAV1;CASQ2;BIN1
GO:0009889,regulation of biosynthetic process (GO:0009889),11,3,0.760785379,3.943293445,0.035792493,0.313171292,6622;5105;7069,PCK1;SNCA;THRSP
GO:0032736,positive regulation of interleukin-13 production (GO:0032736),11,3,0.760785379,3.943293445,0.035792493,0.313171292,7292;2625;85480,TSLP;TNFSF4;GATA3
GO:0099068,postsynapse assembly (GO:0099068),11,3,0.760785379,3.943293445,0.035792493,0.313171292,9378;57502;4038,NRXN1;LRP4;NLGN4X
GO:1903170,negative regulation of calcium ion transmembrane transport (GO:1903170),11,3,0.760785379,3.943293445,0.035792493,0.313171292,150;477;274,ATP1A2;BIN1;ADRA2A
GO:0060055,angiogenesis involved in wound healing (GO:0060055),11,3,0.760785379,3.943293445,0.035792493,0.313171292,4162;79625;947,CD34;MCAM;NDNF
GO:0048246,macrophage chemotaxis (GO:0048246),11,3,0.760785379,3.943293445,0.035792493,0.313171292,6288;1910;1907,SAA1;EDNRB;EDN2
GO:0048484,enteric nervous system development (GO:0048484),11,3,0.760785379,3.943293445,0.035792493,0.313171292,6663;26153;1910,SOX10;EDNRB;KIF26A
GO:0071397,cellular response to cholesterol (GO:0071397),11,3,0.760785379,3.943293445,0.035792493,0.313171292,1066;2822;5727,CES1;GPLD1;PTCH1
GO:0071492,cellular response to UV-A (GO:0071492),11,3,0.760785379,3.943293445,0.035792493,0.313171292,4311;4314;4318,MME;MMP3;MMP9
GO:0001325,formation of extrachromosomal circular DNA (GO:0001325),11,3,0.760785379,3.943293445,0.035792493,0.313171292,1763;641;9156,EXO1;BLM;DNA2
GO:0090656,t-circle formation (GO:0090656),11,3,0.760785379,3.943293445,0.035792493,0.313171292,1763;641;9156,EXO1;BLM;DNA2
GO:0090737,telomere maintenance via telomere trimming (GO:0090737),11,3,0.760785379,3.943293445,0.035792493,0.313171292,1763;641;9156,EXO1;BLM;DNA2
GO:2000052,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),11,3,0.760785379,3.943293445,0.035792493,0.313171292,6422;57664;84870,SFRP1;RSPO3;PLEKHA4
GO:0001558,regulation of cell growth (GO:0001558),212,22,14.66240913,1.500435556,0.036854047,0.321990809,11170;9472;1956;9928;3624;7481;185;80736;26153;6586;3249;4881;64321;6422;3373;8835;10110;8425;2273;92304;56981;8643,INHBA;KIF14;FAM107A;SFRP1;FHL1;NPR1;LTBP4;SGK2;PRDM11;EGFR;HYAL1;PTCH2;SOX17;AKAP6;SOCS2;SCGB3A1;SLIT3;KIF26A;WNT11;SLC44A4;HPN;AGTR1
GO:0007043,cell-cell junction assembly (GO:0007043),66,9,4.564712277,1.971646723,0.037103966,0.323234692,1000;1009;5010;84612;7122;1828;83660;5317;2706,GJB2;CLDN11;CLDN5;DSG1;CDH11;TLN2;PKP1;PARD6B;CDH2
GO:0022411,cellular component disassembly (GO:0022411),66,9,4.564712277,1.971646723,0.037103966,0.323234692,2934;1511;4314;4318;4320;101;25818;5650;11096,MMP11;ADAMTS5;GSN;ADAM8;MMP3;MMP9;KLK5;CTSG;KLK7
GO:0070098,chemokine-mediated signaling pathway (GO:0070098),56,8,3.873089204,2.065534662,0.037693132,0.327609417,10563;6366;3627;4283;2920;6387;6376;2296,CXCL2;CX3CL1;CXCL10;CCL21;CXCL12;CXCL9;FOXC1;CXCL13
GO:0042417,dopamine metabolic process (GO:0042417),19,4,1.314083837,3.043945817,0.038260158,0.327609417,6622;9627;4129;4128,SNCA;MAOA;SNCAIP;MAOB
GO:1902001,fatty acid transmembrane transport (GO:1902001),19,4,1.314083837,3.043945817,0.038260158,0.327609417,32;948;7069;225,ACACB;CD36;ABCD2;THRSP
GO:0070723,response to cholesterol (GO:0070723),19,4,1.314083837,3.043945817,0.038260158,0.327609417,7048;1066;2822;5727,CES1;TGFBR2;GPLD1;PTCH1
GO:0048713,regulation of oligodendrocyte differentiation (GO:0048713),19,4,1.314083837,3.043945817,0.038260158,0.327609417,5803;146433;5764;23500,PTN;PTPRZ1;IL34;DAAM2
GO:0050670,regulation of lymphocyte proliferation (GO:0050670),19,4,1.314083837,3.043945817,0.038260158,0.327609417,2255;3952;6664;30835,LEP;FGF10;CD209;SOX11
GO:2000047,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),19,4,1.314083837,3.043945817,0.038260158,0.327609417,8728;654;3169;4072,ADAM19;BMP6;EPCAM;FOXA1
GO:0071280,cellular response to copper ion (GO:0071280),19,4,1.314083837,3.043945817,0.038260158,0.327609417,6622;358;4499;4501,MT1M;MT1X;SNCA;AQP1
GO:1905523,positive regulation of macrophage migration (GO:1905523),19,4,1.314083837,3.043945817,0.038260158,0.327609417,64805;5919;6376;146433,CX3CL1;P2RY12;IL34;RARRES2
GO:0003181,atrioventricular valve morphogenesis (GO:0003181),19,4,1.314083837,3.043945817,0.038260158,0.327609417,7048;650;23493;6586,TGFBR2;BMP2;SLIT3;HEY2
GO:0061436,establishment of skin barrier (GO:0061436),19,4,1.314083837,3.043945817,0.038260158,0.327609417,26154;8626;4233;3868,MET;TP63;ABCA12;KRT16
GO:0033561,regulation of water loss via skin (GO:0033561),19,4,1.314083837,3.043945817,0.038260158,0.327609417,26154;8626;4233;3868,MET;TP63;ABCA12;KRT16
GO:0046324,regulation of glucose import (GO:0046324),37,6,2.559005367,2.344660967,0.039747156,0.330184056,3952;3479;10580;8660;9370;55022,LEP;ADIPOQ;SORBS1;PID1;IRS2;IGF1
GO:0051260,protein homooligomerization (GO:0051260),121,14,8.368639174,1.672912371,0.039771678,0.330184056,32;1894;10721;6263;6261;220;362;286133;641;115362;8854;79689;23237;7083,SCARA5;RYR3;TK1;ALDH1A2;ACACB;POLQ;ECT2;ARC;BLM;ALDH1A3;AQP5;RYR1;GBP5;STEAP4
GO:0072348,sulfur compound transport (GO:0072348),28,5,1.936544602,2.581918327,0.040733044,0.330184056,9368;9429;80736;29127;148641,RACGAP1;SLC9A3R1;ABCG2;SLC44A4;SLC35F3
GO:1903036,positive regulation of response to wounding (GO:1903036),28,5,1.936544602,2.581918327,0.040733044,0.330184056,301;150;4638;5764;23189,ANXA1;MYLK;PTN;KANK1;ADRA2A
GO:0043552,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),28,5,1.936544602,2.581918327,0.040733044,0.330184056,3815;6366;64805;2247;7010,FGF2;KIT;P2RY12;CCL21;TEK
GO:0060412,ventricular septum morphogenesis (GO:0060412),28,5,1.936544602,2.581918327,0.040733044,0.330184056,7048;23493;6586;6664;7049,TGFBR3;TGFBR2;SLIT3;HEY2;SOX11
GO:0048146,positive regulation of fibroblast proliferation (GO:0048146),28,5,1.936544602,2.581918327,0.040733044,0.330184056,3479;358;2335;1869;4921,FN1;AQP1;E2F1;IGF1;DDR2
GO:1901019,regulation of calcium ion transmembrane transporter activity (GO:1901019),28,5,1.936544602,2.581918327,0.040733044,0.330184056,1756;150;287;57158;3270,DMD;JPH2;ANK2;HRC;ADRA2A
GO:1901890,positive regulation of cell junction assembly (GO:1901890),57,8,3.942251512,2.029297212,0.041298661,0.330184056,857;9378;7122;92359;2047;26047;6422;7010,CAV1;SFRP1;EPHB1;CLDN5;NRXN1;CNTNAP2;TEK;CRB3
GO:0042420,dopamine catabolic process (GO:0042420),5,2,0.345811536,5.783497053,0.041527058,0.330184056,4129;4128,MAOA;MAOB
GO:0071472,cellular response to salt stress (GO:0071472),5,2,0.345811536,5.783497053,0.041527058,0.330184056,825;358,AQP1;CAPN3
GO:0032415,regulation of sodium:proton antiporter activity (GO:0032415),5,2,0.345811536,5.783497053,0.041527058,0.330184056,9368;54997,TESC;SLC9A3R1
GO:0031394,positive regulation of prostaglandin biosynthetic process (GO:0031394),5,2,0.345811536,5.783497053,0.041527058,0.330184056,301;5743,ANXA1;PTGS2
GO:0086100,endothelin receptor signaling pathway (GO:0086100),5,2,0.345811536,5.783497053,0.041527058,0.330184056,1910;1906,EDNRB;EDN1
GO:0036018,cellular response to erythropoietin (GO:0036018),5,2,0.345811536,5.783497053,0.041527058,0.330184056,3815;4501,KIT;MT1X
GO:0070836,caveola assembly (GO:0070836),5,2,0.345811536,5.783497053,0.041527058,0.330184056,857;858,CAV1;CAV2
GO:0086018,SA node cell to atrial cardiac muscle cell signaling (GO:0086018),5,2,0.345811536,5.783497053,0.041527058,0.330184056,55800;287,SCN3B;ANK2
GO:2000481,positive regulation of cAMP-dependent protein kinase activity (GO:2000481),5,2,0.345811536,5.783497053,0.041527058,0.330184056,154;9370,ADRB2;ADIPOQ
GO:0006837,serotonin transport (GO:0006837),5,2,0.345811536,5.783497053,0.041527058,0.330184056,6581;222962,SLC22A3;SLC29A4
GO:0051610,serotonin uptake (GO:0051610),5,2,0.345811536,5.783497053,0.041527058,0.330184056,6581;222962,SLC22A3;SLC29A4
GO:1903020,positive regulation of glycoprotein metabolic process (GO:1903020),5,2,0.345811536,5.783497053,0.041527058,0.330184056,6366;3479,CCL21;IGF1
GO:1903975,regulation of glial cell migration (GO:1903975),5,2,0.345811536,5.783497053,0.041527058,0.330184056,64805;482,P2RY12;ATP1B2
GO:2001268,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),5,2,0.345811536,5.783497053,0.041527058,0.330184056,4318;5329,MMP9;PLAUR
GO:1901509,regulation of endothelial tube morphogenesis (GO:1901509),5,2,0.345811536,5.783497053,0.041527058,0.330184056,2246;3627,FGF1;CXCL10
GO:1905605,positive regulation of blood-brain barrier permeability (GO:1905605),5,2,0.345811536,5.783497053,0.041527058,0.330184056,284;27134,ANGPT1;TJP3
GO:0003348,cardiac endothelial cell differentiation (GO:0003348),5,2,0.345811536,5.783497053,0.041527058,0.330184056,3084;64321,SOX17;NRG1
GO:0060956,endocardial cell differentiation (GO:0060956),5,2,0.345811536,5.783497053,0.041527058,0.330184056,3084;64321,SOX17;NRG1
GO:0003175,tricuspid valve development (GO:0003175),5,2,0.345811536,5.783497053,0.041527058,0.330184056,7048;23493,TGFBR2;HEY2
GO:0003186,tricuspid valve morphogenesis (GO:0003186),5,2,0.345811536,5.783497053,0.041527058,0.330184056,7048;23493,TGFBR2;HEY2
GO:0035701,hematopoietic stem cell migration (GO:0035701),5,2,0.345811536,5.783497053,0.041527058,0.330184056,2822;58494,JAM2;GPLD1
GO:0045650,negative regulation of macrophage differentiation (GO:0045650),5,2,0.345811536,5.783497053,0.041527058,0.330184056,3624;9370,INHBA;ADIPOQ
GO:1904778,positive regulation of protein localization to cell cortex (GO:1904778),5,2,0.345811536,5.783497053,0.041527058,0.330184056,2037;2770,GNAI1;EPB41L2
GO:0090521,glomerular visceral epithelial cell migration (GO:0090521),5,2,0.345811536,5.783497053,0.041527058,0.330184056,54443;23189,ANLN;KANK1
GO:0070120,ciliary neurotrophic factor-mediated signaling pathway (GO:0070120),5,2,0.345811536,5.783497053,0.041527058,0.330184056,1271;3977,LIFR;CNTFR
GO:0052646,alditol phosphate metabolic process (GO:0052646),5,2,0.345811536,5.783497053,0.041527058,0.330184056,57678;2819,GPD1;GPAM
GO:0061156,pulmonary artery morphogenesis (GO:0061156),5,2,0.345811536,5.783497053,0.041527058,0.330184056,64220;23493,HEY2;STRA6
GO:0010754,negative regulation of cGMP-mediated signaling (GO:0010754),5,2,0.345811536,5.783497053,0.041527058,0.330184056,5138;50940,PDE2A;PDE11A
GO:0072207,metanephric epithelium development (GO:0072207),5,2,0.345811536,5.783497053,0.041527058,0.330184056,7477;130497,OSR1;WNT7B
GO:0072176,nephric duct development (GO:0072176),5,2,0.345811536,5.783497053,0.041527058,0.330184056,7481;2625,WNT11;GATA3
GO:0030540,female genitalia development (GO:0030540),5,2,0.345811536,5.783497053,0.041527058,0.330184056,64220;5950,RBP4;STRA6
GO:0072524,pyridine-containing compound metabolic process (GO:0072524),5,2,0.345811536,5.783497053,0.041527058,0.330184056,23498;316,AOX1;HAAO
GO:0071504,cellular response to heparin (GO:0071504),5,2,0.345811536,5.783497053,0.041527058,0.330184056,6422;1958,SFRP1;EGR1
GO:0015670,carbon dioxide transport (GO:0015670),5,2,0.345811536,5.783497053,0.041527058,0.330184056,358;362,AQP1;AQP5
GO:0019732,antifungal humoral response (GO:0019732),5,2,0.345811536,5.783497053,0.041527058,0.330184056,4057;5919,RARRES2;LTF
GO:0071655,regulation of granulocyte colony-stimulating factor production (GO:0071655),5,2,0.345811536,5.783497053,0.041527058,0.330184056,947;85480,TSLP;CD34
GO:0021871,forebrain regionalization (GO:0021871),5,2,0.345811536,5.783497053,0.041527058,0.330184056,650;7477,BMP2;WNT7B
GO:2001225,regulation of chloride transport (GO:2001225),5,2,0.345811536,5.783497053,0.041527058,0.330184056,2564;5243,ABCB1;GABRE
GO:0003100,regulation of systemic arterial blood pressure by endothelin (GO:0003100),5,2,0.345811536,5.783497053,0.041527058,0.330184056,1906;1907,EDN1;EDN2
GO:0060425,lung morphogenesis (GO:0060425),5,2,0.345811536,5.783497053,0.041527058,0.330184056,6664;7477,WNT7B;SOX11
GO:0120193,tight junction organization (GO:0120193),5,2,0.345811536,5.783497053,0.041527058,0.330184056,5010;7122,CLDN11;CLDN5
GO:0035360,positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),5,2,0.345811536,5.783497053,0.041527058,0.330184056,5740;55885,PTGIS;LMO3
GO:0035860,glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),5,2,0.345811536,5.783497053,0.041527058,0.330184056,5979;23213,SULF1;RET
GO:0006003,"fructose 2,6-bisphosphate metabolic process (GO:0006003)",5,2,0.345811536,5.783497053,0.041527058,0.330184056,5207;5209,PFKFB1;PFKFB3
GO:0045003,double-strand break repair via synthesis-dependent strand annealing (GO:0045003),5,2,0.345811536,5.783497053,0.041527058,0.330184056,5888;8438,RAD51;RAD54L
GO:0006813,potassium ion transport (GO:0006813),122,14,8.437801481,1.659199974,0.042193361,0.335038698,3745;3753;358;3779;30819;3777;3249;477;10060;7881;9132;3742;3776;60598,KCNE1;ATP1A2;KCNIP2;KCNMB1;AQP1;KCNB1;KCNAB1;KCNA6;KCNQ4;KCNK3;KCNK15;HPN;ABCC9;KCNK2
GO:0051099,positive regulation of binding (GO:0051099),89,11,6.155445343,1.787035606,0.042697696,0.33859611,5468;3479;857;650;7122;81620;4233;4318;2296;57761;5329,CAV1;CLDN5;BMP2;PPARG;MET;CDT1;TRIB3;MMP9;PLAUR;IGF1;FOXC1
GO:0060828,regulation of canonical Wnt signaling pathway (GO:0060828),252,25,17.42890142,1.434399071,0.043648172,0.344461522,9368;2255;55366;1956;857;7481;2719;2348;79971;650;59352;64321;6422;8322;4038;3489;1277;27303;83595;23189;57664;92162;23500;51704;284654,IGFBP6;CAV1;SFRP1;GPC3;KANK1;RBMS3;BMP2;EGFR;TMEM88;LRP4;LGR6;GPRC5B;SOX17;FGF10;SOX7;LGR4;PLEKHA4;FZD4;WLS;DAAM2;FOLR1;WNT11;SLC9A3R1;RSPO1;COL1A1
GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),68,9,4.703036891,1.913657113,0.043764027,0.344461522,7048;857;63976;2201;10252;10253;1149;54756;54829,SPRY2;CAV1;CIDEA;TGFBR2;SPRY1;FBN2;IL17RD;PRDM16;ASPN
GO:0051591,response to cAMP (GO:0051591),38,6,2.628167674,2.282959363,0.044546508,0.344461522,3753;9472;5138;358;4435;10411,KCNE1;PDE2A;RAPGEF3;AQP1;AKAP6;CITED1
GO:0032024,positive regulation of insulin secretion (GO:0032024),38,6,2.628167674,2.282959363,0.044546508,0.344461522,8660;2822;4826;8447;5950;25924,RBP4;NNAT;GPLD1;IRS2;DOC2B;MYRIP
GO:0051173,positive regulation of nitrogen compound metabolic process (GO:0051173),20,4,1.383246144,2.891748527,0.045291299,0.344461522,2625;3249;10365;9314,KLF4;KLF2;HPN;GATA3
GO:2000404,regulation of T cell migration (GO:2000404),20,4,1.383246144,2.891748527,0.045291299,0.344461522,6366;3627;6387;347,CXCL10;APOD;CCL21;CXCL12
GO:0003231,cardiac ventricle development (GO:0003231),20,4,1.383246144,2.891748527,0.045291299,0.344461522,5138;64220;23493;2625,PDE2A;HEY2;STRA6;GATA3
GO:0010888,negative regulation of lipid storage (GO:0010888),20,4,1.383246144,2.891748527,0.045291299,0.344461522,5468;3569;57104;1066,CES1;PPARG;IL6;PNPLA2
GO:0002673,regulation of acute inflammatory response (GO:0002673),20,4,1.383246144,2.891748527,0.045291299,0.344461522,3569;1776;101;2161,DNASE1L3;ADAM8;F12;IL6
GO:0060317,cardiac epithelial to mesenchymal transition (GO:0060317),20,4,1.383246144,2.891748527,0.045291299,0.344461522,650;23493;7049;10252,TGFBR3;BMP2;SPRY1;HEY2
GO:0048709,oligodendrocyte differentiation (GO:0048709),20,4,1.383246144,2.891748527,0.045291299,0.344461522,6663;11076;55553;5803,PTPRZ1;SOX10;TPPP;SOX6
GO:0030851,granulocyte differentiation (GO:0030851),20,4,1.383246144,2.891748527,0.045291299,0.344461522,51176;1050;1869;6886,E2F1;LEF1;TAL1;CEBPA
GO:0021952,central nervous system projection neuron axonogenesis (GO:0021952),12,3,0.829947687,3.614685658,0.045328409,0.344461522,4781;2051;2047,EPHB1;NFIB;EPHB6
GO:0015791,polyol transport (GO:0015791),12,3,0.829947687,3.614685658,0.045328409,0.344461522,358;364;6523,AQP7;AQP1;SLC5A1
GO:0001504,neurotransmitter uptake (GO:0001504),12,3,0.829947687,3.614685658,0.045328409,0.344461522,6581;477;222962,ATP1A2;SLC22A3;SLC29A4
GO:0051547,regulation of keratinocyte migration (GO:0051547),12,3,0.829947687,3.614685658,0.045328409,0.344461522,2255;2252;4318,FGF10;MMP9;FGF7
GO:0044788,modulation by host of viral process (GO:0044788),12,3,0.829947687,3.614685658,0.045328409,0.344461522,4057;858;5806,CAV2;PTX3;LTF
GO:0090257,regulation of muscle system process (GO:0090257),12,3,0.829947687,3.614685658,0.045328409,0.344461522,477;4660;10398,PPP1R12B;ATP1A2;MYL9
GO:1904752,regulation of vascular associated smooth muscle cell migration (GO:1904752),12,3,0.829947687,3.614685658,0.045328409,0.344461522,9370;8013;9510,ADAMTS1;ADIPOQ;NR4A3
GO:1902307,positive regulation of sodium ion transmembrane transport (GO:1902307),12,3,0.829947687,3.614685658,0.045328409,0.344461522,1756;482;5348,FXYD1;DMD;ATP1B2
GO:0014821,phasic smooth muscle contraction (GO:0014821),12,3,0.829947687,3.614685658,0.045328409,0.344461522,1910;1906;1907,EDNRB;EDN1;EDN2
GO:0043116,negative regulation of vascular permeability (GO:0043116),12,3,0.829947687,3.614685658,0.045328409,0.344461522,284;5138;7122,PDE2A;CLDN5;ANGPT1
GO:0048710,regulation of astrocyte differentiation (GO:0048710),12,3,0.829947687,3.614685658,0.045328409,0.344461522,3569;650;274,BMP2;BIN1;IL6
GO:0010896,regulation of triglyceride catabolic process (GO:0010896),12,3,0.829947687,3.614685658,0.045328409,0.344461522,57104;2822;440503,GPLD1;PNPLA2;PLIN5
GO:1900047,negative regulation of hemostasis (GO:1900047),12,3,0.829947687,3.614685658,0.045328409,0.344461522,947;1906;7035,TFPI;CD34;EDN1
GO:0007063,regulation of sister chromatid cohesion (GO:0007063),12,3,0.829947687,3.614685658,0.045328409,0.344461522,9700;699;113130,BUB1;CDCA5;ESPL1
GO:0002003,angiotensin maturation (GO:0002003),12,3,0.829947687,3.614685658,0.045328409,0.344461522,4311;1066;1511,MME;CES1;CTSG
GO:0002002,regulation of angiotensin levels in blood (GO:0002002),12,3,0.829947687,3.614685658,0.045328409,0.344461522,4311;1066;1511,MME;CES1;CTSG
GO:0000075,cell cycle checkpoint signaling (GO:0000075),12,3,0.829947687,3.614685658,0.045328409,0.344461522,701;11130;699,BUB1;ZWINT;BUB1B
GO:1903083,protein localization to condensed chromosome (GO:1903083),12,3,0.829947687,3.614685658,0.045328409,0.344461522,983;9212;7272,CDK1;TTK;AURKB
GO:0010755,regulation of plasminogen activation (GO:0010755),12,3,0.829947687,3.614685658,0.045328409,0.344461522,3249;7123;2161,CLEC3B;F12;HPN
GO:0048791,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),12,3,0.829947687,3.614685658,0.045328409,0.344461522,9783;8447;90019,RIMS3;SYT8;DOC2B
GO:0030208,dermatan sulfate biosynthetic process (GO:0030208),12,3,0.829947687,3.614685658,0.045328409,0.344461522,1462;633;1634,BGN;VCAN;DCN
GO:0045930,negative regulation of mitotic cell cycle (GO:0045930),48,7,3.319790747,2.108566634,0.045609163,0.345720907,9368;701;4085;11130;699;2296;1028,BUB1;ZWINT;BUB1B;CDKN1C;MAD2L1;SLC9A3R1;FOXC1
GO:0070373,negative regulation of ERK1 and ERK2 cascade (GO:0070373),48,7,3.319790747,2.108566634,0.045609163,0.345720907,9368;57556;9370;10252;1848;10253;55885,SPRY2;ADIPOQ;DUSP6;SEMA6A;SPRY1;SLC9A3R1;LMO3
GO:0030855,epithelial cell differentiation (GO:0030855),101,12,6.985393029,1.717870412,0.045770167,0.346504374,301;5468;983;1066;2625;1645;4435;1646;230;5105;5017;6876,CDK1;ANXA1;PCK1;CES1;AKR1C1;AKR1C2;PPARG;ALDOC;CITED1;TAGLN;GATA3;OVOL1
GO:0002687,positive regulation of leukocyte migration (GO:0002687),29,5,2.005706909,2.492886661,0.046520761,0.350861097,3569;1907;101;8784;5764,PTN;ADAM8;IL6;TNFRSF18;EDN2
GO:0097581,lamellipodium organization (GO:0097581),29,5,2.005706909,2.492886661,0.046520761,0.350861097,1901;3815;64805;22885;50649,KIT;P2RY12;ARHGEF4;S1PR1;ABLIM3
GO:0061028,establishment of endothelial barrier (GO:0061028),29,5,2.005706909,2.492886661,0.046520761,0.350861097,5138;54538;10411;27134;26051,PDE2A;RAPGEF3;PPP1R16B;ROBO4;TJP3
GO:0036294,cellular response to decreased oxygen levels (GO:0036294),69,9,4.772199198,1.885922952,0.047376175,0.356864894,6326;358;79625;5366;5740;5743;6422;101;2034,SFRP1;AQP1;ADAM8;SCN2A;PTGS2;EPAS1;PTGIS;PMAIP1;NDNF
GO:0072659,protein localization to plasma membrane (GO:0072659),136,15,9.406073782,1.594714261,0.048858988,0.367573688,9368;3745;55800;10267;26154;92359;287;6711;5727;9370;54997;30846;112609;84668;92162,FAM126A;TESC;ADIPOQ;SCN3B;TMEM88;KCNB1;SPTBN1;PTCH1;ANK2;MRAP2;RAMP1;EHD2;SLC9A3R1;CRB3;ABCA12
GO:0032412,regulation of ion transmembrane transporter activity (GO:0032412),39,6,2.697329982,2.224421943,0.049692076,0.37282522,55800;6327;287;6330;5348;2273,FXYD1;SCN4B;FHL1;SCN2B;SCN3B;ANK2
GO:0061097,regulation of protein tyrosine kinase activity (GO:0061097),39,6,2.697329982,2.224421943,0.049692076,0.37282522,857;2209;5649;5753;146433;51704,RELN;CAV1;GPRC5B;FCGR1A;IL34;PTK6
GO:0072657,protein localization to membrane (GO:0072657),195,20,13.48664991,1.482947962,0.049743109,0.37282522,9368;3745;55800;825;857;10267;26154;9378;92359;287;6711;5727;9370;54997;30846;5764;5284;112609;84668;92162,FAM126A;TESC;CAV1;ADIPOQ;SCN3B;NRXN1;PTN;TMEM88;KCNB1;SPTBN1;CAPN3;PIGR;PTCH1;ANK2;MRAP2;RAMP1;EHD2;SLC9A3R1;CRB3;ABCA12
GO:0034599,cellular response to oxidative stress (GO:0034599),125,14,8.645288403,1.619379175,0.050079748,0.37416534,6622;1956;5831;4248;2308;8644;10891;4318;3725;2353;2878;2877;6649;847,PYCR1;SNCA;EGFR;GPX3;JUN;FOXO1;SOD3;FOS;MGAT3;CAT;PPARGC1A;AKR1C3;MMP9;GPX2
GO:2000379,positive regulation of reactive oxygen species metabolic process (GO:2000379),49,7,3.388953054,2.065534662,0.050170897,0.37416534,7498;7048;948;185;8644;1645;55022,AKR1C1;CD36;TGFBR2;PID1;AKR1C3;AGTR1;XDH
GO:0009895,negative regulation of catabolic process (GO:0009895),49,7,3.388953054,2.065534662,0.050170897,0.37416534,1956;150;4085;5207;5140;1149;338442,CIDEA;EGFR;MAD2L1;HCAR2;PFKFB1;PDE3B;ADRA2A
GO:0032268,regulation of cellular protein metabolic process (GO:0032268),49,7,3.388953054,2.065534662,0.050170897,0.37416534,3624;185;1910;1906;9314;135293;29128,INHBA;UHRF1;EDNRB;KLF4;PM20D2;EDN1;AGTR1
GO:0030593,neutrophil chemotaxis (GO:0030593),70,9,4.841361506,1.858981196,0.051180637,0.381222815,10563;6366;6288;3627;4283;2920;1906;1907;6376,CXCL2;CX3CL1;SAA1;CXCL10;CCL21;EDN1;CXCL9;EDN2;CXCL13
GO:0019229,regulation of vasoconstriction (GO:0019229),30,5,2.074869217,2.409790439,0.052771543,0.383319485,554;857;133;185;5021,OXTR;CAV1;AVPR2;ADM;AGTR1
GO:0050433,regulation of catecholamine secretion (GO:0050433),30,5,2.074869217,2.409790439,0.052771543,0.383319485,3745;6622;90019;83849;57586,SNCA;KCNB1;SYT8;SYT15;SYT13
GO:1900271,regulation of long-term synaptic potentiation (GO:1900271),30,5,2.074869217,2.409790439,0.052771543,0.383319485,11170;5649;794;23237;5764,RELN;FAM107A;PTN;ARC;CALB2
GO:0051294,establishment of spindle orientation (GO:0051294),30,5,2.074869217,2.409790439,0.052771543,0.383319485,4085;5347;10403;3993;89958,NDC80;PLK1;MAD2L1;LLGL2;SAPCD2
GO:0099024,plasma membrane invagination (GO:0099024),30,5,2.074869217,2.409790439,0.052771543,0.383319485,2934;8685;948;9212;2209,AURKB;CD36;GSN;FCGR1A;MARCO
GO:0030030,cell projection organization (GO:0030030),30,5,2.074869217,2.409790439,0.052771543,0.383319485,2934;64805;57381;58480;482,GSN;P2RY12;RHOJ;ATP1B2;RHOU
GO:0018149,peptide cross-linking (GO:0018149),30,5,2.074869217,2.409790439,0.052771543,0.383319485,301;79625;2335;1281;2125,FN1;ANXA1;EVPL;NDNF;COL3A1
GO:0043392,negative regulation of DNA binding (GO:0043392),30,5,2.074869217,2.409790439,0.052771543,0.383319485,23493;6664;51176;1869;3725,E2F1;JUN;LEF1;HEY2;SOX11
GO:0048704,embryonic skeletal system morphogenesis (GO:0048704),30,5,2.074869217,2.409790439,0.052771543,0.383319485,7048;3201;3200;6664;130497,HOXA4;OSR1;HOXA3;TGFBR2;SOX11
GO:0045638,negative regulation of myeloid cell differentiation (GO:0045638),21,4,1.452408452,2.754046216,0.052992596,0.383319485,7538;3202;7704;4212,HOXA5;ZBTB16;MEIS2;ZFP36
GO:2000242,negative regulation of reproductive process (GO:2000242),21,4,1.452408452,2.754046216,0.052992596,0.383319485,3479;130399;23213;1843,ACVR1C;SULF1;DUSP1;IGF1
GO:0010648,negative regulation of cell communication (GO:0010648),21,4,1.452408452,2.754046216,0.052992596,0.383319485,26153;9370;5753;6725,ADIPOQ;KIF26A;SRMS;PTK6
GO:0032413,negative regulation of ion transmembrane transporter activity (GO:0032413),21,4,1.452408452,2.754046216,0.052992596,0.383319485,150;845;130497;4318,OSR1;CASQ2;MMP9;ADRA2A
GO:0014902,myotube differentiation (GO:0014902),21,4,1.452408452,2.754046216,0.052992596,0.383319485,3479;11096;8038;58494,ADAMTS5;JAM2;IGF1;ADAM12
GO:0071383,cellular response to steroid hormone stimulus (GO:0071383),21,4,1.452408452,2.754046216,0.052992596,0.383319485,8644;477;2908;7035,ATP1A2;NR3C1;TFPI;AKR1C3
GO:0052652,cyclic purine nucleotide metabolic process (GO:0052652),21,4,1.452408452,2.754046216,0.052992596,0.383319485,111;196883;4881;4882,NPR1;ADCY4;NPR2;ADCY5
GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),21,4,1.452408452,2.754046216,0.052992596,0.383319485,948;4057;654;6376,CX3CL1;CD36;BMP6;LTF
GO:0071241,cellular response to inorganic substance (GO:0071241),21,4,1.452408452,2.754046216,0.052992596,0.383319485,358;2308;4314;641,AQP1;FOXO1;BLM;MMP3
GO:0015918,sterol transport (GO:0015918),21,4,1.452408452,2.754046216,0.052992596,0.383319485,857;10351;948;3931,CAV1;ABCA8;LCAT;CD36
GO:1903077,negative regulation of protein localization to plasma membrane (GO:1903077),21,4,1.452408452,2.754046216,0.052992596,0.383319485,55022;91461;112609;131578,LRRC15;PID1;MRAP2;PKDCC
GO:0009435,NAD biosynthetic process (GO:0009435),21,4,1.452408452,2.754046216,0.052992596,0.383319485,23498;5740;5743;23057,PTGS2;NMNAT2;HAAO;PTGIS
GO:0042572,retinol metabolic process (GO:0042572),21,4,1.452408452,2.754046216,0.052992596,0.383319485,5950;125;126;124,RBP4;ADH1C;ADH1A;ADH1B
GO:0030206,chondroitin sulfate biosynthetic process (GO:0030206),21,4,1.452408452,2.754046216,0.052992596,0.383319485,1462;633;1634;9469,BGN;CHST3;VCAN;DCN
GO:1904376,negative regulation of protein localization to cell periphery (GO:1904376),21,4,1.452408452,2.754046216,0.052992596,0.383319485,55022;112609;89958;131578,LRRC15;PID1;MRAP2;SAPCD2
GO:0048585,negative regulation of response to stimulus (GO:0048585),60,8,4.149738433,1.927832351,0.053459815,0.385770649,150;947;26153;1281;5753;9314;50943;6725,KLF4;FOXP3;CD34;KIF26A;SRMS;PTK6;ADRA2A;COL3A1
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),60,8,4.149738433,1.927832351,0.053459815,0.385770649,57863;1000;2196;64221;57549;54538;347902;4680,ROBO3;FAT2;CADM3;CEACAM6;ROBO4;CDH2;IGSF9;AMIGO2
GO:0043065,positive regulation of apoptotic process (GO:0043065),307,29,21.23282832,1.365809565,0.054064887,0.387824179,6622;4804;1894;130399;3569;650;3202;7153;84883;8626;9833;2191;2308;5366;5740;2822;9370;6422;1869;1848;274;3725;943;3169;54507;50649;56981;25803;80034,HOXA5;TOP2A;MELK;SFRP1;ADIPOQ;ECT2;SNCA;PRDM11;ACVR1C;BMP2;E2F1;NGFR;JUN;GPLD1;FOXO1;DUSP6;ARHGEF4;FAP;TP63;CSRNP3;ADAMTSL4;BIN1;IL6;PTGIS;AIFM2;TNFRSF8;PMAIP1;FOXA1;SPDEF
GO:0001764,neuron migration (GO:0001764),50,7,3.458115361,2.024223969,0.055010909,0.387824179,4915;10371;79625;5649;51473;460;347733,NTRK2;RELN;TUBB2B;ASTN1;SEMA3A;NDNF;DCDC2
GO:0051262,protein tetramerization (GO:0051262),71,9,4.910523813,1.832798362,0.055180141,0.387824179,32;6622;6263;6261;220;362;115362;8854;7083,RYR3;TK1;ALDH1A2;ACACB;SNCA;ALDH1A3;AQP5;RYR1;GBP5
GO:0042632,cholesterol homeostasis (GO:0042632),71,9,4.910523813,1.832798362,0.055180141,0.387824179,84649;4023;338328;857;1066;1645;51302;23461;3931,GPIHBP1;CAV1;LPL;LCAT;ABCA5;CES1;AKR1C1;CYP39A1;DGAT2
GO:0044273,sulfur compound catabolic process (GO:0044273),40,6,2.766492289,2.168811395,0.055187458,0.387824179,3373;1462;633;1634;4969;5549,BGN;HYAL1;OGN;VCAN;DCN;PRELP
GO:0090303,positive regulation of wound healing (GO:0090303),40,6,2.766492289,2.168811395,0.055187458,0.387824179,301;150;4638;55612;23189;2161,ANXA1;MYLK;KANK1;F12;ADRA2A;FERMT1
GO:0032869,cellular response to insulin stimulus (GO:0032869),127,14,8.783613017,1.593877141,0.055871658,0.387824179,5468;10580;5919;2308;8660;2822;9370;5105;6517;5166;858;11031;5140;57761,PDK4;SLC2A4;CAV2;ADIPOQ;PCK1;SORBS1;PPARG;GPLD1;FOXO1;IRS2;TRIB3;RAB31;PDE3B;RARRES2
GO:0006576,cellular biogenic amine metabolic process (GO:0006576),13,3,0.899109994,3.336632915,0.055981764,0.387824179,6581;4128;222962,MAOA;SLC22A3;SLC29A4
GO:0032370,positive regulation of lipid transport (GO:0032370),13,3,0.899109994,3.336632915,0.055981764,0.387824179,26154;6696;9370,ADIPOQ;SPP1;ABCA12
GO:0097066,response to thyroid hormone (GO:0097066),13,3,0.899109994,3.336632915,0.055981764,0.387824179,3249;7068;687,KLF9;THRB;HPN
GO:0010649,regulation of cell communication by electrical coupling (GO:0010649),13,3,0.899109994,3.336632915,0.055981764,0.387824179,857;845;3270,CAV1;CASQ2;HRC
GO:0043267,negative regulation of potassium ion transport (GO:0043267),13,3,0.899109994,3.336632915,0.055981764,0.387824179,857;845;274,CAV1;CASQ2;BIN1
GO:0035113,embryonic appendage morphogenesis (GO:0035113),13,3,0.899109994,3.336632915,0.055981764,0.387824179,4621;56603;5727,MYH3;PTCH1;CYP26B1
GO:0010765,positive regulation of sodium ion transport (GO:0010765),13,3,0.899109994,3.336632915,0.055981764,0.387824179,55800;6330;5652,SCN4B;SCN3B;PRSS8
GO:0060306,regulation of membrane repolarization (GO:0060306),13,3,0.899109994,3.336632915,0.055981764,0.387824179,9472;857;845,CAV1;AKAP6;CASQ2
GO:0005513,detection of calcium ion (GO:0005513),13,3,0.899109994,3.336632915,0.055981764,0.387824179,3779;30819;845,KCNIP2;KCNMB1;CASQ2
GO:0010039,response to iron ion (GO:0010039),13,3,0.899109994,3.336632915,0.055981764,0.387824179,6622;7018;654,TF;SNCA;BMP6
GO:0010745,negative regulation of macrophage derived foam cell differentiation (GO:0010745),13,3,0.899109994,3.336632915,0.055981764,0.387824179,5468;9370;23461,ADIPOQ;ABCA5;PPARG
GO:1903206,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),13,3,0.899109994,3.336632915,0.055981764,0.387824179,5831;4233;8013,PYCR1;MET;NR4A3
GO:0071731,response to nitric oxide (GO:0071731),13,3,0.899109994,3.336632915,0.055981764,0.387824179,358;2308;4314,AQP1;FOXO1;MMP3
GO:0070741,response to interleukin-6 (GO:0070741),13,3,0.899109994,3.336632915,0.055981764,0.387824179,5740;4435;55022,PID1;CITED1;PTGIS
GO:0060389,pathway-restricted SMAD protein phosphorylation (GO:0060389),13,3,0.899109994,3.336632915,0.055981764,0.387824179,7048;650;7049,TGFBR3;TGFBR2;BMP2
GO:0044774,mitotic DNA integrity checkpoint signaling (GO:0044774),13,3,0.899109994,3.336632915,0.055981764,0.387824179,63967;990;4998,CLSPN;CDC6;ORC1
GO:0060537,muscle tissue development (GO:0060537),13,3,0.899109994,3.336632915,0.055981764,0.387824179,5239;64220;5727,PGM5;PTCH1;STRA6
GO:0034370,triglyceride-rich lipoprotein particle remodeling (GO:0034370),13,3,0.899109994,3.336632915,0.055981764,0.387824179,4023;338328;3931,GPIHBP1;LPL;LCAT
GO:0021510,spinal cord development (GO:0021510),13,3,0.899109994,3.336632915,0.055981764,0.387824179,6664;5649;5212,VIT;RELN;SOX11
GO:0032674,regulation of interleukin-5 production (GO:0032674),13,3,0.899109994,3.336632915,0.055981764,0.387824179,2625;51176;85480,TSLP;LEF1;GATA3
GO:0030205,dermatan sulfate metabolic process (GO:0030205),13,3,0.899109994,3.336632915,0.055981764,0.387824179,1462;633;1634,BGN;VCAN;DCN
GO:0036376,sodium ion export across plasma membrane (GO:0036376),13,3,0.899109994,3.336632915,0.055981764,0.387824179,8671;477;482,ATP1A2;ATP1B2;SLC4A4
GO:0071805,potassium ion transmembrane transport (GO:0071805),139,15,9.613560704,1.560295968,0.057142297,0.387824179,3745;3753;23704;30819;3777;3249;477;10060;7881;9132;3742;482;84561;3776;60598,KCNE1;ATP1A2;KCNIP2;KCNB1;KCNAB1;ATP1B2;KCNA6;SLC12A8;KCNQ4;KCNK3;KCNK15;HPN;ABCC9;KCNE4;KCNK2
GO:0055092,sterol homeostasis (GO:0055092),72,9,4.97968612,1.807342829,0.059377036,0.387824179,84649;4023;338328;857;1066;1645;51302;23461;3931,GPIHBP1;CAV1;LPL;LCAT;ABCA5;CES1;AKR1C1;CYP39A1;DGAT2
GO:0045647,negative regulation of erythrocyte differentiation (GO:0045647),6,2,0.414973843,4.819580878,0.059475651,0.387824179,7538;3202,HOXA5;ZFP36
GO:0006572,tyrosine catabolic process (GO:0006572),6,2,0.414973843,4.819580878,0.059475651,0.387824179,6898;259307,TAT;IL4I1
GO:1902172,regulation of keratinocyte apoptotic process (GO:1902172),6,2,0.414973843,4.819580878,0.059475651,0.387824179,7538;2934,GSN;ZFP36
GO:0097011,cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),6,2,0.414973843,4.819580878,0.059475651,0.387824179,7538;4882,NPR2;ZFP36
GO:0097012,response to granulocyte macrophage colony-stimulating factor (GO:0097012),6,2,0.414973843,4.819580878,0.059475651,0.387824179,7538;4882,NPR2;ZFP36
GO:0071869,response to catecholamine (GO:0071869),6,2,0.414973843,4.819580878,0.059475651,0.387824179,54331;8013,GNG2;NR4A3
GO:0030835,negative regulation of actin filament depolymerization (GO:0030835),6,2,0.414973843,4.819580878,0.059475651,0.387824179,2934;130271,GSN;PLEKHH2
GO:0070365,hepatocyte differentiation (GO:0070365),6,2,0.414973843,4.819580878,0.059475651,0.387824179,301;5105,ANXA1;PCK1
GO:0046877,regulation of saliva secretion (GO:0046877),6,2,0.414973843,4.819580878,0.059475651,0.387824179,2255;358,AQP1;FGF10
GO:0043583,ear development (GO:0043583),6,2,0.414973843,4.819580878,0.059475651,0.387824179,64220;2625,STRA6;GATA3
GO:0044854,plasma membrane raft assembly (GO:0044854),6,2,0.414973843,4.819580878,0.059475651,0.387824179,857;858,CAV1;CAV2
GO:0014819,regulation of skeletal muscle contraction (GO:0014819),6,2,0.414973843,4.819580878,0.059475651,0.387824179,1756;6329,DMD;SCN4A
GO:0097647,amylin receptor signaling pathway (GO:0097647),6,2,0.414973843,4.819580878,0.059475651,0.387824179,133;10267,RAMP1;ADM
GO:0002063,chondrocyte development (GO:0002063),6,2,0.414973843,4.819580878,0.059475651,0.387824179,658;23213,SULF1;BMPR1B
GO:0010891,negative regulation of sequestering of triglyceride (GO:0010891),6,2,0.414973843,4.819580878,0.059475651,0.387824179,5468;57104,PPARG;PNPLA2
GO:0015874,norepinephrine transport (GO:0015874),6,2,0.414973843,4.819580878,0.059475651,0.387824179,6581;222962,SLC22A3;SLC29A4
GO:1990962,xenobiotic transport across blood-brain barrier (GO:1990962),6,2,0.414973843,4.819580878,0.059475651,0.387824179,9429;5243,ABCB1;ABCG2
GO:1904141,positive regulation of microglial cell migration (GO:1904141),6,2,0.414973843,4.819580878,0.059475651,0.387824179,64805;6376,CX3CL1;P2RY12
GO:0070303,negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),6,2,0.414973843,4.819580878,0.059475651,0.387824179,2308;2305,FOXM1;FOXO1
GO:0010746,regulation of long-chain fatty acid import across plasma membrane (GO:0010746),6,2,0.414973843,4.819580878,0.059475651,0.387824179,2180;8660,IRS2;ACSL1
GO:0090205,positive regulation of cholesterol metabolic process (GO:0090205),6,2,0.414973843,4.819580878,0.059475651,0.387824179,2246;1066,FGF1;CES1
GO:0006072,glycerol-3-phosphate metabolic process (GO:0006072),6,2,0.414973843,4.819580878,0.059475651,0.387824179,57678;2819,GPD1;GPAM
GO:0090209,negative regulation of triglyceride metabolic process (GO:0090209),6,2,0.414973843,4.819580878,0.059475651,0.387824179,2822;440503,GPLD1;PLIN5
GO:0010986,positive regulation of lipoprotein particle clearance (GO:0010986),6,2,0.414973843,4.819580878,0.059475651,0.387824179,338328;2822,GPIHBP1;GPLD1
GO:0033292,T-tubule organization (GO:0033292),6,2,0.414973843,4.819580878,0.059475651,0.387824179,287;274,ANK2;BIN1
GO:1903598,positive regulation of gap junction assembly (GO:1903598),6,2,0.414973843,4.819580878,0.059475651,0.387824179,857;26047,CAV1;CNTNAP2
GO:2000345,regulation of hepatocyte proliferation (GO:2000345),6,2,0.414973843,4.819580878,0.059475651,0.387824179,3249;5764,PTN;HPN
GO:0033690,positive regulation of osteoblast proliferation (GO:0033690),6,2,0.414973843,4.819580878,0.059475651,0.387824179,4057;650,BMP2;LTF
GO:0072311,glomerular epithelial cell differentiation (GO:0072311),6,2,0.414973843,4.819580878,0.059475651,0.387824179,8842;28999,KLF15;PROM1
GO:0061318,renal filtration cell differentiation (GO:0061318),6,2,0.414973843,4.819580878,0.059475651,0.387824179,8842;28999,KLF15;PROM1
GO:2000389,regulation of neutrophil extravasation (GO:2000389),6,2,0.414973843,4.819580878,0.059475651,0.387824179,101;10562,ADAM8;OLFM4
GO:0060563,neuroepithelial cell differentiation (GO:0060563),6,2,0.414973843,4.819580878,0.059475651,0.387824179,7481;6664,WNT11;SOX11
GO:0010994,free ubiquitin chain polymerization (GO:0010994),6,2,0.414973843,4.819580878,0.059475651,0.387824179,11065;27338,UBE2C;UBE2S
GO:0044314,protein K27-linked ubiquitination (GO:0044314),6,2,0.414973843,4.819580878,0.059475651,0.387824179,27338;29089,UBE2T;UBE2S
GO:0035519,protein K29-linked ubiquitination (GO:0035519),6,2,0.414973843,4.819580878,0.059475651,0.387824179,27338;29089,UBE2T;UBE2S
GO:0015820,leucine transport (GO:0015820),6,2,0.414973843,4.819580878,0.059475651,0.387824179,8140;3993,LLGL2;SLC7A5
GO:0072205,metanephric collecting duct development (GO:0072205),6,2,0.414973843,4.819580878,0.059475651,0.387824179,5727;7477,PTCH1;WNT7B
GO:0071281,cellular response to iron ion (GO:0071281),6,2,0.414973843,4.819580878,0.059475651,0.387824179,7018;654,TF;BMP6
GO:0070601,centromeric sister chromatid cohesion (GO:0070601),6,2,0.414973843,4.819580878,0.059475651,0.387824179,701;699,BUB1;BUB1B
GO:0033047,regulation of mitotic sister chromatid segregation (GO:0033047),6,2,0.414973843,4.819580878,0.059475651,0.387824179,891;1843,CCNB1;DUSP1
GO:1903504,regulation of mitotic spindle checkpoint (GO:1903504),6,2,0.414973843,4.819580878,0.059475651,0.387824179,891;1843,CCNB1;DUSP1
GO:0001692,histamine metabolic process (GO:0001692),6,2,0.414973843,4.819580878,0.059475651,0.387824179,6581;222962,SLC22A3;SLC29A4
GO:2000726,negative regulation of cardiac muscle cell differentiation (GO:2000726),6,2,0.414973843,4.819580878,0.059475651,0.387824179,650;55553,BMP2;SOX6
GO:0031076,embryonic camera-type eye development (GO:0031076),6,2,0.414973843,4.819580878,0.059475651,0.387824179,10763;220,NES;ALDH1A3
GO:0021795,cerebral cortex cell migration (GO:0021795),6,2,0.414973843,4.819580878,0.059475651,0.387824179,5649;26468,RELN;LHX6
GO:0120040,regulation of macrophage proliferation (GO:0120040),6,2,0.414973843,4.819580878,0.059475651,0.387824179,146433;90865,IL33;IL34
GO:0030854,positive regulation of granulocyte differentiation (GO:0030854),6,2,0.414973843,4.819580878,0.059475651,0.387824179,51176;54997,TESC;LEF1
GO:0061469,regulation of type B pancreatic cell proliferation (GO:0061469),6,2,0.414973843,4.819580878,0.059475651,0.387824179,3164;8013,NR4A1;NR4A3
GO:1902747,negative regulation of lens fiber cell differentiation (GO:1902747),6,2,0.414973843,4.819580878,0.059475651,0.387824179,10252;10253,SPRY2;SPRY1
GO:2000096,"positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",6,2,0.414973843,4.819580878,0.059475651,0.387824179,57664;84870,RSPO3;PLEKHA4
GO:0010216,maintenance of DNA methylation (GO:0010216),6,2,0.414973843,4.819580878,0.059475651,0.387824179,3070;29128,UHRF1;HELLS
GO:0015889,cobalamin transport (GO:0015889),6,2,0.414973843,4.819580878,0.059475651,0.387824179,8029;6947,CUBN;TCN1
GO:0071320,cellular response to cAMP (GO:0071320),31,5,2.144031524,2.332055263,0.05948659,0.387824179,3753;9472;5138;358;10411,KCNE1;PDE2A;RAPGEF3;AQP1;AKAP6
GO:0048638,regulation of developmental growth (GO:0048638),31,5,2.144031524,2.332055263,0.05948659,0.387824179,2690;3952;3479;6776;10551,LEP;GHR;STAT5A;IGF1;AGR2
GO:0007259,receptor signaling pathway via JAK-STAT (GO:0007259),31,5,2.144031524,2.332055263,0.05948659,0.387824179,2690;3952;5753;8835;6776,LEP;GHR;STAT5A;SOCS2;PTK6
GO:0032148,activation of protein kinase B activity (GO:0032148),31,5,2.144031524,2.332055263,0.05948659,0.387824179,4916;3479;150;2246;3084,FGF1;NTRK3;NRG1;IGF1;ADRA2A
GO:0003091,renal water homeostasis (GO:0003091),31,5,2.144031524,2.332055263,0.05948659,0.387824179,554;111;196883;5577;358,AVPR2;AQP1;ADCY4;ADCY5;PRKAR2B
GO:0070328,triglyceride homeostasis (GO:0070328),31,5,2.144031524,2.332055263,0.05948659,0.387824179,84649;4023;51085;51129;338328,GPIHBP1;LPL;MLXIPL;ANGPTL4;DGAT2
GO:0032233,positive regulation of actin filament bundle assembly (GO:0032233),51,7,3.527277668,1.984533303,0.060131857,0.389916495,22899;7481;10411;6422;6376;11346;171024,CX3CL1;SFRP1;SYNPO2;RAPGEF3;ARHGEF15;WNT11;SYNPO
GO:0050770,regulation of axonogenesis (GO:0050770),51,7,3.527277668,1.984533303,0.060131857,0.389916495,4804;4915;1000;1949;91584;4038;79006,NTRK2;NGFR;LRP4;PLXNA4;METRN;EFNB3;CDH2
GO:0010632,regulation of epithelial cell migration (GO:0010632),51,7,3.527277668,1.984533303,0.060131857,0.389916495,2255;168667;3373;57381;57111;5168;5764,ENPP2;BMPER;PTN;RHOJ;HYAL1;FGF10;RAB25
GO:0030301,cholesterol transport (GO:0030301),51,7,3.527277668,1.984533303,0.060131857,0.389916495,857;10351;948;1066;1645;23461;3931,CAV1;ABCA8;LCAT;ABCA5;CES1;AKR1C1;CD36
GO:0008015,blood circulation (GO:0008015),51,7,3.527277668,1.984533303,0.060131857,0.389916495,3627;135;185;6387;4881;4223;4973,NPR1;MEOX2;CXCL10;OLR1;CXCL12;ADORA2A;AGTR1
GO:0031334,positive regulation of protein-containing complex assembly (GO:0031334),117,13,8.091989945,1.606526959,0.060585616,0.391529143,6622;10563;3084;948;11076;81620;54922;55612;4314;9636;115362;6886;51673,SNCA;CD36;TAL1;RASIP1;CDT1;TPPP;MMP3;ISG15;NRG1;TPPP3;GBP5;FERMT1;CXCL13
GO:0031346,positive regulation of cell projection organization (GO:0031346),117,13,8.091989945,1.606526959,0.060585616,0.391529143,4804;4916;4915;79625;5979;5649;91584;8322;6376;482;5753;5764;79006,NTRK2;CX3CL1;RELN;PTN;NGFR;PLXNA4;NTRK3;ATP1B2;METRN;FZD4;PTK6;NDNF;RET
GO:0060047,heart contraction (GO:0060047),41,6,2.835654596,2.115913556,0.061034909,0.391529143,1756;55800;6327;6330;477;845,DMD;SCN4B;ATP1A2;SCN2B;SCN3B;CASQ2
GO:1904064,positive regulation of cation transmembrane transport (GO:1904064),41,6,2.835654596,2.115913556,0.061034909,0.391529143,3753;9472;54331;3779;287;6769,KCNE1;KCNMB1;AKAP6;ANK2;STAC;GNG2
GO:0019318,hexose metabolic process (GO:0019318),41,6,2.835654596,2.115913556,0.061034909,0.391529143,8660;347;9370;230;5105;6652,ADIPOQ;PCK1;ALDOC;APOD;IRS2;SORD
GO:0048705,skeletal system morphogenesis (GO:0048705),41,6,2.835654596,2.115913556,0.061034909,0.391529143,4057;3201;3200;6664;56603;2201,HOXA4;HOXA3;FBN2;CYP26B1;SOX11;LTF
GO:1905039,carboxylic acid transmembrane transport (GO:1905039),41,6,2.835654596,2.115913556,0.061034909,0.391529143,11254;8140;23657;9194;9058;5243,ABCB1;SLC16A7;SLC6A14;SLC7A5;SLC13A2;SLC7A11
GO:0070371,ERK1 and ERK2 cascade (GO:0070371),22,4,1.521570759,2.628862297,0.061357587,0.391529143,2255;3479;5734;983,CDK1;PTGER4;FGF10;IGF1
GO:0032703,negative regulation of interleukin-2 production (GO:0032703),22,4,1.521570759,2.628862297,0.061357587,0.391529143,7538;947;1378;50943,FOXP3;ZFP36;CD34;CR1
GO:0010883,regulation of lipid storage (GO:0010883),22,4,1.521570759,2.628862297,0.061357587,0.391529143,3569;4023;440503;4232,LPL;IL6;MEST;PLIN5
GO:0099623,regulation of cardiac muscle cell membrane repolarization (GO:0099623),22,4,1.521570759,2.628862297,0.061357587,0.391529143,3753;23704;287;6330,SCN4B;KCNE1;ANK2;KCNE4
GO:0035108,limb morphogenesis (GO:0035108),22,4,1.521570759,2.628862297,0.061357587,0.391529143,4621;658;56603;5727,MYH3;PTCH1;CYP26B1;BMPR1B
GO:0034389,lipid droplet organization (GO:0034389),22,4,1.521570759,2.628862297,0.061357587,0.391529143,63924;6713;1149;440503,CIDEC;CIDEA;SQLE;PLIN5
GO:0050996,positive regulation of lipid catabolic process (GO:0050996),22,4,1.521570759,2.628862297,0.061357587,0.391529143,57104;8660;225;440503,ABCD2;IRS2;PNPLA2;PLIN5
GO:0007093,mitotic cell cycle checkpoint signaling (GO:0007093),22,4,1.521570759,2.628862297,0.061357587,0.391529143,701;9212;11130;699,BUB1;ZWINT;BUB1B;AURKB
GO:0006261,DNA-dependent DNA replication (GO:0006261),129,14,8.921937632,1.569165867,0.062104657,0.395876027,81620;1763;8317;990;9401;641;4173;55388;23594;4998;8318;5888;51659;9837,CDC6;RAD51;GINS1;CDC45;MCM10;RECQL4;ORC6;ORC1;MCM4;CDT1;BLM;DNA2;CDC7;GINS2
GO:2000113,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),542,47,37.48597051,1.253802405,0.063451913,0.404035431,5468;3084;825;7292;51085;7481;650;3204;23493;2625;8626;7704;2308;51176;1063;4435;9370;63976;6422;1050;1869;2305;990;7298;332;3725;2908;9314;1410;57761;50943;2146;83595;5187;90993;84913;1028;862;56981;23034;10644;51222;93986;56849;91133;3400;55635,PER1;CENPF;ATOH8;DEPDC1;FOXM1;BIRC5;ZBTB16;TCEAL7;CRYAB;CDC6;SFRP1;HOXA7;ID4;ADIPOQ;EZH2;MLXIPL;PRDM11;CDKN1C;BMP2;TNFSF4;PPARG;E2F1;NR3C1;JUN;FOXO1;LEF1;CAPN3;KLF4;ZNF219;RUNX1T1;FOXP3;TYMS;L3MBTL4;TRIB3;TP63;SAMD4A;SOX7;FOXP2;IGF2BP2;NRG1;CITED1;PRDM16;CREB3L1;HEY2;WNT11;CEBPA;GATA3
GO:0008285,negative regulation of cell population proliferation (GO:0008285),375,34,25.93586521,1.310925999,0.063603446,0.404571761,9368;554;5468;3624;130399;3569;5744;650;2625;2191;6664;347;3249;2822;7049;658;6422;5950;1050;1033;1869;63923;990;3489;5784;9314;54997;943;8854;50943;83595;9510;4969;1028,INHBA;CDKN3;IGFBP6;TESC;RBP4;CDC6;SFRP1;ALDH1A2;AVPR2;ADAMTS1;TGFBR3;ACVR1C;CDKN1C;BMP2;PPARG;E2F1;PTPN14;GPLD1;KLF4;APOD;OGN;FOXP3;FAP;SOX7;IL6;SLC9A3R1;BMPR1B;TNFRSF8;HPN;CEBPA;PTHLH;GATA3;TNN;SOX11
GO:0090263,positive regulation of canonical Wnt signaling pathway (GO:0090263),130,14,8.991099939,1.55709536,0.065389698,0.41549416,2255;55366;1956;857;2719;79971;59352;6422;1277;23189;57664;23500;51704;284654,CAV1;SFRP1;GPC3;KANK1;EGFR;LGR6;GPRC5B;FGF10;LGR4;PLEKHA4;WLS;DAAM2;RSPO1;COL1A1
GO:0006275,regulation of DNA replication (GO:0006275),52,7,3.596439976,1.946369201,0.065535571,0.415692983,1956;81620;1763;890;990;641;157570,CCNA2;CDC6;ESCO2;EGFR;CDT1;BLM;DNA2
GO:0030336,negative regulation of cell migration (GO:0030336),142,15,9.821047626,1.527331968,0.066339233,0.415692983,4804;130399;7481;3204;7122;2247;23213;9370;6422;6376;482;63923;1281;3868;23189,CX3CL1;SFRP1;HOXA7;FGF2;CLDN5;ADIPOQ;ACVR1C;KANK1;SULF1;NGFR;ATP1B2;WNT11;TNN;COL3A1;KRT16
GO:0048662,negative regulation of smooth muscle cell proliferation (GO:0048662),32,5,2.213193831,2.259178536,0.066664726,0.415692983,5468;347;9370;4969;1264,CNN1;ADIPOQ;PPARG;APOD;OGN
GO:0010828,positive regulation of glucose transmembrane transport (GO:0010828),32,5,2.213193831,2.259178536,0.066664726,0.415692983,3479;10580;8660;9370;8013,ADIPOQ;SORBS1;IRS2;IGF1;NR4A3
GO:1904894,positive regulation of receptor signaling pathway via STAT (GO:1904894),32,5,2.213193831,2.259178536,0.066664726,0.415692983,3815;2690;3952;3569;85480,TSLP;LEP;KIT;GHR;IL6
GO:0032733,positive regulation of interleukin-10 production (GO:0032733),32,5,2.213193831,2.259178536,0.066664726,0.415692983,3569;7292;947;9636;85480,TSLP;TNFSF4;CD34;ISG15;IL6
GO:1900015,regulation of cytokine production involved in inflammatory response (GO:1900015),42,6,2.904816903,2.065534662,0.067235349,0.415692983,3952;3569;347;115362;5187;225,PER1;LEP;APOD;ABCD2;IL6;GBP5
GO:0032642,regulation of chemokine production (GO:0032642),42,6,2.904816903,2.065534662,0.067235349,0.415692983,3569;7292;4023;1958;85480;90865,TSLP;LPL;EGR1;IL33;TNFSF4;IL6
GO:0061098,positive regulation of protein tyrosine kinase activity (GO:0061098),42,6,2.904816903,2.065534662,0.067235349,0.415692983,4915;150;2209;5649;146433;51704,NTRK2;RELN;GPRC5B;FCGR1A;IL34;ADRA2A
GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),42,6,2.904816903,2.065534662,0.067235349,0.415692983,57863;347902;6403;30835;79633;4680,CADM3;CD209;CEACAM6;FAT4;SELP;AMIGO2
GO:0044843,cell cycle G1/S phase transition (GO:0044843),63,8,4.357225355,1.83603081,0.067701366,0.415692983,3624;993;8317;1033;1869;890;9134;898,INHBA;CDKN3;CCNE2;CCNA2;E2F1;CDC7;CDC25A;CCNE1
GO:0031532,actin cytoskeleton reorganization (GO:0031532),63,8,4.357225355,1.83603081,0.067701366,0.415692983,2934;301;8572;1901;3815;2255;2252;80731,ANXA1;KIT;GSN;FGF10;S1PR1;THSD7B;PDLIM4;FGF7
GO:0009952,anterior/posterior pattern specification (GO:0009952),63,8,4.357225355,1.83603081,0.067701366,0.415692983,79971;650;3201;3200;3204;55502;3202;23493,HOXA4;HOXA5;HOXA3;HOXA7;BMP2;HES6;WLS;HEY2
GO:0006939,smooth muscle contraction (GO:0006939),14,3,0.968272301,3.098301993,0.067703116,0.415692983,4638;4629;59,MYH11;MYLK;ACTA2
GO:0046903,secretion (GO:0046903),14,3,0.968272301,3.098301993,0.067703116,0.415692983,7163;4881;10516,NPR1;FBLN5;TPD52
GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),14,3,0.968272301,3.098301993,0.067703116,0.415692983,4223;9314;79812,MEOX2;KLF4;MMRN2
GO:1901018,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),14,3,0.968272301,3.098301993,0.067703116,0.415692983,30819;287;482,KCNIP2;ATP1B2;ANK2
GO:0086011,membrane repolarization during action potential (GO:0086011),14,3,0.968272301,3.098301993,0.067703116,0.415692983,3753;23704;30819,KCNE1;KCNIP2;KCNE4
GO:0097623,potassium ion export across plasma membrane (GO:0097623),14,3,0.968272301,3.098301993,0.067703116,0.415692983,3753;23704;30819,KCNE1;KCNIP2;KCNE4
GO:0042311,vasodilation (GO:0042311),14,3,0.968272301,3.098301993,0.067703116,0.415692983,154;1373;10365,ADRB2;CPS1;KLF2
GO:0046058,cAMP metabolic process (GO:0046058),14,3,0.968272301,3.098301993,0.067703116,0.415692983,111;196883;5744,ADCY4;ADCY5;PTHLH
GO:0042093,T-helper cell differentiation (GO:0042093),14,3,0.968272301,3.098301993,0.067703116,0.415692983,3569;5734;51176,LEF1;PTGER4;IL6
GO:0038083,peptidyl-tyrosine autophosphorylation (GO:0038083),14,3,0.968272301,3.098301993,0.067703116,0.415692983,1956;660;6725,BMX;EGFR;SRMS
GO:0045725,positive regulation of glycogen biosynthetic process (GO:0045725),14,3,0.968272301,3.098301993,0.067703116,0.415692983,3479;10580;8660,SORBS1;IRS2;IGF1
GO:0003171,atrioventricular valve development (GO:0003171),14,3,0.968272301,3.098301993,0.067703116,0.415692983,7048;650;6586,TGFBR2;BMP2;SLIT3
GO:0031998,regulation of fatty acid beta-oxidation (GO:0031998),14,3,0.968272301,3.098301993,0.067703116,0.415692983,8660;225;440503,ABCD2;IRS2;PLIN5
GO:0061037,negative regulation of cartilage development (GO:0061037),14,3,0.968272301,3.098301993,0.067703116,0.415692983,5744;7481;2202,EFEMP1;WNT11;PTHLH
GO:0046462,monoacylglycerol metabolic process (GO:0046462),14,3,0.968272301,3.098301993,0.067703116,0.415692983,84649;11343;5321,PLA2G4A;DGAT2;MGLL
GO:0050819,negative regulation of coagulation (GO:0050819),14,3,0.968272301,3.098301993,0.067703116,0.415692983,947;1906;7035,TFPI;CD34;EDN1
GO:0045591,positive regulation of regulatory T cell differentiation (GO:0045591),14,3,0.968272301,3.098301993,0.067703116,0.415692983,259307;1378;50943,FOXP3;IL4I1;CR1
GO:0060349,bone morphogenesis (GO:0060349),14,3,0.968272301,3.098301993,0.067703116,0.415692983,4057;658;56603,CYP26B1;BMPR1B;LTF
GO:0034501,protein localization to kinetochore (GO:0034501),14,3,0.968272301,3.098301993,0.067703116,0.415692983,983;9212;7272,CDK1;TTK;AURKB
GO:0042574,retinal metabolic process (GO:0042574),14,3,0.968272301,3.098301993,0.067703116,0.415692983,8644;1645;220,AKR1C1;AKR1C3;ALDH1A3
GO:0032787,monocarboxylic acid metabolic process (GO:0032787),143,15,9.890209933,1.516651325,0.069613,0.42698341,5468;3479;57678;4023;948;1645;56603;220;9123;8854;1160;125;126;124;3945,ADH1C;ALDH1A2;LPL;ADH1A;ADH1B;GPAM;AKR1C1;CD36;CKMT2;PPARG;SLC16A3;ALDH1A3;IGF1;LDHB;CYP26B1
GO:0001818,negative regulation of cytokine production (GO:0001818),179,18,12.38005299,1.453951773,0.070169106,0.427729802,7538;301;55366;3624;3569;7292;5734;947;1378;2335;347;51176;6376;9636;9314;50943;225;1149,INHBA;CX3CL1;FN1;ANXA1;CIDEA;TNFSF4;LEF1;KLF4;APOD;PTGER4;FOXP3;ABCD2;ZFP36;CD34;LGR4;ISG15;IL6;CR1
GO:1904037,positive regulation of epithelial cell apoptotic process (GO:1904037),23,4,1.590733066,2.514563936,0.070375108,0.427729802,2934;3569;8644;641700,GSN;AKR1C3;ECSCR;IL6
GO:0043534,blood vessel endothelial cell migration (GO:0043534),23,4,1.590733066,2.514563936,0.070375108,0.427729802,2822;1960;2247;3164,FGF2;GPLD1;EGR3;NR4A1
GO:0002385,mucosal immune response (GO:0002385),23,4,1.590733066,2.514563936,0.070375108,0.427729802,4057;1672;5284;92747,DEFB1;PIGR;LTF;BPIFB1
GO:1903169,regulation of calcium ion transmembrane transport (GO:1903169),23,4,1.590733066,2.514563936,0.070375108,0.427729802,287;477;845;3270,ATP1A2;CASQ2;ANK2;HRC
GO:0046463,acylglycerol biosynthetic process (GO:0046463),23,4,1.590733066,2.514563936,0.070375108,0.427729802,84649;57104;5321;57678,GPAM;PLA2G4A;DGAT2;PNPLA2
GO:0046339,diacylglycerol metabolic process (GO:0046339),23,4,1.590733066,2.514563936,0.070375108,0.427729802,84649;57104;57678;3991,GPAM;LIPE;DGAT2;PNPLA2
GO:0046688,response to copper ion (GO:0046688),23,4,1.590733066,2.514563936,0.070375108,0.427729802,6622;358;4499;4501,MT1M;MT1X;SNCA;AQP1
GO:0019433,triglyceride catabolic process (GO:0019433),23,4,1.590733066,2.514563936,0.070375108,0.427729802,57104;2167;1373;4023,FABP4;LPL;CPS1;PNPLA2
GO:0007010,cytoskeleton organization (GO:0007010),120,13,8.299476867,1.566363785,0.071168311,0.43113976,9645;390;27289;81624;10810;1674;57556;667;58480;274;23237;3868;152503,DST;MICAL2;DIAPH3;WASF3;SH3D19;ARC;RND3;SEMA6A;DES;RHOU;BIN1;RND1;KRT16
GO:0055074,calcium ion homeostasis (GO:0055074),97,11,6.708743801,1.639651226,0.071182398,0.43113976,6622;857;5745;287;6387;1906;1907;57402;344905;9104;57158,CAV1;RGN;JPH2;SNCA;CXCL12;PTH1R;ANK2;S100A14;EDN1;EDN2;ATP13A5
GO:0015698,inorganic anion transport (GO:0015698),53,7,3.665602283,1.909645253,0.071223055,0.43113976,29127;10568;203859;5348;53405;57348;5169,FXYD1;TTYH1;RACGAP1;CLIC5;ANO5;ENPP3;SLC34A2
GO:0032722,positive regulation of chemokine production (GO:0032722),53,7,3.665602283,1.909645253,0.071223055,0.43113976,3569;7292;4023;9370;1958;85480;90865,TSLP;LPL;EGR1;ADIPOQ;IL33;TNFSF4;IL6
GO:0031669,cellular response to nutrient levels (GO:0031669),64,8,4.426387662,1.807342829,0.072919904,0.440524164,11170;3745;4023;2308;8644;6422;5166;213,PDK4;FAM107A;SFRP1;LPL;KCNB1;FOXO1;ALB;AKR1C3
GO:0010948,negative regulation of cell cycle process (GO:0010948),64,8,4.426387662,1.807342829,0.072919904,0.440524164,9212;9700;6241;8317;1869;4751;5888;2146,NEK2;RRM2;RAD51;AURKB;EZH2;ESPL1;E2F1;CDC7
GO:0008543,fibroblast growth factor receptor signaling pathway (GO:0008543),75,9,5.187173042,1.735049116,0.073169766,0.441589825,2255;2252;2246;23768;2247;9365;54845;152831;79801,FGF1;SHCBP1;KL;FGF2;KLB;FGF10;FLRT2;FGF7;ESRP1
GO:0019319,hexose biosynthetic process (GO:0019319),43,6,2.973979211,2.017498972,0.073788382,0.444177276,10891;230;5207;5950;5105;6652,RBP4;PCK1;PFKFB1;ALDOC;PPARGC1A;SORD
GO:0010863,positive regulation of phospholipase C activity (GO:0010863),43,6,2.973979211,2.017498972,0.073788382,0.444177276,3815;4916;4915;64805;1956;2247,NTRK2;FGF2;KIT;P2RY12;EGFR;NTRK3
GO:1901215,negative regulation of neuron death (GO:1901215),98,11,6.777906108,1.622920091,0.075431834,0.444177276,6622;4915;9928;79625;947;7301;219699;4435;10891;101;5803,NTRK2;KIF14;SNCA;UNC5B;PTPRZ1;ADAM8;CD34;PPARGC1A;CITED1;NDNF;TYRO3
GO:0043523,regulation of neuron apoptotic process (GO:0043523),98,11,6.777906108,1.622920091,0.075431834,0.444177276,3745;4915;9928;79625;7301;219699;4435;10891;101;5803;23321,NTRK2;KIF14;UNC5B;PTPRZ1;ADAM8;KCNB1;PPARGC1A;CITED1;TRIM2;NDNF;TYRO3
GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),98,11,6.777906108,1.622920091,0.075431834,0.444177276,24137;29127;9493;81930;11004;10437;1062;3832;56992;10053;26153,KIF4A;KIF2C;KIF11;CENPE;KIF23;KIF18A;KIF15;RACGAP1;IFI30;KIF26A;AP1M2
GO:0002495,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),98,11,6.777906108,1.622920091,0.075431834,0.444177276,24137;29127;9493;81930;11004;10437;1062;3832;56992;10053;26153,KIF4A;KIF2C;KIF11;CENPE;KIF23;KIF18A;KIF15;RACGAP1;IFI30;KIF26A;AP1M2
GO:0006641,triglyceride metabolic process (GO:0006641),54,7,3.73476459,1.874281452,0.077194482,0.444177276,84649;57104;57678;2167;1373;4023;857,FABP4;CAV1;LPL;GPAM;DGAT2;CPS1;PNPLA2
GO:0034644,cellular response to UV (GO:0034644),76,9,5.256335349,1.712219522,0.078171945,0.444177276,358;4311;9212;3373;993;4314;4318;1396;4239,MME;AURKB;AQP1;HYAL1;MFAP4;MMP3;MMP9;CDC25A;CRIP1
GO:0042424,catecholamine catabolic process (GO:0042424),7,2,0.484136151,4.131069324,0.079526643,0.444177276,4129;4128,MAOA;MAOB
GO:0060216,definitive hemopoiesis (GO:0060216),7,2,0.484136151,4.131069324,0.079526643,0.444177276,7049;7010,TGFBR3;TEK
GO:0044806,G-quadruplex DNA unwinding (GO:0044806),7,2,0.484136151,4.131069324,0.079526643,0.444177276,1763;641,BLM;DNA2
GO:0140059,dendrite arborization (GO:0140059),7,2,0.484136151,4.131069324,0.079526643,0.444177276,10371;5764,PTN;SEMA3A
GO:0007191,adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),7,2,0.484136151,4.131069324,0.079526643,0.444177276,54331;2774,GNAL;GNG2
GO:0071868,cellular response to monoamine stimulus (GO:0071868),7,2,0.484136151,4.131069324,0.079526643,0.444177276,54331;8013,GNG2;NR4A3
GO:1905330,regulation of morphogenesis of an epithelium (GO:1905330),7,2,0.484136151,4.131069324,0.079526643,0.444177276,2246;3627,FGF1;CXCL10
GO:0031392,regulation of prostaglandin biosynthetic process (GO:0031392),7,2,0.484136151,4.131069324,0.079526643,0.444177276,301;5743,ANXA1;PTGS2
GO:0045625,regulation of T-helper 1 cell differentiation (GO:0045625),7,2,0.484136151,4.131069324,0.079526643,0.444177276,301;7292,ANXA1;TNFSF4
GO:0071476,cellular hypotonic response (GO:0071476),7,2,0.484136151,4.131069324,0.079526643,0.444177276,4638;362,MYLK;AQP5
GO:0006971,hypotonic response (GO:0006971),7,2,0.484136151,4.131069324,0.079526643,0.444177276,4638;362,MYLK;AQP5
GO:0035272,exocrine system development (GO:0035272),7,2,0.484136151,4.131069324,0.079526643,0.444177276,2255;25837,RAB26;FGF10
GO:0010919,regulation of inositol phosphate biosynthetic process (GO:0010919),7,2,0.484136151,4.131069324,0.079526643,0.444177276,6622;5745,SNCA;PTH1R
GO:0032060,bleb assembly (GO:0032060),7,2,0.484136151,4.131069324,0.079526643,0.444177276,4638;2012,MYLK;EMP1
GO:0032488,Cdc42 protein signal transduction (GO:0032488),7,2,0.484136151,4.131069324,0.079526643,0.444177276,57381;58480,RHOJ;RHOU
GO:0038166,angiotensin-activated signaling pathway (GO:0038166),7,2,0.484136151,4.131069324,0.079526643,0.444177276,857;185,CAV1;AGTR1
GO:0014061,regulation of norepinephrine secretion (GO:0014061),7,2,0.484136151,4.131069324,0.079526643,0.444177276,3745;150,KCNB1;ADRA2A
GO:0044091,membrane biogenesis (GO:0044091),7,2,0.484136151,4.131069324,0.079526643,0.444177276,6711;116238,TLCD1;SPTBN1
GO:0060371,regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),7,2,0.484136151,4.131069324,0.079526643,0.444177276,55800;6327,SCN2B;SCN3B
GO:0086015,SA node cell action potential (GO:0086015),7,2,0.484136151,4.131069324,0.079526643,0.444177276,55800;287,SCN3B;ANK2
GO:0097646,calcitonin family receptor signaling pathway (GO:0097646),7,2,0.484136151,4.131069324,0.079526643,0.444177276,133;10267,RAMP1;ADM
GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),7,2,0.484136151,4.131069324,0.079526643,0.444177276,5468;3479,PPARG;IGF1
GO:0090493,catecholamine uptake (GO:0090493),7,2,0.484136151,4.131069324,0.079526643,0.444177276,6581;222962,SLC22A3;SLC29A4
GO:0015872,dopamine transport (GO:0015872),7,2,0.484136151,4.131069324,0.079526643,0.444177276,6581;222962,SLC22A3;SLC29A4
GO:2000669,negative regulation of dendritic cell apoptotic process (GO:2000669),7,2,0.484136151,4.131069324,0.079526643,0.444177276,6366;6387,CCL21;CXCL12
GO:1904139,regulation of microglial cell migration (GO:1904139),7,2,0.484136151,4.131069324,0.079526643,0.444177276,64805;6376,CX3CL1;P2RY12
GO:2000322,regulation of glucocorticoid receptor signaling pathway (GO:2000322),7,2,0.484136151,4.131069324,0.079526643,0.444177276,5187;55885,PER1;LMO3
GO:1903524,positive regulation of blood circulation (GO:1903524),7,2,0.484136151,4.131069324,0.079526643,0.444177276,477;3270,ATP1A2;HRC
GO:1905603,regulation of blood-brain barrier permeability (GO:1905603),7,2,0.484136151,4.131069324,0.079526643,0.444177276,284;27134,ANGPT1;TJP3
GO:0002664,regulation of T cell tolerance induction (GO:0002664),7,2,0.484136151,4.131069324,0.079526643,0.444177276,7048;50943,TGFBR2;FOXP3
GO:0045620,negative regulation of lymphocyte differentiation (GO:0045620),7,2,0.484136151,4.131069324,0.079526643,0.444177276,3624;6422,INHBA;SFRP1
GO:1905278,positive regulation of epithelial tube formation (GO:1905278),7,2,0.484136151,4.131069324,0.079526643,0.444177276,2625;2247,FGF2;GATA3
GO:0006640,monoacylglycerol biosynthetic process (GO:0006640),7,2,0.484136151,4.131069324,0.079526643,0.444177276,84649;5321,PLA2G4A;DGAT2
GO:0033483,gas homeostasis (GO:0033483),7,2,0.484136151,4.131069324,0.079526643,0.444177276,857;7477,CAV1;WNT7B
GO:0019065,receptor-mediated endocytosis of virus by host cell (GO:0019065),7,2,0.484136151,4.131069324,0.079526643,0.444177276,857;858,CAV1;CAV2
GO:0010566,regulation of ketone biosynthetic process (GO:0010566),7,2,0.484136151,4.131069324,0.079526643,0.444177276,8644;1958,EGR1;AKR1C3
GO:0030213,hyaluronan biosynthetic process (GO:0030213),7,2,0.484136151,4.131069324,0.079526643,0.444177276,3373;3038,HAS3;HYAL1
GO:0010752,regulation of cGMP-mediated signaling (GO:0010752),7,2,0.484136151,4.131069324,0.079526643,0.444177276,5138;50940,PDE2A;PDE11A
GO:0002068,glandular epithelial cell development (GO:0002068),7,2,0.484136151,4.131069324,0.079526643,0.444177276,1000;654,BMP6;CDH2
GO:0003323,type B pancreatic cell development (GO:0003323),7,2,0.484136151,4.131069324,0.079526643,0.444177276,1000;654,BMP6;CDH2
GO:0033005,positive regulation of mast cell activation (GO:0033005),7,2,0.484136151,4.131069324,0.079526643,0.444177276,8013;85480,TSLP;NR4A3
GO:0072189,ureter development (GO:0072189),7,2,0.484136151,4.131069324,0.079526643,0.444177276,64321;130497,OSR1;SOX17
GO:0032347,regulation of aldosterone biosynthetic process (GO:0032347),7,2,0.484136151,4.131069324,0.079526643,0.444177276,650;654,BMP2;BMP6
GO:0032754,positive regulation of interleukin-5 production (GO:0032754),7,2,0.484136151,4.131069324,0.079526643,0.444177276,2625;85480,TSLP;GATA3
GO:0090267,positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),7,2,0.484136151,4.131069324,0.079526643,0.444177276,4085;10403,NDC80;MAD2L1
GO:0090232,positive regulation of spindle checkpoint (GO:0090232),7,2,0.484136151,4.131069324,0.079526643,0.444177276,4085;10403,NDC80;MAD2L1
GO:0019359,nicotinamide nucleotide biosynthetic process (GO:0019359),7,2,0.484136151,4.131069324,0.079526643,0.444177276,23498;23057,NMNAT2;HAAO
GO:0071499,cellular response to laminar fluid shear stress (GO:0071499),7,2,0.484136151,4.131069324,0.079526643,0.444177276,10365;9314,KLF4;KLF2
GO:0032291,axon ensheathment in central nervous system (GO:0032291),7,2,0.484136151,4.131069324,0.079526643,0.444177276,6663;5354,PLP1;SOX10
GO:0015793,glycerol transport (GO:0015793),7,2,0.484136151,4.131069324,0.079526643,0.444177276,358;364,AQP7;AQP1
GO:0035810,positive regulation of urine volume (GO:0035810),7,2,0.484136151,4.131069324,0.079526643,0.444177276,4881;4883,NPR1;NPR3
GO:0070344,regulation of fat cell proliferation (GO:0070344),7,2,0.484136151,4.131069324,0.079526643,0.444177276,1869;55022,E2F1;PID1
GO:0048387,negative regulation of retinoic acid receptor signaling pathway (GO:0048387),7,2,0.484136151,4.131069324,0.079526643,0.444177276,56603;2146,EZH2;CYP26B1
GO:0045110,intermediate filament bundle assembly (GO:0045110),7,2,0.484136151,4.131069324,0.079526643,0.444177276,5317;3861,KRT14;PKP1
GO:1901387,positive regulation of voltage-gated calcium channel activity (GO:1901387),7,2,0.484136151,4.131069324,0.079526643,0.444177276,6769;342667,STAC2;STAC
GO:0072234,metanephric nephron tubule development (GO:0072234),7,2,0.484136151,4.131069324,0.079526643,0.444177276,7477;130497,OSR1;WNT7B
GO:2000739,regulation of mesenchymal stem cell differentiation (GO:2000739),7,2,0.484136151,4.131069324,0.079526643,0.444177276,55553;6660,SOX6;SOX5
GO:0015671,oxygen transport (GO:0015671),7,2,0.484136151,4.131069324,0.079526643,0.444177276,3043;4151,HBB;MB
GO:0032387,negative regulation of intracellular transport (GO:0032387),7,2,0.484136151,4.131069324,0.079526643,0.444177276,9370;1410,CRYAB;ADIPOQ
GO:0001886,endothelial cell morphogenesis (GO:0001886),7,2,0.484136151,4.131069324,0.079526643,0.444177276,4233;64102,TNMD;MET
GO:0031935,regulation of chromatin silencing (GO:0031935),7,2,0.484136151,4.131069324,0.079526643,0.444177276,8318;29028,CDC45;ATAD2
GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),24,4,1.659895373,2.409790439,0.080029734,0.444177276,10365;467;4582;90993,ATF3;MUC1;CREB3L1;KLF2
GO:0010837,regulation of keratinocyte proliferation (GO:0010837),24,4,1.659895373,2.409790439,0.080029734,0.444177276,7538;2255;2252;687,KLF9;ZFP36;FGF10;FGF7
GO:0000132,establishment of mitotic spindle orientation (GO:0000132),24,4,1.659895373,2.409790439,0.080029734,0.444177276,4085;5347;10403;89958,NDC80;PLK1;MAD2L1;SAPCD2
GO:0010518,positive regulation of phospholipase activity (GO:0010518),24,4,1.659895373,2.409790439,0.080029734,0.444177276,3815;4916;185;2247,FGF2;KIT;NTRK3;AGTR1
GO:0032768,regulation of monooxygenase activity (GO:0032768),24,4,1.659895373,2.409790439,0.080029734,0.444177276,6622;1956;3952;857,LEP;CAV1;SNCA;EGFR
GO:0030879,mammary gland development (GO:0030879),24,4,1.659895373,2.409790439,0.080029734,0.444177276,3084;857;5021;7477,OXTR;CAV1;NRG1;WNT7B
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),24,4,1.659895373,2.409790439,0.080029734,0.444177276,2348;6664;7049;8425,LTBP4;TGFBR3;FOLR1;SOX11
GO:0008207,C21-steroid hormone metabolic process (GO:0008207),24,4,1.659895373,2.409790439,0.080029734,0.444177276,8644;1645;1583;1646,AKR1C1;AKR1C2;CYP11A1;AKR1C3
GO:0035994,response to muscle stretch (GO:0035994),15,3,1.037434608,2.891748527,0.080434128,0.444177276,2934;1756;1000,DMD;GSN;CDH2
GO:0050974,detection of mechanical stimulus involved in sensory perception (GO:0050974),15,3,1.037434608,2.891748527,0.080434128,0.444177276,3815;3249;1301,COL11A1;KIT;HPN
GO:1900274,regulation of phospholipase C activity (GO:1900274),15,3,1.037434608,2.891748527,0.080434128,0.444177276,3815;4916;2247,FGF2;KIT;NTRK3
GO:0010715,regulation of extracellular matrix disassembly (GO:0010715),15,3,1.037434608,2.891748527,0.080434128,0.444177276,3569;2191;4921,FAP;IL6;DDR2
GO:0051047,positive regulation of secretion (GO:0051047),15,3,1.037434608,2.891748527,0.080434128,0.444177276,358;4881;2822,NPR1;AQP1;GPLD1
GO:0051293,establishment of spindle localization (GO:0051293),15,3,1.037434608,2.891748527,0.080434128,0.444177276,9700;3993;51203,NUSAP1;ESPL1;LLGL2
GO:0007520,myoblast fusion (GO:0007520),15,3,1.037434608,2.891748527,0.080434128,0.444177276,11096;8038;58494,ADAMTS5;JAM2;ADAM12
GO:0045649,regulation of macrophage differentiation (GO:0045649),15,3,1.037434608,2.891748527,0.080434128,0.444177276,3624;9370;146433,INHBA;ADIPOQ;IL34
GO:2001026,regulation of endothelial cell chemotaxis (GO:2001026),15,3,1.037434608,2.891748527,0.080434128,0.444177276,2246;2247;4233,FGF1;FGF2;MET
GO:0002675,positive regulation of acute inflammatory response (GO:0002675),15,3,1.037434608,2.891748527,0.080434128,0.444177276,3569;5743;101,ADAM8;PTGS2;IL6
GO:0031057,negative regulation of histone modification (GO:0031057),15,3,1.037434608,2.891748527,0.080434128,0.444177276,6622;10157;50943,SNCA;AASS;FOXP3
GO:0010819,regulation of T cell chemotaxis (GO:0010819),15,3,1.037434608,2.891748527,0.080434128,0.444177276,10563;6366;3627,CXCL10;CCL21;CXCL13
GO:0070875,positive regulation of glycogen metabolic process (GO:0070875),15,3,1.037434608,2.891748527,0.080434128,0.444177276,3479;10580;8660,SORBS1;IRS2;IGF1
GO:0007492,endoderm development (GO:0007492),15,3,1.037434608,2.891748527,0.080434128,0.444177276,64321;1843;83595,SOX17;DUSP1;SOX7
GO:0050651,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),15,3,1.037434608,2.891748527,0.080434128,0.444177276,1462;633;1634,BGN;VCAN;DCN
GO:1904645,response to amyloid-beta (GO:1904645),44,6,3.043141518,1.971646723,0.080692328,0.444177276,154;4804;3479;948;4314;4318,ADRB2;CD36;NGFR;MMP3;MMP9;IGF1
GO:0098655,cation transmembrane transport (GO:0098655),44,6,3.043141518,1.971646723,0.080692328,0.444177276,8140;80736;140803;477;222962;10060,ATP1A2;TRPM6;SLC7A5;SLC29A4;SLC44A4;ABCC9
GO:2000351,regulation of endothelial cell apoptotic process (GO:2000351),44,6,3.043141518,1.971646723,0.080692328,0.444177276,284;79625;2625;8644;7010;641700,ANGPT1;AKR1C3;ECSCR;TEK;NDNF;GATA3
GO:0048247,lymphocyte chemotaxis (GO:0048247),44,6,3.043141518,1.971646723,0.080692328,0.444177276,10563;6366;6288;3627;6376;101,CX3CL1;SAA1;CXCL10;ADAM8;CCL21;CXCL13
GO:0010976,positive regulation of neuron projection development (GO:0010976),88,10,6.086283036,1.643038936,0.08186625,0.450226925,4916;4915;79625;5979;7436;5649;6376;482;5753;5764,NTRK2;CX3CL1;RELN;PTN;NTRK3;ATP1B2;VLDLR;PTK6;NDNF;RET
GO:0014065,phosphatidylinositol 3-kinase signaling (GO:0014065),34,5,2.351518446,2.126285681,0.082394236,0.450247049,3479;2625;7301;1906;5288,PIK3C2G;IGF1;EDN1;TYRO3;GATA3
GO:0010906,regulation of glucose metabolic process (GO:0010906),34,5,2.351518446,2.126285681,0.082394236,0.450247049,5366;8660;2822;9370;5166,PDK4;ADIPOQ;GPLD1;IRS2;PMAIP1
GO:0031648,protein destabilization (GO:0031648),34,5,2.351518446,2.126285681,0.082394236,0.450247049,2934;6622;825;5347;64321,PLK1;SNCA;GSN;CAPN3;SOX17
GO:0043537,negative regulation of blood vessel endothelial cell migration (GO:0043537),34,5,2.351518446,2.126285681,0.082394236,0.450247049,5468;4223;2247;9314;79812,FGF2;MEOX2;PPARG;KLF4;MMRN2
GO:1903305,regulation of regulated secretory pathway (GO:1903305),34,5,2.351518446,2.126285681,0.082394236,0.450247049,9783;90019;83849;57586;140730,RIMS3;SYT8;SYT15;SYT13;RIMS4
GO:0060562,epithelial tube morphogenesis (GO:0060562),34,5,2.351518446,2.126285681,0.082394236,0.450247049,2255;2625;54922;64321;4233,MET;SOX17;RASIP1;FGF10;GATA3
GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),34,5,2.351518446,2.126285681,0.082394236,0.450247049,150;4318;5753;10551;5329,MMP9;PLAUR;PTK6;ADRA2A;AGR2
GO:0070374,positive regulation of ERK1 and ERK2 cascade (GO:0070374),171,17,11.82675453,1.437418858,0.083304448,0.453948608,2255;6366;4916;4915;1956;284;8685;948;650;2247;168667;255743;6376;7010;10253;5320;80310,SPRY2;NTRK2;CX3CL1;FGF2;CD36;BMPER;BMP2;EGFR;ANGPT1;PDGFD;CCL21;NTRK3;FGF10;MARCO;NPNT;TEK;PLA2G2A
GO:1990266,neutrophil migration (GO:1990266),77,9,5.325497656,1.689982905,0.083377381,0.453948608,10563;6366;6288;3627;4283;2920;1906;1907;6376,CXCL2;CX3CL1;SAA1;CXCL10;CCL21;EDN1;CXCL9;EDN2;CXCL13
GO:0001938,positive regulation of endothelial cell proliferation (GO:0001938),77,9,5.325497656,1.689982905,0.083377381,0.453948608,2152;185;650;1960;2247;3164;7010;6776;26051,FGF2;BMP2;F3;EGR3;STAT5A;NR4A1;PPP1R16B;TEK;AGTR1
GO:0006090,pyruvate metabolic process (GO:0006090),55,7,3.803926897,1.840203608,0.083449212,0.453948608,10993;230;5207;5105;9123;8013;3945,PCK1;SDS;PFKFB1;ALDOC;SLC16A3;LDHB;NR4A3
GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),55,7,3.803926897,1.840203608,0.083449212,0.453948608,6622;4804;358;2537;4318;9314;5329,SNCA;AQP1;NGFR;KLF4;MMP9;IFI6;PLAUR
GO:0034097,response to cytokine (GO:0034097),148,15,10.23602147,1.465413105,0.087579069,0.475553554,301;9472;6622;4311;51176;4435;9370;6403;55022;1281;9636;5784;3977;8854;7079,MME;LIFR;ANXA1;ALDH1A2;TIMP4;ADIPOQ;SNCA;PTPN14;LEF1;PID1;AKAP6;ISG15;CITED1;SELP;COL3A1
GO:0010389,regulation of G2/M transition of mitotic cell cycle (GO:0010389),148,15,10.23602147,1.465413105,0.087579069,0.475553554,5577;22974;9928;983;6790;5347;891;1063;993;8317;10733;4751;51514;3161;2273,NEK2;TPX2;CENPF;CDK1;DTL;HMMR;PLK1;AURKA;KIF14;CCNB1;FHL1;PLK4;CDC7;CDC25A;PRKAR2B
GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",56,7,3.873089204,1.807342829,0.089985795,0.483784905,983;6790;891;5325;1869;4582;51512,CDK1;AURKA;CCNB1;GTSE1;PLAGL1;E2F1;MUC1
GO:0042058,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),67,8,4.633874584,1.726417031,0.089997204,0.483784905,1956;2537;10252;4318;5753;10253;10551;5329,SPRY2;EGFR;SPRY1;MMP9;IFI6;PLAUR;PTK6;AGR2
GO:0051283,negative regulation of sequestering of calcium ion (GO:0051283),25,4,1.729057681,2.313398821,0.090302223,0.483784905,6366;2247;6263;6261,RYR3;FGF2;CCL21;RYR1
GO:0014059,regulation of dopamine secretion (GO:0014059),25,4,1.729057681,2.313398821,0.090302223,0.483784905,6622;90019;83849;57586,SNCA;SYT8;SYT15;SYT13
GO:2000406,positive regulation of T cell migration (GO:2000406),25,4,1.729057681,2.313398821,0.090302223,0.483784905,10563;6366;3627;6387,CXCL10;CCL21;CXCL12;CXCL13
GO:0023057,negative regulation of signaling (GO:0023057),25,4,1.729057681,2.313398821,0.090302223,0.483784905,26153;9370;5753;6725,ADIPOQ;KIF26A;SRMS;PTK6
GO:1901186,positive regulation of ERBB signaling pathway (GO:1901186),25,4,1.729057681,2.313398821,0.090302223,0.483784905,4318;5753;10551;5329,MMP9;PLAUR;PTK6;AGR2
GO:2000677,regulation of transcription regulatory region DNA binding (GO:2000677),25,4,1.729057681,2.313398821,0.090302223,0.483784905,3479;23493;2625;6664,IGF1;HEY2;GATA3;SOX11
GO:0009746,response to hexose (GO:0009746),25,4,1.729057681,2.313398821,0.090302223,0.483784905,4023;8660;2822;9370,LPL;ADIPOQ;GPLD1;IRS2
GO:0043271,negative regulation of ion transport (GO:0043271),25,4,1.729057681,2.313398821,0.090302223,0.483784905,6622;150;845;2824,SNCA;CASQ2;GPM6B;ADRA2A
GO:0001701,in utero embryonic development (GO:0001701),25,4,1.729057681,2.313398821,0.090302223,0.483784905,650;9915;7477;6491,STIL;BMP2;ARNT2;WNT7B
GO:0072507,divalent inorganic cation homeostasis (GO:0072507),25,4,1.729057681,2.313398821,0.090302223,0.483784905,6622;857;57402;57158,CAV1;JPH2;SNCA;S100A14
GO:0007422,peripheral nervous system development (GO:0007422),25,4,1.729057681,2.313398821,0.090302223,0.483784905,6663;1959;7368;23114,SOX10;EGR2;NFASC;UGT8
GO:0010575,positive regulation of vascular endothelial growth factor production (GO:0010575),25,4,1.729057681,2.313398821,0.090302223,0.483784905,3569;5743;147372;23213,SULF1;PTGS2;CCBE1;IL6
GO:0055090,acylglycerol homeostasis (GO:0055090),25,4,1.729057681,2.313398821,0.090302223,0.483784905,4023;51085;51129;338328,GPIHBP1;LPL;MLXIPL;ANGPTL4
GO:0015701,bicarbonate transport (GO:0015701),35,5,2.420680753,2.065534662,0.090932275,0.485429755,358;3043;8671;762;761,CA4;CA3;HBB;AQP1;SLC4A4
GO:0050768,negative regulation of neurogenesis (GO:0050768),35,5,2.420680753,2.065534662,0.090932275,0.485429755,4804;3569;1949;4038;5764,PTN;NGFR;LRP4;IL6;EFNB3
GO:0043551,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),35,5,2.420680753,2.065534662,0.090932275,0.485429755,3815;6366;64805;2247;7010,FGF2;KIT;P2RY12;CCL21;TEK
GO:0046580,negative regulation of Ras protein signal transduction (GO:0046580),35,5,2.420680753,2.065534662,0.090932275,0.485429755,54922;4233;10252;10253;23189,SPRY2;KANK1;MET;RASIP1;SPRY1
GO:0019722,calcium-mediated signaling (GO:0019722),102,11,7.054555337,1.559276166,0.09400334,0.493624517,64805;1956;5737;185;1672;287;1910;1906;1907;6403;1827,P2RY12;EGFR;PTGFR;EDNRB;DEFB1;RCAN1;ANK2;EDN1;SELP;EDN2;AGTR1
GO:0034329,cell junction assembly (GO:0034329),102,11,7.054555337,1.559276166,0.09400334,0.493624517,1000;1009;9378;84612;7122;2335;1828;83660;5317;2318;55679,FN1;LIMS2;CLDN5;NRXN1;DSG1;CDH11;TLN2;PKP1;FLNC;PARD6B;CDH2
GO:0051094,positive regulation of developmental process (GO:0051094),174,17,12.03424146,1.412635774,0.094075163,0.493624517,3952;991;6790;650;9378;7704;7436;5649;658;55553;10411;8322;6660;5168;1634;5764;10551,LEP;AURKA;CDC20;RELN;ZBTB16;RAPGEF3;NRXN1;ENPP2;PTN;BMP2;FZD4;DCN;SOX6;BMPR1B;VLDLR;SOX5;AGR2
GO:0060143,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),16,3,1.106596916,2.711014244,0.094109748,0.493624517,10411;30846;92304,RAPGEF3;SCGB3A1;EHD2
GO:0046320,regulation of fatty acid oxidation (GO:0046320),16,3,1.106596916,2.711014244,0.094109748,0.493624517,10891;5166;8013,PDK4;PPARGC1A;NR4A3
GO:0070633,transepithelial transport (GO:0070633),16,3,1.106596916,2.711014244,0.094109748,0.493624517,9429;2822;5243,ABCB1;GPLD1;ABCG2
GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),16,3,1.106596916,2.711014244,0.094109748,0.493624517,3815;8013;51704,KIT;GPRC5B;NR4A3
GO:0048485,sympathetic nervous system development (GO:0048485),16,3,1.106596916,2.711014244,0.094109748,0.493624517,10371;2625;6664,SEMA3A;GATA3;SOX11
GO:1904706,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),16,3,1.106596916,2.711014244,0.094109748,0.493624517,5468;9370;1264,CNN1;ADIPOQ;PPARG
GO:0008045,motor neuron axon guidance (GO:0008045),16,3,1.106596916,2.711014244,0.094109748,0.493624517,10371;494470;3918,SEMA3A;RNF165;LAMC2
GO:0002227,innate immune response in mucosa (GO:0002227),16,3,1.106596916,2.711014244,0.094109748,0.493624517,4057;1672;92747,DEFB1;LTF;BPIFB1
GO:2000811,negative regulation of anoikis (GO:2000811),16,3,1.106596916,2.711014244,0.094109748,0.493624517,857;5166;4680,PDK4;CAV1;CEACAM6
GO:0045907,positive regulation of vasoconstriction (GO:0045907),16,3,1.106596916,2.711014244,0.094109748,0.493624517,554;857;5021,OXTR;CAV1;AVPR2
GO:0010885,regulation of cholesterol storage (GO:0010885),16,3,1.106596916,2.711014244,0.094109748,0.493624517,5468;4023;1066,LPL;CES1;PPARG
GO:0036315,cellular response to sterol (GO:0036315),16,3,1.106596916,2.711014244,0.094109748,0.493624517,1066;2822;5727,CES1;GPLD1;PTCH1
GO:0060485,mesenchyme development (GO:0060485),16,3,1.106596916,2.711014244,0.094109748,0.493624517,7481;650;4222,BMP2;MEOX1;WNT11
GO:0071711,basement membrane organization (GO:0071711),16,3,1.106596916,2.711014244,0.094109748,0.493624517,3914;3249;23768,LAMB3;FLRT2;HPN
GO:0014003,oligodendrocyte development (GO:0014003),16,3,1.106596916,2.711014244,0.094109748,0.493624517,6663;5354;11076,PLP1;SOX10;TPPP
GO:0043923,positive regulation by host of viral transcription (GO:0043923),16,3,1.106596916,2.711014244,0.094109748,0.493624517,3249;51176;3725,JUN;LEF1;HPN
GO:0006688,glycosphingolipid biosynthetic process (GO:0006688),16,3,1.106596916,2.711014244,0.094109748,0.493624517,8128;6489;256435,ST6GALNAC3;ST8SIA1;ST8SIA2
GO:0098662,inorganic cation transmembrane transport (GO:0098662),274,25,18.95047218,1.319228342,0.094640551,0.495975897,3745;6329;6326;3753;6335;6332;6328;55800;11254;6327;3777;6330;3249;8671;6263;140803;477;10060;7881;9132;3742;286133;3776;60598;9481,SCARA5;SCN4B;KCNE1;SCN3A;ATP1A2;RYR3;SLC25A27;SCN2B;SCN3B;SCN4A;SCN2A;KCNB1;KCNAB1;TRPM6;KCNA6;SLC4A4;SCN9A;SLC6A14;KCNQ4;KCNK3;SCN7A;KCNK15;HPN;ABCC9;KCNK2
GO:1901605,alpha-amino acid metabolic process (GO:1901605),46,6,3.181466132,1.885922952,0.095540024,0.49938355,1373;8564;5831;339983;2875;10003,PYCR1;NAALAD2;NAT8L;CPS1;GPT;KMO
GO:0051966,"regulation of synaptic transmission, glutamatergic (GO:0051966)",46,6,3.181466132,1.885922952,0.095540024,0.49938355,1000;9378;5649;477;23542;27092,ATP1A2;RELN;NRXN1;MAPK8IP2;CDH2;CACNG4
GO:0048145,regulation of fibroblast proliferation (GO:0048145),46,6,3.181466132,1.885922952,0.095540024,0.49938355,3479;358;2335;6422;1869;4921,FN1;SFRP1;AQP1;E2F1;IGF1;DDR2
GO:0060070,canonical Wnt signaling pathway (GO:0060070),68,8,4.703036891,1.701028545,0.096161628,0.501596542,857;7481;2625;83439;51176;6422;8322;7477,CAV1;SFRP1;LEF1;FZD4;TCF7L1;WNT11;GATA3;WNT7B
GO:0045862,positive regulation of proteolysis (GO:0045862),57,7,3.942251512,1.77563506,0.096801993,0.501596542,150;825;5347;2822;147372;101;152503,PLK1;ADAM8;GPLD1;SH3D19;CAPN3;CCBE1;ADRA2A
GO:0015718,monocarboxylic acid transport (GO:0015718),57,7,3.942251512,1.77563506,0.096801993,0.501596542,9368;9429;948;9194;1645;9123;9120,AKR1C1;CD36;SLC16A3;SLC16A7;SLC9A3R1;ABCG2;SLC16A6
GO:0019216,regulation of lipid metabolic process (GO:0019216),91,10,6.293769957,1.588872817,0.097273315,0.501596542,32;5468;57678;857;5919;8660;5105;7069;6713;83643,CAV1;ACACB;PCK1;GPAM;SQLE;PPARG;IRS2;CCDC3;THRSP;RARRES2
GO:0007605,sensory perception of sound (GO:0007605),91,10,6.293769957,1.588872817,0.097273315,0.501596542,3815;3753;3249;64072;51473;332;53405;1277;1301;286262,COL11A1;KCNE1;BIRC5;KIT;TPRN;CLIC5;CDH23;HPN;COL1A1;DCDC2
GO:0002478,antigen processing and presentation of exogenous peptide antigen (GO:0002478),103,11,7.123717644,1.544137563,0.099040562,0.501596542,24137;29127;9493;81930;11004;10437;1062;3832;56992;10053;26153,KIF4A;KIF2C;KIF11;CENPE;KIF23;KIF18A;KIF15;RACGAP1;IFI30;KIF26A;AP1M2
GO:0071709,membrane assembly (GO:0071709),36,5,2.48984306,2.008158699,0.099906984,0.501596542,9378;57502;6711;4038;116238,TLCD1;NRXN1;LRP4;SPTBN1;NLGN4X
GO:0070527,platelet aggregation (GO:0070527),36,5,2.48984306,2.008158699,0.099906984,0.501596542,64805;7301;2335;3043;10398,FN1;HBB;P2RY12;MYL9;TYRO3
GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),36,5,2.48984306,2.008158699,0.099906984,0.501596542,1009;64072;6403;1828;8641,DSG1;CDH11;CDH23;SELP;PCDHGB4
GO:0002028,regulation of sodium ion transport (GO:0002028),36,5,2.48984306,2.008158699,0.099906984,0.501596542,55800;6330;5187;5652;79570,PER1;SCN4B;SCN3B;NKAIN1;PRSS8
GO:0007190,activation of adenylate cyclase activity (GO:0007190),36,5,2.48984306,2.008158699,0.099906984,0.501596542,554;55366;111;196883;154,ADRB2;AVPR2;ADCY4;ADCY5;LGR4
GO:1903076,regulation of protein localization to plasma membrane (GO:1903076),80,9,5.532984578,1.626608546,0.100210899,0.501596542,1956;10580;6711;55022;10551;112609;131578;6769;342667,LRRC15;SORBS1;STAC2;EGFR;SPTBN1;PID1;MRAP2;STAC;AGR2
GO:0051155,positive regulation of striated muscle cell differentiation (GO:0051155),26,4,1.798219988,2.224421943,0.101169959,0.501596542,9472;3479;3084;1906,AKAP6;NRG1;IGF1;EDN1
GO:0090025,regulation of monocyte chemotaxis (GO:0090025),26,4,1.798219988,2.224421943,0.101169959,0.501596542,3627;6387;57402;1843,CXCL10;CXCL12;DUSP1;S100A14
GO:0046326,positive regulation of glucose import (GO:0046326),26,4,1.798219988,2.224421943,0.101169959,0.501596542,3479;10580;8660;9370,ADIPOQ;SORBS1;IRS2;IGF1
GO:1905476,negative regulation of protein localization to membrane (GO:1905476),26,4,1.798219988,2.224421943,0.101169959,0.501596542,3753;55022;112609;131578,KCNE1;LRRC15;PID1;MRAP2
GO:0032231,regulation of actin filament bundle assembly (GO:0032231),26,4,1.798219988,2.224421943,0.101169959,0.501596542,5734;6376;11346;171024,CX3CL1;SYNPO2;PTGER4;SYNPO
GO:0010721,negative regulation of cell development (GO:0010721),26,4,1.798219988,2.224421943,0.101169959,0.501596542,3479;3569;5744;4057,IGF1;IL6;PTHLH;LTF
GO:0010574,regulation of vascular endothelial growth factor production (GO:0010574),26,4,1.798219988,2.224421943,0.101169959,0.501596542,3569;5743;147372;23213,SULF1;PTGS2;CCBE1;IL6
GO:0030513,positive regulation of BMP signaling pathway (GO:0030513),26,4,1.798219988,2.224421943,0.101169959,0.501596542,6664;494470;658;23213,SULF1;BMPR1B;RNF165;SOX11
GO:0009308,amine metabolic process (GO:0009308),8,2,0.553298458,3.614685658,0.101303976,0.501596542,8639;11185,AOC3;INMT
GO:0046325,negative regulation of glucose import (GO:0046325),8,2,0.553298458,3.614685658,0.101303976,0.501596542,3952;55022,LEP;PID1
GO:1900119,positive regulation of execution phase of apoptosis (GO:1900119),8,2,0.553298458,3.614685658,0.101303976,0.501596542,2191;5740,FAP;PTGIS
GO:0060159,regulation of dopamine receptor signaling pathway (GO:0060159),8,2,0.553298458,3.614685658,0.101303976,0.501596542,858;5064,CAV2;PALM
GO:0086026,atrial cardiac muscle cell to AV node cell signaling (GO:0086026),8,2,0.553298458,3.614685658,0.101303976,0.501596542,55800;287,SCN3B;ANK2
GO:0010519,negative regulation of phospholipase activity (GO:0010519),8,2,0.553298458,3.614685658,0.101303976,0.501596542,301;5997,ANXA1;RGS2
GO:0032429,regulation of phospholipase A2 activity (GO:0032429),8,2,0.553298458,3.614685658,0.101303976,0.501596542,301;185,ANXA1;AGTR1
GO:0045628,regulation of T-helper 2 cell differentiation (GO:0045628),8,2,0.553298458,3.614685658,0.101303976,0.501596542,301;7292,ANXA1;TNFSF4
GO:0007260,tyrosine phosphorylation of STAT protein (GO:0007260),8,2,0.553298458,3.614685658,0.101303976,0.501596542,3952;5753,LEP;PTK6
GO:0033145,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),8,2,0.553298458,3.614685658,0.101303976,0.501596542,3169;55885,LMO3;FOXA1
GO:0002279,mast cell activation involved in immune response (GO:0002279),8,2,0.553298458,3.614685658,0.101303976,0.501596542,3815;8013,KIT;NR4A3
GO:0043303,mast cell degranulation (GO:0043303),8,2,0.553298458,3.614685658,0.101303976,0.501596542,3815;8013,KIT;NR4A3
GO:0048846,axon extension involved in axon guidance (GO:0048846),8,2,0.553298458,3.614685658,0.101303976,0.501596542,10371;6586,SLIT3;SEMA3A
GO:0071679,commissural neuron axon guidance (GO:0071679),8,2,0.553298458,3.614685658,0.101303976,0.501596542,4781;4684,NFIB;NCAM1
GO:1902284,neuron projection extension involved in neuron projection guidance (GO:1902284),8,2,0.553298458,3.614685658,0.101303976,0.501596542,10371;6586,SLIT3;SEMA3A
GO:0090091,positive regulation of extracellular matrix disassembly (GO:0090091),8,2,0.553298458,3.614685658,0.101303976,0.501596542,3569;4921,IL6;DDR2
GO:1900272,negative regulation of long-term synaptic potentiation (GO:1900272),8,2,0.553298458,3.614685658,0.101303976,0.501596542,11170;5764,FAM107A;PTN
GO:0006000,fructose metabolic process (GO:0006000),8,2,0.553298458,3.614685658,0.101303976,0.501596542,230;6652,ALDOC;SORD
GO:0072698,protein localization to microtubule cytoskeleton (GO:0072698),8,2,0.553298458,3.614685658,0.101303976,0.501596542,4281;81610,FAM83D;MID1
GO:0015884,folic acid transport (GO:0015884),8,2,0.553298458,3.614685658,0.101303976,0.501596542,2350;2348,FOLR1;FOLR2
GO:1901017,negative regulation of potassium ion transmembrane transporter activity (GO:1901017),8,2,0.553298458,3.614685658,0.101303976,0.501596542,845;7881,KCNAB1;CASQ2
GO:1904714,regulation of chaperone-mediated autophagy (GO:1904714),8,2,0.553298458,3.614685658,0.101303976,0.501596542,6622;1917,SNCA;EEF1A2
GO:0050926,regulation of positive chemotaxis (GO:0050926),8,2,0.553298458,3.614685658,0.101303976,0.501596542,2152;4916,F3;NTRK3
GO:0098810,neurotransmitter reuptake (GO:0098810),8,2,0.553298458,3.614685658,0.101303976,0.501596542,6581;222962,SLC22A3;SLC29A4
GO:0070099,regulation of chemokine-mediated signaling pathway (GO:0070099),8,2,0.553298458,3.614685658,0.101303976,0.501596542,6586;1906,SLIT3;EDN1
GO:0140354,lipid import into cell (GO:0140354),8,2,0.553298458,3.614685658,0.101303976,0.501596542,2180;948,CD36;ACSL1
GO:1904754,positive regulation of vascular associated smooth muscle cell migration (GO:1904754),8,2,0.553298458,3.614685658,0.101303976,0.501596542,8013;9510,ADAMTS1;NR4A3
GO:1903977,positive regulation of glial cell migration (GO:1903977),8,2,0.553298458,3.614685658,0.101303976,0.501596542,64805;6376,CX3CL1;P2RY12
GO:2000480,negative regulation of cAMP-dependent protein kinase activity (GO:2000480),8,2,0.553298458,3.614685658,0.101303976,0.501596542,5577;5570,PRKAR2B;PKIB
GO:0021879,forebrain neuron differentiation (GO:0021879),8,2,0.553298458,3.614685658,0.101303976,0.501596542,3624;26468,INHBA;LHX6
GO:0043372,"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",8,2,0.553298458,3.614685658,0.101303976,0.501596542,7292;50943,TNFSF4;FOXP3
GO:0019626,short-chain fatty acid catabolic process (GO:0019626),8,2,0.553298458,3.614685658,0.101303976,0.501596542,5105;35,PCK1;ACADS
GO:0002076,osteoblast development (GO:0002076),8,2,0.553298458,3.614685658,0.101303976,0.501596542,5744;63923,PTHLH;TNN
GO:0072044,collecting duct development (GO:0072044),8,2,0.553298458,3.614685658,0.101303976,0.501596542,5727;7477,PTCH1;WNT7B
GO:0015844,monoamine transport (GO:0015844),8,2,0.553298458,3.614685658,0.101303976,0.501596542,6581;222962,SLC22A3;SLC29A4
GO:0044070,regulation of anion transport (GO:0044070),8,2,0.553298458,3.614685658,0.101303976,0.501596542,1066;5243,CES1;ABCB1
GO:0051177,meiotic sister chromatid cohesion (GO:0051177),8,2,0.553298458,3.614685658,0.101303976,0.501596542,701;699,BUB1;BUB1B
GO:0002903,negative regulation of B cell apoptotic process (GO:0002903),8,2,0.553298458,3.614685658,0.101303976,0.501596542,9212;8660,AURKB;IRS2
GO:0051984,positive regulation of chromosome segregation (GO:0051984),8,2,0.553298458,3.614685658,0.101303976,0.501596542,891;990,CCNB1;CDC6
GO:0048711,positive regulation of astrocyte differentiation (GO:0048711),8,2,0.553298458,3.614685658,0.101303976,0.501596542,650;274,BMP2;BIN1
GO:1900426,positive regulation of defense response to bacterium (GO:1900426),8,2,0.553298458,3.614685658,0.101303976,0.501596542,25818;5650,KLK5;KLK7
GO:2001251,negative regulation of chromosome organization (GO:2001251),8,2,0.553298458,3.614685658,0.101303976,0.501596542,7153;9700,TOP2A;ESPL1
GO:0033689,negative regulation of osteoblast proliferation (GO:0033689),8,2,0.553298458,3.614685658,0.101303976,0.501596542,6422;63923,SFRP1;TNN
GO:0061820,telomeric D-loop disassembly (GO:0061820),8,2,0.553298458,3.614685658,0.101303976,0.501596542,9401;641,RECQL4;BLM
GO:0042060,wound healing (GO:0042060),69,8,4.772199198,1.676375957,0.10255972,0.507396277,2255;3479;2246;3084;667;2247;1281;2125,FGF1;DST;FGF2;FGF10;NRG1;IGF1;EVPL;COL3A1
GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),47,6,3.250628439,1.845796932,0.103474335,0.509405594,3479;4057;947;9370;6376;1149,CX3CL1;CIDEA;ADIPOQ;CD34;IGF1;LTF
GO:0031323,regulation of cellular metabolic process (GO:0031323),47,6,3.250628439,1.845796932,0.103474335,0.509405594,32;5166;2305;55022;135293;284654,FOXM1;PDK4;ACACB;PID1;PM20D2;RSPO1
GO:0051246,regulation of protein metabolic process (GO:0051246),47,6,3.250628439,1.845796932,0.103474335,0.509405594,10365;9314;135293;81610;5329;8425,FAM83D;LTBP4;KLF4;PLAUR;PM20D2;KLF2
GO:0061041,regulation of wound healing (GO:0061041),47,6,3.250628439,1.845796932,0.103474335,0.509405594,301;150;857;4638;2247;23189,CAV1;ANXA1;MYLK;FGF2;KANK1;ADRA2A
GO:0022409,positive regulation of cell-cell adhesion (GO:0022409),47,6,3.250628439,1.845796932,0.103474335,0.509405594,10563;8728;6376;4680;3169;5329,CX3CL1;ADAM19;PLAUR;CEACAM6;CXCL13;FOXA1
GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),47,6,3.250628439,1.845796932,0.103474335,0.509405594,3624;650;353500;654;2662;7272,INHBA;BMP8A;GDF10;TTK;BMP2;BMP6
GO:0099601,regulation of neurotransmitter receptor activity (GO:0099601),58,7,4.011413819,1.745020663,0.103894801,0.510639123,2892;2893;5649;23542;27092;729993;66004,RELN;GRIA4;LYNX1;MAPK8IP2;GRIA3;CACNG4;SHISA9
GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),58,7,4.011413819,1.745020663,0.103894801,0.510639123,3624;650;168667;353500;654;2662;7272,INHBA;BMP8A;GDF10;TTK;BMPER;BMP2;BMP6
GO:0010557,positive regulation of macromolecule biosynthetic process (GO:0010557),128,13,8.852775324,1.468466049,0.104988956,0.515595271,6366;1956;3479;10580;3569;81620;8660;1763;2247;9314;90865;23034;55323,FGF2;SORBS1;IL33;EGFR;KLF4;CCL21;CDT1;LARP6;IRS2;DNA2;SAMD4A;IGF1;IL6
GO:1902430,negative regulation of amyloid-beta formation (GO:1902430),17,3,1.175759223,2.551542818,0.108660085,0.52504483,4915;3479;274,NTRK2;BIN1;IGF1
GO:0072337,modified amino acid transport (GO:0072337),17,3,1.175759223,2.551542818,0.108660085,0.52504483,9368;2350;2348,FOLR1;SLC9A3R1;FOLR2
GO:0014911,positive regulation of smooth muscle cell migration (GO:0014911),17,3,1.175759223,2.551542818,0.108660085,0.52504483,3479;8013;9510,ADAMTS1;IGF1;NR4A3
GO:0002685,regulation of leukocyte migration (GO:0002685),17,3,1.175759223,2.551542818,0.108660085,0.52504483,301;3204;8784,ANXA1;HOXA7;TNFRSF18
GO:0003382,epithelial cell morphogenesis (GO:0003382),17,3,1.175759223,2.551542818,0.108660085,0.52504483,4233;57111;64102,TNMD;MET;RAB25
GO:0032878,regulation of establishment or maintenance of cell polarity (GO:0032878),17,3,1.175759223,2.551542818,0.108660085,0.52504483,3993;7010;23189,KANK1;LLGL2;TEK
GO:1903579,negative regulation of ATP metabolic process (GO:1903579),17,3,1.175759223,2.551542818,0.108660085,0.52504483,51085;5207;55022,MLXIPL;PFKFB1;PID1
GO:0034199,activation of protein kinase A activity (GO:0034199),17,3,1.175759223,2.551542818,0.108660085,0.52504483,111;196883;5577,ADCY4;ADCY5;PRKAR2B
GO:0032682,negative regulation of chemokine production (GO:0032682),17,3,1.175759223,2.551542818,0.108660085,0.52504483,3569;347;9314,KLF4;APOD;IL6
GO:0050927,positive regulation of positive chemotaxis (GO:0050927),17,3,1.175759223,2.551542818,0.108660085,0.52504483,2152;4916;6387,F3;CXCL12;NTRK3
GO:0045740,positive regulation of DNA replication (GO:0045740),17,3,1.175759223,2.551542818,0.108660085,0.52504483,1956;81620;1763,EGFR;CDT1;DNA2
GO:0014074,response to purine-containing compound (GO:0014074),17,3,1.175759223,2.551542818,0.108660085,0.52504483,4435;6261;10060,CITED1;RYR1;ABCC9
GO:0060037,pharyngeal system development (GO:0060037),17,3,1.175759223,2.551542818,0.108660085,0.52504483,2348;2625;5727,PTCH1;FOLR1;GATA3
GO:0048864,stem cell development (GO:0048864),17,3,1.175759223,2.551542818,0.108660085,0.52504483,3084;1000;6664,NRG1;CDH2;SOX11
GO:0009894,regulation of catabolic process (GO:0009894),17,3,1.175759223,2.551542818,0.108660085,0.52504483,5919;2191;81610,FAM83D;FAP;RARRES2
GO:0043691,reverse cholesterol transport (GO:0043691),17,3,1.175759223,2.551542818,0.108660085,0.52504483,1066;23461;3931,LCAT;ABCA5;CES1
GO:0030277,maintenance of gastrointestinal epithelium (GO:0030277),17,3,1.175759223,2.551542818,0.108660085,0.52504483,5950;4588;7031,RBP4;MUC6;TFF1
GO:0071459,"protein localization to chromosome, centromeric region (GO:0071459)",17,3,1.175759223,2.551542818,0.108660085,0.52504483,983;9212;7272,CDK1;TTK;AURKB
GO:1904355,positive regulation of telomere capping (GO:1904355),17,3,1.175759223,2.551542818,0.108660085,0.52504483,9212;4751;5570,NEK2;AURKB;PKIB
GO:0030322,stabilization of membrane potential (GO:0030322),17,3,1.175759223,2.551542818,0.108660085,0.52504483,3777;3776;60598,KCNK3;KCNK15;KCNK2
GO:1900744,regulation of p38MAPK cascade (GO:1900744),37,5,2.559005367,1.95388414,0.109306957,0.526899853,7498;3952;650;1843;5187,PER1;LEP;BMP2;DUSP1;XDH
GO:0032355,response to estradiol (GO:0032355),37,5,2.559005367,1.95388414,0.109306957,0.526899853,301;1956;6422;8835;3169,ANXA1;SFRP1;EGFR;SOCS2;FOXA1
GO:2000273,positive regulation of signaling receptor activity (GO:2000273),37,5,2.559005367,1.95388414,0.109306957,0.526899853,154;150;5649;1906;23237,RELN;ADRB2;ARC;EDN1;ADRA2A
GO:0014070,response to organic cyclic compound (GO:0014070),59,7,4.080576126,1.715444041,0.111260464,0.534174641,301;6696;5366;6422;8835;3169;249,ANXA1;SFRP1;SOCS2;ALPL;SPP1;PMAIP1;FOXA1
GO:1990000,amyloid fibril formation (GO:1990000),59,7,4.080576126,1.715444041,0.111260464,0.534174641,2934;6622;6288;948;4057;4240;9627,SAA1;SNCA;CD36;GSN;MFGE8;SNCAIP;LTF
GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),59,7,4.080576126,1.715444041,0.111260464,0.534174641,3815;2690;3479;3569;5753;85480;8784,TSLP;KIT;GHR;IGF1;IL6;TNFRSF18;PTK6
GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),59,7,4.080576126,1.715444041,0.111260464,0.534174641,10563;3627;4283;4057;1672;2920;9547,CXCL2;CXCL10;DEFB1;CXCL9;CXCL14;CXCL13;LTF
GO:0044773,mitotic DNA damage checkpoint signaling (GO:0044773),59,7,4.080576126,1.715444041,0.111260464,0.534174641,63967;983;5347;641;51514;8555;168448,CDK1;DTL;CLSPN;PLK1;CDC14B;CDC14C;BLM
GO:0032663,regulation of interleukin-2 production (GO:0032663),48,6,3.319790747,1.807342829,0.111740789,0.534772198,7538;301;947;1378;6711;50943,ANXA1;SPTBN1;FOXP3;ZFP36;CD34;CR1
GO:0043536,positive regulation of blood vessel endothelial cell migration (GO:0043536),48,6,3.319790747,1.807342829,0.111740789,0.534772198,301;284;5743;2247;57381;6776,ANXA1;FGF2;RHOJ;ANGPT1;STAT5A;PTGS2
GO:0034446,substrate adhesion-dependent cell spreading (GO:0034446),48,6,3.319790747,1.807342829,0.111740789,0.534772198,9928;7301;2335;3914;7010;10319,FN1;KIF14;LAMB3;TEK;LAMC3;TYRO3
GO:0032653,regulation of interleukin-10 production (GO:0032653),48,6,3.319790747,1.807342829,0.111740789,0.534772198,3569;7292;947;9636;85480;50943,TSLP;TNFSF4;FOXP3;CD34;ISG15;IL6
GO:0051209,release of sequestered calcium ion into cytosol (GO:0051209),27,4,1.867382295,2.142035946,0.112607389,0.535508712,6366;2247;6263;6261,RYR3;FGF2;CCL21;RYR1
GO:2001258,negative regulation of cation channel activity (GO:2001258),27,4,1.867382295,2.142035946,0.112607389,0.535508712,845;7881;4318;2946,GSTM2;KCNAB1;CASQ2;MMP9
GO:0051785,positive regulation of nuclear division (GO:0051785),27,4,1.867382295,2.142035946,0.112607389,0.535508712,3479;6790;1906;51203,NUSAP1;AURKA;IGF1;EDN1
GO:0045931,positive regulation of mitotic cell cycle (GO:0045931),27,4,1.867382295,2.142035946,0.112607389,0.535508712,891;4212;3169;6886,CCNB1;MEIS2;TAL1;FOXA1
GO:0140238,presynaptic endocytosis (GO:0140238),27,4,1.867382295,2.142035946,0.112607389,0.535508712,6622;6623;57502;90019,SNCA;SNCG;SYT8;NLGN4X
GO:0002526,acute inflammatory response (GO:0002526),27,4,1.867382295,2.142035946,0.112607389,0.535508712,2152;3569;7292;6288,SAA1;TNFSF4;F3;IL6
GO:2000352,negative regulation of endothelial cell apoptotic process (GO:2000352),27,4,1.867382295,2.142035946,0.112607389,0.535508712,284;79625;2625;7010,ANGPT1;TEK;NDNF;GATA3
GO:0050650,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),27,4,1.867382295,2.142035946,0.112607389,0.535508712,1462;633;1634;9469,BGN;CHST3;VCAN;DCN
GO:0060548,negative regulation of cell death (GO:0060548),94,10,6.501256879,1.53816411,0.11427018,0.542986601,6622;7481;947;6664;2247;347902;10891;213;10551;155465,FGF2;SNCA;ALB;CD34;PPARGC1A;WNT11;AMIGO2;SOX11;AGR2;AGR3
GO:0045927,positive regulation of growth (GO:0045927),71,8,4.910523813,1.629154099,0.116047582,0.55056197,9472;1956;3952;80736;3249;6422;3373;10551,LEP;SFRP1;EGFR;HYAL1;AKAP6;SLC44A4;HPN;AGR2
GO:0071773,cellular response to BMP stimulus (GO:0071773),71,8,4.910523813,1.629154099,0.116047582,0.55056197,650;7049;353500;56963;654;658;55273;6422,BMP8A;SFRP1;TGFBR3;TMEM100;BMP2;RGMA;BMP6;BMPR1B
GO:1902531,regulation of intracellular signal transduction (GO:1902531),437,37,30.22392826,1.2241956,0.116666168,0.5530602,9472;1894;4916;4915;1956;5577;22974;2246;825;2770;9590;5138;983;6790;9212;29127;8626;1763;9104;57381;58480;7010;83990;116028;641;9156;26051;81610;7450;50649;8395;56981;9824;343578;79817;10144;57569,TPX2;NTRK2;CDK1;EXO1;AURKA;ARHGAP20;FGF1;FAM83D;PDE2A;FAM13A;AURKB;RGN;RMI2;ECT2;RACGAP1;PRDM11;ARHGAP11A;RHOJ;EGFR;BRIP1;CAPN3;ARHGEF4;AKAP6;NTRK3;BLM;DNA2;AKAP12;TP63;GNAI1;MOB3B;PPP1R16B;RHOU;VWF;TEK;PRKAR2B;PIP5K1B;ARHGAP40
GO:0010646,regulation of cell communication (GO:0010646),38,5,2.628167674,1.902466136,0.119119146,0.555968171,301;11343;287;845;8835,ANXA1;SOCS2;CASQ2;ANK2;MGLL
GO:0061448,connective tissue development (GO:0061448),38,5,2.628167674,1.902466136,0.119119146,0.555968171,7704;23213;55553;3373;6660,ZBTB16;SULF1;HYAL1;SOX6;SOX5
GO:0070317,negative regulation of G0 to G1 transition (GO:0070317),38,5,2.628167674,1.902466136,0.119119146,0.555968171,6241;8317;1869;5888;2146,RRM2;RAD51;EZH2;E2F1;CDC7
GO:0031623,receptor internalization (GO:0031623),49,6,3.388953054,1.770458282,0.120331936,0.555968171,6622;857;133;10267;948;11031,CAV1;SNCA;CD36;RAB31;RAMP1;ADM
GO:0042542,response to hydrogen peroxide (GO:0042542),49,6,3.388953054,1.770458282,0.120331936,0.555968171,301;1894;3569;358;3043;847,ANXA1;ECT2;HBB;AQP1;CAT;IL6
GO:0009749,response to glucose (GO:0009749),49,6,3.388953054,1.770458282,0.120331936,0.555968171,3745;4023;8660;2822;9370;5105,LPL;ADIPOQ;PCK1;KCNB1;GPLD1;IRS2
GO:0002237,response to molecule of bacterial origin (GO:0002237),72,8,4.97968612,1.606526959,0.1231314,0.555968171,6622;3569;1373;6590;2920;4435;57402;6403,CXCL2;SNCA;CPS1;CITED1;IL6;S100A14;SELP;SLPI
GO:0034330,cell junction organization (GO:0034330),72,8,4.97968612,1.606526959,0.1231314,0.555968171,6622;6623;57502;7477;2318;55679;4038;27134,LIMS2;SNCA;LRP4;SNCG;FLNC;NLGN4X;TJP3;WNT7B
GO:0000904,cell morphogenesis involved in differentiation (GO:0000904),72,8,4.97968612,1.606526959,0.1231314,0.555968171,9928;7301;2335;5649;3914;7010;10319;57111,FN1;KIF14;RELN;LAMB3;TEK;LAMC3;TYRO3;RAB25
GO:0010468,regulation of gene expression (GO:0010468),1073,84,74.21115565,1.131905295,0.123827224,0.555968171,2934;2255;2252;554;2152;7498;4916;4915;3479;2246;284;3624;3569;51085;5744;5138;7481;8140;948;4057;8728;6790;947;650;55502;3202;23493;4857;153579;2625;7122;287;2335;6664;3249;83439;51176;2247;64321;654;55553;9915;4435;10891;2202;6422;1050;130497;1869;5317;55022;79924;1396;2296;2908;1958;54845;9314;10253;54997;50943;2146;90865;27303;5304;10551;675;83595;5187;1382;59;90993;84913;8736;72;57716;3547;56981;10644;51222;83643;5178;4605;51442,INHBA;SPRY2;PER1;NTRK2;BTNL9;HOXA5;ATOH8;FN1;AURKA;FGF1;TESC;PDE2A;OSR1;SFRP1;MYOM1;MYBL2;EGR1;AVPR2;FGF2;ACTG2;CLDN5;EZH2;MLXIPL;CD36;GSN;IL33;PRDM11;RBMS3;BMP2;E2F1;PRX;NR3C1;F3;ADAM19;LEF1;KLF4;ANGPT1;PID1;ZNF219;SOX17;FOXP3;HES6;EFEMP1;NTRK3;CCDC3;FGF10;CD34;PPARGC1A;ANK2;SOX7;NOVA1;PKP1;BMP6;IGF2BP2;ACTA2;CITED1;ADM2;BRCA2;IGF1;IL6;TCF7L1;CREB3L1;SOX6;IGSF1;HEY2;WNT11;FGF7;FOXC1;SLC7A5;VGLL1;HPN;ESRP1;ARNT2;CEBPA;CRABP2;PEG3;PTHLH;CRIP1;XDH;GATA3;SOX11;LTF;AGR2;PIP
GO:0045577,regulation of B cell differentiation (GO:0045577),18,3,1.24492153,2.409790439,0.124011999,0.555968171,3624;259307;6422,INHBA;SFRP1;IL4I1
GO:0042044,fluid transport (GO:0042044),18,3,1.24492153,2.409790439,0.124011999,0.555968171,358;364;362,AQP7;AQP1;AQP5
GO:0048678,response to axon injury (GO:0048678),18,3,1.24492153,2.409790439,0.124011999,0.555968171,64805;2348;347,P2RY12;APOD;FOLR1
GO:0071467,cellular response to pH (GO:0071467),18,3,1.24492153,2.409790439,0.124011999,0.555968171,2822;3373;8111,GPLD1;HYAL1;GPR68
GO:0042551,neuron maturation (GO:0042551),18,3,1.24492153,2.409790439,0.124011999,0.555968171,27289;6376;163175,CX3CL1;LGI4;RND1
GO:1903055,positive regulation of extracellular matrix organization (GO:1903055),18,3,1.24492153,2.409790439,0.124011999,0.555968171,3569;650;4921,BMP2;IL6;DDR2
GO:2000042,negative regulation of double-strand break repair via homologous recombination (GO:2000042),18,3,1.24492153,2.409790439,0.124011999,0.555968171,10721;116028;55010,RMI2;POLQ;PARPBP
GO:0001935,endothelial cell proliferation (GO:0001935),18,3,1.24492153,2.409790439,0.124011999,0.555968171,947;168667;7010,BMPER;CD34;TEK
GO:0003254,regulation of membrane depolarization (GO:0003254),18,3,1.24492153,2.409790439,0.124011999,0.555968171,55800;6327;2273,FHL1;SCN2B;SCN3B
GO:0045109,intermediate filament organization (GO:0045109),18,3,1.24492153,2.409790439,0.124011999,0.555968171,1674;5317;3861,DES;KRT14;PKP1
GO:0045745,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),18,3,1.24492153,2.409790439,0.124011999,0.555968171,5653;25818;112609,MRAP2;KLK5;KLK6
GO:0051968,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",18,3,1.24492153,2.409790439,0.124011999,0.555968171,9378;5649;27092,RELN;NRXN1;CACNG4
GO:0071634,regulation of transforming growth factor beta production (GO:0071634),18,3,1.24492153,2.409790439,0.124011999,0.555968171,947;5743;2335,FN1;PTGS2;CD34
GO:0035024,negative regulation of Rho protein signal transduction (GO:0035024),18,3,1.24492153,2.409790439,0.124011999,0.555968171,54922;4233;23189,KANK1;MET;RASIP1
GO:0002696,positive regulation of leukocyte activation (GO:0002696),18,3,1.24492153,2.409790439,0.124011999,0.555968171,1050;85480;90865,TSLP;IL33;CEBPA
GO:0032753,positive regulation of interleukin-4 production (GO:0032753),18,3,1.24492153,2.409790439,0.124011999,0.555968171,7292;8140;2625,TNFSF4;SLC7A5;GATA3
GO:0090224,regulation of spindle organization (GO:0090224),18,3,1.24492153,2.409790439,0.124011999,0.555968171,22974;2770;10460,TPX2;TACC3;GNAI1
GO:0007019,microtubule depolymerization (GO:0007019),18,3,1.24492153,2.409790439,0.124011999,0.555968171,9928;81930;11004,KIF2C;KIF14;KIF18A
GO:0019432,triglyceride biosynthetic process (GO:0019432),18,3,1.24492153,2.409790439,0.124011999,0.555968171,84649;57678;5105,PCK1;GPAM;DGAT2
GO:0034375,high-density lipoprotein particle remodeling (GO:0034375),18,3,1.24492153,2.409790439,0.124011999,0.555968171,213;23461;3931,LCAT;ABCA5;ALB
GO:0006692,prostanoid metabolic process (GO:0006692),18,3,1.24492153,2.409790439,0.124011999,0.555968171,8644;1645;1646,AKR1C1;AKR1C2;AKR1C3
GO:0022616,DNA strand elongation (GO:0022616),18,3,1.24492153,2.409790439,0.124011999,0.555968171,4173;51659;9837,GINS1;MCM4;GINS2
GO:0006271,DNA strand elongation involved in DNA replication (GO:0006271),18,3,1.24492153,2.409790439,0.124011999,0.555968171,4173;51659;9837,GINS1;MCM4;GINS2
GO:0032026,response to magnesium ion (GO:0032026),9,2,0.622460765,3.213053918,0.124473467,0.555968171,6622;6263,RYR3;SNCA
GO:1903555,regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),9,2,0.622460765,3.213053918,0.124473467,0.555968171,7538;4057,ZFP36;LTF
GO:1900227,positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),9,2,0.622460765,3.213053918,0.124473467,0.555968171,948;115362,CD36;GBP5
GO:0045161,neuronal ion channel clustering (GO:0045161),9,2,0.622460765,3.213053918,0.124473467,0.555968171,30819;26047,KCNIP2;CNTNAP2
GO:0045920,negative regulation of exocytosis (GO:0045920),9,2,0.622460765,3.213053918,0.124473467,0.555968171,301;6622,ANXA1;SNCA
GO:0031338,regulation of vesicle fusion (GO:0031338),9,2,0.622460765,3.213053918,0.124473467,0.555968171,301;8447,ANXA1;DOC2B
GO:0002448,mast cell mediated immunity (GO:0002448),9,2,0.622460765,3.213053918,0.124473467,0.555968171,3815;8013,KIT;NR4A3
GO:0030299,intestinal cholesterol absorption (GO:0030299),9,2,0.622460765,3.213053918,0.124473467,0.555968171,948;1645,AKR1C1;CD36
GO:0048741,skeletal muscle fiber development (GO:0048741),9,2,0.622460765,3.213053918,0.124473467,0.555968171,6261;858,CAV2;RYR1
GO:0060732,positive regulation of inositol phosphate biosynthetic process (GO:0060732),9,2,0.622460765,3.213053918,0.124473467,0.555968171,6622;5745,SNCA;PTH1R
GO:1904322,cellular response to forskolin (GO:1904322),9,2,0.622460765,3.213053918,0.124473467,0.555968171,111;2770,GNAI1;ADCY5
GO:1904321,response to forskolin (GO:1904321),9,2,0.622460765,3.213053918,0.124473467,0.555968171,111;2770,GNAI1;ADCY5
GO:0010739,positive regulation of protein kinase A signaling (GO:0010739),9,2,0.622460765,3.213053918,0.124473467,0.555968171,154;9370,ADRB2;ADIPOQ
GO:2001171,positive regulation of ATP biosynthetic process (GO:2001171),9,2,0.622460765,3.213053918,0.124473467,0.555968171,10891;55022,PID1;PPARGC1A
GO:0033599,regulation of mammary gland epithelial cell proliferation (GO:0033599),9,2,0.622460765,3.213053918,0.124473467,0.555968171,2625;675,BRCA2;GATA3
GO:1900407,regulation of cellular response to oxidative stress (GO:1900407),9,2,0.622460765,3.213053918,0.124473467,0.555968171,84883;10516,FBLN5;AIFM2
GO:0001910,regulation of leukocyte mediated cytotoxicity (GO:0001910),9,2,0.622460765,3.213053918,0.124473467,0.555968171,3952;1776,LEP;DNASE1L3
GO:1903589,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),9,2,0.622460765,3.213053918,0.124473467,0.555968171,185;26051,PPP1R16B;AGTR1
GO:1902959,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),9,2,0.622460765,3.213053918,0.124473467,0.555968171,1944;274,BIN1;EFNA3
GO:2000049,positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),9,2,0.622460765,3.213053918,0.124473467,0.555968171,8728;3169,ADAM19;FOXA1
GO:0043382,positive regulation of memory T cell differentiation (GO:0043382),9,2,0.622460765,3.213053918,0.124473467,0.555968171,7292;5105,PCK1;TNFSF4
GO:0070664,negative regulation of leukocyte proliferation (GO:0070664),9,2,0.622460765,3.213053918,0.124473467,0.555968171,90865;5169,IL33;ENPP3
GO:0034371,chylomicron remodeling (GO:0034371),9,2,0.622460765,3.213053918,0.124473467,0.555968171,4023;338328,GPIHBP1;LPL
GO:0034372,very-low-density lipoprotein particle remodeling (GO:0034372),9,2,0.622460765,3.213053918,0.124473467,0.555968171,4023;3931,LPL;LCAT
GO:1901607,alpha-amino acid biosynthetic process (GO:1901607),9,2,0.622460765,3.213053918,0.124473467,0.555968171,1373;10993,SDS;CPS1
GO:1903596,regulation of gap junction assembly (GO:1903596),9,2,0.622460765,3.213053918,0.124473467,0.555968171,857;26047,CAV1;CNTNAP2
GO:0002691,regulation of cellular extravasation (GO:0002691),9,2,0.622460765,3.213053918,0.124473467,0.555968171,101;10562,ADAM8;OLFM4
GO:0003309,type B pancreatic cell differentiation (GO:0003309),9,2,0.622460765,3.213053918,0.124473467,0.555968171,1000;654,BMP6;CDH2
GO:0085020,protein K6-linked ubiquitination (GO:0085020),9,2,0.622460765,3.213053918,0.124473467,0.555968171,27338;29089,UBE2T;UBE2S
GO:0033273,response to vitamin (GO:0033273),9,2,0.622460765,3.213053918,0.124473467,0.555968171,6696;249,ALPL;SPP1
GO:0031103,axon regeneration (GO:0031103),9,2,0.622460765,3.213053918,0.124473467,0.555968171,2348;347,APOD;FOLR1
GO:0048557,embryonic digestive tract morphogenesis (GO:0048557),9,2,0.622460765,3.213053918,0.124473467,0.555968171,6664;348093,RBPMS2;SOX11
GO:0046602,regulation of mitotic centrosome separation (GO:0046602),9,2,0.622460765,3.213053918,0.124473467,0.555968171,3832;4751,NEK2;KIF11
GO:2000095,"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",9,2,0.622460765,3.213053918,0.124473467,0.555968171,57664;84870,RSPO3;PLEKHA4
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),28,4,1.936544602,2.065534662,0.124586446,0.555968171,3624;2537;5979;219699,INHBA;UNC5B;IFI6;RET
GO:0050864,regulation of B cell activation (GO:0050864),28,4,1.936544602,2.065534662,0.124586446,0.555968171,3569;7292;259307;55024,TNFSF4;IL4I1;IL6;BANK1
GO:0043113,receptor clustering (GO:0043113),28,4,1.936544602,2.065534662,0.124586446,0.555968171,9378;4038;5764;5284,NRXN1;PTN;LRP4;PIGR
GO:1901654,response to ketone (GO:1901654),28,4,1.936544602,2.065534662,0.124586446,0.555968171,6366;857;6586;7049,CAV1;TGFBR3;CCL21;SLIT3
GO:1901020,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),28,4,1.936544602,2.065534662,0.124586446,0.555968171,150;477;845;2946,ATP1A2;GSTM2;CASQ2;ADRA2A
GO:0050771,negative regulation of axonogenesis (GO:0050771),28,4,1.936544602,2.065534662,0.124586446,0.555968171,4804;56920;1949;4038,SEMA3G;NGFR;LRP4;EFNB3
GO:0071354,cellular response to interleukin-6 (GO:0071354),28,4,1.936544602,2.065534662,0.124586446,0.555968171,3569;5740;1050;55022,PID1;IL6;PTGIS;CEBPA
GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),28,4,1.936544602,2.065534662,0.124586446,0.555968171,111;150;26154;2822,GPLD1;ADCY5;ADRA2A;ABCA12
GO:1902305,regulation of sodium ion transmembrane transport (GO:1902305),28,4,1.936544602,2.065534662,0.124586446,0.555968171,55800;6327;6330;5348,FXYD1;SCN4B;SCN2B;SCN3B
GO:0016042,lipid catabolic process (GO:0016042),28,4,1.936544602,2.065534662,0.124586446,0.555968171,4023;3991;1066;3290,LPL;LIPE;CES1;HSD11B1
GO:0002637,regulation of immunoglobulin production (GO:0002637),28,4,1.936544602,2.065534662,0.124586446,0.555968171,3569;7292;1378;5950,RBP4;TNFSF4;IL6;CR1
GO:0042743,hydrogen peroxide metabolic process (GO:0042743),28,4,1.936544602,2.065534662,0.124586446,0.555968171,3043;4129;2878;847,HBB;GPX3;CAT;MAOB
GO:0045892,"negative regulation of transcription, DNA-templated (GO:0045892)",938,74,64.87424417,1.140668395,0.126593982,0.564507733,7538;6622;5468;3084;825;7292;51085;857;5138;7481;6663;9212;5347;650;3204;23493;2625;8626;7704;2308;10157;6664;1910;51176;1906;10365;654;5727;1063;4212;4435;9370;63976;6422;1050;130497;1869;2305;7068;332;8013;467;3725;2296;2908;4582;9314;1410;57761;50943;2146;90865;29128;83595;5187;90993;84913;79192;1028;862;56981;51222;93986;56849;91133;3400;55635;53335;25803;2354;5178;23492;84733;9079,PER1;CENPF;ATOH8;UHRF1;CBX7;PLK1;DEPDC1;FOXM1;BIRC5;FOSB;ZBTB16;TCEAL7;CRYAB;PDE2A;CAV1;OSR1;SFRP1;HOXA7;AURKB;ID4;ADIPOQ;EZH2;SNCA;MLXIPL;LDB2;IL33;MEIS2;IRX1;PRDM11;CDKN1C;BMP2;TNFSF4;PPARG;SOX10;E2F1;NR3C1;AASS;EDNRB;JUN;FOXO1;LEF1;CAPN3;KLF4;ZNF219;RUNX1T1;FOXP3;L3MBTL4;ZFP36;ATF3;TRIB3;TP63;PTCH1;SOX7;MUC1;THRB;FOXP2;BMP6;NRG1;CITED1;PRDM16;CREB3L1;HEY2;EDN1;WNT11;FOXC1;CBX2;KLF2;NR4A3;CEBPA;PEG3;BCL11A;GATA3;SOX11;SPDEF
GO:0055088,lipid homeostasis (GO:0055088),61,7,4.218900741,1.659199974,0.126791783,0.564970652,5468;84649;57104;51085;8660;1050;116238,TLCD1;MLXIPL;PPARG;IRS2;DGAT2;PNPLA2;CEBPA
GO:0008154,actin polymerization or depolymerization (GO:0008154),50,6,3.458115361,1.735049116,0.129239349,0.573301383,2934;11170;9645;1073;81624;10810,FAM107A;GSN;MICAL2;DIAPH3;WASF3;CFL2
GO:1901652,response to peptide (GO:1901652),39,5,2.697329982,1.853684953,0.129329009,0.573301383,301;2770;4314;4318;6776,ANXA1;STAT5A;GNAI1;MMP3;MMP9
GO:0043542,endothelial cell migration (GO:0043542),39,5,2.697329982,1.853684953,0.129329009,0.573301383,2191;1960;3164;85329;6286,S100P;LGALS12;EGR3;FAP;NR4A1
GO:0031297,replication fork processing (GO:0031297),39,5,2.697329982,1.853684953,0.129329009,0.573301383,1763;641;5888;675;4796,RAD51;BLM;DNA2;TONSL;BRCA2
GO:0045580,regulation of T cell differentiation (GO:0045580),39,5,2.697329982,1.853684953,0.129329009,0.573301383,2625;1378;2175;8784;50943,FOXP3;FANCA;TNFRSF18;CR1;GATA3
GO:0019731,antibacterial humoral response (GO:0019731),39,5,2.697329982,1.853684953,0.129329009,0.573301383,4057;1511;7018;6590;1672,TF;DEFB1;CTSG;SLPI;LTF
GO:0050999,regulation of nitric-oxide synthase activity (GO:0050999),39,5,2.697329982,1.853684953,0.129329009,0.573301383,1956;3952;857;4883;6271,LEP;CAV1;EGFR;NPR3;S100A1
GO:0030155,regulation of cell adhesion (GO:0030155),133,13,9.198586861,1.413260558,0.130291221,0.577141143,27289;284;9928;6288;5979;6387;91584;3373;101;1843;5140;54997;8784,KIF14;TESC;SAA1;ADAM8;ANGPT1;HYAL1;PLXNA4;CXCL12;DUSP1;PDE3B;TNFRSF18;RET;RND1
GO:0046470,phosphatidylcholine metabolic process (GO:0046470),73,8,5.048848427,1.584519741,0.130437014,0.577361482,5321;80736;2822;5168;3931;5320;10809;129642,LCAT;ENPP2;GPLD1;PLA2G4A;MBOAT2;STARD10;SLC44A4;PLA2G2A
GO:0046777,protein autophosphorylation (GO:0046777),158,15,10.92764454,1.37266544,0.131623641,0.582185216,3815;4915;1956;6790;9212;660;7301;9833;2047;4751;7010;5753;23235;4921;6725,NEK2;NTRK2;AURKA;MELK;AURKB;EPHB1;KIT;BMX;EGFR;SIK2;DDR2;TEK;SRMS;PTK6;TYRO3
GO:0006890,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",85,9,5.878796114,1.530925691,0.132250539,0.584527933,24137;29127;9493;81930;11004;1062;3832;56992;26153,KIF4A;KIF2C;KIF11;CENPE;KIF23;KIF18A;KIF15;RACGAP1;KIF26A
GO:0010043,response to zinc ion (GO:0010043),29,4,2.005706909,1.994309329,0.137076956,0.602316944,23498;4499;4501;1396,MT1M;MT1X;HAAO;CRIP1
GO:0032689,negative regulation of interferon-gamma production (GO:0032689),29,4,2.005706909,1.994309329,0.137076956,0.602316944,3624;7292;1378;50943,INHBA;TNFSF4;FOXP3;CR1
GO:0043030,regulation of macrophage activation (GO:0043030),29,4,2.005706909,1.994309329,0.137076956,0.602316944,3569;1050;145581;90865,IL33;LRFN5;IL6;CEBPA
GO:0006942,regulation of striated muscle contraction (GO:0006942),29,4,2.005706909,1.994309329,0.137076956,0.602316944,7140;1756;287;477,DMD;ATP1A2;TNNT3;ANK2
GO:0030041,actin filament polymerization (GO:0030041),29,4,2.005706909,1.994309329,0.137076956,0.602316944,2934;11170;81624;10810,FAM107A;GSN;DIAPH3;WASF3
GO:0061045,negative regulation of wound healing (GO:0061045),29,4,2.005706909,1.994309329,0.137076956,0.602316944,947;1906;2247;7035,FGF2;TFPI;CD34;EDN1
GO:0051057,positive regulation of small GTPase mediated signal transduction (GO:0051057),29,4,2.005706909,1.994309329,0.137076956,0.602316944,2255;3479;5649;8660,RELN;IRS2;FGF10;IGF1
GO:0042304,regulation of fatty acid biosynthetic process (GO:0042304),29,4,2.005706909,1.994309329,0.137076956,0.602316944,51085;9370;5166;57761,PDK4;ADIPOQ;MLXIPL;TRIB3
GO:0030330,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",74,8,5.118010734,1.563107312,0.137960231,0.604077339,983;6790;891;5325;1869;2305;4582;51512,CDK1;AURKA;FOXM1;CCNB1;GTSE1;PLAGL1;E2F1;MUC1
GO:2001242,regulation of intrinsic apoptotic signaling pathway (GO:2001242),51,6,3.527277668,1.701028545,0.138453681,0.604077339,9368;857;5366;4318;5329;219790,CAV1;RTKN2;MMP9;PLAUR;SLC9A3R1;PMAIP1
GO:0048762,mesenchymal cell differentiation (GO:0048762),51,6,3.527277668,1.701028545,0.138453681,0.604077339,650;23493;51176;7049;2296;81610,FAM83D;TGFBR3;BMP2;LEF1;HEY2;FOXC1
GO:1901214,regulation of neuron death (GO:1901214),86,9,5.947958421,1.513124229,0.139236349,0.604077339,6622;9928;947;6623;2047;10891;2353;1958;23321,KIF14;EGR1;EPHB1;SNCA;FOS;CD34;SNCG;PPARGC1A;TRIM2
GO:0033135,regulation of peptidyl-serine phosphorylation (GO:0033135),98,10,6.777906108,1.475381901,0.139346413,0.604077339,1756;6622;4916;1956;3569;51085;857;10411;3270;10253,SPRY2;DMD;CAV1;RAPGEF3;SNCA;MLXIPL;EGFR;NTRK3;IL6;HRC
GO:0006094,gluconeogenesis (GO:0006094),40,5,2.766492289,1.807342829,0.13992066,0.604077339,10891;230;5207;5950;5105,RBP4;PCK1;PFKFB1;ALDOC;PPARGC1A
GO:0010812,negative regulation of cell-substrate adhesion (GO:0010812),40,5,2.766492289,1.807342829,0.13992066,0.604077339,3204;8322;6376;23189;10391,CX3CL1;HOXA7;CORO2B;KANK1;FZD4
GO:0030216,keratinocyte differentiation (GO:0030216),40,5,2.766492289,1.807342829,0.13992066,0.604077339,301;8644;2125;3868;10628,ANXA1;TXNIP;AKR1C3;EVPL;KRT16
GO:0048863,stem cell differentiation (GO:0048863),40,5,2.766492289,1.807342829,0.13992066,0.604077339,3815;6422;130497;4222;4072,OSR1;SFRP1;KIT;MEOX1;EPCAM
GO:0016079,synaptic vesicle exocytosis (GO:0016079),40,5,2.766492289,1.807342829,0.13992066,0.604077339,6622;9783;8447;90019;8676,SNCA;RIMS3;SYT8;DOC2B;STX11
GO:0006639,acylglycerol metabolic process (GO:0006639),40,5,2.766492289,1.807342829,0.13992066,0.604077339,84649;11343;57104;4023;857,CAV1;LPL;DGAT2;MGLL;PNPLA2
GO:1902992,negative regulation of amyloid precursor protein catabolic process (GO:1902992),19,3,1.314083837,2.282959363,0.140090469,0.604077339,4915;3479;274,NTRK2;BIN1;IGF1
GO:0090026,positive regulation of monocyte chemotaxis (GO:0090026),19,3,1.314083837,2.282959363,0.140090469,0.604077339,3627;6387;57402,CXCL10;CXCL12;S100A14
GO:0033198,response to ATP (GO:0033198),19,3,1.314083837,2.282959363,0.140090469,0.604077339,64805;6263;10060,RYR3;P2RY12;ABCC9
GO:0032965,regulation of collagen biosynthetic process (GO:0032965),19,3,1.314083837,2.282959363,0.140090469,0.604077339,3569;90993;55323,LARP6;IL6;CREB3L1
GO:0002683,negative regulation of immune system process (GO:0002683),19,3,1.314083837,2.282959363,0.140090469,0.604077339,3204;1281;50943,HOXA7;FOXP3;COL3A1
GO:0071377,cellular response to glucagon stimulus (GO:0071377),19,3,1.314083837,2.282959363,0.140090469,0.604077339,111;196883;5577,ADCY4;ADCY5;PRKAR2B
GO:0051353,positive regulation of oxidoreductase activity (GO:0051353),19,3,1.314083837,2.282959363,0.140090469,0.604077339,185;1906;1907,EDN1;EDN2;AGTR1
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),19,3,1.314083837,2.282959363,0.140090469,0.604077339,3479;650;3489,IGFBP6;BMP2;IGF1
GO:0002688,regulation of leukocyte chemotaxis (GO:0002688),19,3,1.314083837,2.282959363,0.140090469,0.604077339,3569;1907;5764,PTN;IL6;EDN2
GO:2000679,positive regulation of transcription regulatory region DNA binding (GO:2000679),19,3,1.314083837,2.282959363,0.140090469,0.604077339,3479;2625;2296,IGF1;FOXC1;GATA3
GO:0014033,neural crest cell differentiation (GO:0014033),19,3,1.314083837,2.282959363,0.140090469,0.604077339,3084;1000;6664,NRG1;CDH2;SOX11
GO:0051146,striated muscle cell differentiation (GO:0051146),19,3,1.314083837,2.282959363,0.140090469,0.604077339,3084;6382;650,BMP2;NRG1;SDC1
GO:0090208,positive regulation of triglyceride metabolic process (GO:0090208),19,3,1.314083837,2.282959363,0.140090469,0.604077339,57104;2822;440503,GPLD1;PNPLA2;PLIN5
GO:0001941,postsynaptic membrane organization (GO:0001941),19,3,1.314083837,2.282959363,0.140090469,0.604077339,9378;57502;4038,NRXN1;LRP4;NLGN4X
GO:0046655,folic acid metabolic process (GO:0046655),19,3,1.314083837,2.282959363,0.140090469,0.604077339,2350;10840;135293,ALDH1L1;PM20D2;FOLR2
GO:0006874,cellular calcium ion homeostasis (GO:0006874),135,13,9.336911475,1.392323365,0.141290351,0.608814552,857;5745;287;6387;1906;1907;344905;9104;6261;64072;858;3270;794,CAV1;RGN;CAV2;CXCL12;PTH1R;ANK2;CDH23;CALB2;EDN1;EDN2;HRC;RYR1;ATP13A5
GO:0006821,chloride transport (GO:0006821),75,8,5.187173042,1.542265881,0.145696406,0.620881291,2564;2568;6523;84561;203859;5348;53405;57348,FXYD1;TTYH1;GABRE;CLIC5;GABRP;SLC12A8;ANO5;SLC5A1
GO:0015711,organic anion transport (GO:0015711),99,10,6.847068415,1.460479054,0.146032726,0.620881291,9368;368;9429;358;80736;6581;3043;8671;762;761,CA4;CA3;HBB;AQP1;SLC22A3;SLC4A4;SLC9A3R1;ABCC6;ABCG2;SLC44A4
GO:0031327,negative regulation of cellular biosynthetic process (GO:0031327),52,6,3.596439976,1.668316458,0.147964739,0.620881291,857;947;5740;8644;9370;57761,CAV1;ADIPOQ;TRIB3;CD34;AKR1C3;PTGIS
GO:0009913,epidermal cell differentiation (GO:0009913),52,6,3.596439976,1.668316458,0.147964739,0.620881291,301;8644;2125;3868;5017;10628,ANXA1;TXNIP;AKR1C3;EVPL;OVOL1;KRT16
GO:0051248,negative regulation of protein metabolic process (GO:0051248),52,6,3.596439976,1.668316458,0.147964739,0.620881291,1956;4085;1910;1906;1410;5806,CRYAB;PTX3;EGFR;MAD2L1;EDNRB;EDN1
GO:1903078,positive regulation of protein localization to plasma membrane (GO:1903078),52,6,3.596439976,1.668316458,0.147964739,0.620881291,1956;10580;6711;10551;6769;342667,SORBS1;STAC2;EGFR;SPTBN1;STAC;AGR2
GO:0034310,primary alcohol catabolic process (GO:0034310),10,2,0.691623072,2.891748527,0.148738822,0.620881291,27233;8644,AKR1C3;SULT1C4
GO:0031953,negative regulation of protein autophosphorylation (GO:0031953),10,2,0.691623072,2.891748527,0.148738822,0.620881291,857;9370,CAV1;ADIPOQ
GO:1904035,regulation of epithelial cell apoptotic process (GO:1904035),10,2,0.691623072,2.891748527,0.148738822,0.620881291,7538;7010,ZFP36;TEK
GO:1901741,positive regulation of myoblast fusion (GO:1901741),10,2,0.691623072,2.891748527,0.148738822,0.620881291,30846;92304,SCGB3A1;EHD2
GO:0009650,UV protection (GO:0009650),10,2,0.691623072,2.891748527,0.148738822,0.620881291,847;4239,MFAP4;CAT
GO:0009071,serine family amino acid catabolic process (GO:0009071),10,2,0.691623072,2.891748527,0.148738822,0.620881291,10993;275,SDS;AMT
GO:1901998,toxin transport (GO:1901998),10,2,0.691623072,2.891748527,0.148738822,0.620881291,6581;222962,SLC22A3;SLC29A4
GO:0016322,neuron remodeling (GO:0016322),10,2,0.691623072,2.891748527,0.148738822,0.620881291,27289;6376,CX3CL1;RND1
GO:2000048,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),10,2,0.691623072,2.891748527,0.148738822,0.620881291,654;4072,BMP6;EPCAM
GO:2000650,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),10,2,0.691623072,2.891748527,0.148738822,0.620881291,477;130497,ATP1A2;OSR1
GO:1900452,regulation of long-term synaptic depression (GO:1900452),10,2,0.691623072,2.891748527,0.148738822,0.620881291,3745;23237,KCNB1;ARC
GO:0006171,cAMP biosynthetic process (GO:0006171),10,2,0.691623072,2.891748527,0.148738822,0.620881291,111;196883,ADCY4;ADCY5
GO:0006978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",10,2,0.691623072,2.891748527,0.148738822,0.620881291,2305;4582,FOXM1;MUC1
GO:2000757,negative regulation of peptidyl-lysine acetylation (GO:2000757),10,2,0.691623072,2.891748527,0.148738822,0.620881291,6622;28999,KLF15;SNCA
GO:0002357,defense response to tumor cell (GO:0002357),10,2,0.691623072,2.891748527,0.148738822,0.620881291,9314;27303,RBMS3;KLF4
GO:0033629,negative regulation of cell adhesion mediated by integrin (GO:0033629),10,2,0.691623072,2.891748527,0.148738822,0.620881291,4582;5140,MUC1;PDE3B
GO:0042953,lipoprotein transport (GO:0042953),10,2,0.691623072,2.891748527,0.148738822,0.620881291,5468;948,CD36;PPARG
GO:0010887,negative regulation of cholesterol storage (GO:0010887),10,2,0.691623072,2.891748527,0.148738822,0.620881291,5468;1066,CES1;PPARG
GO:0044539,long-chain fatty acid import into cell (GO:0044539),10,2,0.691623072,2.891748527,0.148738822,0.620881291,2180;948,CD36;ACSL1
GO:0033210,leptin-mediated signaling pathway (GO:0033210),10,2,0.691623072,2.891748527,0.148738822,0.620881291,3952;3953,LEP;LEPR
GO:0043217,myelin maintenance (GO:0043217),10,2,0.691623072,2.891748527,0.148738822,0.620881291,225;57716,PRX;ABCD2
GO:0043380,regulation of memory T cell differentiation (GO:0043380),10,2,0.691623072,2.891748527,0.148738822,0.620881291,7292;5105,PCK1;TNFSF4
GO:0001867,"complement activation, lectin pathway (GO:0001867)",10,2,0.691623072,2.891748527,0.148738822,0.620881291,4239;10747,MASP2;MFAP4
GO:0034638,phosphatidylcholine catabolic process (GO:0034638),10,2,0.691623072,2.891748527,0.148738822,0.620881291,5321;5168,ENPP2;PLA2G4A
GO:0034115,negative regulation of heterotypic cell-cell adhesion (GO:0034115),10,2,0.691623072,2.891748527,0.148738822,0.620881291,9370;9314,ADIPOQ;KLF4
GO:0070587,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),10,2,0.691623072,2.891748527,0.148738822,0.620881291,9370;9314,ADIPOQ;KLF4
GO:2001214,positive regulation of vasculogenesis (GO:2001214),10,2,0.691623072,2.891748527,0.148738822,0.620881291,947;55273,TMEM100;CD34
GO:0034616,response to laminar fluid shear stress (GO:0034616),10,2,0.691623072,2.891748527,0.148738822,0.620881291,10365;9314,KLF4;KLF2
GO:0071353,cellular response to interleukin-4 (GO:0071353),10,2,0.691623072,2.891748527,0.148738822,0.620881291,2625;51176,LEF1;GATA3
GO:0030325,adrenal gland development (GO:0030325),10,2,0.691623072,2.891748527,0.148738822,0.620881291,7481;64220,WNT11;STRA6
GO:0060231,mesenchymal to epithelial transition (GO:0060231),10,2,0.691623072,2.891748527,0.148738822,0.620881291,2625;4435,CITED1;GATA3
GO:0048520,positive regulation of behavior (GO:0048520),10,2,0.691623072,2.891748527,0.148738822,0.620881291,64220;8013,NR4A3;STRA6
GO:0097105,presynaptic membrane assembly (GO:0097105),10,2,0.691623072,2.891748527,0.148738822,0.620881291,57502;4038,LRP4;NLGN4X
GO:0031102,neuron projection regeneration (GO:0031102),10,2,0.691623072,2.891748527,0.148738822,0.620881291,2348;5764,PTN;FOLR1
GO:0006182,cGMP biosynthetic process (GO:0006182),10,2,0.691623072,2.891748527,0.148738822,0.620881291,4881;4882,NPR1;NPR2
GO:0007168,receptor guanylyl cyclase signaling pathway (GO:0007168),10,2,0.691623072,2.891748527,0.148738822,0.620881291,4881;4882,NPR1;NPR2
GO:0060218,hematopoietic stem cell differentiation (GO:0060218),10,2,0.691623072,2.891748527,0.148738822,0.620881291,6422;4222,SFRP1;MEOX1
GO:0070296,sarcoplasmic reticulum calcium ion transport (GO:0070296),10,2,0.691623072,2.891748527,0.148738822,0.620881291,287;6261,ANK2;RYR1
GO:0090657,telomeric loop disassembly (GO:0090657),10,2,0.691623072,2.891748527,0.148738822,0.620881291,9401;641,RECQL4;BLM
GO:0006631,fatty acid metabolic process (GO:0006631),124,12,8.576126096,1.399233158,0.149308982,0.622396872,5468;54988;57678;4023;2180;948;1066;5743;9370;10891;225;28965,LPL;ADIPOQ;GPAM;CES1;CD36;ACSM5;PPARG;SLC27A6;ABCD2;PTGS2;PPARGC1A;ACSL1
GO:0002576,platelet degranulation (GO:0002576),124,12,8.576126096,1.399233158,0.149308982,0.622396872,3479;948;7018;5919;2335;6403;213;7123;1675;5627;7450;22915,FN1;TF;CLEC3B;PROS1;CFD;CD36;MMRN1;ALB;IGF1;VWF;SELP;RARRES2
GO:1901606,alpha-amino acid catabolic process (GO:1901606),30,4,2.074869217,1.927832351,0.150047019,0.622881652,6898;8564;23498;259307,TAT;IL4I1;HAAO;KMO
GO:0097305,response to alcohol (GO:0097305),30,4,2.074869217,1.927832351,0.150047019,0.622881652,6366;7048;6586;7049,TGFBR3;TGFBR2;CCL21;SLIT3
GO:0002009,morphogenesis of an epithelium (GO:0002009),30,4,2.074869217,1.927832351,0.150047019,0.622881652,9368;6663;3909;3868,SOX10;LAMA3;SLC9A3R1;KRT16
GO:0046785,microtubule polymerization (GO:0046785),30,4,2.074869217,1.927832351,0.150047019,0.622881652,22974;11076;51673;79649,TPX2;TPPP;MAP7D3;TPPP3
GO:1904062,regulation of cation transmembrane transport (GO:1904062),30,4,2.074869217,1.927832351,0.150047019,0.622881652,3753;30819;7881;3270,KCNE1;KCNIP2;KCNAB1;HRC
GO:0043001,Golgi to plasma membrane protein transport (GO:0043001),30,4,2.074869217,1.927832351,0.150047019,0.622881652,6711;11031;25837;3875,SPTBN1;RAB26;RAB31;KRT18
GO:0030217,T cell differentiation (GO:0030217),41,5,2.835654596,1.763261297,0.150877014,0.624601742,301;3815;3952;2625;3953,LEP;LEPR;ANXA1;KIT;GATA3
GO:0070848,response to growth factor (GO:0070848),41,5,2.835654596,1.763261297,0.150877014,0.624601742,7048;130399;658;6422;9314,SFRP1;TGFBR2;ACVR1C;KLF4;BMPR1B
GO:0022408,negative regulation of cell-cell adhesion (GO:0022408),41,5,2.835654596,1.763261297,0.150877014,0.624601742,650;654;9370;9314;4072,ADIPOQ;BMP2;KLF4;BMP6;EPCAM
GO:0070316,regulation of G0 to G1 transition (GO:0070316),41,5,2.835654596,1.763261297,0.150877014,0.624601742,6241;8317;1869;5888;2146,RRM2;RAD51;EZH2;E2F1;CDC7
GO:0044272,sulfur compound biosynthetic process (GO:0044272),112,11,7.746178409,1.42005508,0.151325959,0.626029141,284;10331;1462;2946;633;1634;9469;1036;2949;4969;5549,CDO1;GSTM5;BGN;CHST3;ANGPT1;OGN;GSTM2;VCAN;DCN;PRELP;B3GNT3
GO:0042129,regulation of T cell proliferation (GO:0042129),76,8,5.256335349,1.521972909,0.153640461,0.635166994,301;3952;3569;7292;259307;1378;30835;50943,LEP;ANXA1;TNFSF4;FOXP3;IL4I1;CD209;IL6;CR1
GO:0030858,positive regulation of epithelial cell differentiation (GO:0030858),20,3,1.383246144,2.168811395,0.156819735,0.642565388,2247;55273;84913,ATOH8;FGF2;TMEM100
GO:0035330,regulation of hippo signaling (GO:0035330),20,3,1.383246144,2.168811395,0.156819735,0.642565388,11113;6664;79817,CIT;MOB3B;SOX11
GO:0032365,intracellular lipid transport (GO:0032365),20,3,1.383246144,2.168811395,0.156819735,0.642565388,32;7069;225,ACACB;ABCD2;THRSP
GO:0006940,regulation of smooth muscle contraction (GO:0006940),20,3,1.383246144,2.168811395,0.156819735,0.642565388,154;857;1264,CNN1;CAV1;ADRB2
GO:0015695,organic cation transport (GO:0015695),20,3,1.383246144,2.168811395,0.156819735,0.642565388,80736;6581;222962,SLC22A3;SLC29A4;SLC44A4
GO:0060396,growth hormone receptor signaling pathway (GO:0060396),20,3,1.383246144,2.168811395,0.156819735,0.642565388,2690;8835;6776,GHR;STAT5A;SOCS2
GO:0016338,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),20,3,1.383246144,2.168811395,0.156819735,0.642565388,5010;7122;9073,CLDN11;CLDN5;CLDN8
GO:0061008,hepaticobiliary system development (GO:0061008),20,3,1.383246144,2.168811395,0.156819735,0.642565388,7049;4233;1050,TGFBR3;MET;CEBPA
GO:2000209,regulation of anoikis (GO:2000209),20,3,1.383246144,2.168811395,0.156819735,0.642565388,857;5166;4680,PDK4;CAV1;CEACAM6
GO:0034103,regulation of tissue remodeling (GO:0034103),20,3,1.383246144,2.168811395,0.156819735,0.642565388,3952;3953;4921,LEP;LEPR;DDR2
GO:0042744,hydrogen peroxide catabolic process (GO:0042744),20,3,1.383246144,2.168811395,0.156819735,0.642565388,3043;2878;847,HBB;GPX3;CAT
GO:0071622,regulation of granulocyte chemotaxis (GO:0071622),20,3,1.383246144,2.168811395,0.156819735,0.642565388,5919;57402;146433,IL34;S100A14;RARRES2
GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),20,3,1.383246144,2.168811395,0.156819735,0.642565388,5347;1050;1028,PLK1;CDKN1C;CEBPA
GO:0070830,bicellular tight junction assembly (GO:0070830),53,6,3.665602283,1.636838789,0.15776155,0.645544368,1894;5010;84612;7122;9073;92359,CLDN11;CLDN5;ECT2;CLDN8;PARD6B;CRB3
GO:2000117,negative regulation of cysteine-type endopeptidase activity (GO:2000117),53,6,3.665602283,1.636838789,0.15776155,0.645544368,6622;4804;358;4057;2537;9314,SNCA;AQP1;NGFR;KLF4;IFI6;LTF
GO:0062197,cellular response to chemical stress (GO:0062197),101,10,6.985393029,1.431558676,0.15988681,0.6533512,6622;857;5831;4248;2308;10891;2878;2877;6649;847,CAV1;PYCR1;SNCA;GPX3;FOXO1;SOD3;MGAT3;CAT;PPARGC1A;GPX2
GO:1905477,positive regulation of protein localization to membrane (GO:1905477),101,10,6.985393029,1.431558676,0.15988681,0.6533512,3745;1956;10580;8626;5366;6711;1869;10551;6769;342667,SORBS1;STAC2;E2F1;EGFR;KCNB1;SPTBN1;TP63;STAC;PMAIP1;AGR2
GO:0001952,regulation of cell-matrix adhesion (GO:0001952),65,7,4.495549969,1.55709536,0.160887579,0.656102604,6366;948;3204;6422;56477;6376;2824,CX3CL1;SFRP1;HOXA7;CD36;CCL21;CCL28;GPM6B
GO:0031571,mitotic G1 DNA damage checkpoint signaling (GO:0031571),65,7,4.495549969,1.55709536,0.160887579,0.656102604,983;6790;891;5325;1869;4582;51512,CDK1;AURKA;CCNB1;GTSE1;PLAGL1;E2F1;MUC1
GO:0030509,BMP signaling pathway (GO:0030509),65,7,4.495549969,1.55709536,0.160887579,0.656102604,650;7049;353500;56963;654;658;55273,BMP8A;TGFBR3;TMEM100;BMP2;RGMA;BMP6;BMPR1B
GO:1902905,positive regulation of supramolecular fiber organization (GO:1902905),89,9,6.155445343,1.462120042,0.161290664,0.656855135,1073;25802;6366;1906;4233;6376;274;11346;171024,LMOD1;CX3CL1;SYNPO2;CFL2;MET;CCL21;BIN1;EDN1;SYNPO
GO:0007179,transforming growth factor beta receptor signaling pathway (GO:0007179),89,9,6.155445343,1.462120042,0.161290664,0.656855135,7048;7122;7049;4435;1281;3725;2353;1278;2662,GDF10;CLDN5;TGFBR3;TGFBR2;JUN;FOS;CITED1;COL3A1;COL1A2
GO:0045926,negative regulation of growth (GO:0045926),126,12,8.71445071,1.377023108,0.161749196,0.658276519,3624;7481;6586;4881;64321;6422;3373;4499;4501;2273;92304;56981,INHBA;MT1M;SFRP1;FHL1;NPR1;MT1X;PRDM11;HYAL1;SOX17;SCGB3A1;SLIT3;WNT11
GO:0032781,positive regulation of ATPase activity (GO:0032781),42,5,2.904816903,1.721278885,0.162179942,0.658691641,2255;7140;9104;482;29128,UHRF1;RGN;TNNT3;FGF10;ATP1B2
GO:0045666,positive regulation of neuron differentiation (GO:0045666),42,5,2.904816903,1.721278885,0.162179942,0.658691641,1894;650;6664;51704;23531,ECT2;BMP2;GPRC5B;MMD;SOX11
GO:0002548,monocyte chemotaxis (GO:0002548),42,5,2.904816903,1.721278885,0.162179942,0.658691641,301;6366;3569;2350;6376,CX3CL1;ANXA1;CCL21;IL6;FOLR2
GO:0006915,apoptotic process (GO:0006915),228,20,15.76900605,1.268310757,0.162406888,0.659167997,6326;4804;7048;825;11113;135;57556;2537;84883;63924;8626;64651;5325;7704;9833;2191;158471;2308;5366;9700,CIDEC;MELK;ZBTB16;PLAGL1;CIT;ESPL1;TGFBR2;SCN2A;NGFR;FOXO1;CAPN3;CSRNP1;SEMA6A;FAP;TP63;IFI6;PRUNE2;ADORA2A;AIFM2;PMAIP1
GO:0045616,regulation of keratinocyte differentiation (GO:0045616),31,4,2.144031524,1.865644211,0.163463379,0.661668936,7538;26154;3204;2296,HOXA7;ZFP36;FOXC1;ABCA12
GO:0071677,positive regulation of mononuclear cell migration (GO:0071677),31,4,2.144031524,1.865644211,0.163463379,0.661668936,3627;6387;57402;58494,CXCL10;JAM2;CXCL12;S100A14
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),31,4,2.144031524,1.865644211,0.163463379,0.661668936,2348;6664;7049;8425,LTBP4;TGFBR3;FOLR1;SOX11
GO:0031055,chromatin remodeling at centromere (GO:0031055),31,4,2.144031524,1.865644211,0.163463379,0.661668936,64105;79019;55355;3070,HJURP;CENPM;CENPK;HELLS
GO:0071417,cellular response to organonitrogen compound (GO:0071417),102,10,7.054555337,1.417523788,0.167048057,0.675724003,3753;9472;64805;5138;2348;358;6263;10411;6422;1958,KCNE1;RYR3;PDE2A;SFRP1;EGR1;RAPGEF3;AQP1;P2RY12;AKAP6;FOLR1
GO:0001960,negative regulation of cytokine-mediated signaling pathway (GO:0001960),54,6,3.73476459,1.606526959,0.167832433,0.67745043,5468;3569;6586;9370;9636;83643,ADIPOQ;PPARG;CCDC3;SLIT3;ISG15;IL6
GO:0002920,regulation of humoral immune response (GO:0002920),54,6,3.73476459,1.606526959,0.167832433,0.67745043,10563;1378;629;5627;729;730,PROS1;CFB;C7;C6;CR1;CXCL13
GO:0010942,positive regulation of cell death (GO:0010942),66,7,4.564712277,1.533503006,0.170001753,0.67745043,6622;948;8644;3043;4314;2353;1958,EGR1;HBB;SNCA;CD36;FOS;AKR1C3;MMP3
GO:0031400,negative regulation of protein modification process (GO:0031400),78,8,5.394659963,1.482947962,0.17012986,0.67745043,1756;7498;4916;11076;55022;5348;26051;401265,FXYD1;DMD;KLHL31;PID1;NTRK3;TPPP;PPP1R16B;XDH
GO:0090277,positive regulation of peptide hormone secretion (GO:0090277),43,5,2.973979211,1.681249143,0.17381041,0.67745043,8660;4826;8447;5950;25924,RBP4;NNAT;IRS2;DOC2B;MYRIP
GO:0001678,cellular glucose homeostasis (GO:0001678),43,5,2.973979211,1.681249143,0.17381041,0.67745043,3745;4804;2308;10891;5105,PCK1;NGFR;KCNB1;FOXO1;PPARGC1A
GO:0001947,heart looping (GO:0001947),43,5,2.973979211,1.681249143,0.17381041,0.67745043,9645;7048;2348;64321;6491,STIL;TGFBR2;MICAL2;SOX17;FOLR1
GO:1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),11,2,0.760785379,2.628862297,0.173838006,0.67745043,467;90993,ATF3;CREB3L1
GO:0031960,response to corticosteroid (GO:0031960),11,2,0.760785379,2.628862297,0.173838006,0.67745043,3569;8644,AKR1C3;IL6
GO:1905954,positive regulation of lipid localization (GO:1905954),11,2,0.760785379,2.628862297,0.173838006,0.67745043,4023;440503,LPL;PLIN5
GO:0002029,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),11,2,0.760785379,2.628862297,0.173838006,0.67745043,154;133,ADRB2;ADM
GO:0006853,carnitine shuttle (GO:0006853),11,2,0.760785379,2.628862297,0.173838006,0.67745043,32;7069,ACACB;THRSP
GO:0048009,insulin-like growth factor receptor signaling pathway (GO:0048009),11,2,0.760785379,2.628862297,0.173838006,0.67745043,2690;3479,GHR;IGF1
GO:0051127,positive regulation of actin nucleation (GO:0051127),11,2,0.760785379,2.628862297,0.173838006,0.67745043,2934;10810,GSN;WASF3
GO:2000108,positive regulation of leukocyte apoptotic process (GO:2000108),11,2,0.760785379,2.628862297,0.173838006,0.67745043,301;338442,ANXA1;HCAR2
GO:0010838,positive regulation of keratinocyte proliferation (GO:0010838),11,2,0.760785379,2.628862297,0.173838006,0.67745043,2255;2252,FGF10;FGF7
GO:0098856,intestinal lipid absorption (GO:0098856),11,2,0.760785379,2.628862297,0.173838006,0.67745043,948;1645,AKR1C1;CD36
GO:2000392,regulation of lamellipodium morphogenesis (GO:2000392),11,2,0.760785379,2.628862297,0.173838006,0.67745043,5168;23189,ENPP2;KANK1
GO:1900006,positive regulation of dendrite development (GO:1900006),11,2,0.760785379,2.628862297,0.173838006,0.67745043,7436;5764,PTN;VLDLR
GO:0042772,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",11,2,0.760785379,2.628862297,0.173838006,0.67745043,2305;4582,FOXM1;MUC1
GO:0099622,cardiac muscle cell membrane repolarization (GO:0099622),11,2,0.760785379,2.628862297,0.173838006,0.67745043,3753;30819,KCNE1;KCNIP2
GO:1903818,positive regulation of voltage-gated potassium channel activity (GO:1903818),11,2,0.760785379,2.628862297,0.173838006,0.67745043,9472;30819,KCNIP2;AKAP6
GO:0006704,glucocorticoid biosynthetic process (GO:0006704),11,2,0.760785379,2.628862297,0.173838006,0.67745043,1583;3290,CYP11A1;HSD11B1
GO:0051931,regulation of sensory perception (GO:0051931),11,2,0.760785379,2.628862297,0.173838006,0.67745043,11343;55273,TMEM100;MGLL
GO:0008211,glucocorticoid metabolic process (GO:0008211),11,2,0.760785379,2.628862297,0.173838006,0.67745043,1583;3290,CYP11A1;HSD11B1
GO:0043029,T cell homeostasis (GO:0043029),11,2,0.760785379,2.628862297,0.173838006,0.67745043,5366;50943,FOXP3;PMAIP1
GO:0036295,cellular response to increased oxygen levels (GO:0036295),11,2,0.760785379,2.628862297,0.173838006,0.67745043,857;2308,CAV1;FOXO1
GO:0150078,positive regulation of neuroinflammatory response (GO:0150078),11,2,0.760785379,2.628862297,0.173838006,0.67745043,3569;90865,IL33;IL6
GO:1903800,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),11,2,0.760785379,2.628862297,0.173838006,0.67745043,1956;3569,EGFR;IL6
GO:0010517,regulation of phospholipase activity (GO:0010517),11,2,0.760785379,2.628862297,0.173838006,0.67745043,6622;5997,SNCA;RGS2
GO:0044872,lipoprotein localization (GO:0044872),11,2,0.760785379,2.628862297,0.173838006,0.67745043,5468;948,CD36;PPARG
GO:0051900,regulation of mitochondrial depolarization (GO:0051900),11,2,0.760785379,2.628862297,0.173838006,0.67745043,2537;1634,IFI6;DCN
GO:2000668,regulation of dendritic cell apoptotic process (GO:2000668),11,2,0.760785379,2.628862297,0.173838006,0.67745043,6366;6387,CCL21;CXCL12
GO:0002430,complement receptor mediated signaling pathway (GO:0002430),11,2,0.760785379,2.628862297,0.173838006,0.67745043,1378;2822,GPLD1;CR1
GO:0046851,negative regulation of bone remodeling (GO:0046851),11,2,0.760785379,2.628862297,0.173838006,0.67745043,3569;6422,SFRP1;IL6
GO:0055089,fatty acid homeostasis (GO:0055089),11,2,0.760785379,2.628862297,0.173838006,0.67745043,84649;51085,MLXIPL;DGAT2
GO:0032700,negative regulation of interleukin-17 production (GO:0032700),11,2,0.760785379,2.628862297,0.173838006,0.67745043,7292;50943,TNFSF4;FOXP3
GO:0010867,positive regulation of triglyceride biosynthetic process (GO:0010867),11,2,0.760785379,2.628862297,0.173838006,0.67745043,2822;440503,GPLD1;PLIN5
GO:0071636,positive regulation of transforming growth factor beta production (GO:0071636),11,2,0.760785379,2.628862297,0.173838006,0.67745043,947;5743,PTGS2;CD34
GO:0045780,positive regulation of bone resorption (GO:0045780),11,2,0.760785379,2.628862297,0.173838006,0.67745043,6696;101,ADAM8;SPP1
GO:0097090,presynaptic membrane organization (GO:0097090),11,2,0.760785379,2.628862297,0.173838006,0.67745043,57502;4038,LRP4;NLGN4X
GO:2000105,positive regulation of DNA-dependent DNA replication (GO:2000105),11,2,0.760785379,2.628862297,0.173838006,0.67745043,81620;8317,CDT1;CDC7
GO:0022010,central nervous system myelination (GO:0022010),11,2,0.760785379,2.628862297,0.173838006,0.67745043,6663;5354,PLP1;SOX10
GO:0042984,regulation of amyloid precursor protein biosynthetic process (GO:0042984),11,2,0.760785379,2.628862297,0.173838006,0.67745043,9452;64168,ITM2A;NECAB1
GO:2000725,regulation of cardiac muscle cell differentiation (GO:2000725),11,2,0.760785379,2.628862297,0.173838006,0.67745043,650;55553,BMP2;SOX6
GO:0071637,regulation of monocyte chemotactic protein-1 production (GO:0071637),11,2,0.760785379,2.628862297,0.173838006,0.67745043,347;9370,ADIPOQ;APOD
GO:0031643,positive regulation of myelination (GO:0031643),11,2,0.760785379,2.628862297,0.173838006,0.67745043,11076;1959,EGR2;TPPP
GO:2000177,regulation of neural precursor cell proliferation (GO:2000177),21,3,1.452408452,2.065534662,0.174124258,0.67745043,10763;5803;79801,SHCBP1;PTPRZ1;NES
GO:0010884,positive regulation of lipid storage (GO:0010884),21,3,1.452408452,2.065534662,0.174124258,0.67745043,4023;1149;440503,LPL;CIDEA;PLIN5
GO:0002684,positive regulation of immune system process (GO:0002684),21,3,1.452408452,2.065534662,0.174124258,0.67745043,301;8784;338442,ANXA1;HCAR2;TNFRSF18
GO:0002064,epithelial cell development (GO:0002064),21,3,1.452408452,2.065534662,0.174124258,0.67745043,7477;57111;59,ACTA2;RAB25;WNT7B
GO:0035584,calcium-mediated signaling using intracellular calcium source (GO:0035584),21,3,1.452408452,2.065534662,0.174124258,0.67745043,5737;1672;6403,PTGFR;DEFB1;SELP
GO:0033137,negative regulation of peptidyl-serine phosphorylation (GO:0033137),21,3,1.452408452,2.065534662,0.174124258,0.67745043,1756;51085;857,DMD;CAV1;MLXIPL
GO:0036150,phosphatidylserine acyl-chain remodeling (GO:0036150),21,3,1.452408452,2.065534662,0.174124258,0.67745043,5321;5320;129642,PLA2G4A;MBOAT2;PLA2G2A
GO:0051402,neuron apoptotic process (GO:0051402),21,3,1.452408452,2.065534662,0.174124258,0.67745043,6326;4804;11113,CIT;SCN2A;NGFR
GO:0033762,response to glucagon (GO:0033762),21,3,1.452408452,2.065534662,0.174124258,0.67745043,111;196883;5577,ADCY4;ADCY5;PRKAR2B
GO:0060759,regulation of response to cytokine stimulus (GO:0060759),21,3,1.452408452,2.065534662,0.174124258,0.67745043,3977;9314;100130733,LIFR;LRRC70;KLF4
GO:0060043,regulation of cardiac muscle cell proliferation (GO:0060043),21,3,1.452408452,2.065534662,0.174124258,0.67745043,2247;7049;5950,RBP4;FGF2;TGFBR3
GO:0051004,regulation of lipoprotein lipase activity (GO:0051004),21,3,1.452408452,2.065534662,0.174124258,0.67745043,4023;51129;338328,GPIHBP1;LPL;ANGPTL4
GO:0051851,modulation by host of symbiont process (GO:0051851),32,4,2.213193831,1.807342829,0.177291758,0.687548875,358;3249;51176;3725,AQP1;JUN;LEF1;HPN
GO:0010638,positive regulation of organelle organization (GO:0010638),32,4,2.213193831,1.807342829,0.177291758,0.687548875,301;154;10891;8447,ANXA1;ADRB2;PPARGC1A;DOC2B
GO:0038128,ERBB2 signaling pathway (GO:0038128),32,4,2.213193831,1.807342829,0.177291758,0.687548875,1956;3084;5753;9542,NRG2;EGFR;NRG1;PTK6
GO:0002244,hematopoietic progenitor cell differentiation (GO:0002244),32,4,2.213193831,1.807342829,0.177291758,0.687548875,3815;3624;6422;4222,INHBA;SFRP1;KIT;MEOX1
GO:2000310,regulation of NMDA receptor activity (GO:2000310),32,4,2.213193831,1.807342829,0.177291758,0.687548875,2892;2893;5649;23542,RELN;GRIA4;MAPK8IP2;GRIA3
GO:0007266,Rho protein signal transduction (GO:0007266),55,6,3.803926897,1.577317378,0.178165073,0.690490169,4804;150;185;57381;58480;1278,RHOJ;NGFR;RHOU;AGTR1;ADRA2A;COL1A2
GO:0043269,regulation of ion transport (GO:0043269),79,8,5.463822271,1.464176469,0.178663085,0.691528527,1128;6622;7018;90019;83849;57586;5187;79570,PER1;TF;SNCA;NKAIN1;SYT8;SYT15;SYT13;CHRM1
GO:0000725,recombinational repair (GO:0000725),79,8,5.463822271,1.464176469,0.178663085,0.691528527,10721;9401;641;5888;7516;10635;675;4796,RAD51;POLQ;RAD51AP1;RECQL4;BLM;TONSL;XRCC2;BRCA2
GO:0043068,positive regulation of programmed cell death (GO:0043068),284,24,19.64209525,1.221865575,0.179403757,0.69394851,6622;4804;1894;130399;3569;650;3202;7153;84883;9833;2308;5366;2822;6422;1869;1848;274;3725;943;3169;54507;50649;25803;80034,HOXA5;TOP2A;MELK;SFRP1;ECT2;SNCA;ACVR1C;BMP2;E2F1;NGFR;JUN;GPLD1;FOXO1;DUSP6;ARHGEF4;CSRNP3;ADAMTSL4;BIN1;IL6;AIFM2;TNFRSF8;PMAIP1;FOXA1;SPDEF
GO:0006875,cellular metal ion homeostasis (GO:0006875),104,10,7.192879951,1.390263715,0.181820865,0.702845799,857;5745;287;6387;1906;1907;344905;9104;477;482,ATP1A2;CAV1;RGN;CXCL12;ATP1B2;PTH1R;ANK2;EDN1;EDN2;ATP13A5
GO:0034109,homotypic cell-cell adhesion (GO:0034109),44,5,3.043141518,1.643038936,0.185748625,0.715269051,64805;7301;2335;3043;10398,FN1;HBB;P2RY12;MYL9;TYRO3
GO:0001578,microtubule bundle formation (GO:0001578),44,5,3.043141518,1.643038936,0.185748625,0.715269051,5347;11076;10112;51673;827,KIF20A;PLK1;CAPN6;TPPP;TPPP3
GO:0022008,neurogenesis (GO:0022008),44,5,3.043141518,1.643038936,0.185748625,0.715269051,301;11113;2047;79633;284403,ANXA1;CIT;EPHB1;WDR62;FAT4
GO:0003208,cardiac ventricle morphogenesis (GO:0003208),44,5,3.043141518,1.643038936,0.185748625,0.715269051,7048;23493;2625;6664;7049,TGFBR3;TGFBR2;HEY2;GATA3;SOX11
GO:0009891,positive regulation of biosynthetic process (GO:0009891),44,5,3.043141518,1.643038936,0.185748625,0.715269051,10580;51085;948;90993;55323,SORBS1;MLXIPL;CD36;LARP6;CREB3L1
GO:0055065,metal ion homeostasis (GO:0055065),44,5,3.043141518,1.643038936,0.185748625,0.715269051,6622;857;57402;57158;84561,CAV1;JPH2;SNCA;SLC12A8;S100A14
GO:0046942,carboxylic acid transport (GO:0046942),56,6,3.873089204,1.549150996,0.188746586,0.725883384,11254;8140;9194;9123;9120;3993,SLC16A3;LLGL2;SLC16A7;SLC6A14;SLC7A5;SLC16A6
GO:0120192,tight junction assembly (GO:0120192),56,6,3.873089204,1.549150996,0.188746586,0.725883384,1894;5010;84612;7122;9073;92359,CLDN11;CLDN5;ECT2;CLDN8;PARD6B;CRB3
GO:0042509,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),68,7,4.703036891,1.488399977,0.188880173,0.725932684,3815;2690;3479;3569;5753;85480;8784,TSLP;KIT;GHR;IGF1;IL6;TNFRSF18;PTK6
GO:0046328,regulation of JNK cascade (GO:0046328),105,10,7.262042258,1.377023108,0.189424517,0.727559599,6366;1956;10371;2047;7049;7477;23542;5187;153769;401265,PER1;EPHB1;TGFBR3;KLHL31;EGFR;CCL21;MAPK8IP2;SEMA3A;SH3RF2;WNT7B
GO:0032660,regulation of interleukin-17 production (GO:0032660),33,4,2.282356138,1.752574865,0.191497174,0.730644937,3569;7292;8140;50943,TNFSF4;FOXP3;IL6;SLC7A5
GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),33,4,2.282356138,1.752574865,0.191497174,0.730644937,3815;2690;3952;3569,LEP;KIT;GHR;IL6
GO:0035065,regulation of histone acetylation (GO:0035065),33,4,2.282356138,1.752574865,0.191497174,0.730644937,6622;10891;10411;50943,RAPGEF3;SNCA;FOXP3;PPARGC1A
GO:0000018,regulation of DNA recombination (GO:0000018),33,4,2.282356138,1.752574865,0.191497174,0.730644937,641;5888;10635;3838,RAD51;KPNA2;RAD51AP1;BLM
GO:0033044,regulation of chromosome organization (GO:0033044),22,3,1.521570759,1.971646723,0.191929522,0.730644937,81620;699;116028,BUB1;RMI2;CDT1
GO:0050869,negative regulation of B cell activation (GO:0050869),22,3,1.521570759,1.971646723,0.191929522,0.730644937,3624;55024;6422,INHBA;SFRP1;BANK1
GO:1900117,regulation of execution phase of apoptosis (GO:1900117),22,3,1.521570759,1.971646723,0.191929522,0.730644937,2191;5740;1149,CIDEA;FAP;PTGIS
GO:1901385,regulation of voltage-gated calcium channel activity (GO:1901385),22,3,1.521570759,1.971646723,0.191929522,0.730644937,1756;6769;342667,DMD;STAC2;STAC
GO:0043090,amino acid import (GO:0043090),22,3,1.521570759,1.971646723,0.191929522,0.730644937,9368;11254;8140,SLC6A14;SLC9A3R1;SLC7A5
GO:0030031,cell projection assembly (GO:0030031),22,3,1.521570759,1.971646723,0.191929522,0.730644937,2934;57381;58480,GSN;RHOJ;RHOU
GO:0051055,negative regulation of lipid biosynthetic process (GO:0051055),22,3,1.521570759,1.971646723,0.191929522,0.730644937,650;8644;57761,BMP2;TRIB3;AKR1C3
GO:0051250,negative regulation of lymphocyte activation (GO:0051250),22,3,1.521570759,1.971646723,0.191929522,0.730644937,259307;6664;55024,IL4I1;BANK1;SOX11
GO:2000378,negative regulation of reactive oxygen species metabolic process (GO:2000378),22,3,1.521570759,1.971646723,0.191929522,0.730644937,4314;225;440503,ABCD2;MMP3;PLIN5
GO:1904030,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),22,3,1.521570759,1.971646723,0.191929522,0.730644937,5347;1050;1028,PLK1;CDKN1C;CEBPA
GO:0006508,proteolysis (GO:0006508),287,24,19.84958217,1.209093461,0.192978434,0.734173016,2152;825;10003;8728;4311;1511;2191;5979;3249;4973;5727;4314;4318;5304;135293;2161;827;92291;290;9718;11131;80332;64129;10753,CAPN11;MME;ADAM33;TINAGL1;NAALAD2;OLR1;F3;ADAM19;CAPN3;CAPN6;FAP;ECE2;PTCH1;F12;MMP3;MMP9;PM20D2;ANPEP;CTSG;CAPN9;HPN;RET;CAPN13;PIP
GO:0010629,negative regulation of gene expression (GO:0010629),314,26,21.71696447,1.197220728,0.194969193,0.735485458,7538;55366;7498;3479;5734;8140;6790;947;650;23493;7122;6664;2247;6422;7298;9314;3070;50943;2146;27303;90993;84913;1149;23034;10644;83643,ATOH8;AURKA;SFRP1;CIDEA;FGF2;CLDN5;EZH2;RBMS3;BMP2;KLF4;PTGER4;FOXP3;TYMS;HELLS;ZFP36;CCDC3;CD34;SAMD4A;LGR4;IGF2BP2;IGF1;CREB3L1;HEY2;SLC7A5;XDH;SOX11
GO:0045859,regulation of protein kinase activity (GO:0045859),106,10,7.331204566,1.364032324,0.197167382,0.735485458,9368;6622;6366;1894;1062;5649;57761;4921;79007;23531,RELN;CENPE;ECT2;SNCA;CCL21;TRIB3;DBNDD1;DDR2;SLC9A3R1;MMD
GO:0032720,negative regulation of tumor necrosis factor production (GO:0032720),45,5,3.112303825,1.606526959,0.197974172,0.735485458,3479;947;9370;6376;1149,CX3CL1;CIDEA;ADIPOQ;CD34;IGF1
GO:0046425,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),45,5,3.112303825,1.606526959,0.197974172,0.735485458,3815;2690;3952;3569;857,LEP;CAV1;KIT;GHR;IL6
GO:0031330,negative regulation of cellular catabolic process (GO:0031330),69,7,4.772199198,1.466828963,0.19862603,0.735485458,3952;2822;54922;4233;3953;440503;7079,LEP;LEPR;TIMP4;GPLD1;MET;RASIP1;PLIN5
GO:0006570,tyrosine metabolic process (GO:0006570),12,2,0.829947687,2.409790439,0.199539926,0.735485458,6898;259307,TAT;IL4I1
GO:0030318,melanocyte differentiation (GO:0030318),12,2,0.829947687,2.409790439,0.199539926,0.735485458,3815;4435,KIT;CITED1
GO:0010829,negative regulation of glucose transmembrane transport (GO:0010829),12,2,0.829947687,2.409790439,0.199539926,0.735485458,3952;55022,LEP;PID1
GO:0044793,negative regulation by host of viral process (GO:0044793),12,2,0.829947687,2.409790439,0.199539926,0.735485458,4057;5806,PTX3;LTF
GO:1901739,regulation of myoblast fusion (GO:1901739),12,2,0.829947687,2.409790439,0.199539926,0.735485458,30846;92304,SCGB3A1;EHD2
GO:0006544,glycine metabolic process (GO:0006544),12,2,0.829947687,2.409790439,0.199539926,0.735485458,10993;275,SDS;AMT
GO:0010458,exit from mitosis (GO:0010458),12,2,0.829947687,2.409790439,0.199539926,0.735485458,11065;27338,UBE2C;UBE2S
GO:0097067,cellular response to thyroid hormone stimulus (GO:0097067),12,2,0.829947687,2.409790439,0.199539926,0.735485458,7068;687,KLF9;THRB
GO:0030948,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),12,2,0.829947687,2.409790439,0.199539926,0.735485458,64102;79812,TNMD;MMRN2
GO:0001655,urogenital system development (GO:0001655),12,2,0.829947687,2.409790439,0.199539926,0.735485458,301;130497,OSR1;ANXA1
GO:1901881,positive regulation of protein depolymerization (GO:1901881),12,2,0.829947687,2.409790439,0.199539926,0.735485458,1073;10763,NES;CFL2
GO:0055123,digestive system development (GO:0055123),12,2,0.829947687,2.409790439,0.199539926,0.735485458,3815;79827,KIT;CLMP
GO:0030219,megakaryocyte differentiation (GO:0030219),12,2,0.829947687,2.409790439,0.199539926,0.735485458,3815;6886,KIT;TAL1
GO:0061548,ganglion development (GO:0061548),12,2,0.829947687,2.409790439,0.199539926,0.735485458,10371;10381,TUBB3;SEMA3A
GO:0030834,regulation of actin filament depolymerization (GO:0030834),12,2,0.829947687,2.409790439,0.199539926,0.735485458,1073;130271,PLEKHH2;CFL2
GO:0098911,regulation of ventricular cardiac muscle cell action potential (GO:0098911),12,2,0.829947687,2.409790439,0.199539926,0.735485458,857;274,CAV1;BIN1
GO:0072112,glomerular visceral epithelial cell differentiation (GO:0072112),12,2,0.829947687,2.409790439,0.199539926,0.735485458,8842;28999,KLF15;PROM1
GO:0051282,regulation of sequestering of calcium ion (GO:0051282),12,2,0.829947687,2.409790439,0.199539926,0.735485458,287;845,CASQ2;ANK2
GO:0071378,cellular response to growth hormone stimulus (GO:0071378),12,2,0.829947687,2.409790439,0.199539926,0.735485458,2690;8835,GHR;SOCS2
GO:1901844,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),12,2,0.829947687,2.409790439,0.199539926,0.735485458,857;3270,CAV1;HRC
GO:0051280,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),12,2,0.829947687,2.409790439,0.199539926,0.735485458,845;2946,GSTM2;CASQ2
GO:0060315,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),12,2,0.829947687,2.409790439,0.199539926,0.735485458,845;2946,GSTM2;CASQ2
GO:0080134,regulation of response to stress (GO:0080134),12,2,0.829947687,2.409790439,0.199539926,0.735485458,5243;10391,CORO2B;ABCB1
GO:0051354,negative regulation of oxidoreductase activity (GO:0051354),12,2,0.829947687,2.409790439,0.199539926,0.735485458,6622;8639,SNCA;AOC3
GO:1903319,positive regulation of protein maturation (GO:1903319),12,2,0.829947687,2.409790439,0.199539926,0.735485458,147372;101,ADAM8;CCBE1
GO:0042423,catecholamine biosynthetic process (GO:0042423),12,2,0.829947687,2.409790439,0.199539926,0.735485458,6622;2625,SNCA;GATA3
GO:2000107,negative regulation of leukocyte apoptotic process (GO:2000107),12,2,0.829947687,2.409790439,0.199539926,0.735485458,6366;6387,CCL21;CXCL12
GO:0002313,mature B cell differentiation involved in immune response (GO:0002313),12,2,0.829947687,2.409790439,0.199539926,0.735485458,3569;139818,IL6;DOCK11
GO:0035051,cardiocyte differentiation (GO:0035051),12,2,0.829947687,2.409790439,0.199539926,0.735485458,3084;650,BMP2;NRG1
GO:0060259,regulation of feeding behavior (GO:0060259),12,2,0.829947687,2.409790439,0.199539926,0.735485458,3953;8013,LEPR;NR4A3
GO:0010614,negative regulation of cardiac muscle hypertrophy (GO:0010614),12,2,0.829947687,2.409790439,0.199539926,0.735485458,2308;5997,FOXO1;RGS2
GO:1902101,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),12,2,0.829947687,2.409790439,0.199539926,0.735485458,9700;9787,DLGAP5;ESPL1
GO:0045842,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),12,2,0.829947687,2.409790439,0.199539926,0.735485458,9700;9787,DLGAP5;ESPL1
GO:1901970,positive regulation of mitotic sister chromatid separation (GO:1901970),12,2,0.829947687,2.409790439,0.199539926,0.735485458,9700;9787,DLGAP5;ESPL1
GO:0015867,ATP transport (GO:0015867),12,2,0.829947687,2.409790439,0.199539926,0.735485458,368;1378,ABCC6;CR1
GO:0071498,cellular response to fluid shear stress (GO:0071498),12,2,0.829947687,2.409790439,0.199539926,0.735485458,10365;9314,KLF4;KLF2
GO:0042340,keratan sulfate catabolic process (GO:0042340),12,2,0.829947687,2.409790439,0.199539926,0.735485458,4969;5549,OGN;PRELP
GO:0002902,regulation of B cell apoptotic process (GO:0002902),12,2,0.829947687,2.409790439,0.199539926,0.735485458,9212;8660,AURKB;IRS2
GO:0072527,pyrimidine-containing compound metabolic process (GO:0072527),12,2,0.829947687,2.409790439,0.199539926,0.735485458,5169;80704,SLC19A3;ENPP3
GO:0051145,smooth muscle cell differentiation (GO:0051145),12,2,0.829947687,2.409790439,0.199539926,0.735485458,23493;1910,EDNRB;HEY2
GO:0019219,regulation of nucleobase-containing compound metabolic process (GO:0019219),12,2,0.829947687,2.409790439,0.199539926,0.735485458,4857;10644,NOVA1;IGF2BP2
GO:0090329,regulation of DNA-dependent DNA replication (GO:0090329),12,2,0.829947687,2.409790439,0.199539926,0.735485458,81620;641,CDT1;BLM
GO:0019369,arachidonic acid metabolic process (GO:0019369),57,6,3.942251512,1.521972909,0.199563597,0.735485458,11343;5321;5730;5740;8644;5743,PLA2G4A;PTGS2;AKR1C3;MGLL;PTGDS;PTGIS
GO:0043648,dicarboxylic acid metabolic process (GO:0043648),57,6,3.942251512,1.521972909,0.199563597,0.735485458,137872;6898;23498;2350;5105;10840,ALDH1L1;PCK1;ADHFE1;TAT;HAAO;FOLR2
GO:1901653,cellular response to peptide (GO:1901653),57,6,3.942251512,1.521972909,0.199563597,0.735485458,154;4804;3479;857;948;1583,CAV1;ADRB2;CD36;NGFR;CYP11A1;IGF1
GO:0010822,positive regulation of mitochondrion organization (GO:0010822),57,6,3.942251512,1.521972909,0.199563597,0.735485458,6790;5366;10891;4318;1634;5329,AURKA;PPARGC1A;MMP9;PLAUR;DCN;PMAIP1
GO:0000165,MAPK cascade (GO:0000165),302,25,20.88701678,1.196915781,0.200890026,0.739920309,7538;3815;2255;2252;1956;3479;2246;284;3084;5734;983;5979;6711;2675;8660;4684;2247;4233;7010;1848;9365;152831;9542;54756;22808,CDK1;NRG2;FGF1;KL;FGF2;KIT;MRAS;KLB;EGFR;SPTBN1;NCAM1;ANGPT1;DUSP6;MET;PTGER4;GFRA2;IRS2;ZFP36;FGF10;IL17RD;NRG1;IGF1;FGF7;TEK;RET
GO:1902532,negative regulation of intracellular signal transduction (GO:1902532),197,17,13.62497452,1.247708755,0.204107536,0.751310714,9368;7498;11113;857;5138;55024;9370;4318;1843;5140;57761;5187;5329;219790;286827;114804;50940,PER1;PDE2A;CAV1;CIT;TRIM59;ADIPOQ;RTKN2;PDE11A;DUSP1;TRIB3;MMP9;PLAUR;PDE3B;SLC9A3R1;RNF157;XDH;BANK1
GO:0051973,positive regulation of telomerase activity (GO:0051973),34,4,2.351518446,1.701028545,0.206044233,0.756586367,9212;4751;9314;5570,NEK2;AURKB;KLF4;PKIB
GO:0036465,synaptic vesicle recycling (GO:0036465),34,4,2.351518446,1.701028545,0.206044233,0.756586367,6622;6623;57502;90019,SNCA;SNCG;SYT8;NLGN4X
GO:0048545,response to steroid hormone (GO:0048545),34,4,2.351518446,1.701028545,0.206044233,0.756586367,857;477;2908;7035,ATP1A2;CAV1;NR3C1;TFPI
GO:0007224,smoothened signaling pathway (GO:0007224),34,4,2.351518446,1.701028545,0.206044233,0.756586367,139411;5727;6491;8643,STIL;PTCHD1;PTCH2;PTCH1
GO:0016125,sterol metabolic process (GO:0016125),70,7,4.841361506,1.445874263,0.208563447,0.76491266,1066;51302;56603;1583;6713;23461;3931,LCAT;ABCA5;CES1;SQLE;CYP39A1;CYP11A1;CYP26B1
GO:1901987,regulation of cell cycle phase transition (GO:1901987),95,9,6.570419186,1.369775618,0.209933653,0.76491266,11065;991;27338;701;983;4085;5347;891;51512,UBE2C;CDK1;PLK1;CCNB1;BUB1B;CDC20;GTSE1;MAD2L1;UBE2S
GO:0001933,negative regulation of protein phosphorylation (GO:0001933),146,13,10.09769685,1.287422289,0.210109564,0.76491266,1756;6622;7498;4916;51085;857;9370;6422;55022;10253;57761;401265;79007,SPRY2;DMD;CAV1;SFRP1;ADIPOQ;SNCA;MLXIPL;KLHL31;PID1;NTRK3;TRIB3;DBNDD1;XDH
GO:0045879,negative regulation of smoothened signaling pathway (GO:0045879),23,3,1.590733066,1.885922952,0.210162684,0.76491266,2719;5727;8643,GPC3;PTCH2;PTCH1
GO:0090317,negative regulation of intracellular protein transport (GO:0090317),23,3,1.590733066,1.885922952,0.210162684,0.76491266,3753;347;9370,KCNE1;ADIPOQ;APOD
GO:0048675,axon extension (GO:0048675),23,3,1.590733066,1.885922952,0.210162684,0.76491266,54437;10371;6586,SEMA5B;SLIT3;SEMA3A
GO:0036152,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),23,3,1.590733066,1.885922952,0.210162684,0.76491266,5321;5320;129642,PLA2G4A;MBOAT2;PLA2G2A
GO:0030262,apoptotic nuclear changes (GO:0030262),23,3,1.590733066,1.885922952,0.210162684,0.76491266,130399;7153;1776,TOP2A;DNASE1L3;ACVR1C
GO:0046825,regulation of protein export from nucleus (GO:0046825),23,3,1.590733066,1.885922952,0.210162684,0.76491266,10411;5784;51512,GTSE1;RAPGEF3;PTPN14
GO:0009117,nucleotide metabolic process (GO:0009117),23,3,1.590733066,1.885922952,0.210162684,0.76491266,5169;23057;26289,NMNAT2;AK5;ENPP3
GO:0035066,positive regulation of histone acetylation (GO:0035066),23,3,1.590733066,1.885922952,0.210162684,0.76491266,10891;4582;50943,FOXP3;PPARGC1A;MUC1
GO:1904353,regulation of telomere capping (GO:1904353),23,3,1.590733066,1.885922952,0.210162684,0.76491266,9212;4751;5570,NEK2;AURKB;PKIB
GO:0008645,hexose transmembrane transport (GO:0008645),23,3,1.590733066,1.885922952,0.210162684,0.76491266,6517;6523;55974,SLC50A1;SLC2A4;SLC5A1
GO:0009152,purine ribonucleotide biosynthetic process (GO:0009152),46,5,3.181466132,1.57160246,0.210466141,0.76491266,111;196883;4881;4882;26289,NPR1;ADCY4;AK5;NPR2;ADCY5
GO:0010569,regulation of double-strand break repair via homologous recombination (GO:0010569),46,5,3.181466132,1.57160246,0.210466141,0.76491266,10721;116028;5888;10635;55010,RAD51;RMI2;POLQ;RAD51AP1;PARPBP
GO:0032496,response to lipopolysaccharide (GO:0032496),159,14,10.99680685,1.273096836,0.21058069,0.76491266,7538;6622;10563;3569;7292;1373;3627;4283;1511;6590;2920;4435;57402;6403,CXCL2;SNCA;CXCL10;TNFSF4;ZFP36;CPS1;CITED1;IL6;S100A14;CXCL9;CTSG;SELP;SLPI;CXCL13
GO:0010977,negative regulation of neuron projection development (GO:0010977),58,6,4.011413819,1.495731996,0.210602304,0.76491266,4804;10371;1949;4038;23189;53335,KANK1;NGFR;LRP4;SEMA3A;EFNB3;BCL11A
GO:0043112,receptor metabolic process (GO:0043112),58,6,4.011413819,1.495731996,0.210602304,0.76491266,6622;857;133;10267;948;11031,CAV1;SNCA;CD36;RAB31;RAMP1;ADM
GO:0006869,lipid transport (GO:0006869),108,10,7.46952918,1.338772466,0.213052736,0.773345407,2180;10351;26154;948;1645;23461;225;10349;23460;10350,ABCA10;ABCA9;ABCA8;ABCA5;AKR1C1;CD36;ABCA6;ABCD2;ACSL1;ABCA12
GO:0042326,negative regulation of phosphorylation (GO:0042326),83,8,5.740471499,1.393613748,0.214562413,0.778355258,7498;4916;3624;8660;5207;55022;1028;401265,INHBA;CDKN1C;KLHL31;PFKFB1;PID1;NTRK3;IRS2;XDH
GO:0007204,positive regulation of cytosolic calcium ion concentration (GO:0007204),147,13,10.16685916,1.278664314,0.217004091,0.786737993,111;10563;6288;857;5737;5734;948;185;1906;1907;57158;6869;2151,CAV1;SAA1;JPH2;CD36;TACR1;PTGFR;PTGER4;ADCY5;EDN1;EDN2;F2RL2;AGTR1;CXCL13
GO:0048015,phosphatidylinositol-mediated signaling (GO:0048015),71,7,4.910523813,1.425509837,0.21868237,0.790914396,3479;2625;7301;8660;1906;5288;9651,IRS2;PIK3C2G;IGF1;EDN1;TYRO3;PLCH2;GATA3
GO:0002573,myeloid leukocyte differentiation (GO:0002573),71,7,4.910523813,1.425509837,0.21868237,0.790914396,3815;5468;7048;51176;1050;1869;4318,KIT;TGFBR2;PPARG;E2F1;LEF1;MMP9;CEBPA
GO:1903829,positive regulation of cellular protein localization (GO:1903829),71,7,4.910523813,1.425509837,0.21868237,0.790914396,4804;983;5347;81620;10403;79608;51512,CDK1;NDC80;PLK1;GTSE1;NGFR;RIC3;CDT1
GO:0050829,defense response to Gram-negative bacterium (GO:0050829),71,7,4.910523813,1.425509837,0.21868237,0.790914396,3569;358;4057;1511;1672;5919;6403,AQP1;DEFB1;IL6;CTSG;SELP;RARRES2;LTF
GO:0060236,regulation of mitotic spindle organization (GO:0060236),35,4,2.420680753,1.652427729,0.220897389,0.797007325,22974;2770;5347;10460,TPX2;PLK1;TACC3;GNAI1
GO:1904646,cellular response to amyloid-beta (GO:1904646),35,4,2.420680753,1.652427729,0.220897389,0.797007325,154;4804;3479;948,ADRB2;CD36;NGFR;IGF1
GO:0070301,cellular response to hydrogen peroxide (GO:0070301),35,4,2.420680753,1.652427729,0.220897389,0.797007325,301;1894;3569;358,ANXA1;ECT2;AQP1;IL6
GO:0046889,positive regulation of lipid biosynthetic process (GO:0046889),35,4,2.420680753,1.652427729,0.220897389,0.797007325,10580;51085;2822;440503,SORBS1;MLXIPL;GPLD1;PLIN5
GO:0050890,cognition (GO:0050890),47,5,3.250628439,1.53816411,0.223203261,0.798311073,11170;64220;4248;139411;55084,FAM107A;SOBP;PTCHD1;MGAT3;STRA6
GO:0061371,determination of heart left/right asymmetry (GO:0061371),47,5,3.250628439,1.53816411,0.223203261,0.798311073,9645;7048;2348;64321;6491,STIL;TGFBR2;MICAL2;SOX17;FOLR1
GO:0003143,embryonic heart tube morphogenesis (GO:0003143),47,5,3.250628439,1.53816411,0.223203261,0.798311073,9645;7048;2348;64321;6491,STIL;TGFBR2;MICAL2;SOX17;FOLR1
GO:0001837,epithelial to mesenchymal transition (GO:0001837),47,5,3.250628439,1.53816411,0.223203261,0.798311073,650;23493;51176;7049;81610,FAM83D;TGFBR3;BMP2;LEF1;HEY2
GO:0051345,positive regulation of hydrolase activity (GO:0051345),148,13,10.23602147,1.270024691,0.223993697,0.798311073,6366;1894;7481;650;139818;10411;6422;858;6376;2146;440503;9628;9824,CX3CL1;SFRP1;CAV2;ECT2;EZH2;RAPGEF3;RGS6;ARHGAP11A;BMP2;CCL21;WNT11;DOCK11;PLIN5
GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),13,2,0.899109994,2.224421943,0.22564141,0.798311073,4023;9314,LPL;KLF4
GO:0021955,central nervous system neuron axonogenesis (GO:0021955),13,2,0.899109994,2.224421943,0.22564141,0.798311073,2051;2047,EPHB1;EPHB6
GO:0035627,ceramide transport (GO:0035627),13,2,0.899109994,2.224421943,0.22564141,0.798311073,26154;5243,ABCB1;ABCA12
GO:0032309,icosanoid secretion (GO:0032309),13,2,0.899109994,2.224421943,0.22564141,0.798311073,301;3952,LEP;ANXA1
GO:0007194,negative regulation of adenylate cyclase activity (GO:0007194),13,2,0.899109994,2.224421943,0.22564141,0.798311073,1910;5064,EDNRB;PALM
GO:0086014,atrial cardiac muscle cell action potential (GO:0086014),13,2,0.899109994,2.224421943,0.22564141,0.798311073,55800;287,SCN3B;ANK2
GO:0060350,endochondral bone morphogenesis (GO:0060350),13,2,0.899109994,2.224421943,0.22564141,0.798311073,658;2296,FOXC1;BMPR1B
GO:1902285,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),13,2,0.899109994,2.224421943,0.22564141,0.798311073,10371;91584,PLXNA4;SEMA3A
GO:2001224,positive regulation of neuron migration (GO:2001224),13,2,0.899109994,2.224421943,0.22564141,0.798311073,57556;10371,SEMA6A;SEMA3A
GO:1904892,regulation of receptor signaling pathway via STAT (GO:1904892),13,2,0.899109994,2.224421943,0.22564141,0.798311073,3569;85480,TSLP;IL6
GO:0045956,positive regulation of calcium ion-dependent exocytosis (GO:0045956),13,2,0.899109994,2.224421943,0.22564141,0.798311073,3745;8447,KCNB1;DOC2B
GO:0106058,positive regulation of calcineurin-mediated signaling (GO:0106058),13,2,0.899109994,2.224421943,0.22564141,0.798311073,9472;3479,AKAP6;IGF1
GO:0070886,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),13,2,0.899109994,2.224421943,0.22564141,0.798311073,9472;3479,AKAP6;IGF1
GO:0051930,regulation of sensory perception of pain (GO:0051930),13,2,0.899109994,2.224421943,0.22564141,0.798311073,11343;55273,TMEM100;MGLL
GO:0030007,cellular potassium ion homeostasis (GO:0030007),13,2,0.899109994,2.224421943,0.22564141,0.798311073,477;482,ATP1A2;ATP1B2
GO:0035296,regulation of tube diameter (GO:0035296),13,2,0.899109994,2.224421943,0.22564141,0.798311073,185;4881,NPR1;AGTR1
GO:0003018,vascular process in circulatory system (GO:0003018),13,2,0.899109994,2.224421943,0.22564141,0.798311073,185;4881,NPR1;AGTR1
GO:1900373,positive regulation of purine nucleotide biosynthetic process (GO:1900373),13,2,0.899109994,2.224421943,0.22564141,0.798311073,10891;55022,PID1;PPARGC1A
GO:0046323,glucose import (GO:0046323),13,2,0.899109994,2.224421943,0.22564141,0.798311073,6517;6523,SLC2A4;SLC5A1
GO:0022011,myelination in peripheral nervous system (GO:0022011),13,2,0.899109994,2.224421943,0.22564141,0.798311073,57716;163175,LGI4;PRX
GO:0150079,negative regulation of neuroinflammatory response (GO:0150079),13,2,0.899109994,2.224421943,0.22564141,0.798311073,3479;6376,CX3CL1;IGF1
GO:0003215,cardiac right ventricle morphogenesis (GO:0003215),13,2,0.899109994,2.224421943,0.22564141,0.798311073,23493;2625,HEY2;GATA3
GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",13,2,0.899109994,2.224421943,0.22564141,0.798311073,7048;7292,TGFBR2;TNFSF4
GO:0034440,lipid oxidation (GO:0034440),13,2,0.899109994,2.224421943,0.22564141,0.798311073,9370;10891,ADIPOQ;PPARGC1A
GO:0045723,positive regulation of fatty acid biosynthetic process (GO:0045723),13,2,0.899109994,2.224421943,0.22564141,0.798311073,51085;225,MLXIPL;ABCD2
GO:0045940,positive regulation of steroid metabolic process (GO:0045940),13,2,0.899109994,2.224421943,0.22564141,0.798311073,1066;185,CES1;AGTR1
GO:0032411,positive regulation of transporter activity (GO:0032411),13,2,0.899109994,2.224421943,0.22564141,0.798311073,9370;10110,ADIPOQ;SGK2
GO:0051917,regulation of fibrinolysis (GO:0051917),13,2,0.899109994,2.224421943,0.22564141,0.798311073,2191;2161,FAP;F12
GO:0030307,positive regulation of cell growth (GO:0030307),97,9,6.708743801,1.341532822,0.227337065,0.803006734,9472;1956;3479;80736;3249;1906;6422;3373;114804,SFRP1;EGFR;HYAL1;AKAP6;IGF1;EDN1;RNF157;SLC44A4;HPN
GO:0071870,cellular response to catecholamine stimulus (GO:0071870),24,3,1.659895373,1.807342829,0.228753105,0.803006734,6622;54331;8013,SNCA;GNG2;NR4A3
GO:1900745,positive regulation of p38MAPK cascade (GO:1900745),24,3,1.659895373,1.807342829,0.228753105,0.803006734,7498;3952;650,LEP;BMP2;XDH
GO:0009154,purine ribonucleotide catabolic process (GO:0009154),24,3,1.659895373,1.807342829,0.228753105,0.803006734,7498;5138;5152,PDE2A;PDE9A;XDH
GO:1900027,regulation of ruffle assembly (GO:1900027),24,3,1.659895373,1.807342829,0.228753105,0.803006734,64805;857;23189,CAV1;KANK1;P2RY12
GO:0030837,negative regulation of actin filament polymerization (GO:0030837),24,3,1.659895373,1.807342829,0.228753105,0.803006734,2934;23189;256949,GSN;KANK1;KANK3
GO:0055013,cardiac muscle cell development (GO:0055013),24,3,1.659895373,1.807342829,0.228753105,0.803006734,80206;23493;4629,MYH11;FHOD3;HEY2
GO:0055007,cardiac muscle cell differentiation (GO:0055007),24,3,1.659895373,1.807342829,0.228753105,0.803006734,3084;650;4629,MYH11;BMP2;NRG1
GO:0055075,potassium ion homeostasis (GO:0055075),24,3,1.659895373,1.807342829,0.228753105,0.803006734,477;482;84561,ATP1A2;ATP1B2;SLC12A8
GO:0009953,dorsal/ventral pattern formation (GO:0009953),24,3,1.659895373,1.807342829,0.228753105,0.803006734,658;5727;6422,SFRP1;PTCH1;BMPR1B
GO:0000096,sulfur amino acid metabolic process (GO:0000096),24,3,1.659895373,1.807342829,0.228753105,0.803006734,1373;23743;1036,CDO1;BHMT2;CPS1
GO:0061099,negative regulation of protein tyrosine kinase activity (GO:0061099),24,3,1.659895373,1.807342829,0.228753105,0.803006734,857;5753;9052,CAV1;GPRC5A;PTK6
GO:1903902,positive regulation of viral life cycle (GO:1903902),24,3,1.659895373,1.807342829,0.228753105,0.803006734,7301;30835;3838,KPNA2;CD209;TYRO3
GO:0032091,negative regulation of protein binding (GO:0032091),72,7,4.97968612,1.405711089,0.228972474,0.803006734,154;857;6790;9212;6590;10763;9370,AURKA;CAV1;ADRB2;AURKB;ADIPOQ;NES;SLPI
GO:0050769,positive regulation of neurogenesis (GO:0050769),72,7,4.97968612,1.405711089,0.228972474,0.803006734,4804;4915;4311;6664;91584;6376;79006,MME;NTRK2;CX3CL1;NGFR;PLXNA4;METRN;SOX11
GO:0032680,regulation of tumor necrosis factor production (GO:0032680),123,11,8.506963788,1.293058284,0.230613155,0.808289023,7538;3479;3569;4023;4057;947;9370;6376;943;90865;1149,CX3CL1;LPL;CIDEA;ADIPOQ;IL33;ZFP36;CD34;IGF1;IL6;TNFRSF8;LTF
GO:0045087,innate immune response (GO:0045087),295,24,20.40288063,1.176304485,0.231586437,0.811227315,6622;5468;6288;3627;4057;6590;1672;5919;2537;1378;6285;4435;5753;9636;4239;1675;629;10747;3868;6725;5806;92747;2161;286827,S100B;SAA1;TRIM59;CFD;SNCA;CXCL10;PPARG;PTX3;DEFB1;MASP2;MFAP4;F12;IFI6;ISG15;CITED1;CFB;SRMS;PTK6;SLPI;CR1;RARRES2;LTF;BPIFB1;KRT16
GO:0043297,apical junction assembly (GO:0043297),60,6,4.149738433,1.445874263,0.233287888,0.815918833,1894;5010;84612;7122;9073;92359,CLDN11;CLDN5;ECT2;CLDN8;PARD6B;CRB3
GO:0070555,response to interleukin-1 (GO:0070555),85,8,5.878796114,1.360822836,0.233468706,0.815918833,301;6622;6366;5740;4435;6422;3373;6376,CX3CL1;ANXA1;SFRP1;SNCA;HYAL1;CCL21;CITED1;PTGIS
GO:0051100,negative regulation of binding (GO:0051100),85,8,5.878796114,1.360822836,0.233468706,0.815918833,857;6790;9212;6590;51176;10763;1869;3725,AURKA;CAV1;AURKB;E2F1;NES;JUN;LEF1;SLPI
GO:0046578,regulation of Ras protein signal transduction (GO:0046578),85,8,5.878796114,1.360822836,0.233468706,0.815918833,2255;3479;9928;8660;10252;2305;10253;23189,SPRY2;KIF14;FOXM1;KANK1;SPRY1;IRS2;FGF10;IGF1
GO:0007223,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",36,4,2.48984306,1.606526959,0.236021189,0.821042154,54331;7481;51176;8322,LEF1;FZD4;WNT11;GNG2
GO:0000041,transition metal ion transport (GO:0000041),36,4,2.48984306,1.606526959,0.236021189,0.821042154,4057;7018;1356;57348,TF;TTYH1;LTF;CP
GO:0030326,embryonic limb morphogenesis (GO:0030326),36,4,2.48984306,1.606526959,0.236021189,0.821042154,4621;56603;5727;130497,OSR1;MYH3;PTCH1;CYP26B1
GO:0003176,aortic valve development (GO:0003176),36,4,2.48984306,1.606526959,0.236021189,0.821042154,650;23493;2625;6586,BMP2;SLIT3;HEY2;GATA3
GO:1902806,regulation of cell cycle G1/S phase transition (GO:1902806),36,4,2.48984306,1.606526959,0.236021189,0.821042154,9928;1869;2146;81610,KIF14;FAM83D;EZH2;E2F1
GO:0071479,cellular response to ionizing radiation (GO:0071479),48,5,3.319790747,1.506119024,0.236164013,0.821042154,1894;641;5888;10635;1410,CRYAB;RAD51;ECT2;RAD51AP1;BLM
GO:0060341,regulation of cellular localization (GO:0060341),48,5,3.319790747,1.506119024,0.236164013,0.821042154,2934;111;26154;84612;10615,SPAG5;GSN;ADCY5;PARD6B;ABCA12
GO:0043407,negative regulation of MAP kinase activity (GO:0043407),48,5,3.319790747,1.506119024,0.236164013,0.821042154,9370;10252;1843;10253;5997,SPRY2;ADIPOQ;RGS2;SPRY1;DUSP1
GO:0045807,positive regulation of endocytosis (GO:0045807),48,5,3.319790747,1.506119024,0.236164013,0.821042154,6622;6366;2719;7018;11031,TF;GPC3;SNCA;CCL21;RAB31
GO:0072503,cellular divalent inorganic cation homeostasis (GO:0072503),111,10,7.677016102,1.302589426,0.237807777,0.826278929,857;5745;287;6387;1906;1907;344905;9104;4499;4501,MT1M;CAV1;RGN;MT1X;CXCL12;PTH1R;ANK2;EDN1;EDN2;ATP13A5
GO:0006836,neurotransmitter transport (GO:0006836),73,7,5.048848427,1.386454773,0.239423205,0.830931227,6581;57030;6854;320;9378;477;222962,ATP1A2;SYN2;SLC17A7;NRXN1;APBA1;SLC22A3;SLC29A4
GO:0008286,insulin receptor signaling pathway (GO:0008286),73,7,5.048848427,1.386454773,0.239423205,0.830931227,10580;5919;2308;8660;2822;5166;858,PDK4;CAV2;SORBS1;GPLD1;FOXO1;IRS2;RARRES2
GO:0048878,chemical homeostasis (GO:0048878),61,6,4.218900741,1.422171406,0.244905645,0.849467877,5468;57104;8660;8671;1050;116238,TLCD1;PPARG;IRS2;SLC4A4;PNPLA2;CEBPA
GO:0098916,anterograde trans-synaptic signaling (GO:0098916),244,20,16.87560296,1.185142839,0.245900975,0.850875483,1128;6622;5577;6623;6327;3779;6854;5354;320;139411;2564;2568;27115;2892;2893;30819;3777;9378;57502;4857,GRIA4;SYN2;KCNIP2;KCNMB1;SCN2B;PLP1;SNCA;NRXN1;PTCHD1;GABRE;APBA1;SNCG;NOVA1;PDE7B;GABRP;NLGN4X;PRKAR2B;KCNK3;GRIA3;CHRM1
GO:0045604,regulation of epidermal cell differentiation (GO:0045604),25,3,1.729057681,1.735049116,0.247632771,0.850875483,7538;26154;23764,MAFF;ZFP36;ABCA12
GO:0046471,phosphatidylglycerol metabolic process (GO:0046471),25,3,1.729057681,1.735049116,0.247632771,0.850875483,5321;57678;5320,GPAM;PLA2G4A;PLA2G2A
GO:0097696,receptor signaling pathway via STAT (GO:0097696),25,3,1.729057681,1.735049116,0.247632771,0.850875483,2690;8835;6776,GHR;STAT5A;SOCS2
GO:0090200,positive regulation of release of cytochrome c from mitochondria (GO:0090200),25,3,1.729057681,1.735049116,0.247632771,0.850875483,5366;4318;5329,MMP9;PLAUR;PMAIP1
GO:0006775,fat-soluble vitamin metabolic process (GO:0006775),25,3,1.729057681,1.735049116,0.247632771,0.850875483,1583;8854;8029,ALDH1A2;CYP11A1;CUBN
GO:0034114,regulation of heterotypic cell-cell adhesion (GO:0034114),25,3,1.729057681,1.735049116,0.247632771,0.850875483,9370;4680;9314,ADIPOQ;KLF4;CEACAM6
GO:1902652,secondary alcohol metabolic process (GO:1902652),49,5,3.388953054,1.475381901,0.249326749,0.850875483,1066;1583;6713;23461;3931,LCAT;ABCA5;CES1;SQLE;CYP11A1
GO:0007229,integrin-mediated signaling pathway (GO:0007229),74,7,5.118010734,1.367718898,0.250023814,0.850875483,2335;3909;667;1281;9636;5764;9510,FN1;DST;ADAMTS1;PTN;LAMA3;ISG15;COL3A1
GO:0045646,regulation of erythrocyte differentiation (GO:0045646),37,4,2.559005367,1.563107312,0.25138049,0.850875483,7538;3624;3202;6886,INHBA;HOXA5;TAL1;ZFP36
GO:0045639,positive regulation of myeloid cell differentiation (GO:0045639),37,4,2.559005367,1.563107312,0.25138049,0.850875483,3624;3202;54997;6886,INHBA;HOXA5;TESC;TAL1
GO:0070507,regulation of microtubule cytoskeleton organization (GO:0070507),37,4,2.559005367,1.563107312,0.25138049,0.850875483,11170;11076;220134;221150,SKA3;SKA1;FAM107A;TPPP
GO:0006911,"phagocytosis, engulfment (GO:0006911)",37,4,2.559005367,1.563107312,0.25138049,0.850875483,2934;8685;948;2209,CD36;GSN;FCGR1A;MARCO
GO:0007519,skeletal muscle tissue development (GO:0007519),37,4,2.559005367,1.563107312,0.25138049,0.850875483,857;1959;6261;858,CAV1;CAV2;EGR2;RYR1
GO:0051928,positive regulation of calcium ion transport (GO:0051928),37,4,2.559005367,1.563107312,0.25138049,0.850875483,857;4638;287;6387,CAV1;MYLK;CXCL12;ANK2
GO:1904036,negative regulation of epithelial cell apoptotic process (GO:1904036),37,4,2.559005367,1.563107312,0.25138049,0.850875483,284;79625;2625;7010,ANGPT1;TEK;NDNF;GATA3
GO:0006336,DNA replication-independent nucleosome assembly (GO:0006336),37,4,2.559005367,1.563107312,0.25138049,0.850875483,64105;79019;55355;55723,ASF1B;HJURP;CENPM;CENPK
GO:0006103,2-oxoglutarate metabolic process (GO:0006103),14,2,0.968272301,2.065534662,0.251964459,0.850875483,137872;6898,ADHFE1;TAT
GO:0006706,steroid catabolic process (GO:0006706),14,2,0.968272301,2.065534662,0.251964459,0.850875483,6696;3290,SPP1;HSD11B1
GO:0009141,nucleoside triphosphate metabolic process (GO:0009141),14,2,0.968272301,2.065534662,0.251964459,0.850875483,5169;26289,AK5;ENPP3
GO:0031280,negative regulation of cyclase activity (GO:0031280),14,2,0.968272301,2.065534662,0.251964459,0.850875483,1910;5064,EDNRB;PALM
GO:0034764,positive regulation of transmembrane transport (GO:0034764),14,2,0.968272301,2.065534662,0.251964459,0.850875483,2180;8013,ACSL1;NR4A3
GO:0022904,respiratory electron transport chain (GO:0022904),14,2,0.968272301,2.065534662,0.251964459,0.850875483,83733;10891,PPARGC1A;SLC25A18
GO:0060397,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),14,2,0.968272301,2.065534662,0.251964459,0.850875483,2690;6776,GHR;STAT5A
GO:0045624,positive regulation of T-helper cell differentiation (GO:0045624),14,2,0.968272301,2.065534662,0.251964459,0.850875483,301;7292,ANXA1;TNFSF4
GO:0010165,response to X-ray (GO:0010165),14,2,0.968272301,2.065534662,0.251964459,0.850875483,301;641,ANXA1;BLM
GO:0002768,immune response-regulating cell surface receptor signaling pathway (GO:0002768),14,2,0.968272301,2.065534662,0.251964459,0.850875483,3815;5284,KIT;PIGR
GO:0001541,ovarian follicle development (GO:0001541),14,2,0.968272301,2.065534662,0.251964459,0.850875483,3815;3624,INHBA;KIT
GO:0050885,neuromuscular process controlling balance (GO:0050885),14,2,0.968272301,2.065534662,0.251964459,0.850875483,9378;64072,NRXN1;CDH23
GO:0051769,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),14,2,0.968272301,2.065534662,0.251964459,0.850875483,1906;90865,IL33;EDN1
GO:2000651,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),14,2,0.968272301,2.065534662,0.251964459,0.850875483,1756;54997,DMD;TESC
GO:1902894,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),14,2,0.968272301,2.065534662,0.251964459,0.850875483,5468;4781,PPARG;NFIB
GO:0010820,positive regulation of T cell chemotaxis (GO:0010820),14,2,0.968272301,2.065534662,0.251964459,0.850875483,10563;6366,CCL21;CXCL13
GO:0002830,positive regulation of type 2 immune response (GO:0002830),14,2,0.968272301,2.065534662,0.251964459,0.850875483,3569;7292,TNFSF4;IL6
GO:0003283,atrial septum development (GO:0003283),14,2,0.968272301,2.065534662,0.251964459,0.850875483,23493;287,ANK2;HEY2
GO:0016569,covalent chromatin modification (GO:0016569),14,2,0.968272301,2.065534662,0.251964459,0.850875483,9212;3070,AURKB;HELLS
GO:0003214,cardiac left ventricle morphogenesis (GO:0003214),14,2,0.968272301,2.065534662,0.251964459,0.850875483,7048;23493,TGFBR2;HEY2
GO:0046638,positive regulation of alpha-beta T cell differentiation (GO:0046638),14,2,0.968272301,2.065534662,0.251964459,0.850875483,7048;7292,TGFBR2;TNFSF4
GO:0060045,positive regulation of cardiac muscle cell proliferation (GO:0060045),14,2,0.968272301,2.065534662,0.251964459,0.850875483,2247;7049,FGF2;TGFBR3
GO:1903978,regulation of microglial cell activation (GO:1903978),14,2,0.968272301,2.065534662,0.251964459,0.850875483,3569;6376,CX3CL1;IL6
GO:0034374,low-density lipoprotein particle remodeling (GO:0034374),14,2,0.968272301,2.065534662,0.251964459,0.850875483,185;5320,AGTR1;PLA2G2A
GO:0048477,oogenesis (GO:0048477),14,2,0.968272301,2.065534662,0.251964459,0.850875483,9319;5764,PTN;TRIP13
GO:0002710,negative regulation of T cell mediated immunity (GO:0002710),14,2,0.968272301,2.065534662,0.251964459,0.850875483,259307;50943,FOXP3;IL4I1
GO:0034356,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),14,2,0.968272301,2.065534662,0.251964459,0.850875483,5740;5743,PTGS2;PTGIS
GO:0010759,positive regulation of macrophage chemotaxis (GO:0010759),14,2,0.968272301,2.065534662,0.251964459,0.850875483,5919;146433,IL34;RARRES2
GO:1901293,nucleoside phosphate biosynthetic process (GO:1901293),14,2,0.968272301,2.065534662,0.251964459,0.850875483,23057;26289,NMNAT2;AK5
GO:0070262,peptidyl-serine dephosphorylation (GO:0070262),14,2,0.968272301,2.065534662,0.251964459,0.850875483,1843;5522,DUSP1;PPP2R2C
GO:0051128,regulation of cellular component organization (GO:0051128),139,12,9.613560704,1.248236774,0.253933507,0.857043409,11170;9928;948;9627;6790;185;8835;10110;55355;8425;8643;4288,HJURP;MKI67;AURKA;KIF14;FAM107A;LTBP4;CD36;SGK2;PTCH2;SOCS2;SNCAIP;AGTR1
GO:0030308,negative regulation of cell growth (GO:0030308),126,11,8.71445071,1.262271182,0.25465324,0.858990251,3624;7481;56920;6586;4881;64321;6422;3373;2273;92304;56981,INHBA;SFRP1;FHL1;NPR1;SEMA3G;PRDM11;HYAL1;SOX17;SCGB3A1;SLIT3;WNT11
GO:2000146,negative regulation of cell motility (GO:2000146),113,10,7.815340716,1.279534746,0.254869629,0.859237992,4804;7481;2625;7122;23213;9370;6422;6376;3868;23189,CX3CL1;SFRP1;CLDN5;ADIPOQ;KANK1;SULF1;NGFR;WNT11;GATA3;KRT16
GO:0032732,positive regulation of interleukin-1 production (GO:0032732),62,6,4.288063048,1.399233158,0.256686986,0.864395224,3569;6288;4023;948;115362;1958,SAA1;LPL;EGR1;CD36;IL6;GBP5
GO:0050767,regulation of neurogenesis (GO:0050767),62,6,4.288063048,1.399233158,0.256686986,0.864395224,3569;4311;55502;23493;6664;6376,MME;CX3CL1;HES6;IL6;HEY2;SOX11
GO:0050671,positive regulation of lymphocyte proliferation (GO:0050671),75,7,5.187173042,1.349482646,0.2607634,0.877630906,301;2255;3952;3569;7292;8660;30835,LEP;ANXA1;TNFSF4;IRS2;FGF10;CD209;IL6
GO:0010605,negative regulation of macromolecule metabolic process (GO:0010605),193,16,13.34832529,1.198652239,0.261288193,0.878905051,7498;3479;8140;6790;947;650;23493;7122;6664;2247;6422;9314;27303;90993;84913;83643,ATOH8;AURKA;SFRP1;FGF2;CLDN5;RBMS3;BMP2;KLF4;CCDC3;CD34;IGF1;CREB3L1;HEY2;SLC7A5;XDH;SOX11
GO:1902476,chloride transmembrane transport (GO:1902476),50,5,3.458115361,1.445874263,0.262669794,0.881650081,2564;2568;6523;84561;203859,GABRE;GABRP;SLC12A8;ANO5;SLC5A1
GO:0030449,regulation of complement activation (GO:0030449),50,5,3.458115361,1.445874263,0.262669794,0.881650081,1378;629;5627;729;730,PROS1;CFB;C7;C6;CR1
GO:0006826,iron ion transport (GO:0006826),50,5,3.458115361,1.445874263,0.262669794,0.881650081,4057;7018;286133;1356;57348,SCARA5;TF;TTYH1;LTF;CP
GO:0050954,sensory perception of mechanical stimulus (GO:0050954),88,8,6.086283036,1.314431148,0.262845427,0.881650081,3753;64072;51473;332;53405;1277;1301;286262,COL11A1;KCNE1;BIRC5;TPRN;CLIC5;CDH23;COL1A1;DCDC2
GO:0043254,regulation of protein-containing complex assembly (GO:0043254),114,10,7.884503023,1.268310757,0.263552038,0.881650081,2934;3084;948;11076;81620;6403;4314;1410;55355;6886,HJURP;CRYAB;CD36;GSN;TAL1;CDT1;TPPP;MMP3;NRG1;SELP
GO:0032270,positive regulation of cellular protein metabolic process (GO:0032270),101,9,6.985393029,1.288402809,0.26363617,0.881650081,3624;825;3569;5347;185;9314;29128;23034;55323,INHBA;UHRF1;PLK1;CAPN3;KLF4;LARP6;SAMD4A;IL6;AGTR1
GO:0070167,regulation of biomineral tissue development (GO:0070167),26,3,1.798219988,1.668316458,0.266736616,0.881650081,1901;23493;4921,S1PR1;HEY2;DDR2
GO:0005979,regulation of glycogen biosynthetic process (GO:0005979),26,3,1.798219988,1.668316458,0.266736616,0.881650081,3479;10580;8660,SORBS1;IRS2;IGF1
GO:0051491,positive regulation of filopodium assembly (GO:0051491),26,3,1.798219988,1.668316458,0.266736616,0.881650081,6366;139818;5064,CCL21;PALM;DOCK11
GO:0032272,negative regulation of protein polymerization (GO:0032272),26,3,1.798219988,1.668316458,0.266736616,0.881650081,6622;23189;256949,SNCA;KANK1;KANK3
GO:1903900,regulation of viral life cycle (GO:1903900),26,3,1.798219988,1.668316458,0.266736616,0.881650081,7301;30835;3838,KPNA2;CD209;TYRO3
GO:1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),26,3,1.798219988,1.668316458,0.266736616,0.881650081,8626;5366;1869,E2F1;TP63;PMAIP1
GO:1900739,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),26,3,1.798219988,1.668316458,0.266736616,0.881650081,8626;5366;1869,E2F1;TP63;PMAIP1
GO:0021782,glial cell development (GO:0021782),26,3,1.798219988,1.668316458,0.266736616,0.881650081,6663;11076;6664,SOX10;TPPP;SOX11
GO:0006029,proteoglycan metabolic process (GO:0006029),26,3,1.798219988,1.668316458,0.266736616,0.881650081,3479;658;23213,SULF1;IGF1;BMPR1B
GO:0048488,synaptic vesicle endocytosis (GO:0048488),38,4,2.628167674,1.521972909,0.266940648,0.881650081,6622;6623;57502;90019,SNCA;SNCG;SYT8;NLGN4X
GO:0002702,positive regulation of production of molecular mediator of immune response (GO:0002702),38,4,2.628167674,1.521972909,0.266940648,0.881650081,3569;7292;8140;5950,RBP4;TNFSF4;IL6;SLC7A5
GO:0072330,monocarboxylic acid biosynthetic process (GO:0072330),63,6,4.357225355,1.377023108,0.268616975,0.881650081,54988;4023;10993;51302;220;8854,ALDH1A2;LPL;SDS;ACSM5;CYP39A1;ALDH1A3
GO:0019932,second-messenger-mediated signaling (GO:0019932),89,8,6.155445343,1.299662259,0.272875527,0.881650081,64805;948;79625;185;1910;1906;1907;1827,CD36;P2RY12;EDNRB;RCAN1;EDN1;EDN2;NDNF;AGTR1
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),89,8,6.155445343,1.299662259,0.272875527,0.881650081,6622;4804;130399;358;2537;5366;9314;83595,SNCA;AQP1;ACVR1C;NGFR;KLF4;SOX7;IFI6;PMAIP1
GO:0030099,myeloid cell differentiation (GO:0030099),51,5,3.527277668,1.417523788,0.276171545,0.881650081,3815;3624;7704;1050;6886,INHBA;ZBTB16;KIT;TAL1;CEBPA
GO:0032508,DNA duplex unwinding (GO:0032508),51,5,3.527277668,1.417523788,0.276171545,0.881650081,301;9401;641;4173;5888,ANXA1;RAD51;RECQL4;MCM4;BLM
GO:0007600,sensory perception (GO:0007600),51,5,3.527277668,1.417523788,0.276171545,0.881650081,6335;2774;135;4311;64072,MME;GNAL;CDH23;SCN9A;ADORA2A
GO:0043604,amide biosynthetic process (GO:0043604),51,5,3.527277668,1.417523788,0.276171545,0.881650081,1756;1373;123099;126410;10351,DMD;ABCA8;CPS1;DEGS2;CYP4F22
GO:0008589,regulation of smoothened signaling pathway (GO:0008589),51,5,3.527277668,1.417523788,0.276171545,0.881650081,2719;5727;6422;51473;8643,SFRP1;GPC3;PTCH2;PTCH1;DCDC2
GO:0043031,negative regulation of macrophage activation (GO:0043031),15,2,1.037434608,1.927832351,0.27835374,0.881650081,6376;145581,CX3CL1;LRFN5
GO:0006084,acetyl-CoA metabolic process (GO:0006084),15,2,1.037434608,1.927832351,0.27835374,0.881650081,3158;32,ACACB;HMGCS2
GO:0042359,vitamin D metabolic process (GO:0042359),15,2,1.037434608,1.927832351,0.27835374,0.881650081,1583;8029,CYP11A1;CUBN
GO:0070207,protein homotrimerization (GO:0070207),15,2,1.037434608,1.927832351,0.27835374,0.881650081,286133;79689,SCARA5;STEAP4
GO:0070206,protein trimerization (GO:0070206),15,2,1.037434608,1.927832351,0.27835374,0.881650081,286133;79689,SCARA5;STEAP4
GO:2000114,regulation of establishment of cell polarity (GO:2000114),15,2,1.037434608,1.927832351,0.27835374,0.881650081,2934;23189,GSN;KANK1
GO:0048011,neurotrophin TRK receptor signaling pathway (GO:0048011),15,2,1.037434608,1.927832351,0.27835374,0.881650081,4804;4915,NTRK2;NGFR
GO:0071318,cellular response to ATP (GO:0071318),15,2,1.037434608,1.927832351,0.27835374,0.881650081,64805;6263,RYR3;P2RY12
GO:0032331,negative regulation of chondrocyte differentiation (GO:0032331),15,2,1.037434608,1.927832351,0.27835374,0.881650081,5744;2202,EFEMP1;PTHLH
GO:0051271,negative regulation of cellular component movement (GO:0051271),15,2,1.037434608,1.927832351,0.27835374,0.881650081,2625;7049,TGFBR3;GATA3
GO:0086013,membrane repolarization during cardiac muscle cell action potential (GO:0086013),15,2,1.037434608,1.927832351,0.27835374,0.881650081,3753;30819,KCNE1;KCNIP2
GO:0043401,steroid hormone mediated signaling pathway (GO:0043401),15,2,1.037434608,1.927832351,0.27835374,0.881650081,2908;4306,NR3C2;NR3C1
GO:2001028,positive regulation of endothelial cell chemotaxis (GO:2001028),15,2,1.037434608,1.927832351,0.27835374,0.881650081,2247;4233,FGF2;MET
GO:0021954,central nervous system neuron development (GO:0021954),15,2,1.037434608,1.927832351,0.27835374,0.881650081,4915;26468,NTRK2;LHX6
GO:2001169,regulation of ATP biosynthetic process (GO:2001169),15,2,1.037434608,1.927832351,0.27835374,0.881650081,10891;55022,PID1;PPARGC1A
GO:0046827,positive regulation of protein export from nucleus (GO:0046827),15,2,1.037434608,1.927832351,0.27835374,0.881650081,10411;51512,GTSE1;RAPGEF3
GO:0043032,positive regulation of macrophage activation (GO:0043032),15,2,1.037434608,1.927832351,0.27835374,0.881650081,1050;90865,IL33;CEBPA
GO:0060760,positive regulation of response to cytokine stimulus (GO:0060760),15,2,1.037434608,1.927832351,0.27835374,0.881650081,85480;100130733,TSLP;LRRC70
GO:1902692,regulation of neuroblast proliferation (GO:1902692),15,2,1.037434608,1.927832351,0.27835374,0.881650081,6376;5764,CX3CL1;PTN
GO:0006953,acute-phase response (GO:0006953),15,2,1.037434608,1.927832351,0.27835374,0.881650081,3569;6288,SAA1;IL6
GO:0010866,regulation of triglyceride biosynthetic process (GO:0010866),15,2,1.037434608,1.927832351,0.27835374,0.881650081,2822;440503,GPLD1;PLIN5
GO:0018130,heterocycle biosynthetic process (GO:0018130),15,2,1.037434608,1.927832351,0.27835374,0.881650081,5831;4337,PYCR1;MOCS1
GO:1901071,glucosamine-containing compound metabolic process (GO:1901071),15,2,1.037434608,1.927832351,0.27835374,0.881650081,4248;9469,CHST3;MGAT3
GO:0001574,ganglioside biosynthetic process (GO:0001574),15,2,1.037434608,1.927832351,0.27835374,0.881650081,8128;256435,ST6GALNAC3;ST8SIA2
GO:0006883,cellular sodium ion homeostasis (GO:0006883),15,2,1.037434608,1.927832351,0.27835374,0.881650081,477;482,ATP1A2;ATP1B2
GO:1903053,regulation of extracellular matrix organization (GO:1903053),15,2,1.037434608,1.927832351,0.27835374,0.881650081,2191;4921,FAP;DDR2
GO:0009251,glucan catabolic process (GO:0009251),15,2,1.037434608,1.927832351,0.27835374,0.881650081,5837;5260,PYGM;PHKG1
GO:0005980,glycogen catabolic process (GO:0005980),15,2,1.037434608,1.927832351,0.27835374,0.881650081,5837;5260,PYGM;PHKG1
GO:0032101,regulation of response to external stimulus (GO:0032101),129,11,8.921937632,1.232916038,0.2795142,0.881650081,301;64805;7292;11343;857;948;185;5743;6376;1259;9397,CX3CL1;CAV1;ANXA1;CD36;TNFSF4;P2RY12;NMT2;PTGS2;MGLL;CNGA1;AGTR1
GO:0050672,negative regulation of lymphocyte proliferation (GO:0050672),39,4,2.697329982,1.482947962,0.282667693,0.881650081,259307;1378;6664;50943,FOXP3;IL4I1;CR1;SOX11
GO:0050709,negative regulation of protein secretion (GO:0050709),39,4,2.697329982,1.482947962,0.282667693,0.881650081,3745;150;353500;6422,BMP8A;SFRP1;KCNB1;ADRA2A
GO:0090407,organophosphate biosynthetic process (GO:0090407),39,4,2.697329982,1.482947962,0.282667693,0.881650081,57678;1373;2247;4337,FGF2;GPAM;MOCS1;CPS1
GO:0031324,negative regulation of cellular metabolic process (GO:0031324),39,4,2.697329982,1.482947962,0.282667693,0.881650081,1910;1906;5806;440503,PTX3;EDNRB;EDN1;PLIN5
GO:0071364,cellular response to epidermal growth factor stimulus (GO:0071364),27,3,1.867382295,1.606526959,0.286002769,0.881650081,7538;1956;2296,EGFR;ZFP36;FOXC1
GO:2000637,positive regulation of gene silencing by miRNA (GO:2000637),27,3,1.867382295,1.606526959,0.286002769,0.881650081,7538;1956;3569,EGFR;ZFP36;IL6
GO:0051149,positive regulation of muscle cell differentiation (GO:0051149),27,3,1.867382295,1.606526959,0.286002769,0.881650081,3084;1000;91653,BOC;NRG1;CDH2
GO:0098815,modulation of excitatory postsynaptic potential (GO:0098815),27,3,1.867382295,1.606526959,0.286002769,0.881650081,9378;57502;5649,RELN;NRXN1;NLGN4X
GO:0007159,leukocyte cell-cell adhesion (GO:0007159),27,3,1.867382295,1.606526959,0.286002769,0.881650081,4973;6403;30835,OLR1;CD209;SELP
GO:0034121,regulation of toll-like receptor signaling pathway (GO:0034121),27,3,1.867382295,1.606526959,0.286002769,0.881650081,55366;948;7301,CD36;LGR4;TYRO3
GO:1903426,regulation of reactive oxygen species biosynthetic process (GO:1903426),27,3,1.867382295,1.606526959,0.286002769,0.881650081,6622;948;225,SNCA;CD36;ABCD2
GO:0015949,nucleobase-containing small molecule interconversion (GO:0015949),27,3,1.867382295,1.606526959,0.286002769,0.881650081,6241;7298;26289,RRM2;TYMS;AK5
GO:0005977,glycogen metabolic process (GO:0005977),27,3,1.867382295,1.606526959,0.286002769,0.881650081,5837;5260;8908,PYGM;GYG2;PHKG1
GO:0045787,positive regulation of cell cycle (GO:0045787),65,6,4.495549969,1.334653166,0.292862972,0.881650081,1956;891;4212;5753;3169;6886,CCNB1;MEIS2;EGFR;TAL1;PTK6;FOXA1
GO:0051050,positive regulation of transport (GO:0051050),91,8,6.293769957,1.271098253,0.293241095,0.881650081,1128;301;6622;2719;2822;8447;10110;10615,SPAG5;ANXA1;GPC3;SNCA;SGK2;GPLD1;DOC2B;CHRM1
GO:0045664,regulation of neuron differentiation (GO:0045664),78,7,5.394659963,1.297579467,0.293705467,0.881650081,1894;650;6664;1840;274;51704;23531,ECT2;BMP2;GPRC5B;DTX1;BIN1;MMD;SOX11
GO:0042742,defense response to bacterium (GO:0042742),171,14,11.82675453,1.183756707,0.295045414,0.881650081,10563;3569;358;4057;1511;7018;6590;1672;5919;57402;6403;9636;306;5320,TF;AQP1;DEFB1;ISG15;IL6;ANXA3;S100A14;CTSG;SELP;SLPI;PLA2G2A;RARRES2;CXCL13;LTF
GO:0051489,regulation of filopodium assembly (GO:0051489),40,4,2.766492289,1.445874263,0.298528474,0.881650081,6366;139818;26051;5064,CCL21;PPP1R16B;PALM;DOCK11
GO:0051898,negative regulation of protein kinase B signaling (GO:0051898),40,4,2.766492289,1.445874263,0.298528474,0.881650081,9368;7498;55024;57761,TRIB3;SLC9A3R1;XDH;BANK1
GO:0060348,bone development (GO:0060348),40,4,2.766492289,1.445874263,0.298528474,0.881650081,5734;4057;23213;56603,SULF1;PTGER4;CYP26B1;LTF
GO:0006114,glycerol biosynthetic process (GO:0006114),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5105,PCK1
GO:0006538,glutamate catabolic process (GO:0006538),5,1,0.345811536,2.891748527,0.301208076,0.881650081,137872,ADHFE1
GO:0009143,nucleoside triphosphate catabolic process (GO:0009143),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5169,ENPP3
GO:0038066,p38MAPK cascade (GO:0038066),5,1,0.345811536,2.891748527,0.301208076,0.881650081,7538,ZFP36
GO:0060967,negative regulation of gene silencing by RNA (GO:0060967),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5468,PPARG
GO:0060149,negative regulation of posttranscriptional gene silencing (GO:0060149),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5468,PPARG
GO:0008063,Toll signaling pathway (GO:0008063),5,1,0.345811536,2.891748527,0.301208076,0.881650081,57161,PELI2
GO:0006220,pyrimidine nucleotide metabolic process (GO:0006220),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5169,ENPP3
GO:0006107,oxaloacetate metabolic process (GO:0006107),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5105,PCK1
GO:0007614,short-term memory (GO:0007614),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6517,SLC2A4
GO:0051954,positive regulation of amine transport (GO:0051954),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3745,KCNB1
GO:0032782,bile acid secretion (GO:0032782),5,1,0.345811536,2.891748527,0.301208076,0.881650081,9368,SLC9A3R1
GO:0060161,positive regulation of dopamine receptor signaling pathway (GO:0060161),5,1,0.345811536,2.891748527,0.301208076,0.881650081,858,CAV2
GO:0034635,glutathione transport (GO:0034635),5,1,0.345811536,2.891748527,0.301208076,0.881650081,9368,SLC9A3R1
GO:0032277,negative regulation of gonadotropin secretion (GO:0032277),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3624,INHBA
GO:1903729,regulation of plasma membrane organization (GO:1903729),5,1,0.345811536,2.891748527,0.301208076,0.881650081,2934,GSN
GO:0035385,Roundabout signaling pathway (GO:0035385),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6586,SLIT3
GO:0046632,alpha-beta T cell differentiation (GO:0046632),5,1,0.345811536,2.891748527,0.301208076,0.881650081,301,ANXA1
GO:0036006,cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5138,PDE2A
GO:0033007,negative regulation of mast cell activation involved in immune response (GO:0033007),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5169,ENPP3
GO:0036005,response to macrophage colony-stimulating factor (GO:0036005),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5138,PDE2A
GO:1903348,positive regulation of bicellular tight junction assembly (GO:1903348),5,1,0.345811536,2.891748527,0.301208076,0.881650081,7122,CLDN5
GO:0002327,immature B cell differentiation (GO:0002327),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3815,KIT
GO:0002705,positive regulation of leukocyte mediated immunity (GO:0002705),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3815,KIT
GO:0051152,positive regulation of smooth muscle cell differentiation (GO:0051152),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3815,KIT
GO:0002730,regulation of dendritic cell cytokine production (GO:0002730),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3815,KIT
GO:0032946,positive regulation of mononuclear cell proliferation (GO:0032946),5,1,0.345811536,2.891748527,0.301208076,0.881650081,2255,FGF10
GO:0007431,salivary gland development (GO:0007431),5,1,0.345811536,2.891748527,0.301208076,0.881650081,2255,FGF10
GO:0036120,cellular response to platelet-derived growth factor stimulus (GO:0036120),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3373,HYAL1
GO:1903391,regulation of adherens junction organization (GO:1903391),5,1,0.345811536,2.891748527,0.301208076,0.881650081,654,BMP6
GO:0060420,regulation of heart growth (GO:0060420),5,1,0.345811536,2.891748527,0.301208076,0.881650081,1848,DUSP6
GO:0032430,positive regulation of phospholipase A2 activity (GO:0032430),5,1,0.345811536,2.891748527,0.301208076,0.881650081,185,AGTR1
GO:0010764,negative regulation of fibroblast migration (GO:0010764),5,1,0.345811536,2.891748527,0.301208076,0.881650081,2247,FGF2
GO:1990416,cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),5,1,0.345811536,2.891748527,0.301208076,0.881650081,4915,NTRK2
GO:1901856,negative regulation of cellular respiration (GO:1901856),5,1,0.345811536,2.891748527,0.301208076,0.881650081,51085,MLXIPL
GO:1900454,positive regulation of long-term synaptic depression (GO:1900454),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3745,KCNB1
GO:0099612,protein localization to axon (GO:0099612),5,1,0.345811536,2.891748527,0.301208076,0.881650081,26047,CNTNAP2
GO:0098915,membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3753,KCNE1
GO:0060452,positive regulation of cardiac muscle contraction (GO:0060452),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5997,RGS2
GO:1901979,regulation of inward rectifier potassium channel activity (GO:1901979),5,1,0.345811536,2.891748527,0.301208076,0.881650081,857,CAV1
GO:0086046,membrane depolarization during SA node cell action potential (GO:0086046),5,1,0.345811536,2.891748527,0.301208076,0.881650081,287,ANK2
GO:0030263,apoptotic chromosome condensation (GO:0030263),5,1,0.345811536,2.891748527,0.301208076,0.881650081,7153,TOP2A
GO:0042749,regulation of circadian sleep/wake cycle (GO:0042749),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5730,PTGDS
GO:0045986,negative regulation of smooth muscle contraction (GO:0045986),5,1,0.345811536,2.891748527,0.301208076,0.881650081,154,ADRB2
GO:0031642,negative regulation of myelination (GO:0031642),5,1,0.345811536,2.891748527,0.301208076,0.881650081,58494,JAM2
GO:1904428,negative regulation of tubulin deacetylation (GO:1904428),5,1,0.345811536,2.891748527,0.301208076,0.881650081,11076,TPPP
GO:0002544,chronic inflammatory response (GO:0002544),5,1,0.345811536,2.891748527,0.301208076,0.881650081,10563,CXCL13
GO:0060252,positive regulation of glial cell proliferation (GO:0060252),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3569,IL6
GO:0031652,positive regulation of heat generation (GO:0031652),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5743,PTGS2
GO:0031620,regulation of fever generation (GO:0031620),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5743,PTGS2
GO:0042416,dopamine biosynthetic process (GO:0042416),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6622,SNCA
GO:0035542,regulation of SNARE complex assembly (GO:0035542),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6622,SNCA
GO:1903421,regulation of synaptic vesicle recycling (GO:1903421),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6622,SNCA
GO:1905563,negative regulation of vascular endothelial cell proliferation (GO:1905563),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5468,PPARG
GO:1905599,positive regulation of low-density lipoprotein receptor activity (GO:1905599),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5468,PPARG
GO:1905461,positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5468,PPARG
GO:0016198,axon choice point recognition (GO:0016198),5,1,0.345811536,2.891748527,0.301208076,0.881650081,64221,ROBO3
GO:0043569,negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569),5,1,0.345811536,2.891748527,0.301208076,0.881650081,650,BMP2
GO:0046102,inosine metabolic process (GO:0046102),5,1,0.345811536,2.891748527,0.301208076,0.881650081,7498,XDH
GO:1903208,negative regulation of hydrogen peroxide-induced neuron death (GO:1903208),5,1,0.345811536,2.891748527,0.301208076,0.881650081,8013,NR4A3
GO:0051901,positive regulation of mitochondrial depolarization (GO:0051901),5,1,0.345811536,2.891748527,0.301208076,0.881650081,1634,DCN
GO:0001768,establishment of T cell polarity (GO:0001768),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6366,CCL21
GO:1905809,negative regulation of synapse organization (GO:1905809),5,1,0.345811536,2.891748527,0.301208076,0.881650081,22899,ARHGEF15
GO:0044381,glucose import in response to insulin stimulus (GO:0044381),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6517,SLC2A4
GO:1990379,lipid transport across blood-brain barrier (GO:1990379),5,1,0.345811536,2.891748527,0.301208076,0.881650081,948,CD36
GO:1903238,positive regulation of leukocyte tethering or rolling (GO:1903238),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6403,SELP
GO:1990051,activation of protein kinase C activity (GO:1990051),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3952,LEP
GO:0014831,gastro-intestinal system smooth muscle contraction (GO:0014831),5,1,0.345811536,2.891748527,0.301208076,0.881650081,23213,SULF1
GO:1900020,positive regulation of protein kinase C activity (GO:1900020),5,1,0.345811536,2.891748527,0.301208076,0.881650081,1956,EGFR
GO:1900019,regulation of protein kinase C activity (GO:1900019),5,1,0.345811536,2.891748527,0.301208076,0.881650081,1956,EGFR
GO:0060038,cardiac muscle cell proliferation (GO:0060038),5,1,0.345811536,2.891748527,0.301208076,0.881650081,7049,TGFBR3
GO:1905007,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),5,1,0.345811536,2.891748527,0.301208076,0.881650081,7048,TGFBR2
GO:0014855,striated muscle cell proliferation (GO:0014855),5,1,0.345811536,2.891748527,0.301208076,0.881650081,7049,TGFBR3
GO:0032096,negative regulation of response to food (GO:0032096),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3952,LEP
GO:0015732,prostaglandin transport (GO:0015732),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3952,LEP
GO:0002715,regulation of natural killer cell mediated immunity (GO:0002715),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3952,LEP
GO:1901984,negative regulation of protein acetylation (GO:1901984),5,1,0.345811536,2.891748527,0.301208076,0.881650081,28999,KLF15
GO:0034392,negative regulation of smooth muscle cell apoptotic process (GO:0034392),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3479,IGF1
GO:0035624,receptor transactivation (GO:0035624),5,1,0.345811536,2.891748527,0.301208076,0.881650081,150,ADRA2A
GO:0045955,negative regulation of calcium ion-dependent exocytosis (GO:0045955),5,1,0.345811536,2.891748527,0.301208076,0.881650081,150,ADRA2A
GO:0030202,heparin metabolic process (GO:0030202),5,1,0.345811536,2.891748527,0.301208076,0.881650081,284,ANGPT1
GO:0060379,cardiac muscle cell myoblast differentiation (GO:0060379),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3084,NRG1
GO:2000563,"positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)",5,1,0.345811536,2.891748527,0.301208076,0.881650081,7048,TGFBR2
GO:0046813,receptor-mediated virion attachment to host cell (GO:0046813),5,1,0.345811536,2.891748527,0.301208076,0.881650081,131578,LRRC15
GO:0061312,BMP signaling pathway involved in heart development (GO:0061312),5,1,0.345811536,2.891748527,0.301208076,0.881650081,650,BMP2
GO:0060911,cardiac cell fate commitment (GO:0060911),5,1,0.345811536,2.891748527,0.301208076,0.881650081,64321,SOX17
GO:0009950,dorsal/ventral axis specification (GO:0009950),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6422,SFRP1
GO:0055012,ventricular cardiac muscle cell differentiation (GO:0055012),5,1,0.345811536,2.891748527,0.301208076,0.881650081,23493,HEY2
GO:0020027,hemoglobin metabolic process (GO:0020027),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3624,INHBA
GO:0071394,cellular response to testosterone stimulus (GO:0071394),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6696,SPP1
GO:0033631,cell-cell adhesion mediated by integrin (GO:0033631),5,1,0.345811536,2.891748527,0.301208076,0.881650081,255743,NPNT
GO:2001015,negative regulation of skeletal muscle cell differentiation (GO:2001015),5,1,0.345811536,2.891748527,0.301208076,0.881650081,2047,EPHB1
GO:0061888,regulation of astrocyte activation (GO:0061888),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3569,IL6
GO:2000674,regulation of type B pancreatic cell apoptotic process (GO:2000674),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3569,IL6
GO:2000373,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),5,1,0.345811536,2.891748527,0.301208076,0.881650081,29128,UHRF1
GO:2000371,regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),5,1,0.345811536,2.891748527,0.301208076,0.881650081,29128,UHRF1
GO:0035710,"CD4-positive, alpha-beta T cell activation (GO:0035710)",5,1,0.345811536,2.891748527,0.301208076,0.881650081,7292,TNFSF4
GO:0045590,negative regulation of regulatory T cell differentiation (GO:0045590),5,1,0.345811536,2.891748527,0.301208076,0.881650081,7292,TNFSF4
GO:1903018,regulation of glycoprotein metabolic process (GO:1903018),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5806,PTX3
GO:0010727,negative regulation of hydrogen peroxide metabolic process (GO:0010727),5,1,0.345811536,2.891748527,0.301208076,0.881650081,4314,MMP3
GO:0046461,neutral lipid catabolic process (GO:0046461),5,1,0.345811536,2.891748527,0.301208076,0.881650081,11343,MGLL
GO:0038171,cannabinoid signaling pathway (GO:0038171),5,1,0.345811536,2.891748527,0.301208076,0.881650081,1268,CNR1
GO:0031670,cellular response to nutrient (GO:0031670),5,1,0.345811536,2.891748527,0.301208076,0.881650081,4023,LPL
GO:0048550,negative regulation of pinocytosis (GO:0048550),5,1,0.345811536,2.891748527,0.301208076,0.881650081,857,CAV1
GO:0072584,caveolin-mediated endocytosis (GO:0072584),5,1,0.345811536,2.891748527,0.301208076,0.881650081,857,CAV1
GO:1903044,protein localization to membrane raft (GO:1903044),5,1,0.345811536,2.891748527,0.301208076,0.881650081,857,CAV1
GO:0010455,positive regulation of cell fate commitment (GO:0010455),5,1,0.345811536,2.891748527,0.301208076,0.881650081,2247,FGF2
GO:0032831,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",5,1,0.345811536,2.891748527,0.301208076,0.881650081,50943,FOXP3
GO:0071321,cellular response to cGMP (GO:0071321),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5138,PDE2A
GO:0070305,response to cGMP (GO:0070305),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5138,PDE2A
GO:0032792,negative regulation of CREB transcription factor activity (GO:0032792),5,1,0.345811536,2.891748527,0.301208076,0.881650081,50943,FOXP3
GO:0014037,Schwann cell differentiation (GO:0014037),5,1,0.345811536,2.891748527,0.301208076,0.881650081,1959,EGR2
GO:0060272,embryonic skeletal joint morphogenesis (GO:0060272),5,1,0.345811536,2.891748527,0.301208076,0.881650081,130497,OSR1
GO:0060219,camera-type eye photoreceptor cell differentiation (GO:0060219),5,1,0.345811536,2.891748527,0.301208076,0.881650081,8842,PROM1
GO:0060539,diaphragm development (GO:0060539),5,1,0.345811536,2.891748527,0.301208076,0.881650081,64220,STRA6
GO:2000391,positive regulation of neutrophil extravasation (GO:2000391),5,1,0.345811536,2.891748527,0.301208076,0.881650081,101,ADAM8
GO:0002067,glandular epithelial cell differentiation (GO:0002067),5,1,0.345811536,2.891748527,0.301208076,0.881650081,650,BMP2
GO:0072162,metanephric mesenchymal cell differentiation (GO:0072162),5,1,0.345811536,2.891748527,0.301208076,0.881650081,130497,OSR1
GO:0042074,cell migration involved in gastrulation (GO:0042074),5,1,0.345811536,2.891748527,0.301208076,0.881650081,2719,GPC3
GO:0009249,protein lipoylation (GO:0009249),5,1,0.345811536,2.891748527,0.301208076,0.881650081,4826,NNAT
GO:0090235,regulation of metaphase plate congression (GO:0090235),5,1,0.345811536,2.891748527,0.301208076,0.881650081,10615,SPAG5
GO:0006501,C-terminal protein lipidation (GO:0006501),5,1,0.345811536,2.891748527,0.301208076,0.881650081,2822,GPLD1
GO:0006561,proline biosynthetic process (GO:0006561),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5831,PYCR1
GO:1902222,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),5,1,0.345811536,2.891748527,0.301208076,0.881650081,259307,IL4I1
GO:0006559,L-phenylalanine catabolic process (GO:0006559),5,1,0.345811536,2.891748527,0.301208076,0.881650081,259307,IL4I1
GO:0015677,copper ion import (GO:0015677),5,1,0.345811536,2.891748527,0.301208076,0.881650081,79689,STEAP4
GO:0032741,positive regulation of interleukin-18 production (GO:0032741),5,1,0.345811536,2.891748527,0.301208076,0.881650081,115362,GBP5
GO:0045617,negative regulation of keratinocyte differentiation (GO:0045617),5,1,0.345811536,2.891748527,0.301208076,0.881650081,3204,HOXA7
GO:0042474,middle ear morphogenesis (GO:0042474),5,1,0.345811536,2.891748527,0.301208076,0.881650081,130497,OSR1
GO:0006001,fructose catabolic process (GO:0006001),5,1,0.345811536,2.891748527,0.301208076,0.881650081,216,ALDH1A1
GO:0061624,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),5,1,0.345811536,2.891748527,0.301208076,0.881650081,216,ALDH1A1
GO:0009448,gamma-aminobutyric acid metabolic process (GO:0009448),5,1,0.345811536,2.891748527,0.301208076,0.881650081,216,ALDH1A1
GO:0006578,amino-acid betaine biosynthetic process (GO:0006578),5,1,0.345811536,2.891748527,0.301208076,0.881650081,8424,BBOX1
GO:0045329,carnitine biosynthetic process (GO:0045329),5,1,0.345811536,2.891748527,0.301208076,0.881650081,8424,BBOX1
GO:0009218,pyrimidine ribonucleotide metabolic process (GO:0009218),5,1,0.345811536,2.891748527,0.301208076,0.881650081,26289,AK5
GO:0071236,cellular response to antibiotic (GO:0071236),5,1,0.345811536,2.891748527,0.301208076,0.881650081,1396,CRIP1
GO:1904796,regulation of core promoter binding (GO:1904796),5,1,0.345811536,2.891748527,0.301208076,0.881650081,2296,FOXC1
GO:0051987,positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),5,1,0.345811536,2.891748527,0.301208076,0.881650081,891,CCNB1
GO:0097734,extracellular exosome biogenesis (GO:0097734),5,1,0.345811536,2.891748527,0.301208076,0.881650081,947,CD34
GO:1903961,positive regulation of anion transmembrane transport (GO:1903961),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5243,ABCB1
GO:0097119,postsynaptic density protein 95 clustering (GO:0097119),5,1,0.345811536,2.891748527,0.301208076,0.881650081,9378,NRXN1
GO:0002087,regulation of respiratory gaseous exchange by nervous system process (GO:0002087),5,1,0.345811536,2.891748527,0.301208076,0.881650081,477,ATP1A2
GO:0120041,positive regulation of macrophage proliferation (GO:0120041),5,1,0.345811536,2.891748527,0.301208076,0.881650081,146433,IL34
GO:0110089,regulation of hippocampal neuron apoptotic process (GO:0110089),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6376,CX3CL1
GO:0002638,negative regulation of immunoglobulin production (GO:0002638),5,1,0.345811536,2.891748527,0.301208076,0.881650081,1378,CR1
GO:1902563,regulation of neutrophil activation (GO:1902563),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5320,PLA2G2A
GO:0046645,positive regulation of gamma-delta T cell activation (GO:0046645),5,1,0.345811536,2.891748527,0.301208076,0.881650081,51176,LEF1
GO:0032696,negative regulation of interleukin-13 production (GO:0032696),5,1,0.345811536,2.891748527,0.301208076,0.881650081,51176,LEF1
GO:0032714,negative regulation of interleukin-5 production (GO:0032714),5,1,0.345811536,2.891748527,0.301208076,0.881650081,51176,LEF1
GO:0060700,regulation of ribonuclease activity (GO:0060700),5,1,0.345811536,2.891748527,0.301208076,0.881650081,8638,OASL
GO:2000288,positive regulation of myoblast proliferation (GO:2000288),5,1,0.345811536,2.891748527,0.301208076,0.881650081,4212,MEIS2
GO:0051106,positive regulation of DNA ligation (GO:0051106),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5888,RAD51
GO:0038146,chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6387,CXCL12
GO:0043504,mitochondrial DNA repair (GO:0043504),5,1,0.345811536,2.891748527,0.301208076,0.881650081,1763,DNA2
GO:0006798,polyphosphate catabolic process (GO:0006798),5,1,0.345811536,2.891748527,0.301208076,0.881650081,158471,PRUNE2
GO:0098708,glucose import across plasma membrane (GO:0098708),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6523,SLC5A1
GO:0060044,negative regulation of cardiac muscle cell proliferation (GO:0060044),5,1,0.345811536,2.891748527,0.301208076,0.881650081,5950,RBP4
GO:0051418,microtubule nucleation by microtubule organizing center (GO:0051418),5,1,0.345811536,2.891748527,0.301208076,0.881650081,11076,TPPP
GO:0032650,regulation of interleukin-1 alpha production (GO:0032650),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6376,CX3CL1
GO:0060993,kidney morphogenesis (GO:0060993),5,1,0.345811536,2.891748527,0.301208076,0.881650081,7477,WNT7B
GO:0035332,positive regulation of hippo signaling (GO:0035332),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6664,SOX11
GO:0106070,regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),5,1,0.345811536,2.891748527,0.301208076,0.881650081,112609,MRAP2
GO:2000405,negative regulation of T cell migration (GO:2000405),5,1,0.345811536,2.891748527,0.301208076,0.881650081,347,APOD
GO:0031064,negative regulation of histone deacetylation (GO:0031064),5,1,0.345811536,2.891748527,0.301208076,0.881650081,50943,FOXP3
GO:0070200,establishment of protein localization to telomere (GO:0070200),5,1,0.345811536,2.891748527,0.301208076,0.881650081,675,BRCA2
GO:2000267,"negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",5,1,0.345811536,2.891748527,0.301208076,0.881650081,2161,F12
GO:2000266,"regulation of blood coagulation, intrinsic pathway (GO:2000266)",5,1,0.345811536,2.891748527,0.301208076,0.881650081,2161,F12
GO:0018057,peptidyl-lysine oxidation (GO:0018057),5,1,0.345811536,2.891748527,0.301208076,0.881650081,84171,LOXL4
GO:0001714,endodermal cell fate specification (GO:0001714),5,1,0.345811536,2.891748527,0.301208076,0.881650081,64321,SOX17
GO:0042438,melanin biosynthetic process (GO:0042438),5,1,0.345811536,2.891748527,0.301208076,0.881650081,4435,CITED1
GO:1905097,regulation of guanyl-nucleotide exchange factor activity (GO:1905097),5,1,0.345811536,2.891748527,0.301208076,0.881650081,4233,MET
GO:0071305,cellular response to vitamin D (GO:0071305),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6422,SFRP1
GO:1904904,regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904),5,1,0.345811536,2.891748527,0.301208076,0.881650081,4680,CEACAM6
GO:0009262,deoxyribonucleotide metabolic process (GO:0009262),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6241,RRM2
GO:0015858,nucleoside transport (GO:0015858),5,1,0.345811536,2.891748527,0.301208076,0.881650081,64078,SLC28A3
GO:0015864,pyrimidine nucleoside transport (GO:0015864),5,1,0.345811536,2.891748527,0.301208076,0.881650081,64078,SLC28A3
GO:0015862,uridine transport (GO:0015862),5,1,0.345811536,2.891748527,0.301208076,0.881650081,64078,SLC28A3
GO:0060707,trophoblast giant cell differentiation (GO:0060707),5,1,0.345811536,2.891748527,0.301208076,0.881650081,10733,PLK4
GO:0097742,de novo centriole assembly (GO:0097742),5,1,0.345811536,2.891748527,0.301208076,0.881650081,10733,PLK4
GO:0098535,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535),5,1,0.345811536,2.891748527,0.301208076,0.881650081,10733,PLK4
GO:0009221,pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),5,1,0.345811536,2.891748527,0.301208076,0.881650081,7298,TYMS
GO:2000253,positive regulation of feeding behavior (GO:2000253),5,1,0.345811536,2.891748527,0.301208076,0.881650081,8013,NR4A3
GO:1902415,regulation of mRNA binding (GO:1902415),5,1,0.345811536,2.891748527,0.301208076,0.881650081,55323,LARP6
GO:0006064,glucuronate catabolic process (GO:0006064),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6652,SORD
GO:0019640,glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6652,SORD
GO:1901159,xylulose 5-phosphate biosynthetic process (GO:1901159),5,1,0.345811536,2.891748527,0.301208076,0.881650081,6652,SORD
GO:0018406,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),5,1,0.345811536,2.891748527,0.301208076,0.881650081,283417,DPY19L2
GO:0018317,protein C-linked glycosylation via tryptophan (GO:0018317),5,1,0.345811536,2.891748527,0.301208076,0.881650081,283417,DPY19L2
GO:0045071,negative regulation of viral genome replication (GO:0045071),53,5,3.665602283,1.364032324,0.303565673,0.881650081,4057;6590;9582;9636;8638,APOBEC3B;ISG15;OASL;SLPI;LTF
GO:0003007,heart morphogenesis (GO:0003007),53,5,3.665602283,1.364032324,0.303565673,0.881650081,650;23493;23768;7049;64321,TGFBR3;BMP2;SOX17;FLRT2;HEY2
GO:0002697,regulation of immune effector process (GO:0002697),53,5,3.665602283,1.364032324,0.303565673,0.881650081,1378;629;5627;729;730,PROS1;CFB;C7;C6;CR1
GO:0002698,negative regulation of immune effector process (GO:0002698),16,2,1.106596916,1.807342829,0.30467431,0.881650081,1378;5169,ENPP3;CR1
GO:0045655,regulation of monocyte differentiation (GO:0045655),16,2,1.106596916,1.807342829,0.30467431,0.881650081,3204;146433,HOXA7;IL34
GO:0060997,dendritic spine morphogenesis (GO:0060997),16,2,1.106596916,1.807342829,0.30467431,0.881650081,2047;23237,EPHB1;ARC
GO:0010675,regulation of cellular carbohydrate metabolic process (GO:0010675),16,2,1.106596916,1.807342829,0.30467431,0.881650081,9370;5166,PDK4;ADIPOQ
GO:0051350,negative regulation of lyase activity (GO:0051350),16,2,1.106596916,1.807342829,0.30467431,0.881650081,1910;5064,EDNRB;PALM
GO:0048008,platelet-derived growth factor receptor signaling pathway (GO:0048008),16,2,1.106596916,1.807342829,0.30467431,0.881650081,8013;80310,PDGFD;NR4A3
GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),16,2,1.106596916,1.807342829,0.30467431,0.881650081,3569;6403,IL6;SELP
GO:0032652,regulation of interleukin-1 production (GO:0032652),16,2,1.106596916,1.807342829,0.30467431,0.881650081,301;6288,ANXA1;SAA1
GO:1901184,regulation of ERBB signaling pathway (GO:1901184),16,2,1.106596916,1.807342829,0.30467431,0.881650081,1956;2537,EGFR;IFI6
GO:0150118,negative regulation of cell-substrate junction organization (GO:0150118),16,2,1.106596916,1.807342829,0.30467431,0.881650081,11170;347,FAM107A;APOD
GO:0051895,negative regulation of focal adhesion assembly (GO:0051895),16,2,1.106596916,1.807342829,0.30467431,0.881650081,11170;347,FAM107A;APOD
GO:2000678,negative regulation of transcription regulatory region DNA binding (GO:2000678),16,2,1.106596916,1.807342829,0.30467431,0.881650081,23493;6664,HEY2;SOX11
GO:0002082,regulation of oxidative phosphorylation (GO:0002082),16,2,1.106596916,1.807342829,0.30467431,0.881650081,51085;1346,MLXIPL;COX7A1
GO:0032967,positive regulation of collagen biosynthetic process (GO:0032967),16,2,1.106596916,1.807342829,0.30467431,0.881650081,90993;55323,LARP6;CREB3L1
GO:2000353,positive regulation of endothelial cell apoptotic process (GO:2000353),16,2,1.106596916,1.807342829,0.30467431,0.881650081,8644;641700,AKR1C3;ECSCR
GO:0042475,odontogenesis of dentin-containing tooth (GO:0042475),16,2,1.106596916,1.807342829,0.30467431,0.881650081,650;2296,BMP2;FOXC1
GO:0007589,body fluid secretion (GO:0007589),16,2,1.106596916,1.807342829,0.30467431,0.881650081,4881;5021,OXTR;NPR1
GO:0048245,eosinophil chemotaxis (GO:0048245),16,2,1.106596916,1.807342829,0.30467431,0.881650081,6366;6376,CX3CL1;CCL21
GO:0072677,eosinophil migration (GO:0072677),16,2,1.106596916,1.807342829,0.30467431,0.881650081,6366;6376,CX3CL1;CCL21
GO:1905508,protein localization to microtubule organizing center (GO:1905508),16,2,1.106596916,1.807342829,0.30467431,0.881650081,6491;10615,SPAG5;STIL
GO:0046641,positive regulation of alpha-beta T cell proliferation (GO:0046641),16,2,1.106596916,1.807342829,0.30467431,0.881650081,7048;7292,TGFBR2;TNFSF4
GO:0042167,heme catabolic process (GO:0042167),16,2,1.106596916,1.807342829,0.30467431,0.881650081,9429;213,ALB;ABCG2
GO:0006787,porphyrin-containing compound catabolic process (GO:0006787),16,2,1.106596916,1.807342829,0.30467431,0.881650081,9429;213,ALB;ABCG2
GO:0006044,N-acetylglucosamine metabolic process (GO:0006044),16,2,1.106596916,1.807342829,0.30467431,0.881650081,4248;9469,CHST3;MGAT3
GO:0044247,cellular polysaccharide catabolic process (GO:0044247),16,2,1.106596916,1.807342829,0.30467431,0.881650081,5837;5260,PYGM;PHKG1
GO:0042102,positive regulation of T cell proliferation (GO:0042102),66,6,4.564712277,1.314431148,0.305149094,0.881650081,301;3952;3479;3569;7292;30835,LEP;ANXA1;TNFSF4;CD209;IGF1;IL6
GO:0038127,ERBB signaling pathway (GO:0038127),66,6,4.564712277,1.314431148,0.305149094,0.881650081,1956;3084;2202;5753;5284;9542,NRG2;EGFR;EFEMP1;PIGR;NRG1;PTK6
GO:0015804,neutral amino acid transport (GO:0015804),28,3,1.936544602,1.549150996,0.305372728,0.881650081,11254;8140;3993,LLGL2;SLC6A14;SLC7A5
GO:0070884,regulation of calcineurin-NFAT signaling cascade (GO:0070884),28,3,1.936544602,1.549150996,0.305372728,0.881650081,9472;3479;1827,AKAP6;RCAN1;IGF1
GO:0018146,keratan sulfate biosynthetic process (GO:0018146),28,3,1.936544602,1.549150996,0.305372728,0.881650081,10331;4969;5549,OGN;PRELP;B3GNT3
GO:0030865,cortical cytoskeleton organization (GO:0030865),41,4,2.835654596,1.410609037,0.314490794,0.906234019,80206;390;27289;3993,RND3;LLGL2;FHOD3;RND1
GO:0090199,regulation of release of cytochrome c from mitochondria (GO:0090199),41,4,2.835654596,1.410609037,0.314490794,0.906234019,3479;5366;4318;5329,MMP9;PLAUR;IGF1;PMAIP1
GO:0060284,regulation of cell development (GO:0060284),41,4,2.835654596,1.410609037,0.314490794,0.906234019,55502;23493;2308;6376,CX3CL1;FOXO1;HES6;HEY2
GO:0046513,ceramide biosynthetic process (GO:0046513),41,4,2.835654596,1.410609037,0.314490794,0.906234019,123099;126410;8128;256435,ST6GALNAC3;DEGS2;ST8SIA2;CYP4F22
GO:0022603,regulation of anatomical structure morphogenesis (GO:0022603),120,10,8.299476867,1.204895219,0.317412541,0.912667133,10563;3952;3569;1000;2247;168667;6422;55022;23237;152503,LEP;SFRP1;FGF2;BMPER;SH3D19;PID1;ARC;IL6;CDH2;CXCL13
GO:0051893,regulation of focal adhesion assembly (GO:0051893),54,5,3.73476459,1.338772466,0.317416004,0.912667133,11170;347;6422;7010;2824,FAM107A;SFRP1;APOD;GPM6B;TEK
GO:0030162,regulation of proteolysis (GO:0030162),54,5,3.73476459,1.338772466,0.317416004,0.912667133,825;857;5347;5329;8425,PLK1;CAV1;LTBP4;CAPN3;PLAUR
GO:0036297,interstrand cross-link repair (GO:0036297),54,5,3.73476459,1.338772466,0.317416004,0.912667133,2175;5888;10635;29089;55215,UBE2T;RAD51;FANCI;RAD51AP1;FANCA
GO:0032273,positive regulation of protein polymerization (GO:0032273),67,6,4.633874584,1.294812773,0.31752419,0.912667133,25802;6366;11076;4233;274;51673,LMOD1;MET;CCL21;TPPP;BIN1;TPPP3
GO:0030182,neuron differentiation (GO:0030182),174,14,12.03424146,1.163347108,0.317634278,0.912667133,4915;3624;7481;57502;6664;4233;8322;7477;26468;3169;84913;79192;79190;50805,INHBA;NTRK2;ATOH8;IRX1;MET;LHX6;IRX6;FZD4;WNT11;NLGN4X;IRX4;WNT7B;SOX11;FOXA1
GO:0006302,double-strand break repair (GO:0006302),161,13,11.13513146,1.167476113,0.322047823,0.915144801,10721;1763;9319;83990;9401;641;5888;7516;10635;113130;3838;675;4796,CDCA5;RAD51;POLQ;KPNA2;RAD51AP1;RECQL4;TRIP13;BRIP1;BLM;DNA2;TONSL;XRCC2;BRCA2
GO:0006835,dicarboxylic acid transport (GO:0006835),29,3,2.005706909,1.495731996,0.324791471,0.915144801,83733;2350;2348,FOLR1;FOLR2;SLC25A18
GO:0051348,negative regulation of transferase activity (GO:0051348),29,3,2.005706909,1.495731996,0.324791471,0.915144801,7538;8660;1028,CDKN1C;IRS2;ZFP36
GO:0051494,negative regulation of cytoskeleton organization (GO:0051494),29,3,2.005706909,1.495731996,0.324791471,0.915144801,23189;130271;256949,KANK1;KANK3;PLEKHH2
GO:0036151,phosphatidylcholine acyl-chain remodeling (GO:0036151),29,3,2.005706909,1.495731996,0.324791471,0.915144801,5321;5320;129642,PLA2G4A;MBOAT2;PLA2G2A
GO:0035306,positive regulation of dephosphorylation (GO:0035306),29,3,2.005706909,1.495731996,0.324791471,0.915144801,650;26051;157313,CDCA2;BMP2;PPP1R16B
GO:0002762,negative regulation of myeloid leukocyte differentiation (GO:0002762),29,3,2.005706909,1.495731996,0.324791471,0.915144801,3624;3204;9370,INHBA;HOXA7;ADIPOQ
GO:0070979,protein K11-linked ubiquitination (GO:0070979),29,3,2.005706909,1.495731996,0.324791471,0.915144801,11065;27338;29089,UBE2T;UBE2C;UBE2S
GO:0061641,CENP-A containing chromatin organization (GO:0061641),29,3,2.005706909,1.495731996,0.324791471,0.915144801,64105;79019;55355,HJURP;CENPM;CENPK
GO:0034080,CENP-A containing nucleosome assembly (GO:0034080),29,3,2.005706909,1.495731996,0.324791471,0.915144801,64105;79019;55355,HJURP;CENPM;CENPK
GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),81,7,5.602146885,1.249520968,0.32749867,0.915144801,1128;64805;150;5745;185;6869;2151,TACR1;P2RY12;PTH1R;F2RL2;AGTR1;ADRA2A;CHRM1
GO:0021762,substantia nigra development (GO:0021762),42,4,2.904816903,1.377023108,0.330523516,0.915144801,5354;4129;6271;57447,NDRG2;PLP1;MAOB;S100A1
GO:0097553,calcium ion transmembrane import into cytosol (GO:0097553),42,4,2.904816903,1.377023108,0.330523516,0.915144801,6366;2247;6263;6261,RYR3;FGF2;CCL21;RYR1
GO:0042177,negative regulation of protein catabolic process (GO:0042177),42,4,2.904816903,1.377023108,0.330523516,0.915144801,6622;1956;4085;7079,TIMP4;SNCA;EGFR;MAD2L1
GO:1990573,potassium ion import across plasma membrane (GO:1990573),42,4,2.904816903,1.377023108,0.330523516,0.915144801,477;10060;482;84561,ATP1A2;ATP1B2;SLC12A8;ABCC9
GO:0022607,cellular component assembly (GO:0022607),258,20,17.84387526,1.120832762,0.330574127,0.915144801,9368;2934;11170;10810;825;57502;84612;6711;10891;57381;58480;5317;2318;55679;3861;116238;2824;9319;3038;2175,FAM107A;HAS3;LIMS2;TLCD1;GSN;RHOJ;TRIP13;WASF3;SPTBN1;CAPN3;GPM6B;PPARGC1A;RHOU;KRT14;PKP1;FANCA;FLNC;SLC9A3R1;NLGN4X;PARD6B
GO:0072091,regulation of stem cell proliferation (GO:0072091),17,2,1.175759223,1.701028545,0.330809541,0.915144801,6664;4072,EPCAM;SOX11
GO:1900017,positive regulation of cytokine production involved in inflammatory response (GO:1900017),17,2,1.175759223,1.701028545,0.330809541,0.915144801,3569;115362,IL6;GBP5
GO:1900225,regulation of NLRP3 inflammasome complex assembly (GO:1900225),17,2,1.175759223,1.701028545,0.330809541,0.915144801,948;115362,CD36;GBP5
GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),17,2,1.175759223,1.701028545,0.330809541,0.915144801,154;150,ADRB2;ADRA2A
GO:0086064,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),17,2,1.175759223,1.701028545,0.330809541,0.915144801,477;482,ATP1A2;ATP1B2
GO:0046597,negative regulation of viral entry into host cell (GO:0046597),17,2,1.175759223,1.701028545,0.330809541,0.915144801,2934;5806,GSN;PTX3
GO:0030194,positive regulation of blood coagulation (GO:0030194),17,2,1.175759223,1.701028545,0.330809541,0.915144801,2152;2161,F3;F12
GO:0009792,embryo development ending in birth or egg hatching (GO:0009792),17,2,1.175759223,1.701028545,0.330809541,0.915144801,2299;56977,STOX2;FOXI1
GO:0035909,aorta morphogenesis (GO:0035909),17,2,1.175759223,1.701028545,0.330809541,0.915144801,23493;4638,MYLK;HEY2
GO:0036149,phosphatidylinositol acyl-chain remodeling (GO:0036149),17,2,1.175759223,1.701028545,0.330809541,0.915144801,5321;5320,PLA2G4A;PLA2G2A
GO:0010714,positive regulation of collagen metabolic process (GO:0010714),17,2,1.175759223,1.701028545,0.330809541,0.915144801,90993;55323,LARP6;CREB3L1
GO:1903307,positive regulation of regulated secretory pathway (GO:1903307),17,2,1.175759223,1.701028545,0.330809541,0.915144801,3745;8447,KCNB1;DOC2B
GO:0009890,negative regulation of biosynthetic process (GO:0009890),17,2,1.175759223,1.701028545,0.330809541,0.915144801,3569;225,ABCD2;IL6
GO:0010804,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),17,2,1.175759223,1.701028545,0.330809541,0.915144801,9370;83643,ADIPOQ;CCDC3
GO:0016540,protein autoprocessing (GO:0016540),17,2,1.175759223,1.701028545,0.330809541,0.915144801,5653;2161,F12;KLK6
GO:0003184,pulmonary valve morphogenesis (GO:0003184),17,2,1.175759223,1.701028545,0.330809541,0.915144801,64220;23493,HEY2;STRA6
GO:0061311,cell surface receptor signaling pathway involved in heart development (GO:0061311),17,2,1.175759223,1.701028545,0.330809541,0.915144801,650;23493,BMP2;HEY2
GO:0050435,amyloid-beta metabolic process (GO:0050435),17,2,1.175759223,1.701028545,0.330809541,0.915144801,4311;4248,MME;MGAT3
GO:0015749,monosaccharide transmembrane transport (GO:0015749),17,2,1.175759223,1.701028545,0.330809541,0.915144801,6523;55974,SLC50A1;SLC5A1
GO:0007221,positive regulation of transcription of Notch receptor target (GO:0007221),17,2,1.175759223,1.701028545,0.330809541,0.915144801,9787;84441,DLGAP5;MAML2
GO:0061952,midbody abscission (GO:0061952),17,2,1.175759223,1.701028545,0.330809541,0.915144801,10112;55165,KIF20A;CEP55
GO:1903321,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),55,5,3.803926897,1.314431148,0.331341097,0.915144801,825;857;9636;10253;153769,SPRY2;CAV1;CAPN3;ISG15;SH3RF2
GO:1903530,regulation of secretion by cell (GO:1903530),55,5,3.803926897,1.314431148,0.331341097,0.915144801,301;6288;9627;3993;25837,ANXA1;SAA1;RAB26;LLGL2;SNCAIP
GO:0000122,negative regulation of transcription by RNA polymerase II (GO:0000122),677,50,46.82288199,1.067853961,0.33294164,0.915144801,7538;6622;5468;857;5138;6663;9212;5347;650;3204;23493;2625;7704;10157;6664;1910;4781;1906;10365;654;5727;4212;63976;130497;1869;2305;7068;8013;467;3725;2296;2908;9314;57761;50943;2146;90865;29128;5187;79192;51222;93986;3400;53335;25803;2354;5178;23492;84733;9079,PER1;UHRF1;CBX7;PLK1;FOXM1;FOSB;ZBTB16;PDE2A;CAV1;OSR1;HOXA7;AURKB;ID4;EZH2;SNCA;LDB2;IL33;MEIS2;IRX1;BMP2;PPARG;SOX10;E2F1;NFIB;NR3C1;AASS;EDNRB;JUN;KLF4;ZNF219;FOXP3;ZFP36;ATF3;TRIB3;PTCH1;THRB;FOXP2;BMP6;PRDM16;HEY2;EDN1;FOXC1;CBX2;KLF2;NR4A3;PEG3;BCL11A;GATA3;SOX11;SPDEF
GO:0030178,negative regulation of Wnt signaling pathway (GO:0030178),190,15,13.14083837,1.141479682,0.335398188,0.915144801,9368;857;7481;650;64321;4435;6422;8322;4038;3489;27303;25928;92162;147495;11197,IGFBP6;WIF1;CAV1;SFRP1;APCDD1;RBMS3;BMP2;TMEM88;SOSTDC1;LRP4;SOX17;FZD4;CITED1;WNT11;SLC9A3R1
GO:0050804,modulation of chemical synaptic transmission (GO:0050804),109,9,7.538691487,1.193841135,0.34069215,0.915144801,1000;9627;57502;5649;9370;9783;477;23542;23237,ATP1A2;RELN;ADIPOQ;ARC;RIMS3;MAPK8IP2;SNCAIP;NLGN4X;CDH2
GO:0048525,negative regulation of viral process (GO:0048525),69,6,4.772199198,1.257281968,0.342482904,0.915144801,7538;4057;6590;9636;8638;5806,PTX3;ZFP36;ISG15;OASL;SLPI;LTF
GO:0030833,regulation of actin filament polymerization (GO:0030833),69,6,4.772199198,1.257281968,0.342482904,0.915144801,25802;6366;274;23189;256949;343578,LMOD1;KANK1;KANK3;CCL21;BIN1;ARHGAP40
GO:0045937,positive regulation of phosphate metabolic process (GO:0045937),30,3,2.074869217,1.445874263,0.344207521,0.915144801,6622;1956;5745,SNCA;EGFR;PTH1R
GO:1905475,regulation of protein localization to membrane (GO:1905475),30,3,2.074869217,1.445874263,0.344207521,0.915144801,2934;2719;6711,GPC3;GSN;SPTBN1
GO:0048844,artery morphogenesis (GO:0048844),30,3,2.074869217,1.445874263,0.344207521,0.915144801,64220;2348;23493,FOLR1;HEY2;STRA6
GO:1903749,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),56,5,3.873089204,1.290959164,0.345320951,0.915144801,8626;5366;58480;1869;22885,E2F1;TP63;RHOU;ABLIM3;PMAIP1
GO:0032731,positive regulation of interleukin-1 beta production (GO:0032731),56,5,3.873089204,1.290959164,0.345320951,0.915144801,3569;4023;948;115362;1958,LPL;EGR1;CD36;IL6;GBP5
GO:0006820,anion transport (GO:0006820),43,4,2.973979211,1.344999315,0.346596655,0.915144801,9429;9058;6581;57030,SLC17A7;SLC22A3;ABCG2;SLC13A2
GO:0050772,positive regulation of axonogenesis (GO:0050772),43,4,2.973979211,1.344999315,0.346596655,0.915144801,4804;4915;91584;79006,NTRK2;NGFR;PLXNA4;METRN
GO:0046546,development of primary male sexual characteristics (GO:0046546),43,4,2.973979211,1.344999315,0.346596655,0.915144801,3815;3624;2625;8644,INHBA;KIT;AKR1C3;GATA3
GO:0008584,male gonad development (GO:0008584),43,4,2.973979211,1.344999315,0.346596655,0.915144801,3815;3624;2625;8644,INHBA;KIT;AKR1C3;GATA3
GO:0008088,axo-dendritic transport (GO:0008088),6,1,0.414973843,2.409790439,0.34955456,0.915144801,320,APBA1
GO:0030643,cellular phosphate ion homeostasis (GO:0030643),6,1,0.414973843,2.409790439,0.34955456,0.915144801,10568,SLC34A2
GO:0072502,cellular trivalent inorganic anion homeostasis (GO:0072502),6,1,0.414973843,2.409790439,0.34955456,0.915144801,10568,SLC34A2
GO:0071221,cellular response to bacterial lipopeptide (GO:0071221),6,1,0.414973843,2.409790439,0.34955456,0.915144801,948,CD36
GO:0034141,positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),6,1,0.414973843,2.409790439,0.34955456,0.915144801,857,CAV1
GO:0071474,cellular hyperosmotic response (GO:0071474),6,1,0.414973843,2.409790439,0.34955456,0.915144801,358,AQP1
GO:1905216,positive regulation of RNA binding (GO:1905216),6,1,0.414973843,2.409790439,0.34955456,0.915144801,55323,LARP6
GO:0006549,isoleucine metabolic process (GO:0006549),6,1,0.414973843,2.409790439,0.34955456,0.915144801,10993,SDS
GO:0030252,growth hormone secretion (GO:0030252),6,1,0.414973843,2.409790439,0.34955456,0.915144801,8425,LTBP4
GO:0060050,positive regulation of protein glycosylation (GO:0060050),6,1,0.414973843,2.409790439,0.34955456,0.915144801,10267,RAMP1
GO:0051481,negative regulation of cytosolic calcium ion concentration (GO:0051481),6,1,0.414973843,2.409790439,0.34955456,0.915144801,477,ATP1A2
GO:0015812,gamma-aminobutyric acid transport (GO:0015812),6,1,0.414973843,2.409790439,0.34955456,0.915144801,9368,SLC9A3R1
GO:1901164,negative regulation of trophoblast cell migration (GO:1901164),6,1,0.414973843,2.409790439,0.34955456,0.915144801,130399,ACVR1C
GO:0033004,negative regulation of mast cell activation (GO:0033004),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5169,ENPP3
GO:0060242,contact inhibition (GO:0060242),6,1,0.414973843,2.409790439,0.34955456,0.915144801,2191,FAP
GO:1901552,positive regulation of endothelial cell development (GO:1901552),6,1,0.414973843,2.409790439,0.34955456,0.915144801,7122,CLDN5
GO:1903142,positive regulation of establishment of endothelial barrier (GO:1903142),6,1,0.414973843,2.409790439,0.34955456,0.915144801,7122,CLDN5
GO:0090315,negative regulation of protein targeting to membrane (GO:0090315),6,1,0.414973843,2.409790439,0.34955456,0.915144801,3753,KCNE1
GO:0035855,megakaryocyte development (GO:0035855),6,1,0.414973843,2.409790439,0.34955456,0.915144801,3815,KIT
GO:0060441,epithelial tube branching involved in lung morphogenesis (GO:0060441),6,1,0.414973843,2.409790439,0.34955456,0.915144801,2255,FGF10
GO:0060019,radial glial cell differentiation (GO:0060019),6,1,0.414973843,2.409790439,0.34955456,0.915144801,2255,FGF10
GO:0044058,regulation of digestive system process (GO:0044058),6,1,0.414973843,2.409790439,0.34955456,0.915144801,2255,FGF10
GO:1900122,positive regulation of receptor binding (GO:1900122),6,1,0.414973843,2.409790439,0.34955456,0.915144801,4318,MMP9
GO:0031290,retinal ganglion cell axon guidance (GO:0031290),6,1,0.414973843,2.409790439,0.34955456,0.915144801,2047,EPHB1
GO:0050957,equilibrioception (GO:0050957),6,1,0.414973843,2.409790439,0.34955456,0.915144801,64072,CDH23
GO:0060297,regulation of sarcomere organization (GO:0060297),6,1,0.414973843,2.409790439,0.34955456,0.915144801,1906,EDN1
GO:0048845,venous blood vessel morphogenesis (GO:0048845),6,1,0.414973843,2.409790439,0.34955456,0.915144801,147372,CCBE1
GO:0055015,ventricular cardiac muscle cell development (GO:0055015),6,1,0.414973843,2.409790439,0.34955456,0.915144801,23493,HEY2
GO:1900748,positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),6,1,0.414973843,2.409790439,0.34955456,0.915144801,147372,CCBE1
GO:0010310,regulation of hydrogen peroxide metabolic process (GO:0010310),6,1,0.414973843,2.409790439,0.34955456,0.915144801,4314,MMP3
GO:0030091,protein repair (GO:0030091),6,1,0.414973843,2.409790439,0.34955456,0.915144801,253827,MSRB3
GO:0042976,activation of Janus kinase activity (GO:0042976),6,1,0.414973843,2.409790439,0.34955456,0.915144801,2690,GHR
GO:0035357,peroxisome proliferator activated receptor signaling pathway (GO:0035357),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5468,PPARG
GO:1901897,regulation of relaxation of cardiac muscle (GO:1901897),6,1,0.414973843,2.409790439,0.34955456,0.915144801,3270,HRC
GO:2000169,regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),6,1,0.414973843,2.409790439,0.34955456,0.915144801,1756,DMD
GO:0071286,cellular response to magnesium ion (GO:0071286),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6263,RYR3
GO:0009992,cellular water homeostasis (GO:0009992),6,1,0.414973843,2.409790439,0.34955456,0.915144801,358,AQP1
GO:0060373,regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),6,1,0.414973843,2.409790439,0.34955456,0.915144801,55800,SCN3B
GO:0034698,response to gonadotropin (GO:0034698),6,1,0.414973843,2.409790439,0.34955456,0.915144801,7049,TGFBR3
GO:1901098,positive regulation of autophagosome maturation (GO:1901098),6,1,0.414973843,2.409790439,0.34955456,0.915144801,154,ADRB2
GO:0001844,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5366,PMAIP1
GO:0070417,cellular response to cold (GO:0070417),6,1,0.414973843,2.409790439,0.34955456,0.915144801,2308,FOXO1
GO:0002579,positive regulation of antigen processing and presentation (GO:0002579),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6366,CCL21
GO:0002606,positive regulation of dendritic cell antigen processing and presentation (GO:0002606),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6366,CCL21
GO:1905331,negative regulation of morphogenesis of an epithelium (GO:1905331),6,1,0.414973843,2.409790439,0.34955456,0.915144801,23213,SULF1
GO:0031622,positive regulation of fever generation (GO:0031622),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5743,PTGS2
GO:1903721,positive regulation of I-kappaB phosphorylation (GO:1903721),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6376,CX3CL1
GO:1902237,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5366,PMAIP1
GO:0032410,negative regulation of transporter activity (GO:0032410),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6622,SNCA
GO:1903588,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588),6,1,0.414973843,2.409790439,0.34955456,0.915144801,4804,NGFR
GO:0090077,foam cell differentiation (GO:0090077),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5468,PPARG
GO:0010742,macrophage derived foam cell differentiation (GO:0010742),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5468,PPARG
GO:0015871,choline transport (GO:0015871),6,1,0.414973843,2.409790439,0.34955456,0.915144801,80736,SLC44A4
GO:0070100,negative regulation of chemokine-mediated signaling pathway (GO:0070100),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6586,SLIT3
GO:0033574,response to testosterone (GO:0033574),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6696,SPP1
GO:0046130,purine ribonucleoside catabolic process (GO:0046130),6,1,0.414973843,2.409790439,0.34955456,0.915144801,7498,XDH
GO:0001767,establishment of lymphocyte polarity (GO:0001767),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6366,CCL21
GO:0035754,B cell chemotaxis (GO:0035754),6,1,0.414973843,2.409790439,0.34955456,0.915144801,10563,CXCL13
GO:0033634,positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),6,1,0.414973843,2.409790439,0.34955456,0.915144801,10563,CXCL13
GO:0002889,regulation of immunoglobulin mediated immune response (GO:0002889),6,1,0.414973843,2.409790439,0.34955456,0.915144801,7292,TNFSF4
GO:1903997,positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),6,1,0.414973843,2.409790439,0.34955456,0.915144801,4915,NTRK2
GO:0045630,positive regulation of T-helper 2 cell differentiation (GO:0045630),6,1,0.414973843,2.409790439,0.34955456,0.915144801,7292,TNFSF4
GO:0009059,macromolecule biosynthetic process (GO:0009059),6,1,0.414973843,2.409790439,0.34955456,0.915144801,1289,COL5A1
GO:2000323,negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5187,PER1
GO:0010749,regulation of nitric oxide mediated signal transduction (GO:0010749),6,1,0.414973843,2.409790439,0.34955456,0.915144801,1956,EGFR
GO:0014060,regulation of epinephrine secretion (GO:0014060),6,1,0.414973843,2.409790439,0.34955456,0.915144801,150,ADRA2A
GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),6,1,0.414973843,2.409790439,0.34955456,0.915144801,168667,BMPER
GO:1903242,regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),6,1,0.414973843,2.409790439,0.34955456,0.915144801,2308,FOXO1
GO:0003223,ventricular compact myocardium morphogenesis (GO:0003223),6,1,0.414973843,2.409790439,0.34955456,0.915144801,7049,TGFBR3
GO:1900037,regulation of cellular response to hypoxia (GO:1900037),6,1,0.414973843,2.409790439,0.34955456,0.915144801,947,CD34
GO:0007172,signal complex assembly (GO:0007172),6,1,0.414973843,2.409790439,0.34955456,0.915144801,23542,MAPK8IP2
GO:0033089,positive regulation of T cell differentiation in thymus (GO:0033089),6,1,0.414973843,2.409790439,0.34955456,0.915144801,101,ADAM8
GO:0070092,regulation of glucagon secretion (GO:0070092),6,1,0.414973843,2.409790439,0.34955456,0.915144801,3569,IL6
GO:2000659,regulation of interleukin-1-mediated signaling pathway (GO:2000659),6,1,0.414973843,2.409790439,0.34955456,0.915144801,3569,IL6
GO:0032494,response to peptidoglycan (GO:0032494),6,1,0.414973843,2.409790439,0.34955456,0.915144801,3569,IL6
GO:0072540,T-helper 17 cell lineage commitment (GO:0072540),6,1,0.414973843,2.409790439,0.34955456,0.915144801,3569,IL6
GO:0002828,regulation of type 2 immune response (GO:0002828),6,1,0.414973843,2.409790439,0.34955456,0.915144801,7292,TNFSF4
GO:0035356,cellular triglyceride homeostasis (GO:0035356),6,1,0.414973843,2.409790439,0.34955456,0.915144801,84649,DGAT2
GO:0051005,negative regulation of lipoprotein lipase activity (GO:0051005),6,1,0.414973843,2.409790439,0.34955456,0.915144801,51129,ANGPTL4
GO:0010886,positive regulation of cholesterol storage (GO:0010886),6,1,0.414973843,2.409790439,0.34955456,0.915144801,4023,LPL
GO:0070508,cholesterol import (GO:0070508),6,1,0.414973843,2.409790439,0.34955456,0.915144801,948,CD36
GO:0035376,sterol import (GO:0035376),6,1,0.414973843,2.409790439,0.34955456,0.915144801,948,CD36
GO:0046885,regulation of hormone biosynthetic process (GO:0046885),6,1,0.414973843,2.409790439,0.34955456,0.915144801,1958,EGR1
GO:0043570,maintenance of DNA repeat elements (GO:0043570),6,1,0.414973843,2.409790439,0.34955456,0.915144801,116028,RMI2
GO:1903792,negative regulation of anion transport (GO:1903792),6,1,0.414973843,2.409790439,0.34955456,0.915144801,2564,GABRE
GO:0002232,leukocyte chemotaxis involved in inflammatory response (GO:0002232),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5764,PTN
GO:0042421,norepinephrine biosynthetic process (GO:0042421),6,1,0.414973843,2.409790439,0.34955456,0.915144801,2625,GATA3
GO:0072161,mesenchymal cell differentiation involved in kidney development (GO:0072161),6,1,0.414973843,2.409790439,0.34955456,0.915144801,130497,OSR1
GO:0071422,succinate transmembrane transport (GO:0071422),6,1,0.414973843,2.409790439,0.34955456,0.915144801,9058,SLC13A2
GO:0045722,positive regulation of gluconeogenesis (GO:0045722),6,1,0.414973843,2.409790439,0.34955456,0.915144801,10891,PPARGC1A
GO:1902221,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),6,1,0.414973843,2.409790439,0.34955456,0.915144801,259307,IL4I1
GO:0042426,choline catabolic process (GO:0042426),6,1,0.414973843,2.409790439,0.34955456,0.915144801,29958,DMGDH
GO:1900038,negative regulation of cellular response to hypoxia (GO:1900038),6,1,0.414973843,2.409790439,0.34955456,0.915144801,947,CD34
GO:0050665,hydrogen peroxide biosynthetic process (GO:0050665),6,1,0.414973843,2.409790439,0.34955456,0.915144801,4129,MAOB
GO:0007405,neuroblast proliferation (GO:0007405),6,1,0.414973843,2.409790439,0.34955456,0.915144801,29127,RACGAP1
GO:0090027,negative regulation of monocyte chemotaxis (GO:0090027),6,1,0.414973843,2.409790439,0.34955456,0.915144801,1843,DUSP1
GO:0019375,galactolipid biosynthetic process (GO:0019375),6,1,0.414973843,2.409790439,0.34955456,0.915144801,7368,UGT8
GO:0006682,galactosylceramide biosynthetic process (GO:0006682),6,1,0.414973843,2.409790439,0.34955456,0.915144801,7368,UGT8
GO:0072080,nephron tubule development (GO:0072080),6,1,0.414973843,2.409790439,0.34955456,0.915144801,130497,OSR1
GO:0006863,purine nucleobase transport (GO:0006863),6,1,0.414973843,2.409790439,0.34955456,0.915144801,64078,SLC28A3
GO:0098700,neurotransmitter loading into synaptic vesicle (GO:0098700),6,1,0.414973843,2.409790439,0.34955456,0.915144801,57030,SLC17A7
GO:0046985,positive regulation of hemoglobin biosynthetic process (GO:0046985),6,1,0.414973843,2.409790439,0.34955456,0.915144801,9314,KLF4
GO:0015015,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",6,1,0.414973843,2.409790439,0.34955456,0.915144801,266722,HS6ST3
GO:1903551,regulation of extracellular exosome assembly (GO:1903551),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6382,SDC1
GO:0032020,ISG15-protein conjugation (GO:0032020),6,1,0.414973843,2.409790439,0.34955456,0.915144801,9636,ISG15
GO:1900003,regulation of serine-type endopeptidase activity (GO:1900003),6,1,0.414973843,2.409790439,0.34955456,0.915144801,1378,CR1
GO:0042985,negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),6,1,0.414973843,2.409790439,0.34955456,0.915144801,9452,ITM2A
GO:0044784,metaphase/anaphase transition of cell cycle (GO:0044784),6,1,0.414973843,2.409790439,0.34955456,0.915144801,10460,TACC3
GO:0007091,metaphase/anaphase transition of mitotic cell cycle (GO:0007091),6,1,0.414973843,2.409790439,0.34955456,0.915144801,10460,TACC3
GO:0035404,histone-serine phosphorylation (GO:0035404),6,1,0.414973843,2.409790439,0.34955456,0.915144801,9212,AURKB
GO:0032466,negative regulation of cytokinesis (GO:0032466),6,1,0.414973843,2.409790439,0.34955456,0.915144801,9212,AURKB
GO:0090435,protein localization to nuclear envelope (GO:0090435),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5347,PLK1
GO:0051447,negative regulation of meiotic cell cycle (GO:0051447),6,1,0.414973843,2.409790439,0.34955456,0.915144801,1843,DUSP1
GO:0070345,negative regulation of fat cell proliferation (GO:0070345),6,1,0.414973843,2.409790439,0.34955456,0.915144801,1869,E2F1
GO:0042723,thiamine-containing compound metabolic process (GO:0042723),6,1,0.414973843,2.409790439,0.34955456,0.915144801,80704,SLC19A3
GO:0003211,cardiac ventricle formation (GO:0003211),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6664,SOX11
GO:0001710,mesodermal cell fate commitment (GO:0001710),6,1,0.414973843,2.409790439,0.34955456,0.915144801,9314,KLF4
GO:0060253,negative regulation of glial cell proliferation (GO:0060253),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6664,SOX11
GO:2000698,positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698),6,1,0.414973843,2.409790439,0.34955456,0.915144801,8842,PROM1
GO:0090394,negative regulation of excitatory postsynaptic potential (GO:0090394),6,1,0.414973843,2.409790439,0.34955456,0.915144801,57502,NLGN4X
GO:0097107,postsynaptic density assembly (GO:0097107),6,1,0.414973843,2.409790439,0.34955456,0.915144801,9378,NRXN1
GO:0010359,regulation of anion channel activity (GO:0010359),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5243,ABCB1
GO:0150146,cell junction disassembly (GO:0150146),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6376,CX3CL1
GO:0046137,negative regulation of vitamin metabolic process (GO:0046137),6,1,0.414973843,2.409790439,0.34955456,0.915144801,8644,AKR1C3
GO:0072175,epithelial tube formation (GO:0072175),6,1,0.414973843,2.409790439,0.34955456,0.915144801,2625,GATA3
GO:0090322,regulation of superoxide metabolic process (GO:0090322),6,1,0.414973843,2.409790439,0.34955456,0.915144801,10516,FBLN5
GO:1900449,regulation of glutamate receptor signaling pathway (GO:1900449),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6376,CX3CL1
GO:1902744,negative regulation of lamellipodium organization (GO:1902744),6,1,0.414973843,2.409790439,0.34955456,0.915144801,23189,KANK1
GO:0032069,regulation of nuclease activity (GO:0032069),6,1,0.414973843,2.409790439,0.34955456,0.915144801,8638,OASL
GO:0070243,regulation of thymocyte apoptotic process (GO:0070243),6,1,0.414973843,2.409790439,0.34955456,0.915144801,101,ADAM8
GO:0032364,oxygen homeostasis (GO:0032364),6,1,0.414973843,2.409790439,0.34955456,0.915144801,7477,WNT7B
GO:1902949,positive regulation of tau-protein kinase activity (GO:1902949),6,1,0.414973843,2.409790439,0.34955456,0.915144801,1958,EGR1
GO:0070163,regulation of adiponectin secretion (GO:0070163),6,1,0.414973843,2.409790439,0.34955456,0.915144801,338442,HCAR2
GO:0006797,polyphosphate metabolic process (GO:0006797),6,1,0.414973843,2.409790439,0.34955456,0.915144801,158471,PRUNE2
GO:1902975,mitotic DNA replication initiation (GO:1902975),6,1,0.414973843,2.409790439,0.34955456,0.915144801,4173,MCM4
GO:1902315,nuclear cell cycle DNA replication initiation (GO:1902315),6,1,0.414973843,2.409790439,0.34955456,0.915144801,4173,MCM4
GO:1901031,regulation of response to reactive oxygen species (GO:1901031),6,1,0.414973843,2.409790439,0.34955456,0.915144801,10516,FBLN5
GO:0072498,embryonic skeletal joint development (GO:0072498),6,1,0.414973843,2.409790439,0.34955456,0.915144801,130497,OSR1
GO:0140271,hexose import across plasma membrane (GO:0140271),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6523,SLC5A1
GO:0055022,negative regulation of cardiac muscle tissue growth (GO:0055022),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5950,RBP4
GO:0046601,positive regulation of centriole replication (GO:0046601),6,1,0.414973843,2.409790439,0.34955456,0.915144801,10733,PLK4
GO:1902572,negative regulation of serine-type peptidase activity (GO:1902572),6,1,0.414973843,2.409790439,0.34955456,0.915144801,1378,CR1
GO:0010571,positive regulation of nuclear cell cycle DNA replication (GO:0010571),6,1,0.414973843,2.409790439,0.34955456,0.915144801,8317,CDC7
GO:0030174,regulation of DNA-dependent DNA replication initiation (GO:0030174),6,1,0.414973843,2.409790439,0.34955456,0.915144801,81620,CDT1
GO:0048793,pronephros development (GO:0048793),6,1,0.414973843,2.409790439,0.34955456,0.915144801,130497,OSR1
GO:0035116,embryonic hindlimb morphogenesis (GO:0035116),6,1,0.414973843,2.409790439,0.34955456,0.915144801,130497,OSR1
GO:0007185,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),6,1,0.414973843,2.409790439,0.34955456,0.915144801,5764,PTN
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808),6,1,0.414973843,2.409790439,0.34955456,0.915144801,6261,RYR1
GO:0070170,regulation of tooth mineralization (GO:0070170),6,1,0.414973843,2.409790439,0.34955456,0.915144801,54829,ASPN
GO:0006677,glycosylceramide metabolic process (GO:0006677),6,1,0.414973843,2.409790439,0.34955456,0.915144801,256435,ST6GALNAC3
GO:0032324,molybdopterin cofactor biosynthetic process (GO:0032324),6,1,0.414973843,2.409790439,0.34955456,0.915144801,4337,MOCS1
GO:0032651,regulation of interleukin-1 beta production (GO:0032651),83,7,5.740471499,1.219412029,0.350352614,0.91643584,3479;3569;4023;948;6376;115362;1958,CX3CL1;LPL;EGR1;CD36;IGF1;IL6;GBP5
GO:0051225,spindle assembly (GO:0051225),83,7,5.740471499,1.219412029,0.350352614,0.91643584,22974;3832;4751;440270;23015;3833;57519,NEK2;TPX2;KIF11;KIFC1;STARD9;GOLGA8A;GOLGA8B
GO:0034612,response to tumor necrosis factor (GO:0034612),110,9,7.607853794,1.182988034,0.350605783,0.916699157,7538;6366;2625;255743;9370;6422;3373;6376;55022,CX3CL1;SFRP1;ADIPOQ;PID1;HYAL1;CCL21;ZFP36;NPNT;GATA3
GO:0010975,regulation of neuron projection development (GO:0010975),165,13,11.41178069,1.139173662,0.354189258,0.918149315,4916;4915;1000;10371;79625;5979;5649;6376;482;5753;23237;5764;23189,NTRK2;CX3CL1;RELN;PTN;KANK1;ARC;NTRK3;ATP1B2;SEMA3A;PTK6;CDH2;NDNF;RET
GO:0006110,regulation of glycolytic process (GO:0006110),70,6,4.841361506,1.239320797,0.355037853,0.918149315,3479;51085;8671;5207;5209;23225,MLXIPL;PFKFB1;NUP210;SLC4A4;IGF1;PFKFB3
GO:0051604,protein maturation (GO:0051604),97,8,6.708743801,1.192473619,0.35615444,0.918149315,2152;8728;4311;4826;5727;54997;2161;9718,MME;TESC;NNAT;F3;ADAM19;ECE2;PTCH1;F12
GO:1900016,negative regulation of cytokine production involved in inflammatory response (GO:1900016),18,2,1.24492153,1.606526959,0.356659233,0.918149315,347;225,APOD;ABCD2
GO:1903798,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),18,2,1.24492153,1.606526959,0.356659233,0.918149315,1956;3569,EGFR;IL6
GO:0009165,nucleotide biosynthetic process (GO:0009165),18,2,1.24492153,1.606526959,0.356659233,0.918149315,6241;23057,RRM2;NMNAT2
GO:0071103,DNA conformation change (GO:0071103),18,2,1.24492153,1.606526959,0.356659233,0.918149315,7153;3149,TOP2A;HMGB3
GO:2000463,positive regulation of excitatory postsynaptic potential (GO:2000463),18,2,1.24492153,1.606526959,0.356659233,0.918149315,9378;5649,RELN;NRXN1
GO:0015800,acidic amino acid transport (GO:0015800),18,2,1.24492153,1.606526959,0.356659233,0.918149315,9368;83733,SLC9A3R1;SLC25A18
GO:0032717,negative regulation of interleukin-8 production (GO:0032717),18,2,1.24492153,1.606526959,0.356659233,0.918149315,301;9314,ANXA1;KLF4
GO:2000300,regulation of synaptic vesicle exocytosis (GO:2000300),18,2,1.24492153,1.606526959,0.356659233,0.918149315,9783;140730,RIMS3;RIMS4
GO:0070102,interleukin-6-mediated signaling pathway (GO:0070102),18,2,1.24492153,1.606526959,0.356659233,0.918149315,3569;1050,IL6;CEBPA
GO:0090141,positive regulation of mitochondrial fission (GO:0090141),18,2,1.24492153,1.606526959,0.356659233,0.918149315,6790;1634,AURKA;DCN
GO:0072678,T cell migration (GO:0072678),18,2,1.24492153,1.606526959,0.356659233,0.918149315,1901;3627,CXCL10;S1PR1
GO:0050901,leukocyte tethering or rolling (GO:0050901),18,2,1.24492153,1.606526959,0.356659233,0.918149315,6403;58494,JAM2;SELP
GO:0000578,embryonic axis specification (GO:0000578),18,2,1.24492153,1.606526959,0.356659233,0.918149315,5727;6491,STIL;PTCH1
GO:0036148,phosphatidylglycerol acyl-chain remodeling (GO:0036148),18,2,1.24492153,1.606526959,0.356659233,0.918149315,5321;5320,PLA2G4A;PLA2G2A
GO:0002819,regulation of adaptive immune response (GO:0002819),18,2,1.24492153,1.606526959,0.356659233,0.918149315,7292;259307,TNFSF4;IL4I1
GO:0042982,amyloid precursor protein metabolic process (GO:0042982),18,2,1.24492153,1.606526959,0.356659233,0.918149315,8728;5653,ADAM19;KLK6
GO:0033233,regulation of protein sumoylation (GO:0033233),18,2,1.24492153,1.606526959,0.356659233,0.918149315,825;1958,EGR1;CAPN3
GO:0051000,positive regulation of nitric-oxide synthase activity (GO:0051000),18,2,1.24492153,1.606526959,0.356659233,0.918149315,4883;6271,NPR3;S100A1
GO:0002275,myeloid cell activation involved in immune response (GO:0002275),18,2,1.24492153,1.606526959,0.356659233,0.918149315,1776;5169,DNASE1L3;ENPP3
GO:1905606,regulation of presynapse assembly (GO:1905606),18,2,1.24492153,1.606526959,0.356659233,0.918149315,6622;145581,SNCA;LRFN5
GO:0099174,regulation of presynapse organization (GO:0099174),18,2,1.24492153,1.606526959,0.356659233,0.918149315,6622;145581,SNCA;LRFN5
GO:1905562,regulation of vascular endothelial cell proliferation (GO:1905562),18,2,1.24492153,1.606526959,0.356659233,0.918149315,5468;2247,FGF2;PPARG
GO:0003177,pulmonary valve development (GO:0003177),18,2,1.24492153,1.606526959,0.356659233,0.918149315,64220;23493,HEY2;STRA6
GO:0140131,positive regulation of lymphocyte chemotaxis (GO:0140131),18,2,1.24492153,1.606526959,0.356659233,0.918149315,10563;6366,CCL21;CXCL13
GO:0071539,protein localization to centrosome (GO:0071539),18,2,1.24492153,1.606526959,0.356659233,0.918149315,6491;10615,SPAG5;STIL
GO:1901989,positive regulation of cell cycle phase transition (GO:1901989),18,2,1.24492153,1.606526959,0.356659233,0.918149315,2146;81610,FAM83D;EZH2
GO:0099054,presynapse assembly (GO:0099054),18,2,1.24492153,1.606526959,0.356659233,0.918149315,57502;4038,LRP4;NLGN4X
GO:0090335,regulation of brown fat cell differentiation (GO:0090335),18,2,1.24492153,1.606526959,0.356659233,0.918149315,3952;5743,LEP;PTGS2
GO:0071294,cellular response to zinc ion (GO:0071294),18,2,1.24492153,1.606526959,0.356659233,0.918149315,4499;4501,MT1M;MT1X
GO:0007263,nitric oxide mediated signal transduction (GO:0007263),18,2,1.24492153,1.606526959,0.356659233,0.918149315,948;79625,CD36;NDNF
GO:0046599,regulation of centriole replication (GO:0046599),18,2,1.24492153,1.606526959,0.356659233,0.918149315,10733;6491,STIL;PLK4
GO:0045091,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),18,2,1.24492153,1.606526959,0.356659233,0.918149315,7153;9582,TOP2A;APOBEC3B
GO:0031646,positive regulation of nervous system process (GO:0031646),18,2,1.24492153,1.606526959,0.356659233,0.918149315,11076;1959,EGR2;TPPP
GO:0006690,icosanoid metabolic process (GO:0006690),57,5,3.942251512,1.268310757,0.359336081,0.924248687,11343;5321;126410;5740;5743,PLA2G4A;PTGS2;MGLL;PTGIS;CYP4F22
GO:0032092,positive regulation of protein binding (GO:0032092),57,5,3.942251512,1.268310757,0.359336081,0.924248687,857;650;7122;4318;57761,CAV1;CLDN5;BMP2;TRIB3;MMP9
GO:0034622,cellular protein-containing complex assembly (GO:0034622),166,13,11.480943,1.13231117,0.362314201,0.931259394,1756;154;6622;284;3084;1062;1063;845;23542;274;1346;54443;9787,DMD;CENPF;DLGAP5;ANLN;CENPE;ADRB2;SNCA;ANGPT1;COX7A1;CASQ2;BIN1;NRG1;MAPK8IP2
GO:0051496,positive regulation of stress fiber assembly (GO:0051496),44,4,3.043141518,1.314431148,0.362681458,0.931259394,22899;7481;10411;6422,SFRP1;RAPGEF3;ARHGEF15;WNT11
GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),44,4,3.043141518,1.314431148,0.362681458,0.931259394,1956;10252;10253;9052,SPRY2;EGFR;GPRC5A;SPRY1
GO:0002833,positive regulation of response to biotic stimulus (GO:0002833),44,4,3.043141518,1.314431148,0.362681458,0.931259394,654;101;115362;8638,ADAM8;BMP6;OASL;GBP5
GO:0006026,aminoglycan catabolic process (GO:0006026),31,3,2.144031524,1.399233158,0.363572965,0.931558863,2719;6382;60495,HPSE2;GPC3;SDC1
GO:0040017,positive regulation of locomotion (GO:0040017),31,3,2.144031524,1.399233158,0.363572965,0.931558863,6366;64805;5919,P2RY12;CCL21;RARRES2
GO:0050920,regulation of chemotaxis (GO:0050920),31,3,2.144031524,1.399233158,0.363572965,0.931558863,6366;64805;5919,P2RY12;CCL21;RARRES2
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),31,3,2.144031524,1.399233158,0.363572965,0.931558863,857;6422;5753,CAV1;SFRP1;PTK6
GO:0000077,DNA damage checkpoint signaling (GO:0000077),31,3,2.144031524,1.399233158,0.363572965,0.931558863,63967;1869;83990,CLSPN;E2F1;BRIP1
GO:0050708,regulation of protein secretion (GO:0050708),125,10,8.645288403,1.156699411,0.363970273,0.932179511,3745;3479;150;3569;6288;654;10411;3993;101;8736,MYOM1;SAA1;RAPGEF3;ADAM8;KCNB1;BMP6;LLGL2;IGF1;IL6;ADRA2A
GO:1902904,negative regulation of supramolecular fiber organization (GO:1902904),71,6,4.910523813,1.221865575,0.367624513,0.936836868,6622;22974;1410;23189;130271;256949,TPX2;CRYAB;SNCA;KANK1;KANK3;PLEKHH2
GO:0010038,response to metal ion (GO:0010038),71,6,4.910523813,1.221865575,0.367624513,0.936836868,6622;825;857;23498;4501;1396,CAV1;MT1X;SNCA;CAPN3;HAAO;CRIP1
GO:0007268,chemical synaptic transmission (GO:0007268),306,23,21.16366601,1.086768237,0.36973396,0.936836868,1128;8572;6622;5577;57030;6623;6327;3779;6854;5354;320;139411;2564;2568;27115;2892;2893;30819;3777;9378;57502;4857;79608,GRIA4;SYN2;KCNIP2;SLC17A7;KCNMB1;SCN2B;PLP1;SNCA;NRXN1;PTCHD1;GABRE;APBA1;RIC3;SNCG;NOVA1;PDE7B;GABRP;PDLIM4;NLGN4X;PRKAR2B;KCNK3;GRIA3;CHRM1
GO:0045732,positive regulation of protein catabolic process (GO:0045732),85,7,5.878796114,1.190719982,0.373365362,0.936836868,150;2719;2308;2822;101;51514;152503,DTL;GPC3;ADAM8;GPLD1;FOXO1;SH3D19;ADRA2A
GO:0006879,cellular iron ion homeostasis (GO:0006879),58,5,4.011413819,1.24644333,0.373367569,0.936836868,9429;7018;654;286133;1356,SCARA5;TF;BMP6;ABCG2;CP
GO:0051056,regulation of small GTPase mediated signal transduction (GO:0051056),140,11,9.682723011,1.136044064,0.375598091,0.936836868,1894;29127;5649;57381;58480;2305;50649;9824;343578;10144;57569,ARHGAP20;FOXM1;RELN;FAM13A;ECT2;RACGAP1;ARHGAP11A;RHOJ;ARHGEF4;RHOU;ARHGAP40
GO:0032874,positive regulation of stress-activated MAPK cascade (GO:0032874),99,8,6.847068415,1.168383243,0.377500427,0.936836868,7498;6366;3952;10371;650;7477;4281;153769,LEP;BMP2;CCL21;MID1;SEMA3A;SH3RF2;XDH;WNT7B
GO:0030218,erythrocyte differentiation (GO:0030218),45,4,3.112303825,1.285221567,0.378750461,0.936836868,3815;3624;7049;6886,INHBA;TGFBR3;KIT;TAL1
GO:0046626,regulation of insulin receptor signaling pathway (GO:0046626),45,4,3.112303825,1.285221567,0.378750461,0.936836868,10580;55022;23235;23189,SORBS1;KANK1;SIK2;PID1
GO:0071478,cellular response to radiation (GO:0071478),45,4,3.112303825,1.285221567,0.378750461,0.936836868,1894;641;5888;10635,RAD51;ECT2;RAD51AP1;BLM
GO:0051962,positive regulation of nervous system development (GO:0051962),45,4,3.112303825,1.285221567,0.378750461,0.936836868,4311;9378;6664;2047,MME;EPHB1;NRXN1;SOX11
GO:0003333,amino acid transmembrane transport (GO:0003333),45,4,3.112303825,1.285221567,0.378750461,0.936836868,83733;11254;8140;23657,SLC6A14;SLC7A5;SLC7A11;SLC25A18
GO:0009068,aspartate family amino acid catabolic process (GO:0009068),19,2,1.314083837,1.521972909,0.382137911,0.936836868,10993;10157,SDS;AASS
GO:0009066,aspartate family amino acid metabolic process (GO:0009066),19,2,1.314083837,1.521972909,0.382137911,0.936836868,339983;10003,NAALAD2;NAT8L
GO:0007616,long-term memory (GO:0007616),19,2,1.314083837,1.521972909,0.382137911,0.936836868,6517;23237,SLC2A4;ARC
GO:2000251,positive regulation of actin cytoskeleton reorganization (GO:2000251),19,2,1.314083837,1.521972909,0.382137911,0.936836868,4916;7010,NTRK3;TEK
GO:0051894,positive regulation of focal adhesion assembly (GO:0051894),19,2,1.314083837,1.521972909,0.382137911,0.936836868,6422;7010,SFRP1;TEK
GO:0061756,leukocyte adhesion to vascular endothelial cell (GO:0061756),19,2,1.314083837,1.521972909,0.382137911,0.936836868,6403;58494,JAM2;SELP
GO:0003209,cardiac atrium morphogenesis (GO:0003209),19,2,1.314083837,1.521972909,0.382137911,0.936836868,650;23493,BMP2;HEY2
GO:0050982,detection of mechanical stimulus (GO:0050982),19,2,1.314083837,1.521972909,0.382137911,0.936836868,1000;114780,PKD1L2;CDH2
GO:0010827,regulation of glucose transmembrane transport (GO:0010827),19,2,1.314083837,1.521972909,0.382137911,0.936836868,8013;57761,TRIB3;NR4A3
GO:0051926,negative regulation of calcium ion transport (GO:0051926),19,2,1.314083837,1.521972909,0.382137911,0.936836868,150;477,ATP1A2;ADRA2A
GO:0050905,neuromuscular process (GO:0050905),19,2,1.314083837,1.521972909,0.382137911,0.936836868,64220;9378,NRXN1;STRA6
GO:0032924,activin receptor signaling pathway (GO:0032924),19,2,1.314083837,1.521972909,0.382137911,0.936836868,3624;130399,INHBA;ACVR1C
GO:0002724,regulation of T cell cytokine production (GO:0002724),19,2,1.314083837,1.521972909,0.382137911,0.936836868,7292;50943,TNFSF4;FOXP3
GO:0051154,negative regulation of striated muscle cell differentiation (GO:0051154),19,2,1.314083837,1.521972909,0.382137911,0.936836868,650;55553,BMP2;SOX6
GO:0003203,endocardial cushion morphogenesis (GO:0003203),19,2,1.314083837,1.521972909,0.382137911,0.936836868,7048;650,TGFBR2;BMP2
GO:0046503,glycerolipid catabolic process (GO:0046503),19,2,1.314083837,1.521972909,0.382137911,0.936836868,11343;5321,PLA2G4A;MGLL
GO:0000729,DNA double-strand break processing (GO:0000729),19,2,1.314083837,1.521972909,0.382137911,0.936836868,1763;641,BLM;DNA2
GO:0006305,DNA alkylation (GO:0006305),19,2,1.314083837,1.521972909,0.382137911,0.936836868,2353;3070,FOS;HELLS
GO:0044728,DNA methylation or demethylation (GO:0044728),19,2,1.314083837,1.521972909,0.382137911,0.936836868,2353;3070,FOS;HELLS
GO:0006491,N-glycan processing (GO:0006491),19,2,1.314083837,1.521972909,0.382137911,0.936836868,8128;6489,ST8SIA1;ST8SIA2
GO:0032206,positive regulation of telomere maintenance (GO:0032206),32,3,2.213193831,1.355507122,0.382843435,0.936836868,9212;4751;5570,NEK2;AURKB;PKIB
GO:0046928,regulation of neurotransmitter secretion (GO:0046928),32,3,2.213193831,1.355507122,0.382843435,0.936836868,9627;9783;140730,RIMS3;SNCAIP;RIMS4
GO:0007202,activation of phospholipase C activity (GO:0007202),32,3,2.213193831,1.355507122,0.382843435,0.936836868,4915;64805;1956,NTRK2;P2RY12;EGFR
GO:0055008,cardiac muscle tissue morphogenesis (GO:0055008),32,3,2.213193831,1.355507122,0.382843435,0.936836868,1901;650;7049,TGFBR3;BMP2;S1PR1
GO:0001953,negative regulation of cell-matrix adhesion (GO:0001953),32,3,2.213193831,1.355507122,0.382843435,0.936836868,11170;3204;347,FAM107A;HOXA7;APOD
GO:1990138,neuron projection extension (GO:1990138),32,3,2.213193831,1.355507122,0.382843435,0.936836868,54437;10371;63923,SEMA5B;SEMA3A;TNN
GO:0031326,regulation of cellular biosynthetic process (GO:0031326),32,3,2.213193831,1.355507122,0.382843435,0.936836868,1066;9370;5166,PDK4;ADIPOQ;CES1
GO:2000780,negative regulation of double-strand break repair (GO:2000780),32,3,2.213193831,1.355507122,0.382843435,0.936836868,10721;116028;55010,RMI2;POLQ;PARPBP
GO:0071333,cellular response to glucose stimulus (GO:0071333),32,3,2.213193831,1.355507122,0.382843435,0.936836868,3745;51085;5105,PCK1;MLXIPL;KCNB1
GO:0003180,aortic valve morphogenesis (GO:0003180),32,3,2.213193831,1.355507122,0.382843435,0.936836868,23493;2625;6586,SLIT3;HEY2;GATA3
GO:0033673,negative regulation of kinase activity (GO:0033673),59,5,4.080576126,1.225317172,0.387397108,0.936836868,6622;8660;57761;1028;79007,SNCA;CDKN1C;IRS2;TRIB3;DBNDD1
GO:0010507,negative regulation of autophagy (GO:0010507),59,5,4.080576126,1.225317172,0.387397108,0.936836868,6622;3952;54922;4233;3953,LEP;LEPR;SNCA;MET;RASIP1
GO:0015849,organic acid transport (GO:0015849),100,8,6.916230722,1.156699411,0.388205579,0.936836868,11254;2180;2350;9429;2348;23657;6545;1645,AKR1C1;SLC6A14;FOLR1;ACSL1;ABCG2;FOLR2;SLC7A11;SLC7A4
GO:0120036,plasma membrane bounded cell projection organization (GO:0120036),128,10,8.852775324,1.129589268,0.39230788,0.936836868,9368;6366;3569;5354;90249;26047;482;57111;2824;114787,GPRIN1;PLP1;CNTNAP2;CCL21;GPM6B;ATP1B2;IL6;SLC9A3R1;RAB25;UNC5A
GO:0032970,regulation of actin filament-based process (GO:0032970),73,6,5.048848427,1.188389805,0.39283874,0.936836868,11170;390;27289;2824;10391;128239,IQGAP3;FAM107A;CORO2B;RND3;GPM6B;RND1
GO:0034645,cellular macromolecule biosynthetic process (GO:0034645),310,23,21.44031524,1.072745421,0.393971441,0.936836868,63967;3624;983;1763;8317;1869;374393;83990;116028;990;9401;1917;7298;10535;641;4173;1840;55388;23594;4998;7068;8318;9156,INHBA;CDK1;EXO1;CLSPN;FAM111B;CDC6;RMI2;CDC45;MCM10;RNASEH2A;RECQL4;E2F1;ORC6;BRIP1;ORC1;MCM4;TYMS;BLM;DNA2;CDC7;DTX1;THRB;EEF1A2
GO:0006068,ethanol catabolic process (GO:0006068),7,1,0.484136151,2.065534662,0.394559213,0.936836868,27233,SULT1C4
GO:2000317,negative regulation of T-helper 17 type immune response (GO:2000317),7,1,0.484136151,2.065534662,0.394559213,0.936836868,50943,FOXP3
GO:0031086,"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",7,1,0.484136151,2.065534662,0.394559213,0.936836868,7538,ZFP36
GO:0051153,regulation of striated muscle cell differentiation (GO:0051153),7,1,0.484136151,2.065534662,0.394559213,0.936836868,3084,NRG1
GO:2000343,positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),7,1,0.484136151,2.065534662,0.394559213,0.936836868,4023,LPL
GO:0006972,hyperosmotic response (GO:0006972),7,1,0.484136151,2.065534662,0.394559213,0.936836868,358,AQP1
GO:0002031,G protein-coupled receptor internalization (GO:0002031),7,1,0.484136151,2.065534662,0.394559213,0.936836868,133,ADM
GO:0033605,positive regulation of catecholamine secretion (GO:0033605),7,1,0.484136151,2.065534662,0.394559213,0.936836868,3745,KCNB1
GO:0043279,response to alkaloid (GO:0043279),7,1,0.484136151,2.065534662,0.394559213,0.936836868,6261,RYR1
GO:0140058,neuron projection arborization (GO:0140058),7,1,0.484136151,2.065534662,0.394559213,0.936836868,5764,PTN
GO:0007217,tachykinin receptor signaling pathway (GO:0007217),7,1,0.484136151,2.065534662,0.394559213,0.936836868,6869,TACR1
GO:0040018,positive regulation of multicellular organism growth (GO:0040018),7,1,0.484136151,2.065534662,0.394559213,0.936836868,2690,GHR
GO:0048715,negative regulation of oligodendrocyte differentiation (GO:0048715),7,1,0.484136151,2.065534662,0.394559213,0.936836868,23500,DAAM2
GO:0022612,gland morphogenesis (GO:0022612),7,1,0.484136151,2.065534662,0.394559213,0.936836868,9368,SLC9A3R1
GO:0010155,regulation of proton transport (GO:0010155),7,1,0.484136151,2.065534662,0.394559213,0.936836868,9368,SLC9A3R1
GO:0010939,regulation of necrotic cell death (GO:0010939),7,1,0.484136151,2.065534662,0.394559213,0.936836868,10562,OLFM4
GO:0015810,aspartate transmembrane transport (GO:0015810),7,1,0.484136151,2.065534662,0.394559213,0.936836868,83733,SLC25A18
GO:0016264,gap junction assembly (GO:0016264),7,1,0.484136151,2.065534662,0.394559213,0.936836868,2706,GJB2
GO:2001046,positive regulation of integrin-mediated signaling pathway (GO:2001046),7,1,0.484136151,2.065534662,0.394559213,0.936836868,55679,LIMS2
GO:1903896,positive regulation of IRE1-mediated unfolded protein response (GO:1903896),7,1,0.484136151,2.065534662,0.394559213,0.936836868,10551,AGR2
GO:0036089,cleavage furrow formation (GO:0036089),7,1,0.484136151,2.065534662,0.394559213,0.936836868,9212,AURKB
GO:0002829,negative regulation of type 2 immune response (GO:0002829),7,1,0.484136151,2.065534662,0.394559213,0.936836868,301,ANXA1
GO:0060232,delamination (GO:0060232),7,1,0.484136151,2.065534662,0.394559213,0.936836868,26154,ABCA12
GO:0098976,excitatory chemical synaptic transmission (GO:0098976),7,1,0.484136151,2.065534662,0.394559213,0.936836868,8572,PDLIM4
GO:0033148,positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),7,1,0.484136151,2.065534662,0.394559213,0.936836868,3169,FOXA1
GO:0003376,sphingosine-1-phosphate receptor signaling pathway (GO:0003376),7,1,0.484136151,2.065534662,0.394559213,0.936836868,1901,S1PR1
GO:0090240,positive regulation of histone H4 acetylation (GO:0090240),7,1,0.484136151,2.065534662,0.394559213,0.936836868,4582,MUC1
GO:1905065,positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),7,1,0.484136151,2.065534662,0.394559213,0.936836868,3815,KIT
GO:1905063,regulation of vascular associated smooth muscle cell differentiation (GO:1905063),7,1,0.484136151,2.065534662,0.394559213,0.936836868,3815,KIT
GO:0051660,establishment of centrosome localization (GO:0051660),7,1,0.484136151,2.065534662,0.394559213,0.936836868,4085,MAD2L1
GO:1903753,negative regulation of p38MAPK cascade (GO:1903753),7,1,0.484136151,2.065534662,0.394559213,0.936836868,1843,DUSP1
GO:0006930,"substrate-dependent cell migration, cell extension (GO:0006930)",7,1,0.484136151,2.065534662,0.394559213,0.936836868,64805,P2RY12
GO:2000394,positive regulation of lamellipodium morphogenesis (GO:2000394),7,1,0.484136151,2.065534662,0.394559213,0.936836868,5168,ENPP2
GO:1903764,regulation of potassium ion export across plasma membrane (GO:1903764),7,1,0.484136151,2.065534662,0.394559213,0.936836868,30819,KCNIP2
GO:0045836,positive regulation of meiotic nuclear division (GO:0045836),7,1,0.484136151,2.065534662,0.394559213,0.936836868,10635,RAD51AP1
GO:0043584,nose development (GO:0043584),7,1,0.484136151,2.065534662,0.394559213,0.936836868,64220,STRA6
GO:0035995,detection of muscle stretch (GO:0035995),7,1,0.484136151,2.065534662,0.394559213,0.936836868,1000,CDH2
GO:1900028,negative regulation of ruffle assembly (GO:1900028),7,1,0.484136151,2.065534662,0.394559213,0.936836868,23189,KANK1
GO:0031915,positive regulation of synaptic plasticity (GO:0031915),7,1,0.484136151,2.065534662,0.394559213,0.936836868,991,CDC20
GO:0052150,modulation by symbiont of host apoptotic process (GO:0052150),7,1,0.484136151,2.065534662,0.394559213,0.936836868,1511,CTSG
GO:1904181,positive regulation of membrane depolarization (GO:1904181),7,1,0.484136151,2.065534662,0.394559213,0.936836868,1634,DCN
GO:0045989,positive regulation of striated muscle contraction (GO:0045989),7,1,0.484136151,2.065534662,0.394559213,0.936836868,5997,RGS2
GO:0086016,AV node cell action potential (GO:0086016),7,1,0.484136151,2.065534662,0.394559213,0.936836868,6330,SCN4B
GO:0062149,detection of stimulus involved in sensory perception of pain (GO:0062149),7,1,0.484136151,2.065534662,0.394559213,0.936836868,2047,EPHB1
GO:0033860,regulation of NAD(P)H oxidase activity (GO:0033860),7,1,0.484136151,2.065534662,0.394559213,0.936836868,185,AGTR1
GO:0001963,"synaptic transmission, dopaminergic (GO:0001963)",7,1,0.484136151,2.065534662,0.394559213,0.936836868,6622,SNCA
GO:0070233,negative regulation of T cell apoptotic process (GO:0070233),7,1,0.484136151,2.065534662,0.394559213,0.936836868,5304,PIP
GO:0031645,negative regulation of nervous system process (GO:0031645),7,1,0.484136151,2.065534662,0.394559213,0.936836868,58494,JAM2
GO:0090043,regulation of tubulin deacetylation (GO:0090043),7,1,0.484136151,2.065534662,0.394559213,0.936836868,11076,TPPP
GO:0014015,positive regulation of gliogenesis (GO:0014015),7,1,0.484136151,2.065534662,0.394559213,0.936836868,3569,IL6
GO:1903719,regulation of I-kappaB phosphorylation (GO:1903719),7,1,0.484136151,2.065534662,0.394559213,0.936836868,6376,CX3CL1
GO:1903209,positive regulation of oxidative stress-induced cell death (GO:1903209),7,1,0.484136151,2.065534662,0.394559213,0.936836868,4314,MMP3
GO:0038092,nodal signaling pathway (GO:0038092),7,1,0.484136151,2.065534662,0.394559213,0.936836868,130399,ACVR1C
GO:0060336,negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),7,1,0.484136151,2.065534662,0.394559213,0.936836868,5468,PPARG
GO:0060331,negative regulation of response to interferon-gamma (GO:0060331),7,1,0.484136151,2.065534662,0.394559213,0.936836868,5468,PPARG
GO:0050872,white fat cell differentiation (GO:0050872),7,1,0.484136151,2.065534662,0.394559213,0.936836868,5468,PPARG
GO:1903514,release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),7,1,0.484136151,2.065534662,0.394559213,0.936836868,6261,RYR1
GO:0002840,regulation of T cell mediated immune response to tumor cell (GO:0002840),7,1,0.484136151,2.065534662,0.394559213,0.936836868,259307,IL4I1
GO:2000543,positive regulation of gastrulation (GO:2000543),7,1,0.484136151,2.065534662,0.394559213,0.936836868,130497,OSR1
GO:0051386,regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),7,1,0.484136151,2.065534662,0.394559213,0.936836868,4916,NTRK3
GO:0042760,very long-chain fatty acid catabolic process (GO:0042760),7,1,0.484136151,2.065534662,0.394559213,0.936836868,225,ABCD2
GO:0002315,marginal zone B cell differentiation (GO:0002315),7,1,0.484136151,2.065534662,0.394559213,0.936836868,139818,DOCK11
GO:1903995,regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),7,1,0.484136151,2.065534662,0.394559213,0.936836868,4915,NTRK2
GO:0008347,glial cell migration (GO:0008347),7,1,0.484136151,2.065534662,0.394559213,0.936836868,64805,P2RY12
GO:0061626,pharyngeal arch artery morphogenesis (GO:0061626),7,1,0.484136151,2.065534662,0.394559213,0.936836868,2348,FOLR1
GO:0062043,positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),7,1,0.484136151,2.065534662,0.394559213,0.936836868,7048,TGFBR2
GO:0032817,regulation of natural killer cell proliferation (GO:0032817),7,1,0.484136151,2.065534662,0.394559213,0.936836868,3952,LEP
GO:0033234,negative regulation of protein sumoylation (GO:0033234),7,1,0.484136151,2.065534662,0.394559213,0.936836868,825,CAPN3
GO:0033604,negative regulation of catecholamine secretion (GO:0033604),7,1,0.484136151,2.065534662,0.394559213,0.936836868,150,ADRA2A
GO:0097084,vascular associated smooth muscle cell development (GO:0097084),7,1,0.484136151,2.065534662,0.394559213,0.936836868,23493,HEY2
GO:1905598,negative regulation of low-density lipoprotein receptor activity (GO:1905598),7,1,0.484136151,2.065534662,0.394559213,0.936836868,9370,ADIPOQ
GO:0051045,negative regulation of membrane protein ectodomain proteolysis (GO:0051045),7,1,0.484136151,2.065534662,0.394559213,0.936836868,7079,TIMP4
GO:1902961,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),7,1,0.484136151,2.065534662,0.394559213,0.936836868,1944,EFNA3
GO:0072539,T-helper 17 cell differentiation (GO:0072539),7,1,0.484136151,2.065534662,0.394559213,0.936836868,3569,IL6
GO:0035965,cardiolipin acyl-chain remodeling (GO:0035965),7,1,0.484136151,2.065534662,0.394559213,0.936836868,5321,PLA2G4A
GO:0052651,monoacylglycerol catabolic process (GO:0052651),7,1,0.484136151,2.065534662,0.394559213,0.936836868,11343,MGLL
GO:0000052,citrulline metabolic process (GO:0000052),7,1,0.484136151,2.065534662,0.394559213,0.936836868,1373,CPS1
GO:1903071,positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),7,1,0.484136151,2.065534662,0.394559213,0.936836868,857,CAV1
GO:1903361,protein localization to basolateral plasma membrane (GO:1903361),7,1,0.484136151,2.065534662,0.394559213,0.936836868,857,CAV1
GO:2000535,regulation of entry of bacterium into host cell (GO:2000535),7,1,0.484136151,2.065534662,0.394559213,0.936836868,857,CAV1
GO:2000064,regulation of cortisol biosynthetic process (GO:2000064),7,1,0.484136151,2.065534662,0.394559213,0.936836868,650,BMP2
GO:0071716,leukotriene transport (GO:0071716),7,1,0.484136151,2.065534662,0.394559213,0.936836868,368,ABCC6
GO:0043616,keratinocyte proliferation (GO:0043616),7,1,0.484136151,2.065534662,0.394559213,0.936836868,55612,FERMT1
GO:0015833,peptide transport (GO:0015833),7,1,0.484136151,2.065534662,0.394559213,0.936836868,30835,CD209
GO:0003357,noradrenergic neuron differentiation (GO:0003357),7,1,0.484136151,2.065534662,0.394559213,0.936836868,6664,SOX11
GO:0042415,norepinephrine metabolic process (GO:0042415),7,1,0.484136151,2.065534662,0.394559213,0.936836868,2625,GATA3
GO:0045685,regulation of glial cell differentiation (GO:0045685),7,1,0.484136151,2.065534662,0.394559213,0.936836868,983,CDK1
GO:0045939,negative regulation of steroid metabolic process (GO:0045939),7,1,0.484136151,2.065534662,0.394559213,0.936836868,650,BMP2
GO:0060976,coronary vasculature development (GO:0060976),7,1,0.484136151,2.065534662,0.394559213,0.936836868,2719,GPC3
GO:0015744,succinate transport (GO:0015744),7,1,0.484136151,2.065534662,0.394559213,0.936836868,9058,SLC13A2
GO:0052031,modulation by symbiont of host defense response (GO:0052031),7,1,0.484136151,2.065534662,0.394559213,0.936836868,4360,MRC1
GO:0052200,response to host defenses (GO:0052200),7,1,0.484136151,2.065534662,0.394559213,0.936836868,4360,MRC1
GO:1904251,regulation of bile acid metabolic process (GO:1904251),7,1,0.484136151,2.065534662,0.394559213,0.936836868,1066,CES1
GO:0019682,glyceraldehyde-3-phosphate metabolic process (GO:0019682),7,1,0.484136151,2.065534662,0.394559213,0.936836868,216,ALDH1A1
GO:0009220,pyrimidine ribonucleotide biosynthetic process (GO:0009220),7,1,0.484136151,2.065534662,0.394559213,0.936836868,26289,AK5
GO:0008652,cellular amino acid biosynthetic process (GO:0008652),7,1,0.484136151,2.065534662,0.394559213,0.936836868,216,ALDH1A1
GO:0006560,proline metabolic process (GO:0006560),7,1,0.484136151,2.065534662,0.394559213,0.936836868,5831,PYCR1
GO:0042178,xenobiotic catabolic process (GO:0042178),7,1,0.484136151,2.065534662,0.394559213,0.936836868,2946,GSTM2
GO:0045605,negative regulation of epidermal cell differentiation (GO:0045605),7,1,0.484136151,2.065534662,0.394559213,0.936836868,3204,HOXA7
GO:0071694,maintenance of protein location in extracellular region (GO:0071694),7,1,0.484136151,2.065534662,0.394559213,0.936836868,2201,FBN2
GO:0015696,ammonium transport (GO:0015696),7,1,0.484136151,2.065534662,0.394559213,0.936836868,358,AQP1
GO:0046476,glycosylceramide biosynthetic process (GO:0046476),7,1,0.484136151,2.065534662,0.394559213,0.936836868,7368,UGT8
GO:1905165,regulation of lysosomal protein catabolic process (GO:1905165),7,1,0.484136151,2.065534662,0.394559213,0.936836868,4248,MGAT3
GO:0070327,thyroid hormone transport (GO:0070327),7,1,0.484136151,2.065534662,0.394559213,0.936836868,8140,SLC7A5
GO:0046984,regulation of hemoglobin biosynthetic process (GO:0046984),7,1,0.484136151,2.065534662,0.394559213,0.936836868,9314,KLF4
GO:0046348,amino sugar catabolic process (GO:0046348),7,1,0.484136151,2.065534662,0.394559213,0.936836868,216,ALDH1A1
GO:0006577,amino-acid betaine metabolic process (GO:0006577),7,1,0.484136151,2.065534662,0.394559213,0.936836868,23743,BHMT2
GO:0071267,L-methionine salvage (GO:0071267),7,1,0.484136151,2.065534662,0.394559213,0.936836868,23743,BHMT2
GO:1901678,iron coordination entity transport (GO:1901678),7,1,0.484136151,2.065534662,0.394559213,0.936836868,4057,LTF
GO:0033212,iron import into cell (GO:0033212),7,1,0.484136151,2.065534662,0.394559213,0.936836868,4057,LTF
GO:0003081,regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),7,1,0.484136151,2.065534662,0.394559213,0.936836868,185,AGTR1
GO:0090166,Golgi disassembly (GO:0090166),7,1,0.484136151,2.065534662,0.394559213,0.936836868,983,CDK1
GO:0045835,negative regulation of meiotic nuclear division (GO:0045835),7,1,0.484136151,2.065534662,0.394559213,0.936836868,9319,TRIP13
GO:0051150,regulation of smooth muscle cell differentiation (GO:0051150),7,1,0.484136151,2.065534662,0.394559213,0.936836868,348093,RBPMS2
GO:0006600,creatine metabolic process (GO:0006600),7,1,0.484136151,2.065534662,0.394559213,0.936836868,1160,CKMT2
GO:0048634,regulation of muscle organ development (GO:0048634),7,1,0.484136151,2.065534662,0.394559213,0.936836868,1063,CENPF
GO:0035907,dorsal aorta development (GO:0035907),7,1,0.484136151,2.065534662,0.394559213,0.936836868,23493,HEY2
GO:0035912,dorsal aorta morphogenesis (GO:0035912),7,1,0.484136151,2.065534662,0.394559213,0.936836868,23493,HEY2
GO:0044065,regulation of respiratory system process (GO:0044065),7,1,0.484136151,2.065534662,0.394559213,0.936836868,477,ATP1A2
GO:1903288,positive regulation of potassium ion import across plasma membrane (GO:1903288),7,1,0.484136151,2.065534662,0.394559213,0.936836868,482,ATP1B2
GO:1903979,negative regulation of microglial cell activation (GO:1903979),7,1,0.484136151,2.065534662,0.394559213,0.936836868,6376,CX3CL1
GO:0035137,hindlimb morphogenesis (GO:0035137),7,1,0.484136151,2.065534662,0.394559213,0.936836868,130497,OSR1
GO:0006266,DNA ligation (GO:0006266),7,1,0.484136151,2.065534662,0.394559213,0.936836868,7153,TOP2A
GO:0032042,mitochondrial DNA metabolic process (GO:0032042),7,1,0.484136151,2.065534662,0.394559213,0.936836868,1763,DNA2
GO:0001672,regulation of chromatin assembly or disassembly (GO:0001672),7,1,0.484136151,2.065534662,0.394559213,0.936836868,6886,TAL1
GO:1904590,negative regulation of protein import (GO:1904590),7,1,0.484136151,2.065534662,0.394559213,0.936836868,347,APOD
GO:0042308,negative regulation of protein import into nucleus (GO:0042308),7,1,0.484136151,2.065534662,0.394559213,0.936836868,347,APOD
GO:0086036,regulation of cardiac muscle cell membrane potential (GO:0086036),7,1,0.484136151,2.065534662,0.394559213,0.936836868,5348,FXYD1
GO:0031666,positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),7,1,0.484136151,2.065534662,0.394559213,0.936836868,654,BMP6
GO:2000465,regulation of glycogen (starch) synthase activity (GO:2000465),7,1,0.484136151,2.065534662,0.394559213,0.936836868,9370,ADIPOQ
GO:0003353,positive regulation of cilium movement (GO:0003353),7,1,0.484136151,2.065534662,0.394559213,0.936836868,6869,TACR1
GO:2000155,positive regulation of cilium-dependent cell motility (GO:2000155),7,1,0.484136151,2.065534662,0.394559213,0.936836868,6869,TACR1
GO:1902093,positive regulation of flagellated sperm motility (GO:1902093),7,1,0.484136151,2.065534662,0.394559213,0.936836868,6869,TACR1
GO:1902416,positive regulation of mRNA binding (GO:1902416),7,1,0.484136151,2.065534662,0.394559213,0.936836868,55323,LARP6
GO:0006776,vitamin A metabolic process (GO:0006776),7,1,0.484136151,2.065534662,0.394559213,0.936836868,8854,ALDH1A2
GO:0051972,regulation of telomerase activity (GO:0051972),46,4,3.181466132,1.257281968,0.394777539,0.936836868,9212;4751;9314;5570,NEK2;AURKB;KLF4;PKIB
GO:0045910,negative regulation of DNA recombination (GO:0045910),46,4,3.181466132,1.257281968,0.394777539,0.936836868,10721;116028;641;55010,RMI2;POLQ;PARPBP;BLM
GO:1900180,regulation of protein localization to nucleus (GO:1900180),46,4,3.181466132,1.257281968,0.394777539,0.936836868,4804;983;5347;51512,CDK1;PLK1;GTSE1;NGFR
GO:0042176,regulation of protein catabolic process (GO:0042176),101,8,6.985393029,1.145246941,0.398921227,0.946296566,1956;2719;4085;2308;1917;51514;81610;25837,DTL;FAM83D;GPC3;EGFR;MAD2L1;FOXO1;RAB26;EEF1A2
GO:0043393,regulation of protein binding (GO:0043393),115,9,7.953665331,1.131553771,0.400622917,0.949958326,857;6790;9212;5347;650;6590;7122;10763;57761,PLK1;AURKA;CAV1;AURKB;CLDN5;BMP2;NES;TRIB3;SLPI
GO:0007219,Notch signaling pathway (GO:0007219),60,5,4.149738433,1.204895219,0.401407037,0.950173073,650;23493;1840;9787;84441,DLGAP5;MAML2;BMP2;DTX1;HEY2
GO:0032212,positive regulation of telomere maintenance via telomerase (GO:0032212),33,3,2.282356138,1.314431148,0.401978061,0.950173073,9212;4751;5570,NEK2;AURKB;PKIB
GO:0002720,positive regulation of cytokine production involved in immune response (GO:0002720),33,3,2.282356138,1.314431148,0.401978061,0.950173073,3815;7292;8140,KIT;TNFSF4;SLC7A5
GO:0006658,phosphatidylserine metabolic process (GO:0006658),33,3,2.282356138,1.314431148,0.401978061,0.950173073,5321;5320;129642,PLA2G4A;MBOAT2;PLA2G2A
GO:0000038,very long-chain fatty acid metabolic process (GO:0000038),33,3,2.282356138,1.314431148,0.401978061,0.950173073,2180;225;28965,SLC27A6;ABCD2;ACSL1
GO:0046329,negative regulation of JNK cascade (GO:0046329),33,3,2.282356138,1.314431148,0.401978061,0.950173073,5187;153769;401265,PER1;KLHL31;SH3RF2
GO:0006656,phosphatidylcholine biosynthetic process (GO:0006656),33,3,2.282356138,1.314431148,0.401978061,0.950173073,80736;3931;10809,LCAT;STARD10;SLC44A4
GO:0042339,keratan sulfate metabolic process (GO:0042339),33,3,2.282356138,1.314431148,0.401978061,0.950173073,10331;4969;5549,OGN;PRELP;B3GNT3
GO:1901566,organonitrogen compound biosynthetic process (GO:1901566),157,12,10.85848223,1.105126825,0.403035719,0.952298627,1756;3624;5321;1373;123099;80736;2946;3931;1036;2949;10809;4337,INHBA;DMD;CDO1;LCAT;GSTM5;PLA2G4A;MOCS1;GSTM2;CPS1;STARD10;DEGS2;SLC44A4
GO:0050870,positive regulation of T cell activation (GO:0050870),74,6,5.118010734,1.172330484,0.405440057,0.952712531,301;3952;3569;7292;2625;30835,LEP;ANXA1;TNFSF4;CD209;IL6;GATA3
GO:0051492,regulation of stress fiber assembly (GO:0051492),74,6,5.118010734,1.172330484,0.405440057,0.952712531,22899;5734;7481;4233;10411;6422,SFRP1;RAPGEF3;MET;PTGER4;ARHGEF15;WNT11
GO:0006644,phospholipid metabolic process (GO:0006644),74,6,5.118010734,1.172330484,0.405440057,0.952712531,5321;57678;4023;5168;3931;5320,LPL;LCAT;GPAM;ENPP2;PLA2G4A;PLA2G2A
GO:1903320,regulation of protein modification by small protein conjugation or removal (GO:1903320),20,2,1.383246144,1.445874263,0.407173264,0.952712531,2034;1958,EGR1;EPAS1
GO:2000758,positive regulation of peptidyl-lysine acetylation (GO:2000758),20,2,1.383246144,1.445874263,0.407173264,0.952712531,10891;50943,FOXP3;PPARGC1A
GO:0071875,adrenergic receptor signaling pathway (GO:0071875),20,2,1.383246144,1.445874263,0.407173264,0.952712531,154;150,ADRB2;ADRA2A
GO:0090162,establishment of epithelial cell polarity (GO:0090162),20,2,1.383246144,1.445874263,0.407173264,0.952712531,9368;55612,SLC9A3R1;FERMT1
GO:0030866,cortical actin cytoskeleton organization (GO:0030866),20,2,1.383246144,1.445874263,0.407173264,0.952712531,80206;3993,LLGL2;FHOD3
GO:1903901,negative regulation of viral life cycle (GO:1903901),20,2,1.383246144,1.445874263,0.407173264,0.952712531,2934;5806,GSN;PTX3
GO:1902410,mitotic cytokinetic process (GO:1902410),20,2,1.383246144,1.445874263,0.407173264,0.952712531,10112;55165,KIF20A;CEP55
GO:0030073,insulin secretion (GO:0030073),20,2,1.383246144,1.445874263,0.407173264,0.952712531,301;54097,ANXA1;FAM3B
GO:0010762,regulation of fibroblast migration (GO:0010762),20,2,1.383246144,1.445874263,0.407173264,0.952712531,2247;4921,FGF2;DDR2
GO:0051058,negative regulation of small GTPase mediated signal transduction (GO:0051058),20,2,1.383246144,1.445874263,0.407173264,0.952712531,10252;10253,SPRY2;SPRY1
GO:0007498,mesoderm development (GO:0007498),20,2,1.383246144,1.445874263,0.407173264,0.952712531,660;4232,BMX;MEST
GO:1904375,regulation of protein localization to cell periphery (GO:1904375),20,2,1.383246144,1.445874263,0.407173264,0.952712531,5347;6711,PLK1;SPTBN1
GO:0071392,cellular response to estradiol stimulus (GO:0071392),20,2,1.383246144,1.445874263,0.407173264,0.952712531,1956;6422,SFRP1;EGFR
GO:0030004,cellular monovalent inorganic cation homeostasis (GO:0030004),20,2,1.383246144,1.445874263,0.407173264,0.952712531,477;482,ATP1A2;ATP1B2
GO:0048016,inositol phosphate-mediated signaling (GO:0048016),20,2,1.383246144,1.445874263,0.407173264,0.952712531,1906;1907,EDN1;EDN2
GO:0007020,microtubule nucleation (GO:0007020),20,2,1.383246144,1.445874263,0.407173264,0.952712531,22974;11076,TPX2;TPPP
GO:0007369,gastrulation (GO:0007369),20,2,1.383246144,1.445874263,0.407173264,0.952712531,2719;8013,GPC3;NR4A3
GO:1901699,cellular response to nitrogen compound (GO:1901699),20,2,1.383246144,1.445874263,0.407173264,0.952712531,1373;641,BLM;CPS1
GO:0006760,folic acid-containing compound metabolic process (GO:0006760),20,2,1.383246144,1.445874263,0.407173264,0.952712531,2350;10840,ALDH1L1;FOLR2
GO:0001573,ganglioside metabolic process (GO:0001573),20,2,1.383246144,1.445874263,0.407173264,0.952712531,8128;256435,ST6GALNAC3;ST8SIA2
GO:1904659,glucose transmembrane transport (GO:1904659),20,2,1.383246144,1.445874263,0.407173264,0.952712531,6517;6523,SLC2A4;SLC5A1
GO:0035305,negative regulation of dephosphorylation (GO:0035305),20,2,1.383246144,1.445874263,0.407173264,0.952712531,26051;153769,PPP1R16B;SH3RF2
GO:0051963,regulation of synapse assembly (GO:0051963),47,4,3.250628439,1.230531288,0.410737937,0.960305616,6622;9378;2047;145581,EPHB1;SNCA;NRXN1;LRFN5
GO:0030838,positive regulation of actin filament polymerization (GO:0030838),47,4,3.250628439,1.230531288,0.410737937,0.960305616,2934;25802;6366;274,LMOD1;GSN;CCL21;BIN1
GO:2000573,positive regulation of DNA biosynthetic process (GO:2000573),61,5,4.218900741,1.185142839,0.415380376,0.96559363,9212;2247;4751;9314;5570,NEK2;AURKB;FGF2;KLF4;PKIB
GO:2000142,"regulation of DNA-templated transcription, initiation (GO:2000142)",61,5,4.218900741,1.185142839,0.415380376,0.96559363,3569;983;891;51176;3725,CDK1;CCNB1;JUN;LEF1;IL6
GO:0055072,iron ion homeostasis (GO:0055072),61,5,4.218900741,1.185142839,0.415380376,0.96559363,9429;7018;654;286133;1356,SCARA5;TF;BMP6;ABCG2;CP
GO:0016266,O-glycan processing (GO:0016266),61,5,4.218900741,1.185142839,0.415380376,0.96559363,10331;4582;118430;4588;143662,MUC1;MUCL1;MUC6;MUC15;B3GNT3
GO:0071456,cellular response to hypoxia (GO:0071456),131,10,9.060262246,1.103720812,0.420758502,0.96559363,6326;358;79625;5366;5740;5743;6422;101;2034;64344,HIF3A;SFRP1;AQP1;ADAM8;SCN2A;PTGS2;EPAS1;PTGIS;PMAIP1;NDNF
GO:0045995,regulation of embryonic development (GO:0045995),34,3,2.351518446,1.275771409,0.420939399,0.96559363,983;29127;64321,CDK1;RACGAP1;SOX17
GO:1902003,regulation of amyloid-beta formation (GO:1902003),34,3,2.351518446,1.275771409,0.420939399,0.96559363,4915;3479;274,NTRK2;BIN1;IGF1
GO:0032271,regulation of protein polymerization (GO:0032271),34,3,2.351518446,1.275771409,0.420939399,0.96559363,11076;51673;343578,TPPP;TPPP3;ARHGAP40
GO:0051251,positive regulation of lymphocyte activation (GO:0051251),34,3,2.351518446,1.275771409,0.420939399,0.96559363,2255;3569;7292,TNFSF4;FGF10;IL6
GO:0014706,striated muscle tissue development (GO:0014706),34,3,2.351518446,1.275771409,0.420939399,0.96559363,5239;857;5950,RBP4;CAV1;PGM5
GO:1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),34,3,2.351518446,1.275771409,0.420939399,0.96559363,8626;5366;1869,E2F1;TP63;PMAIP1
GO:0002639,positive regulation of immunoglobulin production (GO:0002639),34,3,2.351518446,1.275771409,0.420939399,0.96559363,3569;7292;5950,RBP4;TNFSF4;IL6
GO:1903828,negative regulation of cellular protein localization (GO:1903828),34,3,2.351518446,1.275771409,0.420939399,0.96559363,81620;9370;2824,ADIPOQ;CDT1;GPM6B
GO:0006654,phosphatidic acid biosynthetic process (GO:0006654),48,4,3.319790747,1.204895219,0.426608294,0.96559363,5321;57678;2819;5320,GPD1;GPAM;PLA2G4A;PLA2G2A
GO:0043087,regulation of GTPase activity (GO:0043087),188,14,13.00251376,1.076714877,0.427144507,0.96559363,6366;1894;4915;7481;91584;139818;54922;10411;6422;858;6376;2146;9628;9824,NTRK2;CX3CL1;SFRP1;CAV2;ECT2;EZH2;RAPGEF3;RGS6;ARHGAP11A;RASIP1;CCL21;PLXNA4;WNT11;DOCK11
GO:0046579,positive regulation of Ras protein signal transduction (GO:0046579),62,5,4.288063048,1.166027632,0.429300848,0.96559363,2255;3479;8660;1281;2151,IRS2;FGF10;IGF1;F2RL2;COL3A1
GO:0006767,water-soluble vitamin metabolic process (GO:0006767),76,6,5.256335349,1.141479682,0.430568324,0.96559363,2350;10840;8029;6947;316;80704,ALDH1L1;SLC19A3;AOX1;CUBN;FOLR2;TCN1
GO:0032755,positive regulation of interleukin-6 production (GO:0032755),76,6,5.256335349,1.141479682,0.430568324,0.96559363,3952;3569;7292;4023;85480;90865,TSLP;LEP;LPL;IL33;TNFSF4;IL6
GO:0032956,regulation of actin cytoskeleton organization (GO:0032956),90,7,6.22460765,1.124568871,0.431048126,0.96559363,11170;390;27289;10411;2824;10391;128239,IQGAP3;FAM107A;CORO2B;RAPGEF3;RND3;GPM6B;RND1
GO:0008202,steroid metabolic process (GO:0008202),104,8,7.192879951,1.112210972,0.431051626,0.96559363,8644;1645;51302;56603;1583;1646;8029;3290,AKR1C1;AKR1C2;CYP39A1;CYP11A1;AKR1C3;CUBN;CYP26B1;HSD11B1
GO:0035590,purinergic nucleotide receptor signaling pathway (GO:0035590),21,2,1.452408452,1.377023108,0.431704739,0.96559363,1511;10628,TXNIP;CTSG
GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),21,2,1.452408452,1.377023108,0.431704739,0.96559363,7538;23034,ZFP36;SAMD4A
GO:0019233,sensory perception of pain (GO:0019233),21,2,1.452408452,1.377023108,0.431704739,0.96559363,6335;4311,MME;SCN9A
GO:0038179,neurotrophin signaling pathway (GO:0038179),21,2,1.452408452,1.377023108,0.431704739,0.96559363,4804;4915,NTRK2;NGFR
GO:0010922,positive regulation of phosphatase activity (GO:0010922),21,2,1.452408452,1.377023108,0.431704739,0.96559363,650;2822,BMP2;GPLD1
GO:0010543,regulation of platelet activation (GO:0010543),21,2,1.452408452,1.377023108,0.431704739,0.96559363,5321;6403,PLA2G4A;SELP
GO:0002726,positive regulation of T cell cytokine production (GO:0002726),21,2,1.452408452,1.377023108,0.431704739,0.96559363,3569;7292,TNFSF4;IL6
GO:0043651,linoleic acid metabolic process (GO:0043651),21,2,1.452408452,1.377023108,0.431704739,0.96559363,2180;2946,GSTM2;ACSL1
GO:0009235,cobalamin metabolic process (GO:0009235),21,2,1.452408452,1.377023108,0.431704739,0.96559363,8029;6947,CUBN;TCN1
GO:0045880,positive regulation of smoothened signaling pathway (GO:0045880),21,2,1.452408452,1.377023108,0.431704739,0.96559363,6422;51473,SFRP1;DCDC2
GO:0030201,heparan sulfate proteoglycan metabolic process (GO:0030201),21,2,1.452408452,1.377023108,0.431704739,0.96559363,23213;266722,SULF1;HS6ST3
GO:0010528,regulation of transposition (GO:0010528),21,2,1.452408452,1.377023108,0.431704739,0.96559363,9582;143689,PIWIL4;APOBEC3B
GO:0043687,post-translational protein modification (GO:0043687),345,25,23.86099599,1.047734973,0.434061416,0.96559363,3569;57104;1000;2719;4240;6696;7018;7704;2335;3270;1356;8404;54972;213;4148;91851;1462;83987;51514;2034;8835;90293;64344;146330;157570,HIF3A;DTL;FN1;KLHL13;ZBTB16;TF;CHRDL1;ESCO2;GPC3;MATN3;VCAN;SPARCL1;ALB;SOCS2;CCDC8;TMEM132A;SPP1;MFGE8;EPAS1;IL6;PNPLA2;HRC;CDH2;FBXL16;CP
GO:0042537,benzene-containing compound metabolic process (GO:0042537),8,1,0.553298458,1.807342829,0.436452819,0.96559363,8564,KMO
GO:2000320,negative regulation of T-helper 17 cell differentiation (GO:2000320),8,1,0.553298458,1.807342829,0.436452819,0.96559363,50943,FOXP3
GO:0010656,negative regulation of muscle cell apoptotic process (GO:0010656),8,1,0.553298458,1.807342829,0.436452819,0.96559363,3479,IGF1
GO:0034139,regulation of toll-like receptor 3 signaling pathway (GO:0034139),8,1,0.553298458,1.807342829,0.436452819,0.96559363,857,CAV1
GO:0007197,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),8,1,0.553298458,1.807342829,0.436452819,0.96559363,1128,CHRM1
GO:0060049,regulation of protein glycosylation (GO:0060049),8,1,0.553298458,1.807342829,0.436452819,0.96559363,10267,RAMP1
GO:0051584,regulation of dopamine uptake involved in synaptic transmission (GO:0051584),8,1,0.553298458,1.807342829,0.436452819,0.96559363,6622,SNCA
GO:0051683,establishment of Golgi localization (GO:0051683),8,1,0.553298458,1.807342829,0.436452819,0.96559363,9368,SLC9A3R1
GO:0010917,negative regulation of mitochondrial membrane potential (GO:0010917),8,1,0.553298458,1.807342829,0.436452819,0.96559363,5366,PMAIP1
GO:0030832,regulation of actin filament length (GO:0030832),8,1,0.553298458,1.807342829,0.436452819,0.96559363,6387,CXCL12
GO:0090527,actin filament reorganization (GO:0090527),8,1,0.553298458,1.807342829,0.436452819,0.96559363,2934,GSN
GO:2001269,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),8,1,0.553298458,1.807342829,0.436452819,0.96559363,2934,GSN
GO:0046631,alpha-beta T cell activation (GO:0046631),8,1,0.553298458,1.807342829,0.436452819,0.96559363,301,ANXA1
GO:0051451,myoblast migration (GO:0051451),8,1,0.553298458,1.807342829,0.436452819,0.96559363,301,ANXA1
GO:0043403,skeletal muscle tissue regeneration (GO:0043403),8,1,0.553298458,1.807342829,0.436452819,0.96559363,301,ANXA1
GO:0044331,cell-cell adhesion mediated by cadherin (GO:0044331),8,1,0.553298458,1.807342829,0.436452819,0.96559363,1000,CDH2
GO:0042996,regulation of Golgi to plasma membrane protein transport (GO:0042996),8,1,0.553298458,1.807342829,0.436452819,0.96559363,91461,PKDCC
GO:0010763,positive regulation of fibroblast migration (GO:0010763),8,1,0.553298458,1.807342829,0.436452819,0.96559363,4921,DDR2
GO:0034112,positive regulation of homotypic cell-cell adhesion (GO:0034112),8,1,0.553298458,1.807342829,0.436452819,0.96559363,5329,PLAUR
GO:0002732,positive regulation of dendritic cell cytokine production (GO:0002732),8,1,0.553298458,1.807342829,0.436452819,0.96559363,3815,KIT
GO:0060054,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),8,1,0.553298458,1.807342829,0.436452819,0.96559363,2255,FGF10
GO:0035635,entry of bacterium into host cell (GO:0035635),8,1,0.553298458,1.807342829,0.436452819,0.96559363,4233,MET
GO:1902966,positive regulation of protein localization to early endosome (GO:1902966),8,1,0.553298458,1.807342829,0.436452819,0.96559363,4248,MGAT3
GO:1905668,positive regulation of protein localization to endosome (GO:1905668),8,1,0.553298458,1.807342829,0.436452819,0.96559363,4248,MGAT3
GO:1902965,regulation of protein localization to early endosome (GO:1902965),8,1,0.553298458,1.807342829,0.436452819,0.96559363,4248,MGAT3
GO:0060977,coronary vasculature morphogenesis (GO:0060977),8,1,0.553298458,1.807342829,0.436452819,0.96559363,7049,TGFBR3
GO:0070307,lens fiber cell development (GO:0070307),8,1,0.553298458,1.807342829,0.436452819,0.96559363,7477,WNT7B
GO:2000601,positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),8,1,0.553298458,1.807342829,0.436452819,0.96559363,10810,WASF3
GO:1903286,regulation of potassium ion import (GO:1903286),8,1,0.553298458,1.807342829,0.436452819,0.96559363,482,ATP1B2
GO:0001771,immunological synapse formation (GO:0001771),8,1,0.553298458,1.807342829,0.436452819,0.96559363,6366,CCL21
GO:0014866,skeletal myofibril assembly (GO:0014866),8,1,0.553298458,1.807342829,0.436452819,0.96559363,4629,MYH11
GO:0060841,venous blood vessel development (GO:0060841),8,1,0.553298458,1.807342829,0.436452819,0.96559363,147372,CCBE1
GO:0002444,myeloid leukocyte mediated immunity (GO:0002444),8,1,0.553298458,1.807342829,0.436452819,0.96559363,3569,IL6
GO:0110053,regulation of actin filament organization (GO:0110053),8,1,0.553298458,1.807342829,0.436452819,0.96559363,6387,CXCL12
GO:0070486,leukocyte aggregation (GO:0070486),8,1,0.553298458,1.807342829,0.436452819,0.96559363,58494,JAM2
GO:0035372,protein localization to microtubule (GO:0035372),8,1,0.553298458,1.807342829,0.436452819,0.96559363,4281,MID1
GO:0033668,negative regulation by symbiont of host apoptotic process (GO:0033668),8,1,0.553298458,1.807342829,0.436452819,0.96559363,1511,CTSG
GO:0052041,negative regulation by symbiont of host programmed cell death (GO:0052041),8,1,0.553298458,1.807342829,0.436452819,0.96559363,1511,CTSG
GO:0098909,regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),8,1,0.553298458,1.807342829,0.436452819,0.96559363,857,CAV1
GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),8,1,0.553298458,1.807342829,0.436452819,0.96559363,5288,PIK3C2G
GO:2001137,positive regulation of endocytic recycling (GO:2001137),8,1,0.553298458,1.807342829,0.436452819,0.96559363,30846,EHD2
GO:0071872,cellular response to epinephrine stimulus (GO:0071872),8,1,0.553298458,1.807342829,0.436452819,0.96559363,6622,SNCA
GO:0071871,response to epinephrine (GO:0071871),8,1,0.553298458,1.807342829,0.436452819,0.96559363,6622,SNCA
GO:0099625,ventricular cardiac muscle cell membrane repolarization (GO:0099625),8,1,0.553298458,1.807342829,0.436452819,0.96559363,3753,KCNE1
GO:0030104,water homeostasis (GO:0030104),8,1,0.553298458,1.807342829,0.436452819,0.96559363,358,AQP1
GO:0097264,self proteolysis (GO:0097264),8,1,0.553298458,1.807342829,0.436452819,0.96559363,825,CAPN3
GO:0010893,positive regulation of steroid biosynthetic process (GO:0010893),8,1,0.553298458,1.807342829,0.436452819,0.96559363,133,ADM
GO:0032769,negative regulation of monooxygenase activity (GO:0032769),8,1,0.553298458,1.807342829,0.436452819,0.96559363,6622,SNCA
GO:0018401,peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),8,1,0.553298458,1.807342829,0.436452819,0.96559363,283208,P4HA3
GO:0032661,regulation of interleukin-18 production (GO:0032661),8,1,0.553298458,1.807342829,0.436452819,0.96559363,115362,GBP5
GO:1905634,regulation of protein localization to chromatin (GO:1905634),8,1,0.553298458,1.807342829,0.436452819,0.96559363,113130,CDCA5
GO:0046085,adenosine metabolic process (GO:0046085),8,1,0.553298458,1.807342829,0.436452819,0.96559363,7498,XDH
GO:0009169,purine ribonucleoside monophosphate catabolic process (GO:0009169),8,1,0.553298458,1.807342829,0.436452819,0.96559363,7498,XDH
GO:0035313,"wound healing, spreading of epidermal cells (GO:0035313)",8,1,0.553298458,1.807342829,0.436452819,0.96559363,1289,COL5A1
GO:2000510,positive regulation of dendritic cell chemotaxis (GO:2000510),8,1,0.553298458,1.807342829,0.436452819,0.96559363,6366,CCL21
GO:2000553,positive regulation of T-helper 2 cell cytokine production (GO:2000553),8,1,0.553298458,1.807342829,0.436452819,0.96559363,3569,IL6
GO:1905005,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),8,1,0.553298458,1.807342829,0.436452819,0.96559363,7048,TGFBR2
GO:0003222,ventricular trabecula myocardium morphogenesis (GO:0003222),8,1,0.553298458,1.807342829,0.436452819,0.96559363,3084,NRG1
GO:0021884,forebrain neuron development (GO:0021884),8,1,0.553298458,1.807342829,0.436452819,0.96559363,26468,LHX6
GO:2000178,negative regulation of neural precursor cell proliferation (GO:2000178),8,1,0.553298458,1.807342829,0.436452819,0.96559363,5764,PTN
GO:0150012,positive regulation of neuron projection arborization (GO:0150012),8,1,0.553298458,1.807342829,0.436452819,0.96559363,8322,FZD4
GO:0032099,negative regulation of appetite (GO:0032099),8,1,0.553298458,1.807342829,0.436452819,0.96559363,3952,LEP
GO:1901032,negative regulation of response to reactive oxygen species (GO:1901032),8,1,0.553298458,1.807342829,0.436452819,0.96559363,5831,PYCR1
GO:0046322,negative regulation of fatty acid oxidation (GO:0046322),8,1,0.553298458,1.807342829,0.436452819,0.96559363,440503,PLIN5
GO:1904385,cellular response to angiotensin (GO:1904385),8,1,0.553298458,1.807342829,0.436452819,0.96559363,185,AGTR1
GO:0033194,response to hydroperoxide (GO:0033194),8,1,0.553298458,1.807342829,0.436452819,0.96559363,2878,GPX3
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),8,1,0.553298458,1.807342829,0.436452819,0.96559363,3479,IGF1
GO:1903306,negative regulation of regulated secretory pathway (GO:1903306),8,1,0.553298458,1.807342829,0.436452819,0.96559363,150,ADRA2A
GO:1905064,negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),8,1,0.553298458,1.807342829,0.436452819,0.96559363,23493,HEY2
GO:0035457,cellular response to interferon-alpha (GO:0035457),8,1,0.553298458,1.807342829,0.436452819,0.96559363,2625,GATA3
GO:1903689,"regulation of wound healing, spreading of epidermal cells (GO:1903689)",8,1,0.553298458,1.807342829,0.436452819,0.96559363,55612,FERMT1
GO:0014741,negative regulation of muscle hypertrophy (GO:0014741),8,1,0.553298458,1.807342829,0.436452819,0.96559363,5997,RGS2
GO:1905247,positive regulation of aspartic-type peptidase activity (GO:1905247),8,1,0.553298458,1.807342829,0.436452819,0.96559363,1944,EFNA3
GO:0072074,kidney mesenchyme development (GO:0072074),8,1,0.553298458,1.807342829,0.436452819,0.96559363,130497,OSR1
GO:0017121,plasma membrane phospholipid scrambling (GO:0017121),8,1,0.553298458,1.807342829,0.436452819,0.96559363,57088,PLSCR4
GO:1905155,positive regulation of membrane invagination (GO:1905155),8,1,0.553298458,1.807342829,0.436452819,0.96559363,11031,RAB31
GO:0002295,T-helper cell lineage commitment (GO:0002295),8,1,0.553298458,1.807342829,0.436452819,0.96559363,3569,IL6
GO:0010912,positive regulation of isomerase activity (GO:0010912),8,1,0.553298458,1.807342829,0.436452819,0.96559363,29128,UHRF1
GO:0046640,regulation of alpha-beta T cell proliferation (GO:0046640),8,1,0.553298458,1.807342829,0.436452819,0.96559363,7292,TNFSF4
GO:0010898,positive regulation of triglyceride catabolic process (GO:0010898),8,1,0.553298458,1.807342829,0.436452819,0.96559363,57104,PNPLA2
GO:0046469,platelet activating factor metabolic process (GO:0046469),8,1,0.553298458,1.807342829,0.436452819,0.96559363,5321,PLA2G4A
GO:0051006,positive regulation of lipoprotein lipase activity (GO:0051006),8,1,0.553298458,1.807342829,0.436452819,0.96559363,338328,GPIHBP1
GO:0045959,"negative regulation of complement activation, classical pathway (GO:0045959)",8,1,0.553298458,1.807342829,0.436452819,0.96559363,1378,CR1
GO:0035886,vascular associated smooth muscle cell differentiation (GO:0035886),8,1,0.553298458,1.807342829,0.436452819,0.96559363,23493,HEY2
GO:0060973,cell migration involved in heart development (GO:0060973),8,1,0.553298458,1.807342829,0.436452819,0.96559363,2348,FOLR1
GO:0006534,cysteine metabolic process (GO:0006534),8,1,0.553298458,1.807342829,0.436452819,0.96559363,1036,CDO1
GO:0000097,sulfur amino acid biosynthetic process (GO:0000097),8,1,0.553298458,1.807342829,0.436452819,0.96559363,1036,CDO1
GO:0010510,regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),8,1,0.553298458,1.807342829,0.436452819,0.96559363,5166,PDK4
GO:0050812,regulation of acyl-CoA biosynthetic process (GO:0050812),8,1,0.553298458,1.807342829,0.436452819,0.96559363,5166,PDK4
GO:0006681,galactosylceramide metabolic process (GO:0006681),8,1,0.553298458,1.807342829,0.436452819,0.96559363,7368,UGT8
GO:0034340,response to type I interferon (GO:0034340),8,1,0.553298458,1.807342829,0.436452819,0.96559363,9636,ISG15
GO:0062207,regulation of pattern recognition receptor signaling pathway (GO:0062207),8,1,0.553298458,1.807342829,0.436452819,0.96559363,948,CD36
GO:2001204,regulation of osteoclast development (GO:2001204),8,1,0.553298458,1.807342829,0.436452819,0.96559363,4057,LTF
GO:0010839,negative regulation of keratinocyte proliferation (GO:0010839),8,1,0.553298458,1.807342829,0.436452819,0.96559363,687,KLF9
GO:0003330,regulation of extracellular matrix constituent secretion (GO:0003330),8,1,0.553298458,1.807342829,0.436452819,0.96559363,650,BMP2
GO:0009954,proximal/distal pattern formation (GO:0009954),8,1,0.553298458,1.807342829,0.436452819,0.96559363,56603,CYP26B1
GO:0099628,neurotransmitter receptor diffusion trapping (GO:0099628),8,1,0.553298458,1.807342829,0.436452819,0.96559363,27092,CACNG4
GO:0098970,postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),8,1,0.553298458,1.807342829,0.436452819,0.96559363,27092,CACNG4
GO:0097106,postsynaptic density organization (GO:0097106),8,1,0.553298458,1.807342829,0.436452819,0.96559363,9378,NRXN1
GO:0071639,positive regulation of monocyte chemotactic protein-1 production (GO:0071639),8,1,0.553298458,1.807342829,0.436452819,0.96559363,9370,ADIPOQ
GO:0003230,cardiac atrium development (GO:0003230),8,1,0.553298458,1.807342829,0.436452819,0.96559363,287,ANK2
GO:0016202,regulation of striated muscle tissue development (GO:0016202),8,1,0.553298458,1.807342829,0.436452819,0.96559363,1063,CENPF
GO:0006267,pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),8,1,0.553298458,1.807342829,0.436452819,0.96559363,4173,MCM4
GO:0006335,DNA replication-dependent nucleosome assembly (GO:0006335),8,1,0.553298458,1.807342829,0.436452819,0.96559363,55723,ASF1B
GO:0034723,DNA replication-dependent nucleosome organization (GO:0034723),8,1,0.553298458,1.807342829,0.436452819,0.96559363,55723,ASF1B
GO:0070306,lens fiber cell differentiation (GO:0070306),8,1,0.553298458,1.807342829,0.436452819,0.96559363,7477,WNT7B
GO:0045682,regulation of epidermis development (GO:0045682),8,1,0.553298458,1.807342829,0.436452819,0.96559363,23764,MAFF
GO:0016446,somatic hypermutation of immunoglobulin genes (GO:0016446),8,1,0.553298458,1.807342829,0.436452819,0.96559363,10721,POLQ
GO:0006264,mitochondrial DNA replication (GO:0006264),8,1,0.553298458,1.807342829,0.436452819,0.96559363,1763,DNA2
GO:1903251,multi-ciliated epithelial cell differentiation (GO:1903251),8,1,0.553298458,1.807342829,0.436452819,0.96559363,10733,PLK4
GO:0006348,chromatin silencing at telomere (GO:0006348),8,1,0.553298458,1.807342829,0.436452819,0.96559363,2146,EZH2
GO:0048478,replication fork protection (GO:0048478),8,1,0.553298458,1.807342829,0.436452819,0.96559363,641,BLM
GO:0051148,negative regulation of muscle cell differentiation (GO:0051148),8,1,0.553298458,1.807342829,0.436452819,0.96559363,348093,RBPMS2
GO:0042130,negative regulation of T cell proliferation (GO:0042130),35,3,2.420680753,1.239320797,0.439693338,0.97061941,259307;1378;50943,FOXP3;IL4I1;CR1
GO:0098586,cellular response to virus (GO:0098586),35,3,2.420680753,1.239320797,0.439693338,0.97061941,3569;3627;2537,CXCL10;IFI6;IL6
GO:0035335,peptidyl-tyrosine dephosphorylation (GO:0035335),35,3,2.420680753,1.239320797,0.439693338,0.97061941,1848;1843;5803,PTPRZ1;DUSP6;DUSP1
GO:1902807,negative regulation of cell cycle G1/S phase transition (GO:1902807),35,3,2.420680753,1.239320797,0.439693338,0.97061941,11170;9314;2273,FAM107A;FHL1;KLF4
GO:0032886,regulation of microtubule-based process (GO:0032886),35,3,2.420680753,1.239320797,0.439693338,0.97061941,11170;6790;11076,AURKA;FAM107A;TPPP
GO:0099177,regulation of trans-synaptic signaling (GO:0099177),35,3,2.420680753,1.239320797,0.439693338,0.97061941,57502;5649;23237,RELN;ARC;NLGN4X
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),119,9,8.230314559,1.09351835,0.440771371,0.972641964,2934;6622;4804;2152;5468;7498;130399;5366;83595,SNCA;GSN;ACVR1C;PPARG;NGFR;F3;SOX7;PMAIP1;XDH
GO:0071260,cellular response to mechanical stimulus (GO:0071260),49,4,3.388953054,1.180305521,0.442366653,0.974730921,5734;5138;358;943,PDE2A;AQP1;PTGER4;TNFRSF8
GO:0051270,regulation of cellular component movement (GO:0051270),49,4,3.388953054,1.180305521,0.442366653,0.974730921,1956;3084;7049;9542,NRG2;TGFBR3;EGFR;NRG1
GO:0034332,adherens junction organization (GO:0034332),49,4,3.388953054,1.180305521,0.442366653,0.974730921,253559;57863;1000;1009,CADM3;CDH11;CDH2;CADM2
GO:0009311,oligosaccharide metabolic process (GO:0009311),49,4,3.388953054,1.180305521,0.442366653,0.974730921,28;8128;6489;256435,ST6GALNAC3;ST8SIA1;ABO;ST8SIA2
GO:2001234,negative regulation of apoptotic signaling pathway (GO:2001234),77,6,5.325497656,1.12665527,0.443071392,0.975390744,3479;6376;23542;4318;5329;219790,CX3CL1;RTKN2;MMP9;PLAUR;IGF1;MAPK8IP2
GO:0010951,negative regulation of endopeptidase activity (GO:0010951),63,5,4.357225355,1.147519257,0.443152907,0.975390744,4057;1378;274;7079;5268,TIMP4;BIN1;CR1;SERPINB5;LTF
GO:1901565,organonitrogen compound catabolic process (GO:1901565),63,5,4.357225355,1.147519257,0.443152907,0.975390744,825;5321;259307;5168;290,ENPP2;CAPN3;PLA2G4A;IL4I1;ANPEP
GO:0007264,small GTPase mediated signal transduction (GO:0007264),106,8,7.331204566,1.091225859,0.452381535,0.994230878,3479;150;2247;890;3725;9077;22808;6236,CCNA2;FGF2;MRAS;JUN;RRAD;IGF1;DIRAS3;ADRA2A
GO:0016485,protein processing (GO:0016485),106,8,7.331204566,1.091225859,0.452381535,0.994230878,2152;8728;5653;4311;5727;2161;9718;8492,MME;F3;ADAM19;ECE2;PTCH1;F12;PRSS12;KLK6
GO:0046474,glycerophospholipid biosynthetic process (GO:0046474),177,13,12.24172838,1.061941549,0.452739376,0.994230878,5321;57678;2819;80736;660;2247;27132;3931;5320;57664;10809;8395;5288,GPD1;FGF2;LCAT;GPAM;BMX;PLA2G4A;PIK3C2G;PLEKHA4;STARD10;PIP5K1B;SLC44A4;PLA2G2A;CPNE7
GO:0042110,T cell activation (GO:0042110),92,7,6.362932264,1.100121722,0.453976868,0.994230878,3815;6366;3952;7292;2625;3953;50943,LEP;LEPR;KIT;TNFSF4;FOXP3;CCL21;GATA3
GO:0016055,Wnt signaling pathway (GO:0016055),92,7,6.362932264,1.100121722,0.453976868,0.994230878,7481;79971;83439;51176;6422;8322;7477,SFRP1;LEF1;FZD4;WLS;TCF7L1;WNT11;WNT7B
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),78,6,5.394659963,1.112210972,0.455518553,0.994230878,857;991;5347;1050;57761;153769,PLK1;CDC20;CAV1;TRIB3;CEBPA;SH3RF2
GO:0035268,protein mannosylation (GO:0035268),22,2,1.521570759,1.314431148,0.45568226,0.994230878,283417;83857,TMTC1;DPY19L2
GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),22,2,1.521570759,1.314431148,0.45568226,0.994230878,5366;90993,CREB3L1;PMAIP1
GO:0070168,negative regulation of biomineral tissue development (GO:0070168),22,2,1.521570759,1.314431148,0.45568226,0.994230878,23493;54829,HEY2;ASPN
GO:0071624,positive regulation of granulocyte chemotaxis (GO:0071624),22,2,1.521570759,1.314431148,0.45568226,0.994230878,6366;57402,CCL21;S100A14
GO:1902624,positive regulation of neutrophil migration (GO:1902624),22,2,1.521570759,1.314431148,0.45568226,0.994230878,6366;101,ADAM8;CCL21
GO:0045761,regulation of adenylate cyclase activity (GO:0045761),22,2,1.521570759,1.314431148,0.45568226,0.994230878,1910;5064,EDNRB;PALM
GO:0001774,microglial cell activation (GO:0001774),22,2,1.521570759,1.314431148,0.45568226,0.994230878,6622;6376,CX3CL1;SNCA
GO:0008585,female gonad development (GO:0008585),22,2,1.521570759,1.314431148,0.45568226,0.994230878,3815;3624,INHBA;KIT
GO:0045936,negative regulation of phosphate metabolic process (GO:0045936),22,2,1.521570759,1.314431148,0.45568226,0.994230878,3624;1028,INHBA;CDKN1C
GO:2000179,positive regulation of neural precursor cell proliferation (GO:2000179),22,2,1.521570759,1.314431148,0.45568226,0.994230878,10763;6376,CX3CL1;NES
GO:1990090,cellular response to nerve growth factor stimulus (GO:1990090),22,2,1.521570759,1.314431148,0.45568226,0.994230878,4916;4915,NTRK2;NTRK3
GO:0010758,regulation of macrophage chemotaxis (GO:0010758),22,2,1.521570759,1.314431148,0.45568226,0.994230878,5919;146433,IL34;RARRES2
GO:0006783,heme biosynthetic process (GO:0006783),22,2,1.521570759,1.314431148,0.45568226,0.994230878,9429;213,ALB;ABCG2
GO:1901687,glutathione derivative biosynthetic process (GO:1901687),22,2,1.521570759,1.314431148,0.45568226,0.994230878,2946;2949,GSTM5;GSTM2
GO:1901685,glutathione derivative metabolic process (GO:1901685),22,2,1.521570759,1.314431148,0.45568226,0.994230878,2946;2949,GSTM5;GSTM2
GO:0033013,tetrapyrrole metabolic process (GO:0033013),22,2,1.521570759,1.314431148,0.45568226,0.994230878,8029;6947,CUBN;TCN1
GO:0035308,negative regulation of protein dephosphorylation (GO:0035308),22,2,1.521570759,1.314431148,0.45568226,0.994230878,26051;84152,PPP1R16B;PPP1R1B
GO:0035970,peptidyl-threonine dephosphorylation (GO:0035970),22,2,1.521570759,1.314431148,0.45568226,0.994230878,1848;1843,DUSP6;DUSP1
GO:0045637,regulation of myeloid cell differentiation (GO:0045637),64,5,4.426387662,1.129589268,0.456921744,0.995408104,3202;7704;4212;8013;10398,HOXA5;ZBTB16;MEIS2;MYL9;NR4A3
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),64,5,4.426387662,1.129589268,0.456921744,0.995408104,6387;4318;90993;5329;219790,RTKN2;CXCL12;MMP9;PLAUR;CREB3L1
GO:0060260,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),64,5,4.426387662,1.129589268,0.456921744,0.995408104,3569;983;891;23493;51176,CDK1;CCNB1;LEF1;IL6;HEY2
GO:0036388,pre-replicative complex assembly (GO:0036388),64,5,4.426387662,1.129589268,0.456921744,0.995408104,81620;990;4173;23594;4998,CDC6;ORC6;ORC1;MCM4;CDT1
GO:0031397,negative regulation of protein ubiquitination (GO:0031397),50,4,3.458115361,1.156699411,0.457992467,0.995408104,857;9636;10253;153769,SPRY2;CAV1;ISG15;SH3RF2
GO:0006865,amino acid transport (GO:0006865),50,4,3.458115361,1.156699411,0.457992467,0.995408104,11254;8140;23657;6545,SLC6A14;SLC7A5;SLC7A11;SLC7A4
GO:0046473,phosphatidic acid metabolic process (GO:0046473),50,4,3.458115361,1.156699411,0.457992467,0.995408104,5321;57678;2819;5320,GPD1;GPAM;PLA2G4A;PLA2G2A
GO:1904358,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),36,3,2.48984306,1.204895219,0.458208987,0.995408104,9212;4751;5570,NEK2;AURKB;PKIB
GO:0002763,positive regulation of myeloid leukocyte differentiation (GO:0002763),36,3,2.48984306,1.204895219,0.458208987,0.995408104,51176;146433;54997,TESC;LEF1;IL34
GO:0042116,macrophage activation (GO:0042116),36,3,2.48984306,1.204895219,0.458208987,0.995408104,6622;1907;6376,CX3CL1;SNCA;EDN2
GO:0061951,establishment of protein localization to plasma membrane (GO:0061951),36,3,2.48984306,1.204895219,0.458208987,0.995408104,6711;11031;25837,SPTBN1;RAB26;RAB31
GO:0034122,negative regulation of toll-like receptor signaling pathway (GO:0034122),36,3,2.48984306,1.204895219,0.458208987,0.995408104,55366;7301;92747,LGR4;TYRO3;BPIFB1
GO:0050776,regulation of immune response (GO:0050776),178,13,12.31089069,1.055975586,0.460960899,0.998950962,10563;7292;259307;947;2209;1308;1281;1278;3384;1277;50943;2205;146894,CD300LG;TNFSF4;COL17A1;FOXP3;IL4I1;CD34;FCGR1A;ICAM2;FCER1A;CXCL13;COL1A1;COL3A1;COL1A2
GO:0090090,negative regulation of canonical Wnt signaling pathway (GO:0090090),164,12,11.34261838,1.057956778,0.463185676,0.998950962,9368;857;7481;650;64321;6422;8322;4038;63923;3489;27303;92162,IGFBP6;CAV1;SFRP1;RBMS3;BMP2;TMEM88;LRP4;SOX17;FZD4;WNT11;SLC9A3R1;TNN
GO:0033138,positive regulation of peptidyl-serine phosphorylation (GO:0033138),93,7,6.432094572,1.088292456,0.465373925,0.998950962,6622;4916;1956;3569;857;10411;10253,SPRY2;CAV1;RAPGEF3;SNCA;EGFR;NTRK3;IL6
GO:0098661,inorganic anion transmembrane transport (GO:0098661),65,5,4.495549969,1.112210972,0.470593308,0.998950962,2564;2568;6523;84561;203859,GABRE;GABRP;SLC12A8;ANO5;SLC5A1
GO:0051252,regulation of RNA metabolic process (GO:0051252),65,5,4.495549969,1.112210972,0.470593308,0.998950962,4857;54845;8638;57716;10644,PRX;NOVA1;IGF2BP2;OASL;ESRP1
GO:0006694,steroid biosynthetic process (GO:0006694),65,5,4.495549969,1.112210972,0.470593308,0.998950962,8644;51302;1583;6713;3290,SQLE;CYP39A1;CYP11A1;AKR1C3;HSD11B1
GO:0048017,inositol lipid-mediated signaling (GO:0048017),51,4,3.527277668,1.13401903,0.473466588,0.998950962,3479;8660;5288;9651,IRS2;PIK3C2G;IGF1;PLCH2
GO:0051051,negative regulation of transport (GO:0051051),51,4,3.527277668,1.13401903,0.473466588,0.998950962,6622;3084;9370;1410,CRYAB;ADIPOQ;SNCA;NRG1
GO:0008406,gonad development (GO:0008406),51,4,3.527277668,1.13401903,0.473466588,0.998950962,3815;3624;2625;8644,INHBA;KIT;AKR1C3;GATA3
GO:1903897,regulation of PERK-mediated unfolded protein response (GO:1903897),9,1,0.622460765,1.606526959,0.475450238,0.998950962,10551,AGR2
GO:0051788,response to misfolded protein (GO:0051788),9,1,0.622460765,1.606526959,0.475450238,0.998950962,2161,F12
GO:0070189,kynurenine metabolic process (GO:0070189),9,1,0.622460765,1.606526959,0.475450238,0.998950962,8564,KMO
GO:0006265,DNA topological change (GO:0006265),9,1,0.622460765,1.606526959,0.475450238,0.998950962,7153,TOP2A
GO:0046951,ketone body biosynthetic process (GO:0046951),9,1,0.622460765,1.606526959,0.475450238,0.998950962,3158,HMGCS2
GO:0022898,regulation of transmembrane transporter activity (GO:0022898),9,1,0.622460765,1.606526959,0.475450238,0.998950962,6622,SNCA
GO:0046717,acid secretion (GO:0046717),9,1,0.622460765,1.606526959,0.475450238,0.998950962,9368,SLC9A3R1
GO:0045686,negative regulation of glial cell differentiation (GO:0045686),9,1,0.622460765,1.606526959,0.475450238,0.998950962,23500,DAAM2
GO:0035090,maintenance of apical/basal cell polarity (GO:0035090),9,1,0.622460765,1.606526959,0.475450238,0.998950962,9368,SLC9A3R1
GO:0045199,maintenance of epithelial cell apical/basal polarity (GO:0045199),9,1,0.622460765,1.606526959,0.475450238,0.998950962,9368,SLC9A3R1
GO:0045837,negative regulation of membrane potential (GO:0045837),9,1,0.622460765,1.606526959,0.475450238,0.998950962,5366,PMAIP1
GO:0070252,actin-mediated cell contraction (GO:0070252),9,1,0.622460765,1.606526959,0.475450238,0.998950962,2934,GSN
GO:1904019,epithelial cell apoptotic process (GO:1904019),9,1,0.622460765,1.606526959,0.475450238,0.998950962,2934,GSN
GO:0098751,bone cell development (GO:0098751),9,1,0.622460765,1.606526959,0.475450238,0.998950962,3815,KIT
GO:0030953,astral microtubule organization (GO:0030953),9,1,0.622460765,1.606526959,0.475450238,0.998950962,11076,TPPP
GO:0061549,sympathetic ganglion development (GO:0061549),9,1,0.622460765,1.606526959,0.475450238,0.998950962,10371,SEMA3A
GO:0045654,positive regulation of megakaryocyte differentiation (GO:0045654),9,1,0.622460765,1.606526959,0.475450238,0.998950962,54997,TESC
GO:1904667,negative regulation of ubiquitin protein ligase activity (GO:1904667),9,1,0.622460765,1.606526959,0.475450238,0.998950962,4085,MAD2L1
GO:0001958,endochondral ossification (GO:0001958),9,1,0.622460765,1.606526959,0.475450238,0.998950962,2296,FOXC1
GO:0030388,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",9,1,0.622460765,1.606526959,0.475450238,0.998950962,230,ALDOC
GO:0048548,regulation of pinocytosis (GO:0048548),9,1,0.622460765,1.606526959,0.475450238,0.998950962,857,CAV1
GO:0042181,ketone biosynthetic process (GO:0042181),9,1,0.622460765,1.606526959,0.475450238,0.998950962,8644,AKR1C3
GO:0045017,glycerolipid biosynthetic process (GO:0045017),9,1,0.622460765,1.606526959,0.475450238,0.998950962,27132,CPNE7
GO:0003085,negative regulation of systemic arterial blood pressure (GO:0003085),9,1,0.622460765,1.606526959,0.475450238,0.998950962,154,ADRB2
GO:0002604,regulation of dendritic cell antigen processing and presentation (GO:0002604),9,1,0.622460765,1.606526959,0.475450238,0.998950962,6366,CCL21
GO:1905953,negative regulation of lipid localization (GO:1905953),9,1,0.622460765,1.606526959,0.475450238,0.998950962,3569,IL6
GO:0002701,negative regulation of production of molecular mediator of immune response (GO:0002701),9,1,0.622460765,1.606526959,0.475450238,0.998950962,1378,CR1
GO:0060907,positive regulation of macrophage cytokine production (GO:0060907),9,1,0.622460765,1.606526959,0.475450238,0.998950962,51704,GPRC5B
GO:0034393,positive regulation of smooth muscle cell apoptotic process (GO:0034393),9,1,0.622460765,1.606526959,0.475450238,0.998950962,5468,PPARG
GO:0032292,peripheral nervous system axon ensheathment (GO:0032292),9,1,0.622460765,1.606526959,0.475450238,0.998950962,163175,LGI4
GO:0014044,Schwann cell development (GO:0014044),9,1,0.622460765,1.606526959,0.475450238,0.998950962,163175,LGI4
GO:0050865,regulation of cell activation (GO:0050865),9,1,0.622460765,1.606526959,0.475450238,0.998950962,3569,IL6
GO:0090037,positive regulation of protein kinase C signaling (GO:0090037),9,1,0.622460765,1.606526959,0.475450238,0.998950962,7481,WNT11
GO:0016572,histone phosphorylation (GO:0016572),9,1,0.622460765,1.606526959,0.475450238,0.998950962,890,CCNA2
GO:0090331,negative regulation of platelet aggregation (GO:0090331),9,1,0.622460765,1.606526959,0.475450238,0.998950962,170692,ADAMTS18
GO:0034391,regulation of smooth muscle cell apoptotic process (GO:0034391),9,1,0.622460765,1.606526959,0.475450238,0.998950962,3479,IGF1
GO:0045779,negative regulation of bone resorption (GO:0045779),9,1,0.622460765,1.606526959,0.475450238,0.998950962,3569,IL6
GO:0051151,negative regulation of smooth muscle cell differentiation (GO:0051151),9,1,0.622460765,1.606526959,0.475450238,0.998950962,348093,RBPMS2
GO:0042088,T-helper 1 type immune response (GO:0042088),9,1,0.622460765,1.606526959,0.475450238,0.998950962,51176,LEF1
GO:0110150,negative regulation of biomineralization (GO:0110150),9,1,0.622460765,1.606526959,0.475450238,0.998950962,23493,HEY2
GO:0090239,regulation of histone H4 acetylation (GO:0090239),9,1,0.622460765,1.606526959,0.475450238,0.998950962,4582,MUC1
GO:0060100,"positive regulation of phagocytosis, engulfment (GO:0060100)",9,1,0.622460765,1.606526959,0.475450238,0.998950962,11031,RAB31
GO:0006703,estrogen biosynthetic process (GO:0006703),9,1,0.622460765,1.606526959,0.475450238,0.998950962,3294,HSD17B2
GO:0010561,negative regulation of glycoprotein biosynthetic process (GO:0010561),9,1,0.622460765,1.606526959,0.475450238,0.998950962,9452,ITM2A
GO:0008611,ether lipid biosynthetic process (GO:0008611),9,1,0.622460765,1.606526959,0.475450238,0.998950962,5321,PLA2G4A
GO:0006655,phosphatidylglycerol biosynthetic process (GO:0006655),9,1,0.622460765,1.606526959,0.475450238,0.998950962,57678,GPAM
GO:0042157,lipoprotein metabolic process (GO:0042157),9,1,0.622460765,1.606526959,0.475450238,0.998950962,4973,OLR1
GO:0010873,positive regulation of cholesterol esterification (GO:0010873),9,1,0.622460765,1.606526959,0.475450238,0.998950962,185,AGTR1
GO:0061365,positive regulation of triglyceride lipase activity (GO:0061365),9,1,0.622460765,1.606526959,0.475450238,0.998950962,338328,GPIHBP1
GO:0060353,regulation of cell adhesion molecule production (GO:0060353),9,1,0.622460765,1.606526959,0.475450238,0.998950962,857,CAV1
GO:1903069,regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),9,1,0.622460765,1.606526959,0.475450238,0.998950962,857,CAV1
GO:0071355,cellular response to interleukin-9 (GO:0071355),9,1,0.622460765,1.606526959,0.475450238,0.998950962,6776,STAT5A
GO:0038113,interleukin-9-mediated signaling pathway (GO:0038113),9,1,0.622460765,1.606526959,0.475450238,0.998950962,6776,STAT5A
GO:0030450,"regulation of complement activation, classical pathway (GO:0030450)",9,1,0.622460765,1.606526959,0.475450238,0.998950962,1378,CR1
GO:0071715,icosanoid transport (GO:0071715),9,1,0.622460765,1.606526959,0.475450238,0.998950962,368,ABCC6
GO:0070831,basement membrane assembly (GO:0070831),9,1,0.622460765,1.606526959,0.475450238,0.998950962,3914,LAMB3
GO:0002725,negative regulation of T cell cytokine production (GO:0002725),9,1,0.622460765,1.606526959,0.475450238,0.998950962,50943,FOXP3
GO:2000027,regulation of animal organ morphogenesis (GO:2000027),9,1,0.622460765,1.606526959,0.475450238,0.998950962,89958,SAPCD2
GO:0097250,mitochondrial respirasome assembly (GO:0097250),9,1,0.622460765,1.606526959,0.475450238,0.998950962,1346,COX7A1
GO:1901361,organic cyclic compound catabolic process (GO:1901361),9,1,0.622460765,1.606526959,0.475450238,0.998950962,3290,HSD11B1
GO:0006558,L-phenylalanine metabolic process (GO:0006558),9,1,0.622460765,1.606526959,0.475450238,0.998950962,259307,IL4I1
GO:0035999,tetrahydrofolate interconversion (GO:0035999),9,1,0.622460765,1.606526959,0.475450238,0.998950962,7298,TYMS
GO:0051122,hepoxilin biosynthetic process (GO:0051122),9,1,0.622460765,1.606526959,0.475450238,0.998950962,2946,GSTM2
GO:0051121,hepoxilin metabolic process (GO:0051121),9,1,0.622460765,1.606526959,0.475450238,0.998950962,2946,GSTM2
GO:0015697,quaternary ammonium group transport (GO:0015697),9,1,0.622460765,1.606526959,0.475450238,0.998950962,6581,SLC22A3
GO:0009914,hormone transport (GO:0009914),9,1,0.622460765,1.606526959,0.475450238,0.998950962,8140,SLC7A5
GO:0009142,nucleoside triphosphate biosynthetic process (GO:0009142),9,1,0.622460765,1.606526959,0.475450238,0.998950962,26289,AK5
GO:0006165,nucleoside diphosphate phosphorylation (GO:0006165),9,1,0.622460765,1.606526959,0.475450238,0.998950962,26289,AK5
GO:0046939,nucleotide phosphorylation (GO:0046939),9,1,0.622460765,1.606526959,0.475450238,0.998950962,26289,AK5
GO:0019852,L-ascorbic acid metabolic process (GO:0019852),9,1,0.622460765,1.606526959,0.475450238,0.998950962,9104,RGN
GO:0035115,embryonic forelimb morphogenesis (GO:0035115),9,1,0.622460765,1.606526959,0.475450238,0.998950962,130497,OSR1
GO:0043620,regulation of DNA-templated transcription in response to stress (GO:0043620),9,1,0.622460765,1.606526959,0.475450238,0.998950962,4582,MUC1
GO:0060039,pericardium development (GO:0060039),9,1,0.622460765,1.606526959,0.475450238,0.998950962,650,BMP2
GO:0003198,epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),9,1,0.622460765,1.606526959,0.475450238,0.998950962,23493,HEY2
GO:0046189,phenol-containing compound biosynthetic process (GO:0046189),9,1,0.622460765,1.606526959,0.475450238,0.998950962,4435,CITED1
GO:0098883,synapse pruning (GO:0098883),9,1,0.622460765,1.606526959,0.475450238,0.998950962,6376,CX3CL1
GO:0033262,regulation of nuclear cell cycle DNA replication (GO:0033262),9,1,0.622460765,1.606526959,0.475450238,0.998950962,8317,CDC7
GO:0035563,positive regulation of chromatin binding (GO:0035563),9,1,0.622460765,1.606526959,0.475450238,0.998950962,81620,CDT1
GO:1902287,semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),9,1,0.622460765,1.606526959,0.475450238,0.998950962,91584,PLXNA4
GO:0070383,DNA cytosine deamination (GO:0070383),9,1,0.622460765,1.606526959,0.475450238,0.998950962,9582,APOBEC3B
GO:1902369,negative regulation of RNA catabolic process (GO:1902369),9,1,0.622460765,1.606526959,0.475450238,0.998950962,5317,PKP1
GO:0009064,glutamine family amino acid metabolic process (GO:0009064),37,3,2.559005367,1.172330484,0.476458561,0.998950962,6898;1373;5831,PYCR1;TAT;CPS1
GO:0006637,acyl-CoA metabolic process (GO:0006637),37,3,2.559005367,1.172330484,0.476458561,0.998950962,3158;32;54988,ACACB;ACSM5;HMGCS2
GO:0008654,phospholipid biosynthetic process (GO:0008654),37,3,2.559005367,1.172330484,0.476458561,0.998950962,57678;10351;27132,ABCA8;GPAM;CPNE7
GO:0007215,glutamate receptor signaling pathway (GO:0007215),37,3,2.559005367,1.172330484,0.476458561,0.998950962,3745;2892;2893,GRIA4;KCNB1;GRIA3
GO:0051049,regulation of transport (GO:0051049),37,3,2.559005367,1.172330484,0.476458561,0.998950962,6622;3953;57111,LEPR;SNCA;RAB25
GO:2000249,regulation of actin cytoskeleton reorganization (GO:2000249),37,3,2.559005367,1.172330484,0.476458561,0.998950962,4916;10411;7010,RAPGEF3;NTRK3;TEK
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),37,3,2.559005367,1.172330484,0.476458561,0.998950962,11170;9314;2273,FAM107A;FHL1;KLF4
GO:0010720,positive regulation of cell development (GO:0010720),37,3,2.559005367,1.172330484,0.476458561,0.998950962,4311;6664;9370,MME;ADIPOQ;SOX11
GO:0006513,protein monoubiquitination (GO:0006513),37,3,2.559005367,1.172330484,0.476458561,0.998950962,51514;29089;29128,UBE2T;DTL;UHRF1
GO:0043486,histone exchange (GO:0043486),37,3,2.559005367,1.172330484,0.476458561,0.998950962,64105;79019;55355,HJURP;CENPM;CENPK
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),23,2,1.590733066,1.257281968,0.479065077,0.999534946,2537;219699,UNC5B;IFI6
GO:1901099,negative regulation of signal transduction in absence of ligand (GO:1901099),23,2,1.590733066,1.257281968,0.479065077,0.999534946,2537;219699,UNC5B;IFI6
GO:0034143,regulation of toll-like receptor 4 signaling pathway (GO:0034143),23,2,1.590733066,1.257281968,0.479065077,0.999534946,4057;92747,LTF;BPIFB1
GO:0032740,positive regulation of interleukin-17 production (GO:0032740),23,2,1.590733066,1.257281968,0.479065077,0.999534946,3569;8140,IL6;SLC7A5
GO:0008361,regulation of cell size (GO:0008361),23,2,1.590733066,1.257281968,0.479065077,0.999534946,9368;1906,EDN1;SLC9A3R1
GO:1903846,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),23,2,1.590733066,1.257281968,0.479065077,0.999534946,4435;1028,CDKN1C;CITED1
GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),23,2,1.590733066,1.257281968,0.479065077,0.999534946,4435;1028,CDKN1C;CITED1
GO:0071675,regulation of mononuclear cell migration (GO:0071675),23,2,1.590733066,1.257281968,0.479065077,0.999534946,5919;146433,IL34;RARRES2
GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),23,2,1.590733066,1.257281968,0.479065077,0.999534946,64102;79812,TNMD;MMRN2
GO:0090140,regulation of mitochondrial fission (GO:0090140),23,2,1.590733066,1.257281968,0.479065077,0.999534946,6790;1634,AURKA;DCN
GO:0060840,artery development (GO:0060840),23,2,1.590733066,1.257281968,0.479065077,0.999534946,5138;64220,PDE2A;STRA6
GO:0031667,response to nutrient levels (GO:0031667),23,2,1.590733066,1.257281968,0.479065077,0.999534946,11170;3745,FAM107A;KCNB1
GO:2000116,regulation of cysteine-type endopeptidase activity (GO:2000116),23,2,1.590733066,1.257281968,0.479065077,0.999534946,4804;4057,NGFR;LTF
GO:0006306,DNA methylation (GO:0006306),23,2,1.590733066,1.257281968,0.479065077,0.999534946,2353;3070,FOS;HELLS
